{"meta":{"query_hash":"7b6849c69662","filters":{"venue":"Journal of Viral Hepatitis"},"cohort_total":245,"direct_labels_cover":1,"predictions_cover":245,"exported":245,"export_cap":100000,"truncated":false,"label_status":"direct model label, unvalidated","prediction_status":"machine_predicted_unvalidated (Codex and Gemma teacher distillation)","score_status":"score_only:v0-immature-baseline","snapshot":{"source":"OpenAlex, pinned release, all 482 partitions","release":"2026-06-24","frame_built":"2026-07-12"},"permalink":"https://metacan.xera.ac/q/7b6849c69662","api":"https://metacan.xera.ac/api/v1/cohort?venue=Journal+of+Viral+Hepatitis"},"results":[{"id":"W1505220350","doi":"10.1111/jvh.12415","title":"Effect of treatment willingness on specialist assessment and treatment uptake for hepatitis C virus infection among people who use drugs: the <scp>ETHOS</scp> study","year":2015,"lang":"en","type":"article","venue":"Journal of Viral Hepatitis","topic":"Hepatitis C virus research","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"National Health and Medical Research Council; Department of Health and Ageing, Australian Government; NSW Ministry of Health; Australian Government","keywords":"Medicine; Hepatitis C virus; Logistic regression; Hepatitis C; Internal medicine; Cohort; Observational study; Family medicine; Immunology; Virus","score_opus":0.04585300704938643,"score_gpt":0.3752158171919371,"score_spread":0.32936281014255064,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1505220350","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99936086,0.00014458832,0.00002842677,0.000060078033,0.0000056236263,0.000012475037,0.00010796828,0.0000013760643,0.00027863032],"genre_scores_gemma":[0.99953055,0.0000476479,0.00004272515,0.00003403015,0.000007850459,0.000017041244,0.00009122247,0.0000019030207,0.00022713056],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9972262,0.0017507329,0.00021156542,0.000250254,0.00025117883,0.00030997224],"domain_scores_gemma":[0.99006045,0.0044117393,0.0028981105,0.0006970712,0.0005298292,0.0014028669],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005013813,0.0003447347,0.00044648215,0.00051448366,0.00057649607,0.0013649208,0.0006414197,0.0013613441,0.002228818],"category_scores_gemma":[0.012593603,0.00063671893,0.0017286916,0.0005789699,0.0004939747,0.00093450217,0.0010676155,0.001568153,0.0002884975],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011803163,0.00023542835,0.9970149,0.000024777406,0.00022949505,0.000029844763,0.00033528067,0.000025604184,0.000048966947,0.000018577217,0.00008289144,0.0007739699],"study_design_scores_gemma":[0.000055281984,0.0006246415,0.99792886,0.000024614777,0.00017805582,0.00006244938,0.0005460688,0.00036958736,0.000027624217,0.000030396757,0.00014237622,0.000010033351],"about_ca_topic_score_codex":0.013146222,"about_ca_topic_score_gemma":0.013586636,"teacher_disagreement_score":0.013146222,"about_ca_system_score_codex":0.00042988267,"about_ca_system_score_gemma":0.0006044524,"threshold_uncertainty_score":0.026515841},"labels":[],"label_agreement":null},{"id":"W1508173073","doi":"10.1111/j.1365-2893.2011.01440.x","title":"Trends in incidence of hepatocellular carcinoma after diagnosis of hepatitis B or C infection: a population‐based cohort study, 1992–2007","year":2011,"lang":"en","type":"article","venue":"Journal of Viral Hepatitis","topic":"Hepatitis B Virus Studies","field":"Medicine","cited_by":27,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Public Health Ontario; University of Toronto; Toronto Public Health","funders":"","keywords":"Medicine; Incidence (geometry); Population; Hepatocellular carcinoma; Cancer registry; Cohort; Hepatitis B virus; Hepatitis C; Internal medicine; Cohort study; Hepatitis C virus; Confidence interval; Demography; Immunology; Environmental health; Virus","score_opus":0.03273309271260132,"score_gpt":0.29226536986619106,"score_spread":0.25953227715358973,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1508173073","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9946884,0.00027933938,0.00009968239,0.000084801686,0.000010275669,0.000037318026,0.004294091,0.0000087277185,0.0004973922],"genre_scores_gemma":[0.99298143,0.0003810612,0.00018557064,0.00009370601,0.000017133836,0.000051949435,0.0056782453,0.00000593779,0.00060492667],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99943084,0.000085069034,0.000066735294,0.00016432049,0.00014842967,0.00010453446],"domain_scores_gemma":[0.99877864,0.0000690277,0.0003740249,0.00010623286,0.0004781395,0.00019399919],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009248273,0.00023314985,0.00040786384,0.0009715882,0.0004323264,0.00066744897,0.000524189,0.0005183682,0.00066385424],"category_scores_gemma":[0.0017769819,0.00051941996,0.0005598376,0.001463241,0.00020999138,0.0006979649,0.0004680931,0.0008710723,0.00033122432],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012363201,0.00005016429,0.99794453,0.000017166447,0.00011658943,0.00005607054,0.00017558118,0.000038160106,0.00017051621,0.0000133994035,0.00042784514,0.0008662798],"study_design_scores_gemma":[0.000009638144,0.000040853207,0.99932396,0.0000050290264,0.000031490552,0.00011037543,0.000106059284,0.00009057813,0.00002379404,0.000004519285,0.00025010927,0.000003688554],"about_ca_topic_score_codex":0.07424888,"about_ca_topic_score_gemma":0.075762786,"teacher_disagreement_score":0.07424888,"about_ca_system_score_codex":0.0011403136,"about_ca_system_score_gemma":0.000917067,"threshold_uncertainty_score":0.14763343},"labels":[],"label_agreement":null},{"id":"W1527146943","doi":"10.1111/j.1365-2893.2012.01632.x","title":"Genetic diversity of hepatitis B virus genotypes B6, D and F among circumpolar indigenous individuals","year":2012,"lang":"en","type":"article","venue":"Journal of Viral Hepatitis","topic":"Hepatitis B Virus Studies","field":"Medicine","cited_by":38,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Manitoba; Public Health Agency of Canada; University of British Columbia","funders":"Government of Canada","keywords":"Hepatitis B virus; Genotype; Viral quasispecies; Virology; Biology; Genetic diversity; Hepatitis B; Circumpolar star; Hepatocellular carcinoma; Indigenous; Haplogroup; Population; Genetics; Virus; Medicine; Hepatitis C virus; Gene; Ecology; Haplotype; Environmental health","score_opus":0.016669232241017126,"score_gpt":0.2530437090083711,"score_spread":0.23637447676735396,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1527146943","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9998037,0.000047908507,0.000013566492,0.0000037448517,4.46146e-7,0.0000017452386,0.000026144737,5.499079e-7,0.00010213398],"genre_scores_gemma":[0.9997346,0.000052030115,0.000034970897,0.000007654772,0.0000012237383,0.0000016862418,0.000057461733,6.36209e-7,0.00010979337],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99986947,0.000018497309,0.000009295569,0.00003438064,0.000026502768,0.000041923533],"domain_scores_gemma":[0.9997973,0.000027054944,0.00005058339,0.000011853701,0.00003762571,0.00007559102],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014385642,0.00014264836,0.00015616749,0.0006594867,0.0007240732,0.00036327323,0.0001437433,0.0001716262,0.0007132136],"category_scores_gemma":[0.00057522627,0.000093561124,0.000113197355,0.00050556427,0.00028646545,0.00013549416,0.00024760322,0.00013754074,0.00008128444],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001593348,0.000018018593,0.9878297,0.000014079005,0.000027081658,0.00028496722,0.0015666563,0.00003250527,0.006839298,0.000026792426,0.000039081024,0.0031624897],"study_design_scores_gemma":[0.0000011581237,0.000047473724,0.99852824,0.0000029883322,0.000008671204,0.00029067066,0.0008529936,0.00003919065,0.00011895201,0.0000063894245,0.00010063356,0.0000026233624],"about_ca_topic_score_codex":0.13667187,"about_ca_topic_score_gemma":0.14869879,"teacher_disagreement_score":0.13667187,"about_ca_system_score_codex":0.00043323028,"about_ca_system_score_gemma":0.00035655027,"threshold_uncertainty_score":0.27175272},"labels":[],"label_agreement":null},{"id":"W1533496726","doi":"10.1111/j.1365-2893.2012.01610.x","title":"Distinct and overlapping genomic profiles and antiviral effects of Interferon‐λ and ‐α on HCV‐infected and noninfected hepatoma cells","year":2012,"lang":"en","type":"article","venue":"Journal of Viral Hepatitis","topic":"Hepatitis C virus research","field":"Medicine","cited_by":54,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Memorial University of Newfoundland","funders":"National Institute of Allergy and Infectious Diseases; National Institutes of Health","keywords":"Interferon; Hepatitis C virus; Transcriptome; Biology; Virology; Gene; Gene expression; Gene expression profiling; In vitro; Immunology; Virus; Genetics","score_opus":0.011244186275248223,"score_gpt":0.2765785060300632,"score_spread":0.265334319754815,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1533496726","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99448144,0.00087454787,0.0013444569,0.000033016026,0.000016760343,0.000025952862,0.0015068839,0.000030867468,0.0016860004],"genre_scores_gemma":[0.9917755,0.0007237407,0.0014580586,0.00007519535,0.000011515107,0.00007096339,0.00318212,0.000015709218,0.002687168],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99983406,0.000019315035,0.000015164362,0.000042341686,0.000053583484,0.000035446457],"domain_scores_gemma":[0.999871,0.000034783337,0.000021775662,0.000019178653,0.00002718305,0.000025967973],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009711735,0.00013551225,0.00022760907,0.00035418218,0.00018275742,0.0002915621,0.00006528298,0.00013236988,0.0010255578],"category_scores_gemma":[0.00014347491,0.00009557883,0.00028923916,0.0003257745,0.00018182436,0.00012410329,0.00015736376,0.00025006323,0.00035383223],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018202295,0.000013068485,0.0009698211,0.000025429845,0.000004000186,0.000030479227,0.000035919846,0.00003221874,0.9976634,0.000035468714,0.000013269346,0.0009949661],"study_design_scores_gemma":[0.000024410048,0.00093707466,0.24737899,0.000014851911,0.000050249553,0.0006592521,0.00039066732,0.00079476775,0.7462954,0.00015272717,0.0032823295,0.000019312754],"about_ca_topic_score_codex":0.00051138515,"about_ca_topic_score_gemma":0.0006677996,"teacher_disagreement_score":0.0010255578,"about_ca_system_score_codex":0.00015064265,"about_ca_system_score_gemma":0.00018502347,"threshold_uncertainty_score":0.0034308434},"labels":[],"label_agreement":null},{"id":"W1546630735","doi":"10.1111/jvh.12429","title":"Response to treatment following recently acquired hepatitis C virus infection in a multicentre collaborative cohort","year":2015,"lang":"en","type":"article","venue":"Journal of Viral Hepatitis","topic":"Hepatitis C virus research","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Université de Montréal","funders":"National Center for Advancing Translational Sciences; National Institute of Allergy and Infectious Diseases; National Institute on Drug Abuse; Canadian Institutes of Health Research; Burnet Institute; Meso Scale Diagnostics; Schering-Plough; National Institutes of Health","keywords":"Medicine; Cohort; Virology; Hepatitis C virus; Cohort study; Virus; Internal medicine; Intensive care medicine; Immunology","score_opus":0.03352694238214234,"score_gpt":0.3559713813057324,"score_spread":0.3224444389235901,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1546630735","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9994543,0.000076429,0.000048597867,0.000037704922,0.0000049940113,0.000014096276,0.000257016,0.0000024945125,0.00010442283],"genre_scores_gemma":[0.99937963,0.000040281615,0.000059370614,0.00002648529,0.000007807369,0.000014514664,0.00036954993,0.000001962077,0.00010034785],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99835867,0.00067272043,0.00011340537,0.00036585832,0.0002706771,0.00021873512],"domain_scores_gemma":[0.9970458,0.0005304354,0.0008773454,0.0005463938,0.00031743388,0.00068252534],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0027998923,0.00042713096,0.00067711197,0.0007379034,0.0008175603,0.001019192,0.0008050051,0.0007772593,0.0009669979],"category_scores_gemma":[0.004557089,0.0006065721,0.00085917034,0.00097052514,0.0004244403,0.0006881377,0.0008350191,0.000944063,0.00022226098],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005544349,0.000058449998,0.99781126,0.000007702127,0.000099153134,0.00009763407,0.00017327876,0.000040771763,0.00024095949,0.000012739926,0.00015910494,0.0007445686],"study_design_scores_gemma":[0.000040021172,0.00018509696,0.9990778,0.00000474038,0.000039662416,0.0001860979,0.0001102296,0.00021484836,0.00003515132,0.000007890781,0.00009133118,0.0000070654964],"about_ca_topic_score_codex":0.027381487,"about_ca_topic_score_gemma":0.022184948,"teacher_disagreement_score":0.027381487,"about_ca_system_score_codex":0.00071360456,"about_ca_system_score_gemma":0.00076488033,"threshold_uncertainty_score":0.054444194},"labels":[],"label_agreement":null},{"id":"W1563158585","doi":"10.1111/j.1365-2893.2010.01330.x","title":"Hepatitis B Virus Genotype G forms core-like particles with unique structural properties","year":2010,"lang":"en","type":"article","venue":"Journal of Viral Hepatitis","topic":"Hepatitis B Virus Studies","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba; Public Health Agency of Canada","funders":"Health Canada; Public Health Agency; Public Health Agency of Canada","keywords":"Virology; Genotype; Core (optical fiber); Hepatitis B virus; Biology; Virus; Genetics; Gene; Computer science","score_opus":0.021560886267495055,"score_gpt":0.2657926835769595,"score_spread":0.24423179730946445,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1563158585","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9974565,0.00030082677,0.0015881776,0.000021568585,0.0000043773166,0.000007466453,0.000032761163,0.000020297435,0.00056805037],"genre_scores_gemma":[0.99671626,0.00012509372,0.0026896838,0.000018724277,0.0000030698848,0.0000036859033,0.00012774042,0.000011300753,0.000304418],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9999678,0.000004684517,0.000001999179,0.0000070380765,0.000009799659,0.000008676107],"domain_scores_gemma":[0.99991095,0.000010403432,0.000030854968,0.000013711095,0.000013474538,0.000020534364],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000092149996,0.00014924124,0.00014430443,0.00013569859,0.000156797,0.0002815357,0.00013751164,0.00021673946,0.00027979343],"category_scores_gemma":[0.00017773022,0.00016719296,0.00015235912,0.000107605985,0.00016332604,0.00013973571,0.00012979335,0.00018722296,0.00016512464],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010760106,0.000015070511,0.00551644,0.000040042232,0.000014664345,0.0002288929,0.000085280495,0.00045987105,0.9911958,0.00025297623,0.000038290345,0.0020450002],"study_design_scores_gemma":[0.000112215595,0.001293479,0.23977268,0.000043276916,0.00013000936,0.008265167,0.00050591474,0.016645629,0.721105,0.0018822082,0.01018806,0.000056384935],"about_ca_topic_score_codex":0.00074784475,"about_ca_topic_score_gemma":0.0011803011,"teacher_disagreement_score":0.00074784475,"about_ca_system_score_codex":0.00013114142,"about_ca_system_score_gemma":0.000101860256,"threshold_uncertainty_score":0.0014870167},"labels":[],"label_agreement":null},{"id":"W1594353271","doi":"10.1111/j.1365-2893.2010.01356.x","title":"Distinct geographical and demographic distribution of hepatitis B virus genotypes in the Canadian Arctic as revealed through an extensive molecular epidemiological survey","year":2010,"lang":"en","type":"article","venue":"Journal of Viral Hepatitis","topic":"Hepatitis B Virus Studies","field":"Medicine","cited_by":45,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Yukon Health and Social Services","funders":"","keywords":"HBsAg; Genotype; Hepatitis B virus; Virology; Population; Molecular epidemiology; Arctic; Hepatitis B; HBcAg; Circumpolar star; Biology; Medicine; Virus; Genetics; Environmental health; Gene; Ecology","score_opus":0.024431970609219027,"score_gpt":0.30472546811972767,"score_spread":0.28029349751050864,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1594353271","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9979571,0.00029501284,0.00010382644,0.000044350763,0.000002799541,0.000012100184,0.0006134128,0.000004584647,0.0009666914],"genre_scores_gemma":[0.99796885,0.00051830447,0.00029382997,0.00003371385,0.0000036159802,0.000007451454,0.00063965784,0.0000027409467,0.0005317367],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9995285,0.000034007175,0.000021252468,0.00007191778,0.00021119612,0.00013319324],"domain_scores_gemma":[0.9994116,0.000036966234,0.00009947074,0.000022736498,0.0002780666,0.00015118434],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004709606,0.0002185265,0.00021774156,0.0019582952,0.00196415,0.00063861726,0.0003723655,0.00018314729,0.00077259785],"category_scores_gemma":[0.0008848429,0.00018362184,0.00017432695,0.0025464927,0.0006017112,0.00015578541,0.00047597816,0.00016181527,0.0001168362],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013374301,0.000026842947,0.97244376,0.000058922873,0.000051832307,0.0002107308,0.0023514628,0.00021407995,0.0037230854,0.0001271903,0.0005445145,0.020113913],"study_design_scores_gemma":[0.0000013661681,0.000014336552,0.9983766,0.000007802978,0.0000062295067,0.00007192852,0.0006552007,0.00007913852,0.00008128098,0.00000788862,0.000692777,0.000005459557],"about_ca_topic_score_codex":0.97372365,"about_ca_topic_score_gemma":0.98229045,"teacher_disagreement_score":0.02627635,"about_ca_system_score_codex":0.0048363316,"about_ca_system_score_gemma":0.007777637,"threshold_uncertainty_score":0.052862108},"labels":[],"label_agreement":null},{"id":"W1597470062","doi":"10.1111/j.1365-2893.2010.01370.x","title":"Factors associated with specialist assessment and treatment for hepatitis C virus infection in New South Wales, Australia","year":2010,"lang":"en","type":"article","venue":"Journal of Viral Hepatitis","topic":"Hepatitis C virus research","field":"Medicine","cited_by":57,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Canadian Institutes of Health Research","keywords":"Medicine; Internal medicine; Hepatitis C virus; Hepatitis C; Cirrhosis; Gastroenterology; Liver biopsy; Biopsy; Virus; Immunology","score_opus":0.1057075708704663,"score_gpt":0.38981218046303684,"score_spread":0.28410460959257056,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1597470062","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99915755,0.00017335113,0.0000208888,0.00017261026,0.0000049880123,0.000015804004,0.000036966743,6.1052856e-7,0.0004172387],"genre_scores_gemma":[0.9995639,0.00010477136,0.000048828704,0.00006934983,0.0000049193723,0.000013178716,0.000036791676,4.3509198e-7,0.00015777709],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989353,0.00037608782,0.00016171293,0.00012389409,0.00026563075,0.00013737023],"domain_scores_gemma":[0.99677724,0.00049595337,0.0013535221,0.0000716371,0.00045056752,0.0008510293],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00078796997,0.000118856864,0.00027275205,0.000496838,0.00071756466,0.0005865065,0.00035483582,0.00038072802,0.0011421024],"category_scores_gemma":[0.004755146,0.00021434607,0.000224714,0.0006121895,0.00037484153,0.00033598056,0.00068644877,0.0006045812,0.00010910053],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000015725675,0.000045411452,0.9975684,0.000022211383,0.000014887392,0.00012560777,0.00062416575,0.00001422764,0.000114228416,0.000010058866,0.00013028734,0.0013146915],"study_design_scores_gemma":[0.0000013066156,0.000026342896,0.99924374,0.000008855099,0.0000027537685,0.00009898093,0.00047689435,0.0000469836,0.000005049835,0.000004637606,0.00008284785,0.0000015495681],"about_ca_topic_score_codex":0.11873451,"about_ca_topic_score_gemma":0.16702627,"teacher_disagreement_score":0.11873451,"about_ca_system_score_codex":0.0010468652,"about_ca_system_score_gemma":0.001198871,"threshold_uncertainty_score":0.23608679},"labels":[],"label_agreement":null},{"id":"W1597912542","doi":"10.1111/j.1365-2893.2011.01471.x","title":"Preactivation of the interferon signalling in liver is correlated with nonresponse to interferon alpha therapy in patients chronically infected with hepatitis B virus","year":2011,"lang":"en","type":"article","venue":"Journal of Viral Hepatitis","topic":"Hepatitis C virus research","field":"Medicine","cited_by":33,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"Chongqing Medical University; Chongqing University","keywords":"Interferon; Gene; Alpha interferon; Immune system; Biology; Immunology; Gene expression profiling; Gene expression; Hepatitis B virus; Virus; Cancer research; Medicine; Genetics","score_opus":0.027008661669630812,"score_gpt":0.2706603731699786,"score_spread":0.24365171150034778,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1597912542","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9994154,0.00030334678,0.00006273726,0.000016771239,0.0000023424552,0.0000042435404,0.000059054866,0.000003191465,0.00013290704],"genre_scores_gemma":[0.9993957,0.00010980003,0.000119573204,0.000021900543,0.000009324692,0.00001001579,0.00019314108,0.0000021078154,0.00013846178],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9997701,0.00006820531,0.0000357651,0.000051085946,0.000036210164,0.0000385653],"domain_scores_gemma":[0.99932873,0.00015446833,0.000319163,0.000043735607,0.00005955063,0.00009434088],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00024653284,0.00019091326,0.00046445892,0.00047627292,0.00023846643,0.0002890677,0.000091000555,0.00023553858,0.0009230069],"category_scores_gemma":[0.00061268074,0.00013421585,0.0002910616,0.0004769208,0.00024600475,0.00013899046,0.00018296768,0.00034465568,0.00017358534],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004319954,0.00012376232,0.88981557,0.00011899587,0.00009653292,0.0006535804,0.00024172493,0.00015747397,0.09501684,0.000033413547,0.00013214434,0.009289982],"study_design_scores_gemma":[0.000012746179,0.0004003911,0.9967894,0.000005014128,0.000031319836,0.0006228285,0.0001425213,0.00016678438,0.0016373765,0.000029221015,0.00015886637,0.000003638697],"about_ca_topic_score_codex":0.00031587956,"about_ca_topic_score_gemma":0.00045548475,"teacher_disagreement_score":0.0009230069,"about_ca_system_score_codex":0.00013863917,"about_ca_system_score_gemma":0.00010832357,"threshold_uncertainty_score":0.003087759},"labels":[],"label_agreement":null},{"id":"W1600644808","doi":"10.1111/j.1365-2893.2010.01408.x","title":"Persistent pro‐inflammatory cytokines following the initiation of pegylated IFN therapy in hepatitis C infection is associated with treatment‐induced depression","year":2010,"lang":"en","type":"article","venue":"Journal of Viral Hepatitis","topic":"Tryptophan and brain disorders","field":"Neuroscience","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"","keywords":"Depression (economics); Cytokine; Medicine; Peripheral blood mononuclear cell; Internal medicine; Tumor necrosis factor alpha; Beck Depression Inventory; In vivo; Endocrinology; Pegylated interferon; Immunology; Gastroenterology; Chronic hepatitis; Virus; Biology; In vitro; Ribavirin; Anxiety; Psychiatry","score_opus":0.024405714237924057,"score_gpt":0.26555426885557853,"score_spread":0.24114855461765447,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1600644808","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99928826,0.00029164972,0.000066415254,0.00002202532,0.000004045627,0.000010212596,0.000032297845,0.00000265772,0.00028241685],"genre_scores_gemma":[0.99956673,0.00011773055,0.000058394846,0.000025247731,0.0000073685105,0.000007136413,0.000075611584,8.083103e-7,0.00014084295],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99984145,0.000047740326,0.000016665577,0.00002204195,0.000033427208,0.00003869176],"domain_scores_gemma":[0.9993006,0.00011782039,0.0003619542,0.00003158299,0.000060528953,0.00012760214],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023261762,0.00016964063,0.0002919607,0.00024052108,0.00020846169,0.0003356772,0.0000775469,0.00024344791,0.00082854443],"category_scores_gemma":[0.00090816594,0.00015997766,0.00019033454,0.00022732538,0.00016448554,0.00011722903,0.00014976456,0.0005525571,0.0001350717],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009843044,0.00047610607,0.8440246,0.000112659276,0.0001505733,0.0029143875,0.00038751768,0.00015688382,0.11579465,0.000066175235,0.00030648097,0.025766928],"study_design_scores_gemma":[0.000023229964,0.00075172837,0.9958405,0.000008038112,0.000027918393,0.0012091824,0.0000622226,0.00017811822,0.0017316088,0.000020203881,0.00014354644,0.0000037865354],"about_ca_topic_score_codex":0.00062265346,"about_ca_topic_score_gemma":0.0011259243,"teacher_disagreement_score":0.00082854443,"about_ca_system_score_codex":0.00028353362,"about_ca_system_score_gemma":0.0001453587,"threshold_uncertainty_score":0.0027717352},"labels":[],"label_agreement":null},{"id":"W1641474530","doi":"10.1111/j.1365-2893.2010.01279.x","title":"Impact of hepatitis C virus infection on all-cause and liver-related mortality in a large community-based cohort of inner city residents","year":2010,"lang":"en","type":"article","venue":"Journal of Viral Hepatitis","topic":"Hepatitis C virus research","field":"Medicine","cited_by":56,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Simon Fraser University; AIDS Vancouver; BC Centre for Disease Control; University of Waterloo","funders":"Canadian Institutes of Health Research; Ministry of Health, British Columbia","keywords":"Cohort; Medicine; Hepatitis C virus; Virology; Virus; Hepatitis B virus; Internal medicine","score_opus":0.04537107984875106,"score_gpt":0.3817210227460529,"score_spread":0.33634994289730186,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1641474530","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9996735,0.000057225316,0.000024890765,0.00001645038,0.000002295621,0.0000049732134,0.00013042736,0.0000012640163,0.00008904907],"genre_scores_gemma":[0.99937963,0.00007237095,0.00006163683,0.000027702052,0.000008806965,0.000009385978,0.00030420214,0.000001584615,0.00013465431],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99946743,0.00017337778,0.000027491405,0.00010136847,0.00012403933,0.00010629436],"domain_scores_gemma":[0.99864167,0.00018984059,0.0003610049,0.00015329692,0.00028305838,0.00037118842],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009798916,0.000458933,0.00034169157,0.0007679947,0.00069041084,0.00094046746,0.00044679915,0.00052881526,0.00073362805],"category_scores_gemma":[0.0022955888,0.00036154836,0.0006116425,0.0007548231,0.0002872104,0.0004835482,0.0006819928,0.00072891894,0.00022986937],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010871997,0.000060240465,0.9988065,0.0000039157017,0.00005588888,0.000049051294,0.00008885464,0.000024377909,0.00016233746,0.000004525724,0.00006070761,0.0005749647],"study_design_scores_gemma":[0.000006021311,0.00007635414,0.99944705,0.0000029231203,0.000020877604,0.000085092724,0.00014557614,0.000115976676,0.000028213393,0.0000058393002,0.000062781386,0.00000320561],"about_ca_topic_score_codex":0.03572426,"about_ca_topic_score_gemma":0.040684197,"teacher_disagreement_score":0.03572426,"about_ca_system_score_codex":0.0005804271,"about_ca_system_score_gemma":0.00065229164,"threshold_uncertainty_score":0.07103264},"labels":[],"label_agreement":null},{"id":"W1665613262","doi":"10.1111/j.1365-2893.2011.01553.x","title":"Interleukin 28B polymorphisms are the only common genetic variants associated with low‐density lipoprotein cholesterol (LDL‐C) in genotype‐1 chronic hepatitis C and determine the association between LDL‐C and treatment response","year":2012,"lang":"en","type":"article","venue":"Journal of Viral Hepatitis","topic":"Hepatitis C virus research","field":"Medicine","cited_by":38,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Duke Clinical Research Institute; National Institute of Allergy and Infectious Diseases; National Health and Medical Research Council; University of New South Wales; Institute of Infection and Immunity; Gastroenterological Society of Australia; Medical Research Council; Gilead Sciences; American Association for the Study of Liver Diseases","keywords":"Interleukin 28B; Ribavirin; Genotype; Hepatitis C virus; Internal medicine; Hepatitis C; Pharmacogenetics; Medicine; Gastroenterology; Biology; Immunology; Genetics; Gene; Virus","score_opus":0.018614786632539057,"score_gpt":0.2759267810727396,"score_spread":0.25731199444020053,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1665613262","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99925786,0.00025075977,0.00020478792,0.000046409652,0.0000028845925,0.000002844555,0.00013739821,0.000004864847,0.00009224408],"genre_scores_gemma":[0.9994785,0.00004524299,0.00017725599,0.000014681358,0.000005776485,0.0000029884586,0.00017290613,0.0000021372568,0.00010051754],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9997688,0.00007344982,0.000019329345,0.00007111062,0.000038927516,0.000028337501],"domain_scores_gemma":[0.9993436,0.00023710864,0.00025568748,0.00004854292,0.00003323809,0.000081858896],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00041473616,0.00035107526,0.00040780046,0.00028133154,0.00022103882,0.00031850228,0.00024430454,0.0003917076,0.0015073027],"category_scores_gemma":[0.0012796706,0.0001939622,0.00035813675,0.00034576096,0.00030417394,0.00012643225,0.00020904127,0.0007016537,0.0003022755],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00064377044,0.00005107872,0.9900643,0.000020773146,0.00022527449,0.00011062705,0.000058435067,0.00038351264,0.0040367404,0.00004532014,0.00013093086,0.00422928],"study_design_scores_gemma":[0.000058542242,0.00019722428,0.99555343,0.0000084979065,0.00015851483,0.00052811526,0.000052328454,0.0024424144,0.00052834244,0.00020288338,0.00026332744,0.0000062696336],"about_ca_topic_score_codex":0.0025475272,"about_ca_topic_score_gemma":0.0028034602,"teacher_disagreement_score":0.0025475272,"about_ca_system_score_codex":0.00017084998,"about_ca_system_score_gemma":0.00018394498,"threshold_uncertainty_score":0.005065322},"labels":[],"label_agreement":null},{"id":"W1715978924","doi":"10.1111/j.1365-2893.2010.01293.x","title":"Stronger hepatitis C virus-specific CD8+ T-cell responses in HIV coinfection","year":2010,"lang":"en","type":"article","venue":"Journal of Viral Hepatitis","topic":"Hepatitis C virus research","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Capital District Health Authority; Memorial University of Newfoundland; Dalhousie University","funders":"Canadian Institutes of Health Research","keywords":"Coinfection; Hepatitis C virus; Virology; Human immunodeficiency virus (HIV); Hepatitis virus; Hepatitis C; Medicine; CD8; Biology; Virus; Immunology; Immune system","score_opus":0.020662202815348654,"score_gpt":0.3083317766132821,"score_spread":0.28766957379793345,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1715978924","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9990214,0.00048443186,0.000060480426,0.00001115677,0.0000048702964,0.0000074970617,0.000021357386,0.0000034300424,0.0003854116],"genre_scores_gemma":[0.9995468,0.00010011188,0.000078516685,0.000030738076,0.000008261822,0.0000065870245,0.0000369614,0.0000010605401,0.00019099882],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99985266,0.000037129594,0.0000192022,0.000038845115,0.00001940733,0.000032674106],"domain_scores_gemma":[0.9996724,0.000094123454,0.000081854836,0.000028708524,0.000033668948,0.0000891177],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00026738975,0.00024311393,0.0003190004,0.00065528404,0.00029934966,0.00029997647,0.00010286251,0.00036709086,0.0016263098],"category_scores_gemma":[0.0005996301,0.00016331264,0.00012076957,0.000262497,0.00022980319,0.00032300848,0.00037311795,0.00036190182,0.00018094544],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004716642,0.00030206205,0.7321949,0.00024315374,0.000083680774,0.0012157606,0.00074733095,0.00028401104,0.23417674,0.000106552194,0.00019018038,0.02573896],"study_design_scores_gemma":[0.000025051046,0.00090147014,0.99158233,0.000024492127,0.00004281327,0.0016890633,0.00024310627,0.00037399048,0.0044521713,0.00012823426,0.00052915583,0.000007975199],"about_ca_topic_score_codex":0.00031381325,"about_ca_topic_score_gemma":0.0004996622,"teacher_disagreement_score":0.0016263098,"about_ca_system_score_codex":0.00009670694,"about_ca_system_score_gemma":0.00010207826,"threshold_uncertainty_score":0.005440533},"labels":[],"label_agreement":null},{"id":"W1800803354","doi":"10.1111/j.1365-2893.2010.01426.x","title":"Knowledge, attitudes and behaviours associated with the provision of hepatitis C care by Canadian family physicians","year":2011,"lang":"en","type":"article","venue":"Journal of Viral Hepatitis","topic":"Hepatitis C virus research","field":"Medicine","cited_by":33,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Institut National de Santé Publique du Québec; Université du Québec à Montréal; Jewish General Hospital; College of Family Physicians of Canada; McGill University; McGill University Health Centre","funders":"College of Family Physicians of Canada; Public Health Agency of Canada","keywords":"Medicine; Family medicine; Hepatitis C; Guideline; Hepatitis C virus; Multivariate analysis; Nursing; Internal medicine; Immunology","score_opus":0.023734401468603443,"score_gpt":0.29365809719264024,"score_spread":0.2699236957240368,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1800803354","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9972154,0.00036736857,0.00003078376,0.00046328155,0.0000068322593,0.000013638618,0.00022551855,0.0000026074106,0.0016746247],"genre_scores_gemma":[0.9990539,0.00031392803,0.00007358261,0.000111079404,0.000005967656,0.000005588735,0.000109348206,6.724179e-7,0.00032594014],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99879056,0.0001834959,0.00007156545,0.00009659121,0.00060678367,0.00025100537],"domain_scores_gemma":[0.9951239,0.0011149626,0.0015466027,0.00010928462,0.0011516021,0.0009536034],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011646071,0.000178298,0.00021103672,0.00076404837,0.0016182831,0.0007687444,0.0004809471,0.0004666022,0.0021618775],"category_scores_gemma":[0.009843055,0.0002553614,0.00041499385,0.0011984748,0.00057792617,0.000397751,0.00040266177,0.0006120335,0.00014911634],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000027835089,0.000054273773,0.9908742,0.000025180503,0.000023140912,0.000054132033,0.002116931,0.000047999965,0.00006442135,0.000018298742,0.0004528801,0.0062406273],"study_design_scores_gemma":[0.0000033297533,0.000036977963,0.9975763,0.00002295817,0.000008257803,0.000063803054,0.0018025961,0.00010745639,0.000018065104,0.000008074823,0.0003463872,0.00000585289],"about_ca_topic_score_codex":0.9223712,"about_ca_topic_score_gemma":0.92272407,"teacher_disagreement_score":0.07762879,"about_ca_system_score_codex":0.0059461007,"about_ca_system_score_gemma":0.008518662,"threshold_uncertainty_score":0.15617186},"labels":[],"label_agreement":null},{"id":"W1822176756","doi":"10.1111/j.1365-2893.2010.01393.x","title":"Suicide risk in hepatitis C and during interferon-alpha therapy: a review and clinical update","year":2010,"lang":"en","type":"review","venue":"Journal of Viral Hepatitis","topic":"Hepatitis C virus research","field":"Medicine","cited_by":79,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto General Hospital; University of Toronto; University Health Network","funders":"","keywords":"Suicidal ideation; Medicine; Depression (economics); Psychiatry; Hepatitis C; Ribavirin; Population; Antidepressant; Suicide prevention; Poison control; Chronic hepatitis; Internal medicine; Immunology; Anxiety; Medical emergency; Environmental health","score_opus":0.0615420616424336,"score_gpt":0.43200108091394884,"score_spread":0.37045901927151526,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1822176756","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00013254058,0.99961156,0.00001546237,0.00006148368,0.00004981561,0.000005659804,0.000009279603,0.0000010825489,0.000113161965],"genre_scores_gemma":[0.0007772408,0.99897265,0.00007224276,0.00005464607,0.000053661075,0.000008850959,0.000012428008,2.9396745e-7,0.000048099548],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.9993772,0.00019219951,0.00019088392,0.000052437943,0.00016046346,0.000026896789],"domain_scores_gemma":[0.99808264,0.0012533386,0.00034798615,0.000019905568,0.00025114702,0.000044983666],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011398444,0.00088479306,0.0031510692,0.0043464825,0.0002711055,0.0012888623,0.00093353743,0.0014735046,0.0022863313],"category_scores_gemma":[0.003041757,0.00040414094,0.001216436,0.0050542066,0.00036751703,0.0013678226,0.0004590792,0.0007107303,0.00042311024],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00023982768,0.00009168856,0.0010113795,0.17504969,0.0008361036,0.00048247664,0.00020466729,0.00019405602,0.00035508617,0.0005463924,0.01384658,0.80714196],"study_design_scores_gemma":[0.00036681374,0.0009651908,0.02257354,0.30526593,0.0097823115,0.014374267,0.0010424597,0.00042603174,0.0006783975,0.0019023061,0.64250743,0.000115334435],"about_ca_topic_score_codex":0.002727006,"about_ca_topic_score_gemma":0.0050332877,"teacher_disagreement_score":0.0043464825,"about_ca_system_score_codex":0.0009117458,"about_ca_system_score_gemma":0.0019734146,"threshold_uncertainty_score":0.007648587},"labels":[],"label_agreement":null},{"id":"W1871529692","doi":"10.1111/jvh.12464","title":"Grazoprevir plus peginterferon and ribavirin in treatment‐naive patients with hepatitis C virus genotype 1 infection: a randomized trial","year":2015,"lang":"en","type":"article","venue":"Journal of Viral Hepatitis","topic":"Hepatitis C virus research","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"Genentech; Merck; Eisai; Gilead Sciences; GlaxoSmithKline; Bristol-Myers Squibb","keywords":"Medicine; Ribavirin; Internal medicine; Gastroenterology; Adverse effect; Hepatitis C virus; Clinical endpoint; Randomized controlled trial; Virology; Virus","score_opus":0.03152031339558758,"score_gpt":0.31713514824875794,"score_spread":0.28561483485317035,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1871529692","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98026055,0.010852352,0.0003877334,0.0011740222,0.0010968511,0.003621273,0.00063798774,0.0000678193,0.0019013429],"genre_scores_gemma":[0.9858269,0.005087083,0.0008688879,0.0013081766,0.00082529197,0.0034762844,0.00060778944,0.000010860958,0.0019888133],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9991358,0.00052892487,0.00006908333,0.0001160638,0.000048076035,0.0001020201],"domain_scores_gemma":[0.99914885,0.00026943692,0.00021714254,0.00005404806,0.000050081242,0.00026050495],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001946895,0.0013094554,0.0022733212,0.0003526589,0.0004721678,0.0011030629,0.00085163413,0.00185138,0.0067938017],"category_scores_gemma":[0.0017509401,0.0007074087,0.0016499079,0.0003675272,0.0008482327,0.00080240116,0.00040461167,0.0022254507,0.0008517924],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9868253,0.0027916706,0.00058802153,0.0005093894,0.00059348095,0.000023705741,0.000027333506,0.00018246083,0.00067291263,0.00005788711,0.00033580608,0.007392114],"study_design_scores_gemma":[0.9733665,0.024512336,0.00091337855,0.000043917596,0.0003591591,0.000021879354,0.000013387699,0.00021087806,0.00010581603,0.000060926,0.00038487287,0.00000688471],"about_ca_topic_score_codex":0.0009726602,"about_ca_topic_score_gemma":0.002077048,"teacher_disagreement_score":0.0067938017,"about_ca_system_score_codex":0.00068897964,"about_ca_system_score_gemma":0.0010751949,"threshold_uncertainty_score":0.02272749},"labels":[],"label_agreement":null},{"id":"W1899262468","doi":"10.1111/j.1365-2893.2012.01583.x","title":"Immigrant patients with chronic hepatitis C and advanced fibrosis have a higher risk of hepatocellular carcinoma","year":2012,"lang":"en","type":"article","venue":"Journal of Viral Hepatitis","topic":"Hepatitis C virus research","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Toronto; Toronto Public Health","funders":"Canadian Institutes of Health Research","keywords":"Medicine; Internal medicine; Hepatocellular carcinoma; Proportional hazards model; Hazard ratio; Diabetes mellitus; Hepatitis C; Retrospective cohort study; Cohort; Gastroenterology; Endocrinology; Confidence interval","score_opus":0.010746353106375173,"score_gpt":0.255405303560368,"score_spread":0.24465895045399283,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1899262468","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99967754,0.00007051905,0.00003682735,0.000020087251,0.0000032675005,0.0000020236814,0.000044950786,0.000001039945,0.00014389546],"genre_scores_gemma":[0.9995908,0.00006686332,0.00007507802,0.000028045562,0.000010379224,0.0000032707212,0.00012658225,8.6896716e-7,0.000098211705],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99983454,0.00005317773,0.000014659581,0.000024849636,0.000028646771,0.000044131568],"domain_scores_gemma":[0.99908185,0.00017144685,0.00041773045,0.00006679455,0.00008559562,0.00017653457],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00039504873,0.0002020198,0.00021761164,0.00034972318,0.0004174638,0.00039766074,0.00015223307,0.0003496877,0.0022658533],"category_scores_gemma":[0.0015904565,0.0001959598,0.00033835293,0.0004883296,0.00019468817,0.0003321597,0.00034844974,0.00042339126,0.00022206863],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009185145,0.000019867774,0.9987446,0.00000407014,0.000022511013,0.00010876954,0.000052818992,0.00002021416,0.00011948891,0.000015239254,0.00004130809,0.0007591387],"study_design_scores_gemma":[0.0000097274415,0.000100297024,0.99857736,0.0000062456675,0.00001798592,0.00063123874,0.00025989008,0.00017872667,0.000028288214,0.00003444109,0.00015200584,0.0000038148432],"about_ca_topic_score_codex":0.0039872453,"about_ca_topic_score_gemma":0.0051933895,"teacher_disagreement_score":0.0039872453,"about_ca_system_score_codex":0.00014850138,"about_ca_system_score_gemma":0.00024832075,"threshold_uncertainty_score":0.007928073},"labels":[],"label_agreement":null},{"id":"W1918498751","doi":"10.1111/j.1365-2893.2012.01634.x","title":"Hepatitis C therapy in non‐genotype 1 patients: the near future","year":2012,"lang":"en","type":"review","venue":"Journal of Viral Hepatitis","topic":"Hepatitis C virus research","field":"Medicine","cited_by":26,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital Saint-Luc","funders":"","keywords":"NS5A; Ribavirin; Daclatasvir; Sofosbuvir; Virology; Boceprevir; Simeprevir; NS3; Telaprevir; Medicine; Hepatitis C virus; Hepatitis C; Virus; Hepacivirus","score_opus":0.04470723838587006,"score_gpt":0.359725048334704,"score_spread":0.31501780994883394,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1918498751","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00012683225,0.99866736,0.000046842397,0.00034801586,0.00011962744,0.000002454408,0.0000062886556,0.0000048389634,0.0006776668],"genre_scores_gemma":[0.00065546774,0.9982008,0.00012150666,0.00028880063,0.00022714227,0.000003831595,0.000013183909,0.0000010246797,0.00048823515],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9998399,0.000040338506,0.000021445981,0.000022672953,0.00005962583,0.00001595713],"domain_scores_gemma":[0.9997236,0.000099649755,0.000055230194,0.000008882668,0.00007837929,0.00003429922],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006082562,0.00066094776,0.0011051897,0.0010834169,0.00022456513,0.0006685268,0.0005798308,0.0010433403,0.0038064558],"category_scores_gemma":[0.0005057404,0.00016940074,0.000351242,0.0012772676,0.00032763614,0.0012564899,0.00042101103,0.0012291799,0.0025774522],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000077592544,0.000073852025,0.00019150095,0.007909992,0.000033383025,0.00018566397,0.000038233185,0.000118591386,0.0009740294,0.0012768563,0.023085717,0.96603453],"study_design_scores_gemma":[0.000047802874,0.00023010901,0.002048702,0.004829697,0.00010829569,0.0028278031,0.0000987277,0.00010726146,0.00036056226,0.0016223019,0.98770195,0.000016842112],"about_ca_topic_score_codex":0.00071129744,"about_ca_topic_score_gemma":0.0019296098,"teacher_disagreement_score":0.0038064558,"about_ca_system_score_codex":0.00041626548,"about_ca_system_score_gemma":0.0009280514,"threshold_uncertainty_score":0.012733817},"labels":[],"label_agreement":null},{"id":"W1924815855","doi":"10.1111/j.1365-2893.2010.01375.x","title":"The optimal cut‐off for predicting large oesophageal varices using transient elastography is disease specific","year":2010,"lang":"en","type":"article","venue":"Journal of Viral Hepatitis","topic":"Liver Disease Diagnosis and Treatment","field":"Medicine","cited_by":57,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Transient elastography; Varices; Medicine; Cirrhosis; Elastography; Gastroenterology; Internal medicine; Endoscopy; Liver disease; Receiver operating characteristic; Esophageal varices; Alcoholic liver disease; Portal hypertension; Radiology; Ultrasound","score_opus":0.01329517016859205,"score_gpt":0.27336104075417034,"score_spread":0.2600658705855783,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1924815855","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9933867,0.0028808783,0.0021058682,0.0004118201,0.00004108668,0.000026619093,0.00009599297,0.000018345963,0.0010326493],"genre_scores_gemma":[0.9973533,0.00023370072,0.0020179942,0.00010178285,0.000051303017,0.00001956823,0.00014986271,0.000003486563,0.00006888752],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9977914,0.0010837483,0.0003614007,0.00022827256,0.00032008617,0.00021509109],"domain_scores_gemma":[0.99036765,0.007060191,0.0013734617,0.00023070717,0.00049683126,0.00047129096],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0032735148,0.00046812365,0.0010870006,0.0012566916,0.00027962305,0.0008002255,0.00026757157,0.0011530817,0.0009513634],"category_scores_gemma":[0.011953639,0.00026751572,0.000369348,0.00052077183,0.00041702844,0.0005729164,0.00037988383,0.00054422935,0.0003112428],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010084391,0.00011759522,0.9738163,0.000061451436,0.00008579198,0.0003480784,0.0000656353,0.0003359997,0.00286549,0.000083389,0.0003439592,0.02086794],"study_design_scores_gemma":[0.00013605859,0.0010553041,0.9871137,0.00009288827,0.00015881336,0.0027702323,0.00028381532,0.004228275,0.0026713011,0.0007240017,0.0007366153,0.000028933095],"about_ca_topic_score_codex":0.00034432363,"about_ca_topic_score_gemma":0.0005673952,"teacher_disagreement_score":0.0032735148,"about_ca_system_score_codex":0.00023805595,"about_ca_system_score_gemma":0.0004208812,"threshold_uncertainty_score":0.017312229},"labels":[],"label_agreement":null},{"id":"W1937881082","doi":"10.1111/j.1365-2893.2010.01333.x","title":"Factors associated with vaccine failure and vertical transmission of hepatitis B among a cohort of Canadian mothers and infants","year":2010,"lang":"en","type":"article","venue":"Journal of Viral Hepatitis","topic":"Hepatitis B Virus Studies","field":"Medicine","cited_by":106,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Provincial Laboratory of Public Health; Public Health Agency of Canada; University of Alberta","funders":"","keywords":"Medicine; Interquartile range; Viral load; HBsAg; HBeAg; Genotyping; Hepatitis B virus; Transmission (telecommunications); Hepatitis B; Gestational age; Cohort; Pediatrics; Genotype; Asymptomatic; Obstetrics; Immunology; Pregnancy; Internal medicine; Virus; Biology","score_opus":0.0109901932013065,"score_gpt":0.23702482210928366,"score_spread":0.22603462890797715,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1937881082","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99892104,0.00025224985,0.000018864022,0.0000762906,0.0000040395685,0.0000065730014,0.00024513094,0.000003323781,0.00047253544],"genre_scores_gemma":[0.9991799,0.0002392429,0.000055083205,0.00002688689,0.0000033117278,0.0000043136597,0.0002529011,0.0000018935203,0.00023638779],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99953926,0.000031331332,0.000021221364,0.00008752841,0.00015409474,0.00016668686],"domain_scores_gemma":[0.99910706,0.000069905516,0.0003048268,0.000041682983,0.00023087299,0.00024576936],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00038190544,0.00043888486,0.00033890543,0.0008932924,0.0018531176,0.0007929077,0.0008559749,0.0004511459,0.0010829463],"category_scores_gemma":[0.0017287781,0.00048297102,0.00030373433,0.0016111049,0.00055457396,0.0002415009,0.00044685687,0.0004968636,0.0001249983],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000428533,0.0000127977755,0.9980812,0.000005114301,0.00001377359,0.00011554425,0.00030975937,0.000018986428,0.00016504184,0.000021003358,0.00018955248,0.0010244964],"study_design_scores_gemma":[0.0000033521287,0.000023705396,0.998845,0.000009324834,0.000014124002,0.00016236045,0.0005479584,0.00013397505,0.00003362982,0.000008825772,0.00021414888,0.000003688615],"about_ca_topic_score_codex":0.9609469,"about_ca_topic_score_gemma":0.9511301,"teacher_disagreement_score":0.039053082,"about_ca_system_score_codex":0.0072826007,"about_ca_system_score_gemma":0.006983026,"threshold_uncertainty_score":0.078566074},"labels":[],"label_agreement":null},{"id":"W1952890674","doi":"10.1111/j.1365-2893.2009.01263.x","title":"Enhanced Liver Fibrosis (ELF) test accurately identifies liver fibrosis in patients with chronic hepatitis C","year":2010,"lang":"en","type":"article","venue":"Journal of Viral Hepatitis","topic":"Liver Disease Diagnosis and Treatment","field":"Medicine","cited_by":179,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Liver fibrosis; Chronic hepatitis; Fibrosis; Medicine; Internal medicine; Test (biology); Gastroenterology; Pathology; Virology; Biology; Virus","score_opus":0.009182802171521487,"score_gpt":0.24509422902230565,"score_spread":0.23591142685078417,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1952890674","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9853137,0.0044013555,0.0071686027,0.00019740249,0.00002723953,0.000100591285,0.0006513621,0.00009390207,0.0020458503],"genre_scores_gemma":[0.9971879,0.00028766497,0.0019063414,0.000043141492,0.000020511397,0.0000139554995,0.0003440435,0.0000039230554,0.00019249987],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9978818,0.00097109005,0.0001534938,0.0002964978,0.0005559609,0.00014103907],"domain_scores_gemma":[0.994504,0.002954058,0.0012920903,0.0005124246,0.0005931014,0.00014430862],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0038802645,0.00048504554,0.00089973054,0.0010420022,0.00019112126,0.00060408295,0.00024980112,0.00057180953,0.00091283506],"category_scores_gemma":[0.010121345,0.00019421834,0.0007301519,0.00063559576,0.00040736838,0.0005155924,0.00062775647,0.00048954366,0.0002238763],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014975978,0.00007689885,0.95267457,0.00013495666,0.00036938352,0.00011470665,0.00007108956,0.0028089455,0.0016313073,0.00010531486,0.0003868622,0.04012842],"study_design_scores_gemma":[0.000047253132,0.00065050996,0.9829503,0.000052637617,0.00027299067,0.00087369385,0.00004323543,0.012751055,0.0010506482,0.00030302617,0.0009862807,0.000018454613],"about_ca_topic_score_codex":0.0014907711,"about_ca_topic_score_gemma":0.002219754,"teacher_disagreement_score":0.0038802645,"about_ca_system_score_codex":0.00035554284,"about_ca_system_score_gemma":0.00028210587,"threshold_uncertainty_score":0.020521045},"labels":[],"label_agreement":null},{"id":"W1959794404","doi":"10.1111/j.1365-2893.2011.01442.x","title":"Hepatitis C virus persistence after sustained virological response to antiviral therapy in patients with or without past exposure to hepatitis B virus","year":2011,"lang":"en","type":"article","venue":"Journal of Viral Hepatitis","topic":"Hepatitis C virus research","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; Memorial University of Newfoundland","funders":"Canadian Institutes of Health Research","keywords":"Virology; Persistence (discontinuity); Medicine; Antiviral therapy; Virus; Hepatitis C virus; Hepatitis B virus; Hepatitis a virus; Immunology; Chronic hepatitis","score_opus":0.03249988046259781,"score_gpt":0.29087298839275205,"score_spread":0.2583731079301542,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1959794404","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9995782,0.00021690711,0.000031832013,0.000018540606,0.0000029592009,0.0000030575181,0.00002090848,0.0000018196802,0.00012570622],"genre_scores_gemma":[0.99980146,0.000046402805,0.00002778329,0.00001632716,0.000011088188,0.0000022653762,0.000050460978,6.463068e-7,0.00004366076],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99960464,0.00011349212,0.000052399977,0.00007590497,0.00006469701,0.000088798195],"domain_scores_gemma":[0.99832267,0.00038098497,0.0007627086,0.0000736888,0.00012246595,0.00033750822],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005291407,0.0002322535,0.00044398342,0.0006907748,0.00054137246,0.0005701225,0.00021208728,0.00053643127,0.0008321115],"category_scores_gemma":[0.0027058881,0.00020149462,0.00023542925,0.0005554773,0.00031056075,0.0004901374,0.00034487408,0.0004133427,0.00016130893],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004641378,0.000038413164,0.9952631,0.000013646464,0.00002051359,0.00041458514,0.00013099238,0.00001826797,0.0007110585,0.000010222767,0.00003474165,0.0028803393],"study_design_scores_gemma":[0.00002061308,0.0006635221,0.995365,0.000008986983,0.000030190988,0.0030791739,0.00022888511,0.00021310871,0.00018785984,0.000024305386,0.00017172546,0.0000066647394],"about_ca_topic_score_codex":0.0010278817,"about_ca_topic_score_gemma":0.0013476966,"teacher_disagreement_score":0.0010278817,"about_ca_system_score_codex":0.00026315826,"about_ca_system_score_gemma":0.00018204121,"threshold_uncertainty_score":0.0027983785},"labels":[],"label_agreement":null},{"id":"W1960860169","doi":"10.1111/j.1365-2893.2010.01357.x","title":"Human dendritic cells expressing hepatitis C virus core protein display transcriptional and functional changes consistent with maturation","year":2010,"lang":"en","type":"article","venue":"Journal of Viral Hepatitis","topic":"Hepatitis C virus research","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Saskatchewan; University of Alberta; BC Centre for Disease Control; University of British Columbia","funders":"Canadian Institutes of Health Research; Saskatchewan Health Research Foundation","keywords":"Core protein; Virology; Biology; Hepatitis C virus; Virus; Cell biology; Computational biology","score_opus":0.033146576781207304,"score_gpt":0.29263226770535683,"score_spread":0.2594856909241495,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1960860169","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99185294,0.0011857119,0.0028993345,0.00005781322,0.000030179921,0.000047535817,0.0019093282,0.000053481035,0.0019637684],"genre_scores_gemma":[0.9884262,0.00097475055,0.0036345678,0.00013117114,0.000021188107,0.00009716719,0.0039608236,0.000026784226,0.0027272596],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998381,0.000010462977,0.000012082744,0.000043176067,0.000051471954,0.000044748704],"domain_scores_gemma":[0.9998312,0.000034534853,0.000029851759,0.000020750722,0.00004954089,0.000034112625],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009852803,0.00018524606,0.00028308659,0.00025727344,0.0001445081,0.0003145762,0.00006150767,0.00018060603,0.0010363207],"category_scores_gemma":[0.00017434408,0.000120292374,0.00019697417,0.00038526265,0.00014757931,0.00009457781,0.00012607867,0.00040053795,0.00058051734],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011326735,0.0000117794625,0.0006449479,0.000019970923,0.0000028034444,0.000027039347,0.000018329409,0.000017963146,0.9982988,0.00002439421,0.00002068934,0.00080002245],"study_design_scores_gemma":[0.00002495389,0.00033959092,0.041689087,0.00001037725,0.000034650697,0.0004614267,0.00010273528,0.00066834514,0.9527794,0.00013594686,0.0037416506,0.00001176611],"about_ca_topic_score_codex":0.00022774757,"about_ca_topic_score_gemma":0.00023933518,"teacher_disagreement_score":0.0010363207,"about_ca_system_score_codex":0.00018376652,"about_ca_system_score_gemma":0.0001625827,"threshold_uncertainty_score":0.0034668446},"labels":[],"label_agreement":null},{"id":"W1969093502","doi":"10.1111/jvh.12308","title":"Hepatitis B virus (<scp>HBV</scp>) variants fluctuate in paired plasma and peripheral blood mononuclear cells among patient cohorts during different chronic hepatitis B (<scp>CHB</scp>) disease phases","year":2014,"lang":"en","type":"article","venue":"Journal of Viral Hepatitis","topic":"Hepatitis B Virus Studies","field":"Medicine","cited_by":34,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Science Centre for Human and Animal Health; University of Calgary","funders":"","keywords":"Peripheral blood mononuclear cell; Virology; Hepatitis B virus; Immune system; Biology; Virus; Hepatitis B; Immunology; Hepatitis C virus; HBeAg; HBsAg; Genetics; In vitro","score_opus":0.007012449109743854,"score_gpt":0.2145890430288494,"score_spread":0.20757659391910555,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1969093502","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99975914,0.0000584379,0.000045598026,0.0000033706967,8.51257e-7,0.0000022706813,0.000051155344,0.000002316836,0.000076924254],"genre_scores_gemma":[0.9996568,0.000022382426,0.000055320645,0.000010254059,0.0000044008175,0.0000059957833,0.00017811189,0.0000016457,0.00006503252],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99970406,0.00006421406,0.000032291995,0.000118476186,0.00004172452,0.000039194092],"domain_scores_gemma":[0.9994624,0.00020066992,0.00014506173,0.000044330824,0.000052681822,0.00009486003],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00025145206,0.00016641,0.00029642362,0.00042631087,0.00027303697,0.00053078064,0.0000935721,0.00030575268,0.00073691324],"category_scores_gemma":[0.0012887187,0.00015590651,0.000107621076,0.00035026757,0.00021538927,0.00023697302,0.00020616403,0.00022079596,0.0002134121],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012365254,0.00004527702,0.96715707,0.000019842868,0.00005307498,0.00046800732,0.00038870182,0.000096444164,0.024016567,0.000025584908,0.00010626882,0.006386716],"study_design_scores_gemma":[0.000018682138,0.00039113426,0.9940182,0.0000038981225,0.00002669323,0.002583645,0.00020331334,0.00024005197,0.0022027947,0.000033105902,0.00027318933,0.000005213694],"about_ca_topic_score_codex":0.00030600815,"about_ca_topic_score_gemma":0.00032766772,"teacher_disagreement_score":0.00073691324,"about_ca_system_score_codex":0.00010868538,"about_ca_system_score_gemma":0.00005451447,"threshold_uncertainty_score":0.002465248},"labels":[],"label_agreement":null},{"id":"W1969504669","doi":"10.1046/j.1365-2893.2000.00249.x","title":"Serum cytokine values and fatigue in chronic hepatitis C infection","year":2000,"lang":"en","type":"article","venue":"Journal of Viral Hepatitis","topic":"Fibromyalgia and Chronic Fatigue Syndrome Research","field":"Medicine","cited_by":50,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University Health Network","funders":"","keywords":"Medicine; Hepatology; Internal medicine; Cytokine; Alanine transaminase; Gastroenterology; Hepatitis C; Hepatitis; Immunology","score_opus":0.017365794220710395,"score_gpt":0.3042415332430818,"score_spread":0.2868757390223714,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1969504669","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9965744,0.0026978885,0.0001340509,0.000056688183,0.000009725768,0.000011523187,0.000053822347,0.000003282702,0.00045874904],"genre_scores_gemma":[0.9992539,0.000390172,0.00015176933,0.00002356601,0.00001921211,0.00000955022,0.00005797716,7.4414544e-7,0.00009301197],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9996464,0.00015318548,0.000060841,0.00003292851,0.000069375994,0.000037247475],"domain_scores_gemma":[0.9985171,0.0005307217,0.00064453547,0.000034648663,0.00012363207,0.00014927857],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00067104277,0.00024439074,0.00030404492,0.00060970057,0.0002860247,0.00028861582,0.0000908529,0.0003344265,0.0008454182],"category_scores_gemma":[0.0024279994,0.00016357025,0.00014989727,0.00061353884,0.00022793484,0.00026550126,0.0002976413,0.00029512166,0.0001286954],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00088897365,0.00007399722,0.99028206,0.00006916948,0.000024538745,0.00021811949,0.00015793707,0.00006918439,0.0016676524,0.000015873533,0.000081571634,0.006450909],"study_design_scores_gemma":[0.000017395298,0.0005033991,0.99787366,0.00001959609,0.000018836823,0.0008011627,0.00011982889,0.00021081891,0.0001759049,0.00004001775,0.00021572945,0.0000036965093],"about_ca_topic_score_codex":0.00051281287,"about_ca_topic_score_gemma":0.0006726573,"teacher_disagreement_score":0.0008454182,"about_ca_system_score_codex":0.00014602748,"about_ca_system_score_gemma":0.00012591346,"threshold_uncertainty_score":0.0035488605},"labels":[],"label_agreement":null},{"id":"W1975218884","doi":"10.1111/j.1365-2893.2008.01062.x","title":"An independent and prospective comparison of two commercial fibrosis marker panels (HCV FibroSURE and FIBRO<i>Spect</i> II) during albinterferon alfa‐2b combination therapy for chronic hepatitis C","year":2009,"lang":"en","type":"article","venue":"Journal of Viral Hepatitis","topic":"Hepatitis C virus research","field":"Medicine","cited_by":43,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba; University of British Columbia","funders":"","keywords":"Medicine; Gastroenterology; Ribavirin; Liver biopsy; Internal medicine; Fibrosis; Hepatitis C; Stage (stratigraphy); Biopsy; Surrogate endpoint; Liver disease; Chronic hepatitis; Immunology; Biology","score_opus":0.020590479425951973,"score_gpt":0.3473560578726174,"score_spread":0.32676557844666543,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1975218884","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99951947,0.00013732424,0.00010678751,0.0000062803515,0.0000053129925,0.00002114313,0.00006241258,0.000003345013,0.00013780598],"genre_scores_gemma":[0.9994615,0.00002791996,0.0001647965,0.000019957602,0.000011053404,0.000026510605,0.00020373342,0.0000013683011,0.000083195555],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99881625,0.0005749708,0.00007522459,0.00024991354,0.0001884864,0.000095121366],"domain_scores_gemma":[0.9969181,0.0012466437,0.0009193682,0.00026785317,0.00029399767,0.0003540237],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0020772882,0.0005506775,0.0003929186,0.00024467075,0.00024898647,0.0005218929,0.00021034287,0.00056300015,0.00078104],"category_scores_gemma":[0.0034582992,0.00029120067,0.0003508924,0.00019711659,0.0003123614,0.0003417346,0.00024364807,0.0005266068,0.00028581207],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.079569325,0.0022287124,0.8813264,0.00009498233,0.0007445184,0.000083406165,0.00032084063,0.0004447033,0.011297388,0.000052385538,0.0003150949,0.023522219],"study_design_scores_gemma":[0.0035387021,0.03458144,0.95462,0.000014311385,0.00046367344,0.00041680952,0.00007749112,0.0019359252,0.003773777,0.000036077156,0.00051912543,0.00002263972],"about_ca_topic_score_codex":0.00034614603,"about_ca_topic_score_gemma":0.00049650617,"teacher_disagreement_score":0.0020772882,"about_ca_system_score_codex":0.00026657266,"about_ca_system_score_gemma":0.00016965986,"threshold_uncertainty_score":0.010985851},"labels":[],"label_agreement":null},{"id":"W1975750281","doi":"10.1111/j.1365-2893.2004.00523.x","title":"Kinetics of hepatitis B viral load during 48 weeks of treatment with 600 mg <i>vs</i> 100 mg of lamivudine daily*","year":2004,"lang":"en","type":"article","venue":"Journal of Viral Hepatitis","topic":"Hepatitis B Virus Studies","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"British Columbia Centre for Disease Control; GlaxoSmithKline","keywords":"Lamivudine; Viral load; Virology; Medicine; Chronic hepatitis; Population; Viral replication; In vivo; Hepatitis B; Immunology; Gastroenterology; Kinetics; Virus; Internal medicine; Biology","score_opus":0.012440042785060104,"score_gpt":0.2575285913966709,"score_spread":0.24508854861161078,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1975750281","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.998572,0.00040811725,0.00042119378,0.00003434929,0.000008638716,0.000022249362,0.00014211203,0.000023349106,0.00036795464],"genre_scores_gemma":[0.99894625,0.00007141256,0.00027571738,0.0000178002,0.000005123178,0.00002423622,0.00022326487,0.0000054241536,0.00043087662],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9996898,0.00014164741,0.000023804861,0.000041658204,0.000051502913,0.000051639738],"domain_scores_gemma":[0.99923456,0.00034513505,0.000180153,0.00006822418,0.00008313432,0.000088883746],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00078698737,0.00019443568,0.0005693492,0.00015969966,0.00011821643,0.00031252077,0.00015284147,0.00040340825,0.0013249348],"category_scores_gemma":[0.0018528309,0.00012947654,0.00035229351,0.000120421144,0.00015330475,0.00029095312,0.000107427084,0.00038679852,0.0003165193],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.16298068,0.0042653996,0.12497237,0.00033984327,0.0006134035,0.0004248527,0.00062744954,0.01616785,0.5183055,0.00052162027,0.0012096668,0.16957134],"study_design_scores_gemma":[0.0050361194,0.1690033,0.46193328,0.00007812073,0.0009251268,0.00205169,0.0004411923,0.08976256,0.26202473,0.0012440864,0.007288757,0.0002109998],"about_ca_topic_score_codex":0.0006957879,"about_ca_topic_score_gemma":0.00047438286,"teacher_disagreement_score":0.0013249348,"about_ca_system_score_codex":0.00037095818,"about_ca_system_score_gemma":0.00012145048,"threshold_uncertainty_score":0.0044323206},"labels":[],"label_agreement":null},{"id":"W1984604958","doi":"10.1111/j.1365-2893.2009.01230.x","title":"Health care risk factors among women and personal behaviours among men explain the high prevalence of hepatitis C virus infection in Karachi, Pakistan","year":2009,"lang":"en","type":"article","venue":"Journal of Viral Hepatitis","topic":"Hepatitis C virus research","field":"Medicine","cited_by":61,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Centre for Disease Control","funders":"","keywords":"Medicine; Hepatitis C virus; Transmission (telecommunications); Population; Odds ratio; Hepatitis C; Demography; Cross-sectional study; Sexual transmission; Environmental health; Immunology; Human immunodeficiency virus (HIV); Internal medicine; Virus","score_opus":0.012041178231496422,"score_gpt":0.3124106742223875,"score_spread":0.3003694959908911,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1984604958","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9969977,0.0007045053,0.00018387797,0.00030497735,0.000011764649,0.00002622037,0.00044033577,0.0000064288633,0.0013242908],"genre_scores_gemma":[0.99906987,0.00027573152,0.00019785411,0.00007669167,0.000011151504,0.000013098244,0.00013090034,8.037517e-7,0.00022393843],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99970067,0.00008528283,0.000022146256,0.000049165064,0.000060778882,0.00008196089],"domain_scores_gemma":[0.9995745,0.00008471473,0.00019229154,0.000019082305,0.00005257936,0.0000768684],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00031042486,0.00029055448,0.00022021652,0.00045036344,0.0005643167,0.000640875,0.0002888693,0.000364458,0.0025325455],"category_scores_gemma":[0.0014210443,0.00027028867,0.00027187506,0.0008494759,0.00039789415,0.00043379582,0.0004017866,0.00039086555,0.00037271142],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00001139192,0.000020723874,0.997581,0.0000117462,0.000009952521,0.00006498369,0.00018624382,0.000018625633,0.00004768753,0.000016212753,0.00016520174,0.0018662778],"study_design_scores_gemma":[0.0000030666865,0.000035185643,0.9986706,0.00001874693,0.000010200057,0.00022486826,0.00061060686,0.00013188786,0.000020405803,0.000043345215,0.00022845017,0.000002682163],"about_ca_topic_score_codex":0.024792735,"about_ca_topic_score_gemma":0.02174532,"teacher_disagreement_score":0.024792735,"about_ca_system_score_codex":0.0003298746,"about_ca_system_score_gemma":0.0005941672,"threshold_uncertainty_score":0.049296856},"labels":[],"label_agreement":null},{"id":"W1990099284","doi":"10.1111/jvh.12165_3","title":"O115: Assessing the role of intra‐familial transmission in the ongoing propagation of the Egyptian hepatitis C virus epidemic","year":2013,"lang":"en","type":"article","venue":"Journal of Viral Hepatitis","topic":"Hepatitis C virus research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Medicine; Transmission (telecommunications); Demography; Environmental health; Residence; Respondent; Logistic regression; Odds; Odds ratio; Proxy (statistics); Internal medicine","score_opus":0.01730694888308674,"score_gpt":0.3135686466270036,"score_spread":0.29626169774391686,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1990099284","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99805766,0.0003396131,0.00032137963,0.0001495083,0.000008585805,0.00001551862,0.00029221288,0.000004855386,0.0008106818],"genre_scores_gemma":[0.99924743,0.00009972975,0.00026888592,0.000029548257,0.000012123019,0.000008804455,0.00019750804,0.0000020079997,0.00013395783],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9965655,0.0021743625,0.00024612734,0.00030208568,0.00036935936,0.00034259466],"domain_scores_gemma":[0.9867866,0.0053363084,0.005411722,0.00090591173,0.0005268907,0.0010325231],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0072148344,0.00055737223,0.0002685156,0.0012096692,0.00056657783,0.0011676518,0.00076604524,0.00076753844,0.0020014837],"category_scores_gemma":[0.023321016,0.00025062342,0.0006252942,0.0014316528,0.00046403098,0.0010775329,0.0014584971,0.0006606017,0.00019290338],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011581727,0.000031566502,0.9967084,0.000014131812,0.00006732658,0.000028136083,0.000120370394,0.00007556193,0.000024327723,0.000040835635,0.00007532156,0.002698187],"study_design_scores_gemma":[0.0000071495297,0.0003198264,0.9970329,0.000030787465,0.000097053264,0.00013097488,0.0005155331,0.0014045652,0.000045250676,0.000093158786,0.00031721857,0.0000057268935],"about_ca_topic_score_codex":0.01762132,"about_ca_topic_score_gemma":0.013310311,"teacher_disagreement_score":0.01762132,"about_ca_system_score_codex":0.00054082624,"about_ca_system_score_gemma":0.00074428105,"threshold_uncertainty_score":0.038156092},"labels":[],"label_agreement":null},{"id":"W1992745758","doi":"10.1111/j.1365-2893.2005.00684.x","title":"Cleavage of intracellular hepatitis C RNA in the virus core protein coding region by deoxyribozymes","year":2005,"lang":"en","type":"article","venue":"Journal of Viral Hepatitis","topic":"Hepatitis C virus research","field":"Medicine","cited_by":31,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Centre Hospitalier Universitaire Sainte-Justine","funders":"","keywords":"Deoxyribozyme; RNA; Hepatitis C virus; DNA; Virology; Cleave; In vitro; Biology; Ribozyme; Virus; Computational biology; Gene; Biochemistry","score_opus":0.033677375639859015,"score_gpt":0.31089932455563607,"score_spread":0.27722194891577706,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1992745758","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98530084,0.0023014166,0.010477578,0.000039776045,0.00003239897,0.00003849275,0.00011778253,0.000028269045,0.0016634229],"genre_scores_gemma":[0.9893777,0.0010154377,0.0076597924,0.000040785402,0.00001001111,0.000023084402,0.0003796703,0.00001233255,0.0014810823],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99981767,0.000059794762,0.000018475337,0.000032171018,0.00004059145,0.000031219337],"domain_scores_gemma":[0.9998217,0.0000875868,0.00003069157,0.00002455089,0.000019827878,0.00001563216],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00033482208,0.00025797516,0.00024868778,0.00014764407,0.00008166241,0.00024546706,0.00012617728,0.00022241041,0.0005989139],"category_scores_gemma":[0.0003303426,0.00010604158,0.000221344,0.00009206182,0.00017388402,0.000108057386,0.00015239777,0.00025757088,0.0002489245],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000043227923,0.000008264147,0.0000783357,0.000019087911,0.0000018468211,0.00002304601,0.0000079350575,0.00007838218,0.99875414,0.00006706174,0.0000075646826,0.000911009],"study_design_scores_gemma":[0.000006205641,0.00019007425,0.00032420378,0.0000027826277,0.0000037406587,0.00006670815,0.0000047633603,0.0003225886,0.9985624,0.000023256876,0.0004922366,0.0000010812889],"about_ca_topic_score_codex":0.00021261229,"about_ca_topic_score_gemma":0.0003041226,"teacher_disagreement_score":0.0005989139,"about_ca_system_score_codex":0.00016441481,"about_ca_system_score_gemma":0.0001189909,"threshold_uncertainty_score":0.0020035505},"labels":[],"label_agreement":null},{"id":"W1993607717","doi":"10.1111/j.1365-2893.2006.00816.x","title":"Therapeutic issues in HIV/HCV‐coinfected patients","year":2006,"lang":"en","type":"review","venue":"Journal of Viral Hepatitis","topic":"Hepatitis C virus research","field":"Medicine","cited_by":80,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Valeant Pharmaceuticals International; National Institute on Drug Abuse; Vertex Pharmaceuticals; Gilead Sciences","keywords":"Medicine; Ribavirin; Coinfection; Pegylated interferon; Hepatitis C; Hepatitis C virus; Internal medicine; Population; Immunology; Intensive care medicine; Human immunodeficiency virus (HIV); Virus","score_opus":0.04664782216823437,"score_gpt":0.3968295823683239,"score_spread":0.3501817602000895,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1993607717","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00008931009,0.9987808,0.000046793826,0.0004291779,0.00011331426,0.0000041584985,0.0000025374932,0.0000032208084,0.0005306591],"genre_scores_gemma":[0.0011702665,0.9977323,0.00019274387,0.0004399248,0.00020961092,0.000010314243,0.0000073182264,7.856026e-7,0.00023671369],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9994204,0.00025537325,0.000090762325,0.000047927282,0.00015520254,0.000030287149],"domain_scores_gemma":[0.9994967,0.00027087843,0.000101881524,0.0000114166705,0.00008881969,0.000030379662],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011759301,0.00075261516,0.0022168336,0.001675928,0.00040230856,0.0010824238,0.0009250226,0.0017769978,0.0026375102],"category_scores_gemma":[0.0019370826,0.00023034941,0.0005696486,0.0017528472,0.000553769,0.0013876581,0.000505485,0.0014742729,0.0013850058],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001243469,0.00010012157,0.00033461148,0.029120222,0.00013588097,0.0014855128,0.00017497335,0.00019943879,0.0010113324,0.0018842829,0.028570162,0.93685895],"study_design_scores_gemma":[0.00013858391,0.0002975799,0.0026779717,0.019387586,0.00035913652,0.016981298,0.0004073639,0.00015909997,0.00058731943,0.003224458,0.9557428,0.000036905327],"about_ca_topic_score_codex":0.000777937,"about_ca_topic_score_gemma":0.0014268421,"teacher_disagreement_score":0.0026375102,"about_ca_system_score_codex":0.000595604,"about_ca_system_score_gemma":0.0010695027,"threshold_uncertainty_score":0.008823335},"labels":[],"label_agreement":null},{"id":"W1995670220","doi":"10.1111/j.1365-2893.2008.00959.x","title":"Strategies for loading dendritic cells with hepatitis C NS5a antigen and inducing protective immunity","year":2008,"lang":"en","type":"article","venue":"Journal of Viral Hepatitis","topic":"Immunotherapy and Immune Responses","field":"Immunology and Microbiology","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Saskatchewan","funders":"Canadian Institutes of Health Research; Canada Research Chairs","keywords":"NS5A; Virology; Vaccination; Vaccinia; Transfection; Dendritic cell; Immune system; Antigen; Virus; Immunity; Biology; Hepatitis C virus; Immunology; Cell culture; Recombinant DNA; Gene; Hepacivirus; Genetics","score_opus":0.01493295281332378,"score_gpt":0.241688471623288,"score_spread":0.22675551880996422,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1995670220","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.87304217,0.015519801,0.100130945,0.00070137216,0.00033495587,0.00081555115,0.00036490196,0.00041541018,0.008675042],"genre_scores_gemma":[0.946534,0.007540552,0.040902566,0.00028350568,0.000058401514,0.0003066796,0.00029719356,0.000051496318,0.00402547],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9997532,0.000065162276,0.0000224261,0.000038695653,0.00006602395,0.000054581797],"domain_scores_gemma":[0.9999205,0.000020485111,0.000018235343,0.000012669545,0.000014290962,0.000013822468],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00028997503,0.0005443899,0.00034297988,0.00035433855,0.00019138295,0.0005513445,0.00029260857,0.0005804191,0.000974055],"category_scores_gemma":[0.00017959713,0.00018972845,0.00032459054,0.00019462116,0.0003123465,0.0003321543,0.00034783207,0.00074876257,0.00064289133],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000102569844,0.00012035544,0.00011260624,0.00013942302,0.0000067798696,0.000036937327,0.000015742846,0.0002592567,0.98946583,0.0006172488,0.000085548425,0.0090377405],"study_design_scores_gemma":[0.000045348665,0.0005835695,0.0002694904,0.00001727556,0.000025086389,0.00012296729,0.000018545941,0.0012850345,0.9908642,0.00019382183,0.006568562,0.0000060077705],"about_ca_topic_score_codex":0.00021011436,"about_ca_topic_score_gemma":0.00033067123,"teacher_disagreement_score":0.000974055,"about_ca_system_score_codex":0.00037356088,"about_ca_system_score_gemma":0.00033216603,"threshold_uncertainty_score":0.0032585263},"labels":[],"label_agreement":null},{"id":"W1997115629","doi":"10.1111/j.1365-2893.2004.00556.x","title":"Sustained response after a 2‐year course of lamivudine treatment of hepatitis B e antigen‐negative chronic hepatitis B","year":2004,"lang":"en","type":"article","venue":"Journal of Viral Hepatitis","topic":"Hepatitis B Virus Studies","field":"Medicine","cited_by":139,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Toronto","funders":"","keywords":"Lamivudine; Medicine; Internal medicine; Gastroenterology; Hepatitis B; Hepatitis B virus; Chronic hepatitis; Immunology; Virus","score_opus":0.011989512207874215,"score_gpt":0.29128609742873535,"score_spread":0.27929658522086115,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1997115629","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9980141,0.0010920935,0.00013045473,0.00006260403,0.00000869522,0.000037966267,0.000041064086,0.000014383541,0.0005985277],"genre_scores_gemma":[0.99907565,0.00017797237,0.00008673911,0.00009709411,0.000016977294,0.000014368881,0.00013171796,0.0000020901525,0.00039730227],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99959654,0.00006909311,0.000025674719,0.000041573552,0.00011079326,0.00015642215],"domain_scores_gemma":[0.999468,0.000096013435,0.000112864334,0.000033430057,0.00008173959,0.00020800186],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006090474,0.00028118672,0.00053576624,0.00013135931,0.0005004503,0.00029927318,0.00027977664,0.00032977996,0.0008084414],"category_scores_gemma":[0.0015976416,0.00010914829,0.0003724129,0.0001535684,0.00023853964,0.00015255203,0.0001528667,0.0005224377,0.00018797783],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.022385541,0.0044469708,0.53565675,0.0006374021,0.00069091783,0.006478659,0.0020173169,0.0014214783,0.068401806,0.00013085802,0.0027893533,0.3549429],"study_design_scores_gemma":[0.00103934,0.038402054,0.94367146,0.00004533077,0.00024526927,0.0049724877,0.00020268872,0.000682545,0.0059299157,0.00003423143,0.0047390624,0.00003564298],"about_ca_topic_score_codex":0.017980913,"about_ca_topic_score_gemma":0.026353855,"teacher_disagreement_score":0.017980913,"about_ca_system_score_codex":0.00096314115,"about_ca_system_score_gemma":0.0008704968,"threshold_uncertainty_score":0.035752475},"labels":[],"label_agreement":null},{"id":"W1999498806","doi":"10.1111/j.1365-2893.2008.01063.x","title":"The influence of North American Aboriginal ethnicity on pro‐inflammatory and anti‐inflammatory cytokine responses to IFN‐alpha","year":2009,"lang":"en","type":"article","venue":"Journal of Viral Hepatitis","topic":"Hepatitis C virus research","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"","keywords":"Ethnic group; Cytokine; Medicine; Immunology; Alpha (finance); Sociology; Anthropology; Clinical psychology","score_opus":0.01435819948645155,"score_gpt":0.33615049332510905,"score_spread":0.3217922938386575,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1999498806","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99866223,0.00020559158,0.00004253398,0.000027108767,0.0000065922945,0.0000032124417,0.0000413223,0.0000013565297,0.0010100952],"genre_scores_gemma":[0.9987789,0.00015020664,0.00007169789,0.000024922316,0.000005051059,0.0000056306303,0.000035278237,0.0000023771481,0.00092613354],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9998142,0.000064445565,0.000008685221,0.000031933065,0.000036976682,0.000043819535],"domain_scores_gemma":[0.9997003,0.000050854702,0.00006583756,0.0000251416,0.0000753528,0.000082621256],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00028941766,0.00015197403,0.00018354466,0.00018839592,0.000412281,0.00040831434,0.00010081662,0.0001251721,0.0018047187],"category_scores_gemma":[0.00050873397,0.00008725112,0.00014927739,0.0001619468,0.00021846233,0.000080156,0.00018687198,0.00015689677,0.00022799482],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006316027,0.00030755976,0.8025837,0.00021314438,0.00028825208,0.0019838603,0.008726576,0.00011032809,0.15857868,0.00032224593,0.0005685764,0.020001095],"study_design_scores_gemma":[0.000007125632,0.00030555532,0.99609596,0.000012631104,0.000051802494,0.00026711746,0.001196908,0.000076451506,0.0012818599,0.000028025308,0.00067203067,0.000004685938],"about_ca_topic_score_codex":0.03676907,"about_ca_topic_score_gemma":0.055119883,"teacher_disagreement_score":0.03676907,"about_ca_system_score_codex":0.00028235585,"about_ca_system_score_gemma":0.00037657793,"threshold_uncertainty_score":0.0731101},"labels":[],"label_agreement":null},{"id":"W2000668130","doi":"10.1111/j.1365-2893.2007.00921.x","title":"Antiviral therapy: chronic hepatitis C","year":2007,"lang":"en","type":"review","venue":"Journal of Viral Hepatitis","topic":"Hepatitis C virus research","field":"Medicine","cited_by":43,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Ribavirin; Medicine; Dosing; Viral load; Internal medicine; Chronic hepatitis; Pegylated interferon; Hepatitis C virus; Interferon; Hepatitis C; Combination therapy; Immunology; Pharmacology; Gastroenterology; Virus","score_opus":0.09674840743502618,"score_gpt":0.42822321448295797,"score_spread":0.3314748070479318,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2000668130","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00011308821,0.9924015,0.00025022068,0.00043043267,0.0014722978,0.000028742508,0.000029523986,0.00001833812,0.0052559017],"genre_scores_gemma":[0.0013775823,0.98737794,0.00047004098,0.0014343229,0.001541543,0.00004484061,0.00011010972,0.0000059284653,0.007637738],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99954176,0.00013458193,0.000044240074,0.00006782239,0.00017686294,0.000034886878],"domain_scores_gemma":[0.99961495,0.00012667252,0.00007141601,0.000024845247,0.000113844944,0.000048357484],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006086952,0.002161029,0.0021069942,0.0025209098,0.0005190416,0.001107808,0.0012104166,0.0019973277,0.010838951],"category_scores_gemma":[0.00085832423,0.00023156409,0.00044372556,0.0029995122,0.00083081383,0.0012748933,0.00085729716,0.0023981747,0.0139864],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000082318984,0.000112687565,0.00011555851,0.010687905,0.000056967703,0.00029934692,0.000059599643,0.00017557382,0.0013599173,0.0022044175,0.11269792,0.87214774],"study_design_scores_gemma":[0.000031283937,0.00006545226,0.00047083493,0.0032107723,0.00004041556,0.0021763847,0.000025658352,0.000044619286,0.00019255937,0.0012686474,0.9924623,0.000010904674],"about_ca_topic_score_codex":0.001315978,"about_ca_topic_score_gemma":0.001843305,"teacher_disagreement_score":0.010838951,"about_ca_system_score_codex":0.0007390393,"about_ca_system_score_gemma":0.0009108016,"threshold_uncertainty_score":0.03625989},"labels":[],"label_agreement":null},{"id":"W2001237435","doi":"10.1111/j.1365-2893.2005.00615.x","title":"Clinical utility of viral load measurements in individuals with chronic hepatitis C infection on antiviral therapy","year":2005,"lang":"en","type":"article","venue":"Journal of Viral Hepatitis","topic":"Hepatitis C virus research","field":"Medicine","cited_by":37,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Centre for Disease Control; Vancouver General Hospital","funders":"National Institutes of Health; Bayer HealthCare","keywords":"Viral load; BDNA test; Medicine; Ribavirin; Viral hepatitis; Hepatitis C virus; Internal medicine; Immunology; Virology; Antiviral therapy; Virus; Chronic hepatitis","score_opus":0.07804766127706947,"score_gpt":0.3928171565902463,"score_spread":0.31476949531317683,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2001237435","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9962441,0.0009649147,0.00057357195,0.00016395988,0.000020046975,0.00003087503,0.00027078803,0.00003827592,0.0016934474],"genre_scores_gemma":[0.9992236,0.00006641678,0.00039571963,0.000040433464,0.00000960454,0.00000934534,0.00012648386,0.0000018321148,0.00012651512],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989712,0.00047928022,0.000125009,0.00013060264,0.00022758983,0.00006626577],"domain_scores_gemma":[0.9967619,0.0019351508,0.0006426645,0.00008409086,0.0003368225,0.00023923707],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018871741,0.00058596453,0.00053909,0.00060606614,0.000316344,0.0007709354,0.00029979122,0.00060624385,0.00096608204],"category_scores_gemma":[0.005896229,0.00013332056,0.00021159746,0.00041585695,0.00030234607,0.00040899412,0.0002914926,0.0006309063,0.0002968051],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000826323,0.00008999241,0.98216736,0.000052339354,0.000042744745,0.0001205867,0.000109910055,0.0005435136,0.0015651953,0.00003245906,0.00033318307,0.014116318],"study_design_scores_gemma":[0.000043785334,0.001780739,0.9847306,0.00006443483,0.000072151124,0.0013378323,0.00021953676,0.007954986,0.002734786,0.0001939383,0.0008455961,0.000021732316],"about_ca_topic_score_codex":0.0007371844,"about_ca_topic_score_gemma":0.0010214283,"teacher_disagreement_score":0.0018871741,"about_ca_system_score_codex":0.00029185714,"about_ca_system_score_gemma":0.0002519375,"threshold_uncertainty_score":0.00998044},"labels":[],"label_agreement":null},{"id":"W2001800161","doi":"10.1111/j.1365-2893.2005.00676.x","title":"Do antiviral CD8+ T cells select hepatitis C virus escape mutants? Analysis in diverse epitopes targeted by human intrahepatic CD8+ T lymphocytes","year":2005,"lang":"en","type":"article","venue":"Journal of Viral Hepatitis","topic":"Hepatitis C virus research","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto General Hospital; University of Toronto","funders":"Wellcome Trust","keywords":"Epitope; Biology; Virology; Virus; CD8; Hepatitis C virus; Cytotoxic T cell; Immune system; Human leukocyte antigen; Immunology; T cell; Mutation; Antigen; Genetics; Gene","score_opus":0.013805997180324719,"score_gpt":0.30073659733851255,"score_spread":0.28693060015818783,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2001800161","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99956816,0.00007579073,0.00013430891,0.0000073318956,9.728817e-7,0.0000030366377,0.000015959202,0.0000020485836,0.00019247654],"genre_scores_gemma":[0.9994604,0.000048428457,0.00014484771,0.000026071433,0.0000029607577,0.0000065543413,0.0000743987,0.0000022931279,0.00023402653],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.999907,0.000025241781,0.0000066555926,0.000020335738,0.000014257471,0.000026455506],"domain_scores_gemma":[0.9998665,0.00004475377,0.000018978788,0.00002553354,0.000017748305,0.000026466747],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017102063,0.00012104478,0.00016688622,0.00017498559,0.00013060219,0.00026549824,0.00009264818,0.00026239012,0.00076840166],"category_scores_gemma":[0.0004234639,0.00012291686,0.00007588804,0.00011833642,0.0001593723,0.00010698301,0.00009747296,0.00015766462,0.00026311487],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011973783,0.00012870292,0.14814821,0.000048112906,0.000032459648,0.00075440755,0.000642512,0.00040693372,0.8340706,0.00019195506,0.00010769264,0.014271067],"study_design_scores_gemma":[0.00020382908,0.0026940762,0.82750267,0.0000333877,0.00013707689,0.011078039,0.0012620928,0.004210911,0.1478283,0.0007785248,0.00424308,0.000028114722],"about_ca_topic_score_codex":0.00023393345,"about_ca_topic_score_gemma":0.00028576466,"teacher_disagreement_score":0.00076840166,"about_ca_system_score_codex":0.00008290655,"about_ca_system_score_gemma":0.00005504868,"threshold_uncertainty_score":0.00257051},"labels":[],"label_agreement":null},{"id":"W2002437041","doi":"10.1046/j.1365-2893.2001.00262.x","title":"Impact of chronic hepatitis B and interferon‐α therapy on growth of children","year":2001,"lang":"en","type":"article","venue":"Journal of Viral Hepatitis","topic":"Liver Disease Diagnosis and Treatment","field":"Medicine","cited_by":53,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier Universitaire Sainte-Justine; Hospital for Sick Children","funders":"","keywords":"Medicine; Percentile; Internal medicine; Hepatitis B virus; Population; Gastroenterology; Interferon; Alpha interferon; Chronic hepatitis; Hepatitis B; Immunology; Pediatrics; Virus","score_opus":0.01066734556377695,"score_gpt":0.28321368442010825,"score_spread":0.2725463388563313,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2002437041","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9985013,0.0005582081,0.000039700964,0.00007664701,0.0000056382096,0.000002200041,0.00025521414,0.0000064619344,0.000554666],"genre_scores_gemma":[0.99882,0.0003944937,0.000106591026,0.000019234136,0.000007772161,0.0000045294814,0.00037105702,0.0000051396673,0.00027106339],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9992995,0.0002489666,0.000037539827,0.000071784954,0.00018485822,0.00015726524],"domain_scores_gemma":[0.9982552,0.00046351968,0.0007590381,0.00008534896,0.00017126562,0.00026564265],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006330114,0.000381995,0.00032447546,0.0003671964,0.00031382582,0.00047408493,0.0001826426,0.00025057085,0.0008613449],"category_scores_gemma":[0.0038142148,0.00014965906,0.00051796617,0.00038934228,0.0003583087,0.0002829525,0.00044640727,0.00047176558,0.0001786499],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00079333887,0.00008758448,0.985219,0.000021889167,0.00007129381,0.00020014837,0.00015857944,0.00043746992,0.0009806555,0.000059444603,0.00027737123,0.011693149],"study_design_scores_gemma":[0.0000099431645,0.00047671306,0.99794704,0.000008192716,0.000024637466,0.00038929508,0.00009216991,0.00027105826,0.00031679738,0.000023157938,0.00043700635,0.0000039912384],"about_ca_topic_score_codex":0.013141577,"about_ca_topic_score_gemma":0.011377607,"teacher_disagreement_score":0.013141577,"about_ca_system_score_codex":0.0006025812,"about_ca_system_score_gemma":0.000708125,"threshold_uncertainty_score":0.02613014},"labels":[],"label_agreement":null},{"id":"W2009763040","doi":"10.1111/jvh.12165_16","title":"O224: What is in the pipeline for treatment of Hepatitis B? (IFN‐lambda, TLR‐agonists, entry inhibitors etc.)","year":2013,"lang":"en","type":"article","venue":"Journal of Viral Hepatitis","topic":"Hepatitis B Virus Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network","funders":"","keywords":"Interferon; Hepatitis B virus; Immune system; Entecavir; Immunology; Innate immune system; Hepatitis B; Medicine; Virology; Virus; Biology","score_opus":0.01966474117332188,"score_gpt":0.29137233980506455,"score_spread":0.27170759863174265,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2009763040","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00519542,0.61988086,0.0025257412,0.21011011,0.039660197,0.00045399496,0.0024666444,0.0010416065,0.11866546],"genre_scores_gemma":[0.023911629,0.632971,0.005606801,0.11208099,0.046502385,0.0004262714,0.003603022,0.00044720393,0.17445077],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9994429,0.00013215787,0.000039809333,0.00006962929,0.00020560203,0.000109915425],"domain_scores_gemma":[0.99868137,0.00012254408,0.00017877835,0.000046795012,0.00040529142,0.00056519953],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009989486,0.0006453395,0.000852684,0.00076683925,0.0005114261,0.002362263,0.0008569533,0.002939627,0.07886275],"category_scores_gemma":[0.0016909739,0.00018069026,0.0009315845,0.00072819577,0.00058916194,0.0029046545,0.0011534848,0.0024224655,0.044453688],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004787656,0.00017003922,0.00037628267,0.0033529603,0.000028471308,0.00020055474,0.000060810133,0.00008199608,0.0020503164,0.0017841478,0.29411882,0.69729686],"study_design_scores_gemma":[0.00012117076,0.0003409454,0.00076099625,0.0012001015,0.000030284515,0.00031656597,0.00007429949,0.00004926536,0.0003500028,0.001887499,0.99485093,0.000017980597],"about_ca_topic_score_codex":0.0009972136,"about_ca_topic_score_gemma":0.0023363093,"teacher_disagreement_score":0.07886275,"about_ca_system_score_codex":0.00078103965,"about_ca_system_score_gemma":0.002356421,"threshold_uncertainty_score":0.2638222},"labels":[],"label_agreement":null},{"id":"W2010537550","doi":"10.1111/j.1365-2893.2006.00828.x","title":"<i>Staphylococcus aureus</i> bacteremia in patients receiving pegylated interferon‐alpha and ribavirin for chronic hepatitis C virus infection","year":2006,"lang":"en","type":"article","venue":"Journal of Viral Hepatitis","topic":"Antimicrobial Resistance in Staphylococcus","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Saskatchewan Disease Control Laboratory; University of Alberta","funders":"","keywords":"Medicine; Bacteremia; Neutropenia; Internal medicine; Ribavirin; Staphylococcus aureus; Hepatitis C virus; Cirrhosis; Gastroenterology; Sepsis; Septic arthritis; Hepatitis C; Pegylated interferon; Immunology; Antibiotics; Virus; Arthritis; Chemotherapy; Microbiology","score_opus":0.006741975035148963,"score_gpt":0.24877676462486784,"score_spread":0.24203478958971889,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2010537550","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.999124,0.00020438473,0.00008700196,0.000070812006,0.000008796487,0.000008613514,0.000022967643,0.000006010405,0.00046753223],"genre_scores_gemma":[0.99965966,0.00006741603,0.00010028229,0.000058658155,0.000025102583,0.000003821688,0.000029504316,0.0000014646669,0.00005407528],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99955755,0.00009048135,0.0000755515,0.00007719039,0.00008274365,0.000116528456],"domain_scores_gemma":[0.9987735,0.00022576883,0.0006432163,0.0000392695,0.0000625259,0.00025571522],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00032779548,0.00035372982,0.00031004718,0.0008856471,0.00095373346,0.0005870446,0.00019497592,0.00071254687,0.0008062634],"category_scores_gemma":[0.0018751614,0.00034130336,0.0003411968,0.00048547206,0.000557257,0.00037582964,0.0003869586,0.0005324477,0.00016117623],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00023016288,0.000060043632,0.97302306,0.000021671003,0.000022793407,0.020916129,0.00038353459,0.00006495318,0.002280453,0.000025887695,0.00020999603,0.0027613083],"study_design_scores_gemma":[0.00002014752,0.0006434273,0.90381694,0.00002550142,0.00003679661,0.092645265,0.00074369484,0.0003882979,0.0009380769,0.00004527597,0.000676698,0.000019912244],"about_ca_topic_score_codex":0.0019009762,"about_ca_topic_score_gemma":0.0021273496,"teacher_disagreement_score":0.0019009762,"about_ca_system_score_codex":0.00046867575,"about_ca_system_score_gemma":0.00029866464,"threshold_uncertainty_score":0.0037798285},"labels":[],"label_agreement":null},{"id":"W2012666090","doi":"10.1111/j.1365-2893.2008.01058.x","title":"Immunogenicity of CIGB‐230, a therapeutic DNA vaccine preparation, in HCV‐chronically infected individuals in a Phase I clinical trial","year":2008,"lang":"en","type":"article","venue":"Journal of Viral Hepatitis","topic":"Hepatitis C virus research","field":"Medicine","cited_by":90,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Centre Hospitalier de l’Université de Montréal","funders":"Canadian Institutes of Health Research","keywords":"Immunogenicity; Immune system; Medicine; Ribavirin; Immunology; Virology; Antigen; Hepatitis C virus; Vaccination; Immunization; Antibody; Virus","score_opus":0.08496060564450485,"score_gpt":0.44551583001582556,"score_spread":0.3605552243713207,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2012666090","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99782914,0.00074414717,0.00028472955,0.00011802921,0.00004229294,0.00041971085,0.00010230653,0.00003059718,0.000428979],"genre_scores_gemma":[0.9967901,0.0005004902,0.00061170507,0.00025854318,0.000056350702,0.00053441303,0.0003811956,0.000007935571,0.0008592534],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99981445,0.00006896643,0.000009480618,0.000029866436,0.000027776392,0.000049485807],"domain_scores_gemma":[0.99974793,0.000043161555,0.00004363453,0.00001808631,0.00002437786,0.00012271147],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000820968,0.0006347053,0.00065587286,0.00020768853,0.00019197234,0.00047363393,0.00040676421,0.00085324567,0.0015510389],"category_scores_gemma":[0.0004029872,0.000266832,0.00037606602,0.00013751269,0.00058447494,0.000343246,0.0001848896,0.00134477,0.00043560483],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.4977452,0.06952381,0.014349886,0.0011281855,0.0009989091,0.00037750328,0.0005013646,0.0024599116,0.29345077,0.00046744134,0.0025890463,0.11640797],"study_design_scores_gemma":[0.20126244,0.7514565,0.012543356,0.000050808463,0.00045427575,0.00028233737,0.000071175775,0.0015711745,0.02964479,0.00013471552,0.002504206,0.000024143375],"about_ca_topic_score_codex":0.0004934721,"about_ca_topic_score_gemma":0.0006102066,"teacher_disagreement_score":0.0015510389,"about_ca_system_score_codex":0.00041269226,"about_ca_system_score_gemma":0.000681373,"threshold_uncertainty_score":0.0051887035},"labels":[],"label_agreement":null},{"id":"W2016081542","doi":"10.1111/j.1365-2893.2005.00583.x","title":"Prevalence and sexual risk of hepatitis C virus infection when human immunodeficiency virus was acquired through sexual intercourse among patients of the Lyon University Hospitals, France, 1992–2002","year":2005,"lang":"en","type":"article","venue":"Journal of Viral Hepatitis","topic":"Hepatitis C virus research","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"Bristol-Myers Squibb","keywords":"Medicine; Sexual intercourse; Hepatitis C virus; Human immunodeficiency virus (HIV); Logistic regression; Sexual transmission; Cohort; Transmission (telecommunications); Hepatitis C; Virology; Demography; Immunology; Virus; Internal medicine; Population; Environmental health","score_opus":0.011324378981427158,"score_gpt":0.26571898428657514,"score_spread":0.254394605305148,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2016081542","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99874204,0.00037676058,0.00002599452,0.000056874636,0.0000031030518,0.000005476133,0.00043743794,0.0000043548343,0.00034804852],"genre_scores_gemma":[0.9989692,0.0001961726,0.000039368777,0.000043084605,0.000010056883,0.000006745031,0.00048670798,0.0000012433674,0.00024749985],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9997484,0.00006235214,0.000025220332,0.000041151216,0.000052121322,0.00007070034],"domain_scores_gemma":[0.9991037,0.000121703015,0.00044818324,0.000029119914,0.00013398353,0.0001632094],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00030938254,0.00019239509,0.00019290594,0.00058673235,0.0003122033,0.00071196887,0.00021277918,0.0003243372,0.0017982688],"category_scores_gemma":[0.0010857116,0.00017564774,0.0001949142,0.0005312311,0.00013565886,0.00028397594,0.00018899178,0.00031114518,0.0002443204],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000048584683,0.000012910076,0.9985555,0.0000071968075,0.0000226432,0.00008661528,0.00008619405,0.000023575649,0.000102599646,0.000009176608,0.00018934345,0.0008557268],"study_design_scores_gemma":[0.000010795338,0.000059961207,0.9982216,0.000011143055,0.00001528147,0.0007571011,0.0002202208,0.00009110987,0.000056916007,0.0000061812293,0.00054586167,0.0000038421363],"about_ca_topic_score_codex":0.022138065,"about_ca_topic_score_gemma":0.02300231,"teacher_disagreement_score":0.022138065,"about_ca_system_score_codex":0.0007637841,"about_ca_system_score_gemma":0.00041462472,"threshold_uncertainty_score":0.044018388},"labels":[],"label_agreement":null},{"id":"W2016445976","doi":"10.1111/jvh.12243","title":"Pegylated interferons <scp>L</scp>ambda‐1a and alfa‐2a display different gene induction and cytokine and chemokine release profiles in whole blood, human hepatocytes and peripheral blood mononuclear cells","year":2014,"lang":"en","type":"article","venue":"Journal of Viral Hepatitis","topic":"Hepatitis C virus research","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Bristol-Myers Squibb Canada","keywords":"Peripheral blood mononuclear cell; Chemokine; Cytokine; Interferon alfa; Immunology; Ex vivo; Pharmacology; Interferon; Medicine; Alpha interferon; In vivo; Biology; Inflammation; In vitro","score_opus":0.01228368342395859,"score_gpt":0.259426318141343,"score_spread":0.2471426347173844,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2016445976","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99766576,0.000661195,0.00088902004,0.000026160758,0.000009338523,0.000020341575,0.00020976053,0.000020251608,0.00049803825],"genre_scores_gemma":[0.99705386,0.0002637809,0.0011226513,0.00006418893,0.000014455801,0.000050557814,0.0004955184,0.000008603155,0.0009263296],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99985206,0.000045018656,0.000015155801,0.000028467472,0.0000290913,0.000030258763],"domain_scores_gemma":[0.99991953,0.000019345758,0.00002404975,0.000010544179,0.000008750857,0.000017778317],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015402403,0.00014376441,0.000158382,0.000112984155,0.000055748184,0.00022840626,0.00005276165,0.00015786182,0.000735975],"category_scores_gemma":[0.00014829011,0.000076235905,0.00014468431,0.00010601914,0.00012754762,0.00011351114,0.000059979942,0.00023355435,0.0002587474],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006480344,0.00003496465,0.00046690475,0.0000184275,0.0000057844136,0.000024035182,0.000012891327,0.000055831217,0.9964988,0.00002627339,0.000021442569,0.0021866362],"study_design_scores_gemma":[0.0001224913,0.0031516056,0.027966365,0.000006848259,0.000026494445,0.000558879,0.000035779118,0.0008488841,0.96491677,0.00005468702,0.0023028764,0.000008398228],"about_ca_topic_score_codex":0.00015574903,"about_ca_topic_score_gemma":0.00012671456,"teacher_disagreement_score":0.000735975,"about_ca_system_score_codex":0.00014112525,"about_ca_system_score_gemma":0.00007904957,"threshold_uncertainty_score":0.002462089},"labels":[],"label_agreement":null},{"id":"W2017232326","doi":"10.1111/jvh.12248","title":"The present and future disease burden of hepatitis C virus (HCV) infection with today's treatment paradigm","year":2014,"lang":"en","type":"article","venue":"Journal of Viral Hepatitis","topic":"Hepatitis C virus research","field":"Medicine","cited_by":484,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto General Hospital; Health Sciences Centre; Capital District Health Authority; University Health Network; Dalhousie University; University of Toronto; Western University; University of Manitoba; BC Centre for Disease Control; University of British Columbia; Queen Elizabeth II Health Sciences Centre; Université de Montréal; University of Calgary","funders":"National Institute for Health and Care Research; Gilead Sciences; Bristol-Myers Squibb","keywords":"Hepatitis C virus; Medicine; Liver disease; Hepatitis C; Disease; Disease burden; Population; Immunology; Virology; Intensive care medicine; Internal medicine; Virus; Environmental health","score_opus":0.012134175936430834,"score_gpt":0.28715979167180156,"score_spread":0.2750256157353707,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2017232326","genre_codex":"empirical","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8891368,0.012748575,0.041818447,0.016705463,0.0005045306,0.00015676954,0.0023303158,0.00016160577,0.03643754],"genre_scores_gemma":[0.98960215,0.0022130557,0.005872663,0.00048514325,0.000053410382,0.000048375186,0.0005241768,0.000008535439,0.0011925552],"study_design_codex":"simulation_or_modeling","study_design_gemma":"not_applicable","domain_scores_codex":[0.99917454,0.000512883,0.000035744888,0.00008854871,0.00009549311,0.00009276684],"domain_scores_gemma":[0.9992249,0.00041757076,0.00015792785,0.000035142715,0.00010844144,0.000056001412],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0032547552,0.00042544838,0.00029419994,0.0004311288,0.00033672096,0.0018721493,0.00064320513,0.00068779214,0.0014587255],"category_scores_gemma":[0.0027224622,0.00024558435,0.00093257957,0.00057546014,0.00046854775,0.0014171778,0.0005432325,0.00070804305,0.00014016863],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00041238446,0.00019868485,0.21287474,0.00060426694,0.0007414957,0.00048193842,0.0005374525,0.6640187,0.0015429348,0.03043203,0.0058919634,0.082263425],"study_design_scores_gemma":[0.00012727572,0.000749166,0.16214572,0.0006324363,0.0005868146,0.0010979342,0.0023934774,0.76355505,0.0013283408,0.038903207,0.028337672,0.00014291446],"about_ca_topic_score_codex":0.02098621,"about_ca_topic_score_gemma":0.026106546,"teacher_disagreement_score":0.02098621,"about_ca_system_score_codex":0.0026771582,"about_ca_system_score_gemma":0.0020904646,"threshold_uncertainty_score":0.04172808},"labels":[],"label_agreement":null},{"id":"W2020046525","doi":"10.1111/j.1365-2893.2006.00820.x","title":"Trends in testing behaviours for hepatitis C virus infection and associated determinants: results from population‐based laboratory surveillance in Alberta, Canada (1998–2001)","year":2006,"lang":"en","type":"article","venue":"Journal of Viral Hepatitis","topic":"Hepatitis C virus research","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Alberta Health; Provincial Laboratory of Public Health; Public Health Agency of Canada","funders":"","keywords":"Population; Medicine; Hepatitis a virus; Virology; Environmental health; Hepatitis C virus; Demography; Virus","score_opus":0.0225665442839153,"score_gpt":0.3030930953763737,"score_spread":0.2805265510924584,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2020046525","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9878242,0.0011729817,0.00015073238,0.00033977267,0.00001574367,0.00003834122,0.0082828095,0.000041768104,0.002133589],"genre_scores_gemma":[0.99251634,0.00086446165,0.0002935522,0.00014205927,0.000010199911,0.000016394088,0.004688057,0.0000090570775,0.0014599293],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99891126,0.000068154775,0.000073027,0.00015177141,0.0005530995,0.0002427031],"domain_scores_gemma":[0.99690956,0.00014769012,0.00052318216,0.00008246262,0.0018228333,0.0005143992],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001012492,0.00041850854,0.0004150777,0.0020183963,0.001296786,0.0013467906,0.0015448403,0.00055741024,0.001145449],"category_scores_gemma":[0.0019342463,0.00036678865,0.0005886262,0.005111008,0.00073077145,0.00036225098,0.00066166586,0.0007013364,0.00027943437],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012001153,0.000039949875,0.99143946,0.0000553131,0.00006952647,0.000083162944,0.0005374957,0.0003248576,0.00025635294,0.000050460505,0.0013943518,0.005628962],"study_design_scores_gemma":[0.0000040383834,0.000013181036,0.9991442,0.000012229637,0.00001581996,0.000024896075,0.0002855791,0.00016284722,0.000026181193,0.000004563258,0.00030165524,0.0000046964874],"about_ca_topic_score_codex":0.99514186,"about_ca_topic_score_gemma":0.99545175,"teacher_disagreement_score":0.025211645,"about_ca_system_score_codex":0.025211645,"about_ca_system_score_gemma":0.017785804,"threshold_uncertainty_score":0.18292415},"labels":[],"label_agreement":null},{"id":"W2026508243","doi":"10.1111/j.1365-2893.2007.00873.x","title":"Spontaneous clearance of childhood hepatitis C virus infection","year":2007,"lang":"en","type":"article","venue":"Journal of Viral Hepatitis","topic":"Hepatitis C virus research","field":"Medicine","cited_by":107,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; University of Toronto","funders":"","keywords":"Medicine; Clearance; Clearance rate; Hepatitis C virus; Internal medicine; Multivariate analysis; Immunology; Univariate analysis; Antibody; Gastroenterology; Virus","score_opus":0.013348510035869704,"score_gpt":0.30626299883579433,"score_spread":0.29291448879992465,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2026508243","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9965384,0.0016272113,0.00077929907,0.000038895803,0.000009659723,0.000010989905,0.0003959714,0.000030706822,0.0005688708],"genre_scores_gemma":[0.9985594,0.00053111755,0.00023618375,0.000014593739,0.000014088987,0.000007259191,0.00052681257,0.0000075704966,0.000103019396],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990969,0.00025519423,0.000117147596,0.00010353611,0.00025579458,0.00017140462],"domain_scores_gemma":[0.99033546,0.002210132,0.005300076,0.0006616584,0.0009580263,0.0005345926],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010540471,0.00017398653,0.00029026045,0.0007384602,0.00020660876,0.0005057438,0.00029968604,0.00030851862,0.0010059725],"category_scores_gemma":[0.0113271605,0.00014137373,0.00027006713,0.00047789575,0.00030412292,0.00051452435,0.00029240194,0.00041159612,0.00029970004],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001904984,0.000014194186,0.98778874,0.00003640489,0.000025254187,0.0006075255,0.00009987377,0.00026052623,0.00025903824,0.00011048167,0.00026363193,0.010343868],"study_design_scores_gemma":[0.00001786655,0.00036840473,0.96321505,0.00004349531,0.000027028731,0.031622335,0.00013889911,0.0017141383,0.0011431507,0.00016461723,0.0015301073,0.0000147697865],"about_ca_topic_score_codex":0.0012894191,"about_ca_topic_score_gemma":0.0008956553,"teacher_disagreement_score":0.0012894191,"about_ca_system_score_codex":0.0003575125,"about_ca_system_score_gemma":0.00034797785,"threshold_uncertainty_score":0.005574405},"labels":[],"label_agreement":null},{"id":"W2027110018","doi":"10.1111/jvh.12163","title":"<i><scp>HCV E1E</scp>2‐<scp>MF</scp>59</i> vaccine in chronic hepatitis <scp>C</scp> patients treated with <scp>PEG</scp>‐<scp>IFN</scp>α2a and <scp>R</scp>ibavirin: a randomized controlled trial","year":2013,"lang":"en","type":"article","venue":"Journal of Viral Hepatitis","topic":"Hepatitis C virus research","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Virology; Immunology; Medicine","score_opus":0.010235792786872203,"score_gpt":0.262370488722732,"score_spread":0.2521346959358598,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2027110018","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9964515,0.0014893682,0.00017522872,0.00018105093,0.00012305657,0.0009570937,0.0001571909,0.000037624963,0.00042793225],"genre_scores_gemma":[0.99533033,0.0012374024,0.00051801815,0.00029735194,0.00020228929,0.0013029993,0.00031336496,0.000009531545,0.00078873534],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99947006,0.00029624076,0.000043094617,0.00006248203,0.000033126882,0.00009499681],"domain_scores_gemma":[0.999356,0.00014713385,0.00015064502,0.000044508757,0.000046090576,0.0002556019],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001103939,0.0009291844,0.0017214885,0.0002972919,0.00033670748,0.00062075414,0.0004936106,0.0011437655,0.002699508],"category_scores_gemma":[0.0009276413,0.00045474982,0.0013281445,0.00032474034,0.0007949054,0.0005420803,0.00022429507,0.0015184126,0.00038705562],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9684235,0.005371896,0.0010959366,0.00031631938,0.0004579165,0.000030678155,0.000044594457,0.00019979523,0.0055615003,0.00003740311,0.00030270487,0.01815789],"study_design_scores_gemma":[0.7389908,0.2529651,0.0045829653,0.00005255598,0.0005263721,0.000062217674,0.000031144504,0.0005480372,0.0015981953,0.00005443807,0.0005730392,0.000015163646],"about_ca_topic_score_codex":0.0011177469,"about_ca_topic_score_gemma":0.0021506574,"teacher_disagreement_score":0.002699508,"about_ca_system_score_codex":0.00049389584,"about_ca_system_score_gemma":0.0009508776,"threshold_uncertainty_score":0.0090307},"labels":[],"label_agreement":null},{"id":"W2027908402","doi":"10.1111/jvh.12098","title":"Rare occurrence of occult hepatitis C virus in apparently uninfected injecting drug users: a two‐centre, masked, case–control study","year":2013,"lang":"en","type":"article","venue":"Journal of Viral Hepatitis","topic":"Hepatitis C virus research","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Memorial University of Newfoundland","funders":"","keywords":"Occult; Hepatitis C virus; Peripheral blood mononuclear cell; Virology; Medicine; RNA; Hepatitis C; Virus; Nested polymerase chain reaction; Polymerase chain reaction; Immunology; Biology; In vitro; Pathology; Gene; Genetics","score_opus":0.020047125962811642,"score_gpt":0.31630163439434483,"score_spread":0.29625450843153317,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2027908402","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99946314,0.00016681268,0.00012968744,0.00001102647,0.000009239576,0.000028464648,0.00002522877,0.0000030260046,0.00016339491],"genre_scores_gemma":[0.9997123,0.000043950953,0.000080563885,0.00002389711,0.000021352578,0.000012597541,0.0000431007,0.0000017858576,0.000060433427],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9967955,0.0011528843,0.0004181344,0.0008434867,0.00046117112,0.000328899],"domain_scores_gemma":[0.99437356,0.0019505572,0.0012173661,0.0011270805,0.0005207379,0.00081061275],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0023855825,0.00069174945,0.0009423129,0.0011480225,0.0010565489,0.0010276007,0.00078806275,0.0011603119,0.001759246],"category_scores_gemma":[0.0073472383,0.00092920696,0.00054392207,0.000676593,0.0009973862,0.00068534445,0.0007639927,0.0006237577,0.0003187286],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0032319024,0.0006790596,0.9869996,0.00006049112,0.00021149062,0.0026077307,0.0009695896,0.000022379985,0.0030956804,0.00007816808,0.00010520841,0.001938706],"study_design_scores_gemma":[0.0003270504,0.0029978377,0.9877571,0.000016274482,0.00019927906,0.0068949116,0.0005182826,0.00038149668,0.0004408884,0.0000500119,0.0003863949,0.00003046557],"about_ca_topic_score_codex":0.004793431,"about_ca_topic_score_gemma":0.0030685398,"teacher_disagreement_score":0.004793431,"about_ca_system_score_codex":0.00035590096,"about_ca_system_score_gemma":0.000329488,"threshold_uncertainty_score":0.012616336},"labels":[],"label_agreement":null},{"id":"W2029574678","doi":"10.1111/j.1365-2893.2009.01076.x","title":"Comprehensive longitudinal analysis of hepatitis C virus (HCV)‐specific T cell responses during acute HCV infection in the presence of existing HIV‐1 infection","year":2009,"lang":"en","type":"article","venue":"Journal of Viral Hepatitis","topic":"Hepatitis C virus research","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Infection and Immunity","funders":"","keywords":"Hepatitis C virus; CD8; T cell; Virology; Immunology; Cell; Medicine; Hepacivirus; Hepatitis C; Virus; Immune system; Biology","score_opus":0.06139752535879556,"score_gpt":0.36319730192926075,"score_spread":0.3017997765704652,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2029574678","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.999582,0.00013275551,0.00007984949,0.000013748503,0.000002437336,0.000005734384,0.000045139448,0.0000035558394,0.00013494283],"genre_scores_gemma":[0.999607,0.000044022294,0.000061839535,0.00001823359,0.0000047805643,0.0000062174136,0.00014833712,0.0000011269588,0.000108467386],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9996457,0.0001092021,0.000027122062,0.000062520376,0.00005939316,0.000096041505],"domain_scores_gemma":[0.9986935,0.00031821147,0.00040537366,0.000090799134,0.00020279095,0.00028937196],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007801697,0.00020017257,0.00031217505,0.00040003823,0.00043725478,0.0004277748,0.00014789373,0.00032858772,0.00046568294],"category_scores_gemma":[0.0018104576,0.00016409374,0.00019348529,0.00023075432,0.00022707497,0.000335322,0.0003112487,0.00055984565,0.00013682626],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009730202,0.00017230066,0.97124827,0.000025687745,0.00006343866,0.00050983805,0.00052534253,0.00018313553,0.019583855,0.00003099231,0.0001126618,0.006571539],"study_design_scores_gemma":[0.00001339339,0.0014615139,0.99441165,0.000008740166,0.0000587815,0.0009435465,0.00023939995,0.00031323012,0.002111081,0.000020831814,0.00040734373,0.000010493842],"about_ca_topic_score_codex":0.0009726779,"about_ca_topic_score_gemma":0.0009827685,"teacher_disagreement_score":0.0009726779,"about_ca_system_score_codex":0.00018308705,"about_ca_system_score_gemma":0.00016706868,"threshold_uncertainty_score":0.0041259527},"labels":[],"label_agreement":null},{"id":"W2033302237","doi":"10.1111/jvh.12166_31","title":"P32: Hepatitis B screening prior to chemotherapy initiation in a tertiary care center in Québec, Canada","year":2013,"lang":"en","type":"article","venue":"Journal of Viral Hepatitis","topic":"Hepatitis B Virus Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Université de Sherbrooke","funders":"","keywords":"Medicine; Chemotherapy; Internal medicine; HBsAg; Hepatitis B virus; Rituximab; Serology; Hepatitis B; Hepatology; Gastroenterology; Oncology; Immunology; Lymphoma; Antibody; Virus","score_opus":0.009227095587365865,"score_gpt":0.2539717818547663,"score_spread":0.24474468626740045,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2033302237","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9872334,0.0010571657,0.00018755792,0.0019049473,0.000054983237,0.0002168673,0.002547037,0.000032698128,0.006765389],"genre_scores_gemma":[0.9950767,0.00058668747,0.0003291219,0.001029506,0.000030452024,0.000032511056,0.0006913744,0.000013342231,0.002210287],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99920434,0.000059227314,0.00005949236,0.00013672032,0.00019733328,0.0003429843],"domain_scores_gemma":[0.99634725,0.00023326802,0.0007636333,0.0000745071,0.001087739,0.0014936978],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00039177746,0.00045487017,0.00034139544,0.0010910616,0.0052688434,0.0011488725,0.0014908414,0.00090523646,0.0061883545],"category_scores_gemma":[0.0017822931,0.0005778945,0.00030959674,0.0028653175,0.0008625786,0.0005092662,0.0008326946,0.0012209906,0.00053815206],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000074666445,0.00015119818,0.98379517,0.00008332829,0.00002662159,0.0035505851,0.0012959823,0.00014147501,0.0007966536,0.00011651377,0.0040471726,0.0059205713],"study_design_scores_gemma":[0.00002110696,0.000097894495,0.9925034,0.00011084693,0.000016678741,0.0016417853,0.003014378,0.0004388894,0.000116515635,0.00003205635,0.0019825518,0.00002401519],"about_ca_topic_score_codex":0.98787224,"about_ca_topic_score_gemma":0.9938937,"teacher_disagreement_score":0.034435026,"about_ca_system_score_codex":0.034435026,"about_ca_system_score_gemma":0.0432107,"threshold_uncertainty_score":0.24984479},"labels":[],"label_agreement":null},{"id":"W2037406883","doi":"10.1111/jvh.12087","title":"The effects of nucleoside analogue prophylactic treatment on <scp>HBV</scp> activation in <scp>HB</scp>c<scp>A</scp>b+ patients undergoing immunosuppressive therapy","year":2013,"lang":"en","type":"article","venue":"Journal of Viral Hepatitis","topic":"Hepatitis B Virus Studies","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto General Hospital; University of Toronto","funders":"Alberta Innovates - Health Solutions","keywords":"Seroconversion; Medicine; Nucleoside analogue; Antibody; Gastroenterology; Group B; Hepatitis B virus; Internal medicine; Hepatitis B; Group A; Immunology; Nucleoside; Virus; Biology","score_opus":0.010536952532643818,"score_gpt":0.24951124765383978,"score_spread":0.23897429512119597,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2037406883","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99846786,0.001108637,0.000038665217,0.000023796474,0.000008887353,0.000012068486,0.000015594595,0.0000028443287,0.00032161232],"genre_scores_gemma":[0.99955183,0.0002471332,0.00006315346,0.000024777966,0.000019997076,0.000006542794,0.000037859547,5.4002396e-7,0.000048193848],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99980146,0.000097855394,0.000021415808,0.000021444093,0.00002442012,0.000033337754],"domain_scores_gemma":[0.9994599,0.00020520475,0.000124168,0.00003871922,0.00003410142,0.00013792964],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023934818,0.00018040107,0.00044972808,0.00014778237,0.00016210391,0.0001764355,0.00010145728,0.00020981126,0.0006247209],"category_scores_gemma":[0.0011345467,0.00007650493,0.0002788518,0.00011395503,0.00014052217,0.00010764807,0.000086299275,0.000336373,0.00006711548],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.16469054,0.0059020096,0.402306,0.0008109859,0.0009019663,0.0024826867,0.00040484284,0.0009398042,0.088649586,0.00022305496,0.0007331365,0.3319553],"study_design_scores_gemma":[0.00533525,0.16598397,0.80723655,0.00010448068,0.00078864023,0.0036709944,0.00022894533,0.0012069457,0.012547976,0.0001283295,0.0027415482,0.000026217476],"about_ca_topic_score_codex":0.0002535182,"about_ca_topic_score_gemma":0.0004495879,"teacher_disagreement_score":0.0006247209,"about_ca_system_score_codex":0.00012237794,"about_ca_system_score_gemma":0.00016695577,"threshold_uncertainty_score":0.002089858},"labels":[],"label_agreement":null},{"id":"W2038448062","doi":"10.1111/jvh.12121","title":"A paucity of liver disease in <scp>C</scp>anadian <scp>I</scp>nuit with chronic hepatitis <scp>B</scp> virus, subgenotype <scp>B</scp>6 infection","year":2013,"lang":"en","type":"article","venue":"Journal of Viral Hepatitis","topic":"Hepatitis B Virus Studies","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Public Health Agency of Canada; University of Manitoba","funders":"Health Canada; Gilead Sciences","keywords":"Hepatitis B virus; Medicine; Serology; Viral load; Genotype; Hepatitis B; Liver disease; Internal medicine; HBsAg; Virus; Chronic liver disease; Immunology; Gastroenterology; Virology; Biology; Antibody; Gene","score_opus":0.012073174647026928,"score_gpt":0.23879984859277334,"score_spread":0.22672667394574642,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2038448062","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99813014,0.00024703506,0.000044591434,0.00005147879,0.0000035298906,0.000009100855,0.0003049766,0.0000039851857,0.001205125],"genre_scores_gemma":[0.99930215,0.00012690198,0.00004181891,0.000024854744,0.000003025572,0.0000027098042,0.00022778467,0.0000012523539,0.00026962478],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99975926,0.000015252132,0.000017075536,0.000044354394,0.00007684764,0.00008727075],"domain_scores_gemma":[0.9994899,0.000029407958,0.00016022175,0.000027859362,0.00015643532,0.00013613154],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021206503,0.00019647149,0.00022406402,0.0007124093,0.0015888369,0.0008372595,0.00042022477,0.00021230943,0.0021104568],"category_scores_gemma":[0.0009739576,0.00016855757,0.00018837722,0.00094155496,0.00053244265,0.00025276447,0.0004209697,0.00021116354,0.00018667876],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006364638,0.00001070024,0.9951096,0.00002071206,0.000020145279,0.00034807288,0.00042801717,0.000024756913,0.0007885691,0.000045140176,0.00018857511,0.002951947],"study_design_scores_gemma":[0.0000018783596,0.00003336659,0.9980301,0.00001026187,0.000014337482,0.0007187385,0.00054642616,0.0000806693,0.00009311262,0.0000119485285,0.0004556264,0.0000034552309],"about_ca_topic_score_codex":0.7800265,"about_ca_topic_score_gemma":0.8649503,"teacher_disagreement_score":0.2199735,"about_ca_system_score_codex":0.0032077283,"about_ca_system_score_gemma":0.0033375905,"threshold_uncertainty_score":0.4425379},"labels":[],"label_agreement":null},{"id":"W2038454674","doi":"10.1111/j.1365-2893.2009.01111.x","title":"Mutational analysis of the hepatitis C virus E1 glycoprotein in retroviral pseudoparticles and cell‐culture‐derived H77/JFH1 chimeric infectious virus particles","year":2009,"lang":"en","type":"article","venue":"Journal of Viral Hepatitis","topic":"Hepatitis C virus research","field":"Medicine","cited_by":30,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Cancer Institute; National Institute of Allergy and Infectious Diseases; Canadian Institutes of Health Research; National Institutes of Health","keywords":"Infectivity; Virology; Biology; Viral entry; CD81; Lipid bilayer fusion; Mutant; Virus; Retrovirus; Peptide; Glycoprotein; Hepatitis C virus; Viral replication; Molecular biology; Gene; Genetics; Biochemistry","score_opus":0.011838931500617227,"score_gpt":0.28477066896766146,"score_spread":0.27293173746704424,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2038454674","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99806434,0.00013283044,0.0013532343,0.000011565458,0.0000058827436,0.000021260634,0.000115731214,0.000014749707,0.00028054684],"genre_scores_gemma":[0.9967577,0.0001716536,0.002064791,0.000018933424,0.0000033148087,0.00002314883,0.00039192993,0.000015132329,0.0005533337],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998841,0.000024367608,0.000013508697,0.000014744378,0.000044080123,0.000019115158],"domain_scores_gemma":[0.99988794,0.00003357987,0.000030481566,0.000012680978,0.000014931574,0.000020324067],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017592749,0.00031971678,0.00014982598,0.00018922801,0.00014425532,0.00016335485,0.00019484044,0.00025763057,0.0003746113],"category_scores_gemma":[0.00019498038,0.00013374201,0.00033360365,0.0001246189,0.00020406046,0.00011630476,0.00012886708,0.0003198317,0.00019394039],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000043873813,0.00001543633,0.00019403799,0.0000097249185,0.000004454733,0.00008791368,0.000014270486,0.00011974895,0.99909747,0.00007009665,0.0000052894948,0.00033781253],"study_design_scores_gemma":[0.000011082301,0.0002826374,0.004979074,0.0000032222224,0.000018273353,0.0005305532,0.000023364844,0.0019158567,0.99158794,0.00003356916,0.0006077943,0.000006595248],"about_ca_topic_score_codex":0.0011190807,"about_ca_topic_score_gemma":0.00083618594,"teacher_disagreement_score":0.0011190807,"about_ca_system_score_codex":0.00036145444,"about_ca_system_score_gemma":0.00021041468,"threshold_uncertainty_score":0.0026225448},"labels":[],"label_agreement":null},{"id":"W2046752962","doi":"10.1111/jvh.12245","title":"Lower life expectancy among people with an <scp>HCV</scp> notification: a population‐based linkage study","year":2014,"lang":"en","type":"article","venue":"Journal of Viral Hepatitis","topic":"Hepatitis C virus research","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Public Health Ontario; University of Toronto","funders":"Janssen Biotech; Department of Health and Ageing, Australian Government; Bristol-Myers Squibb Canada; AbbVie; Roche","keywords":"Medicine; Life expectancy; Interquartile range; Population; Hepatitis C; Cause of death; Liver disease; Cohort; Demography; Mortality rate; Internal medicine; Disease; Environmental health","score_opus":0.020139504259094766,"score_gpt":0.30210496439090834,"score_spread":0.28196546013181356,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2046752962","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9970402,0.00034286163,0.00016815931,0.0001405372,0.000010707327,0.000030178559,0.0014884222,0.000006802708,0.000772093],"genre_scores_gemma":[0.99781185,0.00025623516,0.00011635356,0.00017795264,0.00001630642,0.00007379945,0.0010863957,0.0000047921276,0.00045625825],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988801,0.00048116312,0.00008889816,0.00025124723,0.00015282563,0.00014574033],"domain_scores_gemma":[0.99801946,0.00039691632,0.0007410643,0.00020968985,0.00037100827,0.00026192868],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0022551194,0.00025517278,0.0005744973,0.0010824017,0.000882878,0.0011702335,0.00053352246,0.00081117963,0.0028017876],"category_scores_gemma":[0.005853339,0.0003558762,0.0006684325,0.0019705577,0.00023843006,0.0010849362,0.0009928534,0.00089493964,0.00051416695],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003615994,0.00028705408,0.99278027,0.0000648097,0.0003566152,0.0002638101,0.0013941273,0.00007561494,0.00016182712,0.00009034763,0.0010804635,0.0030835422],"study_design_scores_gemma":[0.000060452094,0.0002696019,0.99609,0.00004928496,0.00018226319,0.0005497687,0.0008770888,0.00041402935,0.00004354604,0.00012861012,0.001313224,0.000022206317],"about_ca_topic_score_codex":0.012351878,"about_ca_topic_score_gemma":0.00843979,"teacher_disagreement_score":0.012351878,"about_ca_system_score_codex":0.000601659,"about_ca_system_score_gemma":0.0005133198,"threshold_uncertainty_score":0.024559975},"labels":[],"label_agreement":null},{"id":"W2047272500","doi":"10.1111/j.1365-2893.2007.00863.x","title":"Characteristics and survival of HIV‐infected patients not screened for hepatitis C virus infection in a hospital‐based cohort","year":2007,"lang":"en","type":"article","venue":"Journal of Viral Hepatitis","topic":"Hepatitis C virus research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Medicine; Internal medicine; Hepatitis C virus; Cohort; Proportional hazards model; Hepatitis C; Incidence (geometry); Confidence interval; Prospective cohort study; Cohort study; Immunology; Virus","score_opus":0.01677538457266991,"score_gpt":0.30599449202695844,"score_spread":0.2892191074542885,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2047272500","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9995117,0.000083755105,0.000026063673,0.00002902576,0.000004436945,0.0000035574822,0.00023522225,0.0000013023872,0.00010499514],"genre_scores_gemma":[0.9994091,0.00004235405,0.000015963891,0.000020295898,0.000007268736,0.0000049405367,0.0004285372,0.0000010004626,0.00007051059],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9996486,0.00009224803,0.00004020552,0.000083067935,0.00005607369,0.0000797783],"domain_scores_gemma":[0.9983265,0.0003305774,0.0006129199,0.00011248981,0.00015992708,0.00045756032],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005761006,0.0002455663,0.00030340554,0.00075428345,0.00050162186,0.00071989134,0.00032690697,0.0004886488,0.0015593324],"category_scores_gemma":[0.0023669254,0.0002807102,0.00041308132,0.0007895424,0.00027916513,0.0005825973,0.0003118939,0.0006021317,0.0002229784],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011352451,0.000024589335,0.9991122,0.000004094585,0.000035985115,0.0000877631,0.000053648102,0.00004759213,0.00007133906,0.00001173814,0.0000999721,0.0003377183],"study_design_scores_gemma":[0.000017120163,0.00015115345,0.99877006,0.000007244744,0.00002691875,0.00030837624,0.0001935494,0.00033000342,0.000029281147,0.000027716751,0.00013157437,0.000006971416],"about_ca_topic_score_codex":0.005902999,"about_ca_topic_score_gemma":0.0050947424,"teacher_disagreement_score":0.005902999,"about_ca_system_score_codex":0.00041190302,"about_ca_system_score_gemma":0.00038953422,"threshold_uncertainty_score":0.011737287},"labels":[],"label_agreement":null},{"id":"W2047791700","doi":"10.1111/j.1365-2893.2009.01136.x","title":"Prognosis of hepatitis C virus‐infected Canadian post‐transfusion compensation claimant cohort","year":2009,"lang":"en","type":"article","venue":"Journal of Viral Hepatitis","topic":"Hepatitis C virus research","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Toronto Western Hospital; Canadian Blood Services; University of Toronto; Toronto Public Health; University Health Network","funders":"","keywords":"Medicine; Cohort; Hepatocellular carcinoma; Cirrhosis; Internal medicine; Liver disease; Epidemiology; Hepatitis C virus; Blood transfusion; Hepatitis C; Stage (stratigraphy); Cohort study; Virus; Virology; Biology","score_opus":0.015163781740740376,"score_gpt":0.2908237837670969,"score_spread":0.2756600020263565,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2047791700","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9986727,0.0000679476,0.00011836389,0.00009944319,0.000003252402,0.000008115747,0.0006739905,0.0000052063574,0.00035098416],"genre_scores_gemma":[0.9988109,0.00007763523,0.00007753667,0.000009402795,0.000002306974,0.0000032230228,0.00078268204,9.929942e-7,0.00023539897],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9997944,0.000023647215,0.000008736505,0.000031147123,0.000060332204,0.000081813785],"domain_scores_gemma":[0.9989058,0.00013195806,0.00026769907,0.00010120132,0.00034420314,0.0002490653],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00075919216,0.00021506382,0.0002272556,0.00066173775,0.0010507075,0.0005516573,0.00047344682,0.00036285687,0.0011260364],"category_scores_gemma":[0.0031546045,0.00018219367,0.00036777745,0.0005142591,0.00031887784,0.00026109722,0.00032136057,0.00044393053,0.00016698713],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015290832,0.000018540386,0.9944121,0.0000051936718,0.00002571097,0.00010206622,0.0001964245,0.00087899563,0.00017027046,0.000110888446,0.0004969424,0.0034299754],"study_design_scores_gemma":[0.000010606851,0.00005342442,0.9920094,0.000009900202,0.000022496755,0.00016421454,0.00028111605,0.0068223635,0.000097866854,0.000093475646,0.00041836983,0.000016654882],"about_ca_topic_score_codex":0.82765615,"about_ca_topic_score_gemma":0.7765673,"teacher_disagreement_score":0.17234385,"about_ca_system_score_codex":0.004388745,"about_ca_system_score_gemma":0.004139099,"threshold_uncertainty_score":0.3467176},"labels":[],"label_agreement":null},{"id":"W2049037429","doi":"10.1111/jvh.12131","title":"Micro<scp>RNA</scp>‐130a inhibits <scp>HCV</scp> replication by restoring the innate immune response","year":2013,"lang":"en","type":"article","venue":"Journal of Viral Hepatitis","topic":"interferon and immune responses","field":"Immunology and Microbiology","cited_by":64,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto General Hospital; University of Toronto","funders":"","keywords":"Innate immune system; Replicon; Hepatitis C virus; Virology; Interferon; Biology; Immune system; TLR3; RIG-I; Viral replication; Ribavirin; TLR7; RNA interference; RNA; Immunology; Cancer research; Virus; Gene; Toll-like receptor; Genetics","score_opus":0.009506902693502474,"score_gpt":0.24035488364438548,"score_spread":0.23084798095088302,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2049037429","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98579025,0.003444516,0.0054285824,0.0002720255,0.000108153305,0.000066154666,0.00028840854,0.00029611564,0.0043057315],"genre_scores_gemma":[0.99260676,0.001045355,0.00376195,0.0001031677,0.00003058086,0.000032815988,0.00034697488,0.00002561138,0.002046812],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9999305,0.00001389416,0.0000048244924,0.000012641164,0.000026515056,0.0000117615755],"domain_scores_gemma":[0.9999527,0.0000112411535,0.000012624674,0.0000051747807,0.00000639069,0.000011779628],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010630898,0.0002076846,0.00015872474,0.0001565132,0.00009965701,0.00017330883,0.00009576092,0.00013801752,0.0014450724],"category_scores_gemma":[0.00010378878,0.0000733097,0.00020558338,0.00007104054,0.00021166305,0.00011347736,0.000091851885,0.0003704085,0.00040109467],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007822049,0.000030556483,0.00015226532,0.000024551326,0.0000042083398,0.000018832181,0.000004316651,0.00005942699,0.99582076,0.000105481464,0.00009223881,0.0036091523],"study_design_scores_gemma":[0.000020516069,0.0005781456,0.0027361123,0.000005089078,0.000012612659,0.00022197921,0.0000090702215,0.00080746267,0.9906634,0.00008744181,0.0048540584,0.000004041441],"about_ca_topic_score_codex":0.0002726013,"about_ca_topic_score_gemma":0.0005314205,"teacher_disagreement_score":0.0014450724,"about_ca_system_score_codex":0.00013009805,"about_ca_system_score_gemma":0.00018465934,"threshold_uncertainty_score":0.0048342943},"labels":[],"label_agreement":null},{"id":"W2050052235","doi":"10.1111/j.1365-2893.2005.00709.x","title":"Comparison of two PEG‐interferon alpha‐2b doses (1.0 or 1.5 <i>μ</i>g/kg) combined with ribavirin in interferon‐naïve patients with chronic hepatitis C and up to moderate fibrosis","year":2006,"lang":"en","type":"article","venue":"Journal of Viral Hepatitis","topic":"Hepatitis C virus research","field":"Medicine","cited_by":26,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"","keywords":"Ribavirin; Medicine; Gastroenterology; Alpha interferon; Internal medicine; Pegylated interferon; Adverse effect; Hepatitis C; Hepatitis C virus; Pharmacology; PEG ratio; Interferon; Immunology; Virus","score_opus":0.020598205768235442,"score_gpt":0.329723925479694,"score_spread":0.3091257197114585,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2050052235","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9949562,0.0034603504,0.00017186381,0.00020893244,0.00015188755,0.00021910368,0.000088758614,0.000027509723,0.00071546197],"genre_scores_gemma":[0.99674475,0.0013780586,0.00037082835,0.00026203407,0.00022981239,0.00031608788,0.00025599578,0.00000955881,0.00043290996],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99866843,0.0007968135,0.00008324378,0.00021095625,0.00008401773,0.00015655841],"domain_scores_gemma":[0.99853754,0.0005238032,0.0003006191,0.00007977039,0.000048562735,0.00050981645],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013489858,0.0012171321,0.0026270058,0.00051776425,0.0002821987,0.0009937235,0.0007347941,0.0016989948,0.002626048],"category_scores_gemma":[0.0023314995,0.00074331637,0.0017536968,0.0003973339,0.0010805601,0.0009866642,0.00040352673,0.0019629034,0.00078026595],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9423992,0.0109862005,0.0020862524,0.00037051877,0.0008029658,0.00008237501,0.00010441439,0.0005574862,0.005518927,0.00009365181,0.00030320507,0.036694877],"study_design_scores_gemma":[0.51983565,0.46395805,0.011930653,0.00006196853,0.0007258991,0.00015200683,0.00006635654,0.0009973992,0.0013332465,0.00014132145,0.00075974024,0.000037656777],"about_ca_topic_score_codex":0.00050809426,"about_ca_topic_score_gemma":0.0007926834,"teacher_disagreement_score":0.0026270058,"about_ca_system_score_codex":0.0006998299,"about_ca_system_score_gemma":0.0005884643,"threshold_uncertainty_score":0.008785069},"labels":[],"label_agreement":null},{"id":"W2054938157","doi":"10.1111/jvh.12247","title":"Historical epidemiology of hepatitis C virus (<scp>HCV</scp>) in selected countries","year":2014,"lang":"en","type":"review","venue":"Journal of Viral Hepatitis","topic":"Hepatitis C virus research","field":"Medicine","cited_by":241,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen Elizabeth II Health Sciences Centre; University of Calgary; University of Toronto; Western University; BC Centre for Disease Control; University of British Columbia; University of Manitoba; Université de Montréal; Dalhousie University; Capital District Health Authority; Health Sciences Centre; University Health Network; Toronto General Hospital","funders":"Public Health England; National Institute for Health and Care Research; Gilead Sciences","keywords":"Virology; Epidemiology; Hepatitis C virus; Hepatitis virus; Virus; Hepatitis a virus; Environmental health; Medicine; Internal medicine","score_opus":0.06849872591365258,"score_gpt":0.3888201373881694,"score_spread":0.3203214114745168,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2054938157","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00016917827,0.9995171,0.000017895758,0.000072695744,0.000030141246,0.000003166027,0.000022181837,0.0000013166785,0.0001663297],"genre_scores_gemma":[0.0008961176,0.99890304,0.000053155858,0.000044204255,0.00002826974,0.0000042010843,0.00002446983,3.1647926e-7,0.00004618477],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.99955267,0.00009650012,0.00013972468,0.00007481605,0.000108250686,0.000027988302],"domain_scores_gemma":[0.9990903,0.00036334046,0.00027986392,0.000016658205,0.00020398102,0.0000458214],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010505305,0.0007197737,0.0015035564,0.005836274,0.00026730588,0.0010319784,0.000821941,0.0006851743,0.0020473914],"category_scores_gemma":[0.0018527869,0.00037756932,0.00083154766,0.0071886093,0.00049836363,0.0013260134,0.00055424107,0.0007293136,0.0004644554],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019549511,0.000054297027,0.002436567,0.12768926,0.000557122,0.00029861616,0.00030888518,0.00043841833,0.00068692525,0.0018867155,0.016177272,0.8492704],"study_design_scores_gemma":[0.00006969222,0.00037962818,0.034536332,0.11037906,0.002727982,0.007270904,0.00068595255,0.0002123326,0.00070579967,0.0017081079,0.84123105,0.00009316373],"about_ca_topic_score_codex":0.00445858,"about_ca_topic_score_gemma":0.006427749,"teacher_disagreement_score":0.005836274,"about_ca_system_score_codex":0.0010541681,"about_ca_system_score_gemma":0.0019922915,"threshold_uncertainty_score":0.008865237},"labels":[],"label_agreement":null},{"id":"W2057007354","doi":"10.1046/j.1365-2893.2003.00484.x","title":"Improving the accuracy of long‐term prognostic estimates in hepatitis C virus infection","year":2004,"lang":"en","type":"article","venue":"Journal of Viral Hepatitis","topic":"Hepatitis C virus research","field":"Medicine","cited_by":46,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University Health Network","funders":"","keywords":"Statistics; Stage (stratigraphy); Monte Carlo method; Cirrhosis; Series (stratigraphy); Mathematics; Algorithm; Medicine; Internal medicine; Biology","score_opus":0.023947388897651408,"score_gpt":0.33285299865214707,"score_spread":0.30890560975449566,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2057007354","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.5104502,0.013029064,0.46957886,0.001995523,0.00027400182,0.00012152643,0.0010053203,0.0007733148,0.0027722432],"genre_scores_gemma":[0.9575233,0.00082120794,0.040801153,0.00012179258,0.000084223706,0.00006837857,0.00028660634,0.000031247146,0.00026206762],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.97553456,0.019859858,0.001344797,0.0011966075,0.0016998636,0.00036432518],"domain_scores_gemma":[0.7718585,0.19177686,0.015333911,0.012584564,0.0076853326,0.000760697],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.06055324,0.00074341946,0.0011667991,0.0022230842,0.00054949336,0.0019142877,0.0012231958,0.0011789836,0.00060905353],"category_scores_gemma":[0.22659695,0.00072462304,0.0009021337,0.0013397684,0.0008722379,0.0020429515,0.0019498894,0.00135513,0.00021537942],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015251518,0.00007371674,0.6632709,0.00048123434,0.0023949323,0.00019212921,0.00059972884,0.09701429,0.0018729082,0.004906295,0.0018181315,0.22585052],"study_design_scores_gemma":[0.00018577234,0.0006167022,0.35406035,0.00067478465,0.0011939579,0.0007226631,0.0002588219,0.6026799,0.0058137127,0.029245365,0.004269566,0.00027846458],"about_ca_topic_score_codex":0.00581373,"about_ca_topic_score_gemma":0.005509496,"teacher_disagreement_score":0.06055324,"about_ca_system_score_codex":0.0011193937,"about_ca_system_score_gemma":0.0011021323,"threshold_uncertainty_score":0.32023996},"labels":[],"label_agreement":null},{"id":"W2060096504","doi":"10.1111/jvh.12185","title":"The number needed to treat to prevent mortality and cirrhosis‐related complications among patients with cirrhosis and <scp>HCV</scp> genotype 1 infection","year":2013,"lang":"en","type":"article","venue":"Journal of Viral Hepatitis","topic":"Hepatitis C virus research","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network","funders":"Santen","keywords":"Medicine; Internal medicine; Cirrhosis; Hazard ratio; Gastroenterology; Number needed to treat; Hepatitis C; Ribavirin; Cohort; Hepatitis C virus; Adverse effect; Liver disease; Confidence interval; Immunology; Relative risk; Virus","score_opus":0.016455812651438015,"score_gpt":0.297714568539418,"score_spread":0.28125875588798,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2060096504","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.976794,0.017179305,0.0017944387,0.0015428653,0.00019098667,0.00006887871,0.000551904,0.000030137202,0.0018476344],"genre_scores_gemma":[0.9968264,0.0013970839,0.00064028584,0.00034313402,0.00009198839,0.00007810014,0.00041036893,0.0000049729492,0.00020763779],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99762183,0.001619645,0.00022654922,0.00013278332,0.00030221473,0.00009694802],"domain_scores_gemma":[0.9953316,0.0026337588,0.001437972,0.00015634319,0.0001804765,0.00025990672],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003469312,0.00020515629,0.0010555162,0.00032359318,0.00015411263,0.00043315368,0.00034974806,0.00046465153,0.0007603789],"category_scores_gemma":[0.008876371,0.00016141415,0.0010692267,0.00032405625,0.00024224508,0.00053281913,0.00026091008,0.000788699,0.0001301509],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.030795485,0.0007023899,0.7681577,0.0015018103,0.004562345,0.00046415027,0.00020596267,0.012399895,0.0035440882,0.0011907452,0.0048191734,0.17165633],"study_design_scores_gemma":[0.0032249326,0.01163691,0.9430008,0.00034260532,0.0029467547,0.0028108212,0.00018653276,0.023565384,0.0020976735,0.0044934447,0.005583453,0.00011082667],"about_ca_topic_score_codex":0.0003543419,"about_ca_topic_score_gemma":0.0005691653,"teacher_disagreement_score":0.003469312,"about_ca_system_score_codex":0.0006095925,"about_ca_system_score_gemma":0.00037657973,"threshold_uncertainty_score":0.01834774},"labels":[],"label_agreement":null},{"id":"W2061757533","doi":"10.1111/j.1365-2893.2012.01648.x","title":"Factors associated with <scp>HCV</scp> antiviral treatment uptake among participants of a community‐based <scp>HCV</scp> programme for marginalized patients","year":2012,"lang":"en","type":"article","venue":"Journal of Viral Hepatitis","topic":"Hepatitis C virus research","field":"Medicine","cited_by":52,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto East General Hospital; University of Toronto; Regent Park Community Health Centre; St. Michael's Hospital","funders":"Ontario Ministry of Health and Long-Term Care","keywords":"Medicine; Ribavirin; Hepatitis C; Hepatitis C virus; Methadone; Internal medicine; Pegylated interferon; Context (archaeology); Population; Cohort; Immunology; Psychiatry; Virus; Environmental health; Biology","score_opus":0.146859740633206,"score_gpt":0.35291418746467745,"score_spread":0.20605444683147145,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2061757533","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99963975,0.000031525266,0.000012951906,0.00006555746,0.0000016845502,0.0000083302775,0.000032170537,0.0000011262822,0.00020690051],"genre_scores_gemma":[0.99982435,0.000019670288,0.000020860143,0.000027013008,0.0000046968166,0.0000075175412,0.00003498044,6.8301756e-7,0.00006031825],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9994874,0.00015168222,0.00004519091,0.000048704147,0.000109512985,0.00015755423],"domain_scores_gemma":[0.9980515,0.000342544,0.00072349986,0.00006433894,0.00018170345,0.00063640246],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00053333153,0.0001687335,0.00024551738,0.00046054026,0.0007776372,0.00077247084,0.00032681721,0.0004277476,0.0017534222],"category_scores_gemma":[0.0041854824,0.00018573651,0.00037452878,0.0005034407,0.0003142111,0.0003443499,0.00060453074,0.00080836477,0.00016023841],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009684386,0.00018593337,0.9969112,0.0000097605225,0.000020226973,0.000085007654,0.00065145694,0.00001826689,0.00019491746,0.00001920487,0.00010222723,0.0017049422],"study_design_scores_gemma":[0.0000064376954,0.00018306078,0.9983103,0.000009366202,0.0000122304955,0.0001322014,0.0010248469,0.00014136954,0.0000331428,0.000010895179,0.00013203836,0.000004103076],"about_ca_topic_score_codex":0.015447772,"about_ca_topic_score_gemma":0.013920563,"teacher_disagreement_score":0.015447772,"about_ca_system_score_codex":0.00040998292,"about_ca_system_score_gemma":0.00055641145,"threshold_uncertainty_score":0.030715704},"labels":[],"label_agreement":null},{"id":"W2065145796","doi":"10.1046/j.1365-2893.2002.00343.x","title":"Kinetics of serum cytokines reflect changes in the severity of chronic hepatitis C presenting minimal fibrosis","year":2002,"lang":"en","type":"article","venue":"Journal of Viral Hepatitis","topic":"Hepatitis C virus research","field":"Medicine","cited_by":62,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; University of Toronto; Sunnybrook Health Science Centre","funders":"","keywords":"Fibrosis; Medicine; Gastroenterology; Liver biopsy; Hepatitis C virus; Internal medicine; Cytokine; Biopsy; Tumor necrosis factor alpha; Hepatic fibrosis; Chronic hepatitis; Inflammation; Pathology; Immunology; Virus","score_opus":0.043283181199984935,"score_gpt":0.32510723903434213,"score_spread":0.2818240578343572,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2065145796","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99931407,0.00026388088,0.00014272158,0.000007850571,0.0000023833127,0.000011827188,0.000052158928,0.000004916567,0.00020016634],"genre_scores_gemma":[0.99935085,0.00008331846,0.00030416728,0.000011765524,0.000007736178,0.000011647696,0.00011180888,0.0000015860933,0.00011713012],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99974316,0.00008803479,0.000035498037,0.000056886547,0.00004249584,0.000033879347],"domain_scores_gemma":[0.9987042,0.00038495482,0.0005586227,0.000059261834,0.000093792005,0.00019911668],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00041670058,0.0003368616,0.00033477994,0.00045600676,0.00018034653,0.0003806578,0.00009499694,0.00033584045,0.0008770771],"category_scores_gemma":[0.0015397179,0.00014273368,0.00012513355,0.0003342464,0.00023839506,0.00031416916,0.00017087441,0.00032958228,0.00024210999],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0027201842,0.00016927256,0.96675897,0.0000447326,0.000030257,0.00020226763,0.00013591332,0.00014598429,0.02414838,0.000022636475,0.00003256061,0.0055888696],"study_design_scores_gemma":[0.000060178612,0.0031837765,0.98843414,0.00000821835,0.00003888181,0.0014223101,0.00017036896,0.0004967251,0.005890372,0.00004767108,0.00023726498,0.000010086305],"about_ca_topic_score_codex":0.00021525583,"about_ca_topic_score_gemma":0.00024604838,"teacher_disagreement_score":0.0008770771,"about_ca_system_score_codex":0.00016127969,"about_ca_system_score_gemma":0.000101611804,"threshold_uncertainty_score":0.0029341578},"labels":[],"label_agreement":null},{"id":"W2067333579","doi":"10.1111/j.1365-2893.2005.00613.x","title":"Response to long‐term lamivudine treatment (up to 5 years) in patients with severe chronic hepatitis B, role of genotype and drug resistance","year":2005,"lang":"en","type":"article","venue":"Journal of Viral Hepatitis","topic":"Hepatitis B Virus Studies","field":"Medicine","cited_by":50,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Canada; Toronto Western Hospital; University of Toronto; University Health Network","funders":"","keywords":"Lamivudine; Genotype; HBeAg; Hepatitis B virus; Medicine; Virology; Cirrhosis; Genotyping; Hepatitis B; Gastroenterology; Internal medicine; HBsAg; Virus; Biology; Genetics; Gene","score_opus":0.0061573420393609924,"score_gpt":0.24741681213275285,"score_spread":0.24125947009339185,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2067333579","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9959907,0.0033841012,0.00006538552,0.00012264124,0.000015010586,0.00000764092,0.00013495557,0.000005794132,0.00027390983],"genre_scores_gemma":[0.99883014,0.00045010983,0.00008727833,0.00009771158,0.00003446706,0.000010710583,0.00034210383,0.0000012057648,0.00014633496],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99956053,0.00015079846,0.000080381215,0.00006382682,0.00006300259,0.000081365186],"domain_scores_gemma":[0.9987903,0.00029248404,0.00048675312,0.00003947819,0.0001141492,0.00027677653],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00079670944,0.00023054166,0.000492413,0.00032948863,0.00037142332,0.00034429049,0.00019202946,0.00046968157,0.00077978877],"category_scores_gemma":[0.0017256292,0.00010904104,0.00043061454,0.0003818559,0.00019467573,0.00029685916,0.00020500788,0.00032411216,0.00017207157],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018946631,0.00009832232,0.9796611,0.00007657233,0.00014250503,0.00060052186,0.00010339942,0.000125716,0.001424121,0.000011011141,0.00028605448,0.015576078],"study_design_scores_gemma":[0.00009789101,0.0015376973,0.99527174,0.000030248419,0.00007042216,0.0018103225,0.00010106479,0.00019632938,0.00022532296,0.000015786803,0.0006363147,0.000006807046],"about_ca_topic_score_codex":0.0008634655,"about_ca_topic_score_gemma":0.0019256043,"teacher_disagreement_score":0.0008634655,"about_ca_system_score_codex":0.00035472098,"about_ca_system_score_gemma":0.00023851261,"threshold_uncertainty_score":0.0042134523},"labels":[],"label_agreement":null},{"id":"W2068074952","doi":"10.1111/j.1365-2893.2004.00544.x","title":"Survival in HIV‐infected patients is associated with hepatitis C virus infection and injecting drug use since the use of highly active antiretroviral therapy in the Lyon observational database","year":2004,"lang":"en","type":"article","venue":"Journal of Viral Hepatitis","topic":"Hepatitis C virus research","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Hotel Dieu Hospital","funders":"","keywords":"Medicine; Hepatitis C virus; Internal medicine; Hepatitis C; Incidence (geometry); Antiretroviral therapy; Human immunodeficiency virus (HIV); Mortality rate; Cause of death; Viral load; Immunology; Virus; Disease","score_opus":0.07244793788210502,"score_gpt":0.3135545069130945,"score_spread":0.24110656903098948,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2068074952","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99555737,0.0006040447,0.00007608324,0.00012604312,0.0000052066744,0.00000685974,0.003112839,0.000009263198,0.00050229864],"genre_scores_gemma":[0.99704844,0.0001935719,0.000068405134,0.00003533183,0.00001083731,0.000008884246,0.0025230902,0.0000014514202,0.00011007496],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9994068,0.00026305707,0.00007763371,0.00009075659,0.000067775596,0.00009394664],"domain_scores_gemma":[0.9964772,0.0011738188,0.0014834838,0.00021408852,0.0002466876,0.00040470072],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009810171,0.00013735268,0.0003867386,0.00094858336,0.00026360425,0.0005815917,0.00029944442,0.00036219176,0.0014802839],"category_scores_gemma":[0.003105911,0.00016001351,0.0005371481,0.0012119994,0.00016692202,0.00028224415,0.00041397836,0.0003717625,0.00017729608],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017344131,0.000007432537,0.99874914,0.000010357686,0.00007052561,0.000021352991,0.00001547916,0.00008745438,0.000023077719,0.000013743508,0.00021854702,0.0006093893],"study_design_scores_gemma":[0.000018836658,0.00004222035,0.99905044,0.000009808126,0.00004252869,0.00009451531,0.00004950546,0.00038218574,0.000014655196,0.000023046032,0.00026908607,0.0000032703374],"about_ca_topic_score_codex":0.01573827,"about_ca_topic_score_gemma":0.014051772,"teacher_disagreement_score":0.01573827,"about_ca_system_score_codex":0.00055819924,"about_ca_system_score_gemma":0.00039300908,"threshold_uncertainty_score":0.031293333},"labels":[],"label_agreement":null},{"id":"W2073634698","doi":"10.1111/j.1365-2893.2009.01086.x","title":"Entire genome sequences of two new HCV subtypes, 6r and 6s, and characterization of unique HVR1 variation patterns within genotype 6","year":2009,"lang":"en","type":"article","venue":"Journal of Viral Hepatitis","topic":"Hepatitis C virus research","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Institut National de Santé Publique du Québec","funders":"","keywords":"Hypervariable region; Biology; Genetics; Genotype; Genome; Phylogenetic tree; Whole genome sequencing; Gene","score_opus":0.01812975023117602,"score_gpt":0.2971612069482752,"score_spread":0.27903145671709917,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2073634698","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9984837,0.00013252694,0.00029441615,0.000014134805,0.0000019471413,0.000013814156,0.0007797499,0.0000034576947,0.00027635033],"genre_scores_gemma":[0.9914492,0.00018296839,0.0021953515,0.000044426222,0.000009068737,0.000020432602,0.0053650974,0.000008270237,0.00072506943],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9998703,0.0000096633175,0.000008945447,0.00003309489,0.000049387294,0.000028627068],"domain_scores_gemma":[0.99977976,0.000033479606,0.00006524105,0.000025816273,0.000048135335,0.000047597914],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014710541,0.00017689941,0.00018665721,0.00034275255,0.00038442563,0.00029141977,0.00014143523,0.00016510276,0.0008713096],"category_scores_gemma":[0.0003810225,0.00010515306,0.00029283995,0.0005146575,0.00018984335,0.000086455286,0.00016075124,0.0002558881,0.00018092888],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008913613,0.00004661833,0.20173942,0.00014968228,0.000063540385,0.0009770931,0.0018691604,0.00048533932,0.7693024,0.00022263343,0.00022553763,0.024027187],"study_design_scores_gemma":[0.000014455754,0.00018810584,0.9851387,0.000019009398,0.000035874993,0.0009625607,0.00042649504,0.00057541754,0.010124968,0.000022884358,0.0024814869,0.00001004661],"about_ca_topic_score_codex":0.025354628,"about_ca_topic_score_gemma":0.057144612,"teacher_disagreement_score":0.025354628,"about_ca_system_score_codex":0.00049913075,"about_ca_system_score_gemma":0.000555531,"threshold_uncertainty_score":0.050414085},"labels":[],"label_agreement":null},{"id":"W2074985863","doi":"10.1111/j.1365-2893.2006.00834.x","title":"Antagonistic expression of hepatitis C virus and alpha interferon in lymphoid cells during persistent occult infection","year":2007,"lang":"en","type":"article","venue":"Journal of Viral Hepatitis","topic":"Hepatitis C virus research","field":"Medicine","cited_by":28,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Memorial University of Newfoundland","funders":"","keywords":"Hepatitis C virus; Biology; Immunology; Immune system; Viral replication; Virology; Viral load; Interferon; Ex vivo; Downregulation and upregulation; Tumor necrosis factor alpha; T cell; Virus; In vivo; Gene","score_opus":0.015654438648006835,"score_gpt":0.30025496597443085,"score_spread":0.28460052732642405,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2074985863","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9993268,0.0002460575,0.000104077066,0.0000053290582,0.0000012839331,0.0000033807169,0.000017967519,0.0000032766188,0.00029186855],"genre_scores_gemma":[0.9994686,0.000077699835,0.00018499285,0.000012842838,0.0000055482956,0.0000086893015,0.00005034191,0.0000016985275,0.00018956342],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9998062,0.00006072012,0.000012095547,0.000033662665,0.000036358262,0.000051000414],"domain_scores_gemma":[0.9997396,0.00007595041,0.00005750856,0.00002789174,0.000037410224,0.00006157019],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003511946,0.00012547504,0.00024403962,0.00043054376,0.0001701548,0.0003532082,0.000120403005,0.000201442,0.0005873705],"category_scores_gemma":[0.00059933675,0.00013552855,0.00008805579,0.00018827882,0.00025040773,0.0001590808,0.0003060055,0.00018385662,0.00021033385],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0030652052,0.00009314024,0.15573822,0.000067638044,0.00001295465,0.0010847226,0.0003912701,0.00008902969,0.82820994,0.00010520256,0.000051791387,0.011090882],"study_design_scores_gemma":[0.000092538925,0.0025844413,0.8524429,0.000025257681,0.00007548286,0.0061727404,0.00063673547,0.0012408334,0.13520074,0.00026511852,0.0012494776,0.000013624796],"about_ca_topic_score_codex":0.000314215,"about_ca_topic_score_gemma":0.00055651495,"teacher_disagreement_score":0.0005873705,"about_ca_system_score_codex":0.00021127955,"about_ca_system_score_gemma":0.00012308023,"threshold_uncertainty_score":0.0019649863},"labels":[],"label_agreement":null},{"id":"W2076102296","doi":"10.1111/jvh.12019","title":"Chronic hepatitis <scp>B</scp> virus (<scp>HBV</scp>) infection in children: 25 years' experience","year":2012,"lang":"en","type":"article","venue":"Journal of Viral Hepatitis","topic":"Hepatitis B Virus Studies","field":"Medicine","cited_by":31,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute for Work & Health; Institute of Health Services and Policy Research; Hospital for Sick Children; University of Toronto","funders":"Gilead Sciences; Bristol-Myers Squibb","keywords":"Seroconversion; Medicine; HBeAg; HBsAg; Internal medicine; Hepatitis B virus; Immunology; Hepatitis B; Gastroenterology; Viral load; Antibody; Virus","score_opus":0.01353684405594725,"score_gpt":0.27980358130641075,"score_spread":0.2662667372504635,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2076102296","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9988807,0.00053932547,0.00003314238,0.00005193216,0.000004723174,0.0000064502747,0.000083134604,0.0000022696772,0.00039830946],"genre_scores_gemma":[0.99854904,0.001035807,0.00005247145,0.000035718116,0.000014192423,0.000007883183,0.00011772055,0.0000015581938,0.00018561188],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9994468,0.000106844935,0.000059535123,0.000079230755,0.00011218546,0.00019528766],"domain_scores_gemma":[0.99922335,0.00013506266,0.0002677413,0.00003277403,0.000068885434,0.000272161],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008447837,0.00027979506,0.00029687048,0.0006450963,0.00054065353,0.00058622315,0.00028100368,0.00044964833,0.0007917552],"category_scores_gemma":[0.001540303,0.0002811607,0.0003669427,0.00078141707,0.0006478865,0.0006013451,0.00052750483,0.00045382336,0.00021122576],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006953965,0.000064566746,0.9916436,0.000019529522,0.000025555437,0.0014855549,0.0010736015,0.00006536684,0.00018073547,0.000048581147,0.00022423179,0.005099079],"study_design_scores_gemma":[0.000011624507,0.00049295253,0.9909456,0.000026842714,0.000021564778,0.005640844,0.0013312715,0.000063276835,0.00012470057,0.000025601139,0.0013068023,0.000008858696],"about_ca_topic_score_codex":0.014585129,"about_ca_topic_score_gemma":0.01522629,"teacher_disagreement_score":0.014585129,"about_ca_system_score_codex":0.0007249688,"about_ca_system_score_gemma":0.00066463253,"threshold_uncertainty_score":0.029000461},"labels":[],"label_agreement":null},{"id":"W2076368506","doi":"10.1111/jvh.12218","title":"Loss of intrahepatic <scp>HB</scp>s<scp>A</scp>g expression predicts sustained response to peginterferon and is reflected by pronounced serum <scp>HB</scp>s<scp>A</scp>g decline","year":2014,"lang":"en","type":"article","venue":"Journal of Viral Hepatitis","topic":"Hepatitis B Virus Studies","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network","funders":"","keywords":"Medicine; Internal medicine; Hepatitis B; Hepatitis B virus; Gastroenterology; Immunology; Virus","score_opus":0.011445824521247526,"score_gpt":0.27479550720275375,"score_spread":0.2633496826815062,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2076368506","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9995301,0.0001607731,0.00006830569,0.000014654892,0.000002072544,0.0000024029412,0.000022807368,0.0000029349417,0.00019602626],"genre_scores_gemma":[0.9997124,0.000048930175,0.00004782968,0.000009170825,0.000006748498,0.0000026257521,0.000077864424,9.948188e-7,0.000093370756],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9997845,0.00006746337,0.00003006154,0.000041138228,0.00004094659,0.000035896286],"domain_scores_gemma":[0.9988317,0.00032702953,0.0005126092,0.000055305565,0.0000659821,0.00020741657],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00046305754,0.00026157757,0.00023558507,0.0004566784,0.00013152463,0.0003963231,0.0001364738,0.0004134824,0.0012345697],"category_scores_gemma":[0.0014784201,0.00017835223,0.00019197051,0.00024190304,0.00030829516,0.0002833423,0.0001983708,0.00036588917,0.0003578255],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010395497,0.00006187227,0.99224913,0.000010883354,0.000032114924,0.000084371124,0.000029695251,0.00008780449,0.0027648362,0.000010557334,0.00006172152,0.0035675513],"study_design_scores_gemma":[0.000012715626,0.00030455604,0.9981369,0.000003781026,0.00001762283,0.00051707664,0.000036447054,0.00041657066,0.00045077954,0.000018007277,0.000083578736,0.0000020836567],"about_ca_topic_score_codex":0.0006031524,"about_ca_topic_score_gemma":0.00043926868,"teacher_disagreement_score":0.0012345697,"about_ca_system_score_codex":0.00016540608,"about_ca_system_score_gemma":0.00011119027,"threshold_uncertainty_score":0.004130006},"labels":[],"label_agreement":null},{"id":"W2077606460","doi":"10.1111/jvh.12236","title":"Infected hematopoietic stem cells and with integrated <scp>HBV DNA</scp> generate defective <scp>T</scp> cells in chronic <scp>HBV</scp> infection patients","year":2014,"lang":"en","type":"article","venue":"Journal of Viral Hepatitis","topic":"Hepatitis B Virus Studies","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Peking University Health Science Center; Peking University; University of Toronto; Ministry of Education of the People's Republic of China; National Natural Science Foundation of China","keywords":"Haematopoiesis; Virology; Stem cell; Biology; Cell biology","score_opus":0.008363379964173183,"score_gpt":0.22478419587147122,"score_spread":0.21642081590729803,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2077606460","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9991959,0.00019454703,0.00026366304,0.000010484686,0.0000021115723,0.0000112136795,0.0000779579,0.000012085432,0.00023200178],"genre_scores_gemma":[0.9988269,0.00012079559,0.0003047329,0.00002176751,0.000004186646,0.000020345064,0.00029926348,0.000006660931,0.00039528444],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99990404,0.000016477037,0.000016338305,0.000023578372,0.000021861966,0.00001777377],"domain_scores_gemma":[0.9998723,0.000022735094,0.00003066264,0.000019155937,0.000010670878,0.000044430246],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011538084,0.00020478341,0.00021095625,0.00028012763,0.000114442664,0.00020860923,0.00008520883,0.0001996821,0.0020145646],"category_scores_gemma":[0.00017239756,0.0001388012,0.00014869634,0.00016294961,0.00020436403,0.000118917626,0.00016846873,0.00034548022,0.0004136547],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015110058,0.00016680549,0.0266031,0.000064690124,0.000025157553,0.0010506789,0.00014625685,0.00010953516,0.9629394,0.00012986713,0.00013444074,0.0071191657],"study_design_scores_gemma":[0.00047908563,0.008100195,0.36820152,0.000044913035,0.00019718401,0.025677674,0.0004189872,0.0032996435,0.58680314,0.00032460052,0.006429611,0.000023421058],"about_ca_topic_score_codex":0.0002900425,"about_ca_topic_score_gemma":0.00022636054,"teacher_disagreement_score":0.0020145646,"about_ca_system_score_codex":0.00008365552,"about_ca_system_score_gemma":0.0000980118,"threshold_uncertainty_score":0.0067394376},"labels":[],"label_agreement":null},{"id":"W2078178324","doi":"10.1111/j.1365-2893.2007.00942.x","title":"Risk of hepatitis C virus transmission through drug preparation equipment: a systematic and methodological review","year":2008,"lang":"en","type":"review","venue":"Journal of Viral Hepatitis","topic":"Hepatitis C virus research","field":"Medicine","cited_by":54,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institut National de Santé Publique du Québec; Université de Sherbrooke; McGill University","funders":"Canadian Institutes of Health Research","keywords":"Medicine; Incidence (geometry); Transmission (telecommunications); Drug; Hepatitis C; Cohort; Hepatitis C virus; Cohort study; Confounding; Confidence interval; Relative risk; Internal medicine; Environmental health; Virology; Pharmacology; Virus; Computer science","score_opus":0.13032436202156428,"score_gpt":0.44953812826403317,"score_spread":0.3192137662424689,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2078178324","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00082281575,0.9982761,0.00018292974,0.00012659699,0.000058981695,0.00023150127,0.00014346933,0.0000043137547,0.00015332208],"genre_scores_gemma":[0.0077788723,0.9908737,0.00073033693,0.000112142305,0.000024390694,0.00032297277,0.00009507188,0.0000020270436,0.000060486254],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9923206,0.0029452434,0.0028364784,0.00046595582,0.00125651,0.00017521101],"domain_scores_gemma":[0.97079986,0.021118209,0.004865878,0.0004108477,0.002551279,0.00025391387],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.009242505,0.0014724805,0.007941175,0.011566706,0.00060854235,0.0024320649,0.0017780734,0.0015908616,0.0030809857],"category_scores_gemma":[0.043609943,0.00123615,0.0057693557,0.013333093,0.0008146387,0.0017829355,0.0014627597,0.00083154725,0.00028930564],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019693152,0.000018861043,0.0017085143,0.9232928,0.010515442,0.00018660988,0.00019851903,0.0001430561,0.00015930657,0.0002465321,0.0010502202,0.06228318],"study_design_scores_gemma":[0.00027211726,0.000304564,0.008148865,0.84399617,0.12162291,0.0010232917,0.00047647863,0.0001521514,0.00030028183,0.00052577036,0.02312804,0.00004943804],"about_ca_topic_score_codex":0.0073346007,"about_ca_topic_score_gemma":0.020235032,"teacher_disagreement_score":0.011566706,"about_ca_system_score_codex":0.0036346498,"about_ca_system_score_gemma":0.011413201,"threshold_uncertainty_score":0.048879623},"labels":[{"model":"gemma","categories":[],"domain":null,"study_design":"systematic_review","genre":"review","about_ca_system":false,"about_ca_topic":false,"confidence":"low"},{"model":"gpt","categories":["metaresearch"],"domain":"methods","study_design":"systematic_review","genre":"review","about_ca_system":false,"about_ca_topic":false,"confidence":"medium"}],"label_agreement":"split"},{"id":"W2080010723","doi":"10.1111/jvh.12279","title":"<scp>APRI</scp> and <scp>FIB</scp>‐4 are good predictors of the stage of liver fibrosis in chronic hepatitis <scp>B</scp>: the Chronic Hepatitis Cohort Study (<scp>CH</scp>e<scp>CS</scp>)","year":2014,"lang":"en","type":"article","venue":"Journal of Viral Hepatitis","topic":"Hepatitis B Virus Studies","field":"Medicine","cited_by":99,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Janssen Pharmaceuticals; Genentech; AbbVie Canada; Vertex Pharmaceuticals; Centers for Disease Control and Prevention Foundation; AbbVie; Bristol-Myers Squibb","keywords":"Fibrosis; Liver biopsy; Medicine; Liver fibrosis; Internal medicine; Gastroenterology; Stage (stratigraphy); Chronic hepatitis; Biopsy; Immunology; Biology; Virus","score_opus":0.011076889738527787,"score_gpt":0.24399053213968858,"score_spread":0.2329136424011608,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2080010723","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9979989,0.00044571288,0.00030026387,0.00006303165,0.000010837549,0.000014026918,0.0002443385,0.0000075064495,0.00091539294],"genre_scores_gemma":[0.9986045,0.000099418285,0.00056100026,0.000015601176,0.000021140784,0.000011625088,0.00039330256,0.0000029297112,0.00029057314],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9993247,0.00032143766,0.000052164654,0.00009039034,0.00012927632,0.00008203655],"domain_scores_gemma":[0.99715245,0.0012722514,0.00071505783,0.0002074976,0.00027849627,0.00037424837],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0027448966,0.00060912065,0.0003944592,0.0014966612,0.00045827776,0.0007041593,0.00031155214,0.0006214506,0.0020336437],"category_scores_gemma":[0.0053245053,0.00021378152,0.0005008161,0.0005720714,0.0005323893,0.00048361323,0.00058161723,0.00052339665,0.00038739355],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00045230292,0.000021210155,0.99566615,0.0000101382375,0.00008484312,0.00002660334,0.000023176755,0.00007546485,0.0004631604,0.00001661809,0.00007380661,0.0030864715],"study_design_scores_gemma":[0.00001636795,0.00017449475,0.99860966,0.000004791387,0.00006395039,0.00015404278,0.000047356,0.00036909443,0.0002880888,0.00007071625,0.00019565999,0.000005586921],"about_ca_topic_score_codex":0.0016644591,"about_ca_topic_score_gemma":0.003104389,"teacher_disagreement_score":0.0027448966,"about_ca_system_score_codex":0.00019961869,"about_ca_system_score_gemma":0.00035887142,"threshold_uncertainty_score":0.014516592},"labels":[],"label_agreement":null},{"id":"W2081137746","doi":"10.1111/j.1365-2893.2009.01097.x","title":"Treatment of hepatitis C infection for current or former substance abusers in a community setting","year":2009,"lang":"en","type":"article","venue":"Journal of Viral Hepatitis","topic":"Hepatitis C virus research","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Public Health Ontario; Yorkville University; University of Toronto; Toronto Public Health; University Health Network","funders":"","keywords":"Medicine; Hepatitis C; Substance abuse; Context (archaeology); Internal medicine; Urine; Ribavirin; Hepatitis C virus; Psychiatry; Immunology; Virus; Biology","score_opus":0.05819071225426575,"score_gpt":0.3903572395361643,"score_spread":0.33216652728189855,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2081137746","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98765635,0.003149522,0.0014313352,0.0013924651,0.000051822848,0.00076821935,0.00010823854,0.000067654604,0.0053743892],"genre_scores_gemma":[0.9881272,0.0032650963,0.005188492,0.0008496812,0.00014161367,0.0003471559,0.00022348181,0.000010374533,0.0018469993],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99938107,0.00034826677,0.000030803258,0.00004226446,0.00010773594,0.00008979947],"domain_scores_gemma":[0.99895704,0.00015242212,0.00030771355,0.00004780475,0.00008386035,0.00045120803],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006017427,0.00017920713,0.00026780434,0.00031688221,0.0012378071,0.0005312557,0.00050325185,0.00044889288,0.0034416756],"category_scores_gemma":[0.0017644479,0.00016264504,0.00021733712,0.00035907503,0.00034560557,0.00029592833,0.0007546458,0.00053768134,0.0005760737],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010978625,0.009207864,0.5480416,0.0007312772,0.0001354744,0.0026500858,0.0012824875,0.00074061524,0.0073659886,0.00042395978,0.009291811,0.41903114],"study_design_scores_gemma":[0.00086026406,0.018424863,0.94720846,0.0005118878,0.00016989856,0.009613519,0.002453997,0.0036954165,0.0014398553,0.0007287603,0.014832911,0.000060192833],"about_ca_topic_score_codex":0.0060148174,"about_ca_topic_score_gemma":0.024994636,"teacher_disagreement_score":0.0060148174,"about_ca_system_score_codex":0.0006929702,"about_ca_system_score_gemma":0.0020115816,"threshold_uncertainty_score":0.011959612},"labels":[],"label_agreement":null},{"id":"W2082200384","doi":"10.1111/j.1365-2893.2006.00753.x","title":"HCV‐related advanced fibrosis/cirrhosis: randomized controlled trial of pegylated interferon<i>α</i>‐2a and ribavirin","year":2006,"lang":"en","type":"article","venue":"Journal of Viral Hepatitis","topic":"Hepatitis C virus research","field":"Medicine","cited_by":70,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"","keywords":"Medicine; Ribavirin; Pegylated interferon; Gastroenterology; Internal medicine; Tolerability; Cirrhosis; Hepatitis C virus; Hepatitis C; Adverse effect; Randomized controlled trial; Immunology; Virus","score_opus":0.007071358825222683,"score_gpt":0.2841870347743046,"score_spread":0.27711567594908193,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2082200384","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9773796,0.0097160265,0.00080435653,0.001413013,0.0014958726,0.0051365388,0.0011173818,0.00026025475,0.0026768988],"genre_scores_gemma":[0.98111284,0.004115443,0.0017646971,0.0020678272,0.0008138881,0.0055772904,0.0012058981,0.000032151085,0.0033099307],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9991449,0.0004898238,0.00005760419,0.00012664145,0.000050537896,0.00013050233],"domain_scores_gemma":[0.99896693,0.0002876976,0.00026590406,0.000066163695,0.00005330267,0.00035992343],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017845045,0.0014943342,0.0035299321,0.00042679356,0.00049213803,0.0011098847,0.0011225091,0.0022605052,0.0054675657],"category_scores_gemma":[0.001714404,0.0007430218,0.0018407423,0.00047307104,0.0015460639,0.00094335765,0.0004499532,0.003003272,0.0008593476],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9911534,0.0017885426,0.00030989866,0.00034037282,0.00045001213,0.000018638886,0.000019495681,0.00012341773,0.00046748805,0.000061966486,0.0004097526,0.004856867],"study_design_scores_gemma":[0.9837984,0.014444426,0.0007570355,0.000022228485,0.00022488416,0.000016614027,0.000009276273,0.00028126908,0.00010814166,0.00006794143,0.00026350562,0.0000062215913],"about_ca_topic_score_codex":0.0018837668,"about_ca_topic_score_gemma":0.0031326178,"teacher_disagreement_score":0.0054675657,"about_ca_system_score_codex":0.0007533772,"about_ca_system_score_gemma":0.0011128776,"threshold_uncertainty_score":0.018290818},"labels":[],"label_agreement":null},{"id":"W2085673843","doi":"10.1111/jvh.12166_19","title":"P20: Understanding the impact of a cure for hepatitis C from the patient perspective","year":2013,"lang":"en","type":"article","venue":"Journal of Viral Hepatitis","topic":"Hepatitis C virus research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Thematic analysis; Hepatitis C; Qualitative research; Quality of life (healthcare); Asymptomatic; Stigma (botany); Disease; Family medicine; Internal medicine; Psychiatry; Nursing","score_opus":0.04967900589149202,"score_gpt":0.3565578193475997,"score_spread":0.3068788134561077,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2085673843","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.3907052,0.027349943,0.008881564,0.46738577,0.0030818183,0.0005731982,0.00062699494,0.0000805952,0.10131487],"genre_scores_gemma":[0.94731575,0.012907436,0.0027143194,0.032066245,0.00067573384,0.00020263917,0.00011437251,0.000040308896,0.0039632926],"study_design_codex":"qualitative","study_design_gemma":"qualitative","domain_scores_codex":[0.99042714,0.007075428,0.00019410934,0.0002978156,0.0010063406,0.0009992579],"domain_scores_gemma":[0.99075013,0.005860954,0.0006921006,0.0001601748,0.00095876615,0.0015778698],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.010218825,0.00067802536,0.0005537766,0.0009940577,0.008591401,0.008031827,0.0020148042,0.0035706058,0.0066235606],"category_scores_gemma":[0.012734944,0.00038606822,0.00079693645,0.001326542,0.017540896,0.0091793975,0.006844027,0.008000859,0.000645083],"study_design_candidate":"qualitative","study_design_consensus":"qualitative","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007434099,0.00008738884,0.005824762,0.0012701337,0.000030042294,0.0019406569,0.9047003,0.00019321575,0.0005805261,0.027575953,0.02121968,0.03650301],"study_design_scores_gemma":[0.00002460013,0.00016953656,0.004140787,0.0013469807,0.00003478251,0.0023684793,0.86440164,0.00024509188,0.0002535684,0.015854063,0.11111666,0.000043862423],"about_ca_topic_score_codex":0.025097245,"about_ca_topic_score_gemma":0.031196173,"teacher_disagreement_score":0.025097245,"about_ca_system_score_codex":0.011662378,"about_ca_system_score_gemma":0.017095955,"threshold_uncertainty_score":0.0846169},"labels":[],"label_agreement":null},{"id":"W2088738784","doi":"10.1111/j.1365-2893.2004.00507.x","title":"Serum immunoglobulins predict the extent of hepatic fibrosis in patients with chronic hepatitis C virus infection","year":2004,"lang":"en","type":"article","venue":"Journal of Viral Hepatitis","topic":"Hepatitis C virus research","field":"Medicine","cited_by":46,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"","keywords":"Antibody; Medicine; Immunology; Serology; Hepatitis C virus; Fibrosis; Hepatic fibrosis; Immunoglobulin G; Immunoglobulin A; Immunoglobulin M; Gastroenterology; Internal medicine; Virus","score_opus":0.00877060117949128,"score_gpt":0.264208526295404,"score_spread":0.2554379251159127,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2088738784","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.999111,0.00045917762,0.000092829345,0.000036353496,0.00000524493,0.000004395886,0.00005286528,0.00000500565,0.00023318829],"genre_scores_gemma":[0.99961805,0.00010515884,0.00010743681,0.000014355021,0.000010344584,0.0000030959081,0.00007763545,0.0000010171224,0.00006292365],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9997168,0.00010497202,0.000042272088,0.000032603217,0.00006204901,0.000041188396],"domain_scores_gemma":[0.9978275,0.00097522733,0.00059713284,0.000074648684,0.00021929946,0.0003062015],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00049462257,0.00034056682,0.00032566366,0.000730549,0.00027275234,0.00033353115,0.00015406766,0.0005434699,0.0010277438],"category_scores_gemma":[0.0032950712,0.00017489152,0.00018189615,0.0005148604,0.0003288892,0.00034484957,0.0002310436,0.00046103002,0.00018136931],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000062612424,0.000008463535,0.999046,0.00000326019,0.00000854642,0.000049596347,0.000013791559,0.000025932497,0.00015785635,0.000002206479,0.000021358117,0.0006003979],"study_design_scores_gemma":[0.000005661338,0.00011411154,0.99882084,0.0000048410416,0.000014955821,0.0005658083,0.000058654,0.00026357512,0.0000709945,0.0000097323,0.00006899323,0.0000018660371],"about_ca_topic_score_codex":0.0015865406,"about_ca_topic_score_gemma":0.0020330457,"teacher_disagreement_score":0.0015865406,"about_ca_system_score_codex":0.00012159464,"about_ca_system_score_gemma":0.00018406833,"threshold_uncertainty_score":0.0034381151},"labels":[],"label_agreement":null},{"id":"W2095079937","doi":"10.1111/jvh.12402","title":"Hepatitis B reactivation in HBsAg‐negative/HBcAb‐positive patients receiving rituximab for lymphoma: a meta‐analysis","year":2015,"lang":"en","type":"review","venue":"Journal of Viral Hepatitis","topic":"Hepatitis B Virus Studies","field":"Medicine","cited_by":128,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto Western Hospital; Sunnybrook Health Science Centre; St. Michael's Hospital","funders":"","keywords":"Medicine; HBsAg; Rituximab; Hepatitis B virus; Internal medicine; Hepatitis B; Prospective cohort study; Meta-analysis; Gastroenterology; Immunology; Lymphoma; Virology; Virus","score_opus":0.07986019504834359,"score_gpt":0.36813493434342764,"score_spread":0.28827473929508407,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2095079937","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.01717235,0.9810814,0.00050863955,0.00015223103,0.00014009129,0.00018876095,0.00038822799,0.00003478671,0.00033349748],"genre_scores_gemma":[0.44382328,0.550729,0.0017242223,0.0011697749,0.00025566222,0.0006031822,0.0010566787,0.000051497394,0.00058667146],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99509674,0.002540111,0.0011926813,0.0005460852,0.00039277412,0.0002316508],"domain_scores_gemma":[0.9914004,0.006157268,0.0012774494,0.00035613414,0.0006207513,0.00018803532],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.008297549,0.0026047814,0.014718881,0.0038209972,0.00058076467,0.0031798072,0.0018563308,0.0020318958,0.0029445945],"category_scores_gemma":[0.015380382,0.001415434,0.04142527,0.0042097573,0.00056888274,0.0013356718,0.0012129915,0.0019034152,0.0003324949],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0046613696,0.00003685787,0.004274123,0.12495409,0.8575804,0.00018289304,0.000060497106,0.00066897715,0.00031815819,0.00006334766,0.0003417899,0.0068576103],"study_design_scores_gemma":[0.00050393457,0.00017139364,0.0027500384,0.0042832824,0.9913509,0.000070765105,0.000020705698,0.00016798981,0.00007815493,0.00007995111,0.000510227,0.0000125800125],"about_ca_topic_score_codex":0.0060752556,"about_ca_topic_score_gemma":0.011549127,"teacher_disagreement_score":0.014718881,"about_ca_system_score_codex":0.0021355595,"about_ca_system_score_gemma":0.0016818814,"threshold_uncertainty_score":0.04388213},"labels":[],"label_agreement":null},{"id":"W2095416281","doi":"10.1111/j.1365-2893.2008.00985.x","title":"Health care costs of persons with newly diagnosed hepatitis C virus: a population‐based, observational study","year":2008,"lang":"en","type":"article","venue":"Journal of Viral Hepatitis","topic":"Hepatitis C virus research","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Capital District Health Authority; University of Alberta; Alberta Health","funders":"","keywords":"Medicine; Observational study; Health care; Population; Hepatitis C; Family medicine; Medical record; Demography; Environmental health; Emergency medicine; Internal medicine","score_opus":0.07009147985287144,"score_gpt":0.3625939495572139,"score_spread":0.29250246970434246,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2095416281","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99908686,0.00014072633,0.000027898128,0.00003622181,0.0000027376786,0.000012285478,0.00053770567,0.0000011630785,0.00015433259],"genre_scores_gemma":[0.9985839,0.00017917634,0.00005773569,0.000039143084,0.000010549243,0.000013097868,0.0009910121,0.0000010537132,0.00012430016],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9991565,0.00020129993,0.000063325046,0.000096327385,0.00030307795,0.00017939863],"domain_scores_gemma":[0.99818677,0.00034978695,0.0007366974,0.00011575722,0.0003072254,0.00030377327],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006835222,0.000346385,0.0004501173,0.0010554584,0.0009622735,0.0009781502,0.0007781052,0.0006388309,0.00079532166],"category_scores_gemma":[0.0032949867,0.0005348152,0.0006723573,0.002394216,0.00047266783,0.00067195983,0.0005322237,0.0011611118,0.00015832372],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010281552,0.00008572938,0.9989002,0.0000075990665,0.000049764876,0.000071734925,0.00010820396,0.000056858044,0.000038110156,0.0000138633995,0.00009593592,0.0004691715],"study_design_scores_gemma":[0.000012054307,0.00006679861,0.9992902,0.000004489146,0.000020717593,0.00013606166,0.00021310664,0.00014553775,0.000008267557,0.000010988977,0.00008761298,0.0000041283247],"about_ca_topic_score_codex":0.33050662,"about_ca_topic_score_gemma":0.41647303,"teacher_disagreement_score":0.33050662,"about_ca_system_score_codex":0.0034054855,"about_ca_system_score_gemma":0.0022401859,"threshold_uncertainty_score":0.6571657},"labels":[],"label_agreement":null},{"id":"W2095538783","doi":"10.1111/j.1365-2893.2007.00846.x","title":"Risk factors for anaemia in human immunodeficiency virus/hepatitis C virus‐coinfected patients treated with interferon plus ribavirin","year":2007,"lang":"en","type":"article","venue":"Journal of Viral Hepatitis","topic":"Hepatitis C virus research","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hotel Dieu Hospital","funders":"Sidaction","keywords":"Ribavirin; Medicine; Internal medicine; Zidovudine; Hepatitis C virus; Gastroenterology; Discontinuation; Hepatitis C; Adverse effect; Combination therapy; Incidence (geometry); Virology; Virus; Viral disease","score_opus":0.01963728474974307,"score_gpt":0.3152238943803466,"score_spread":0.2955866096306035,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2095538783","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9988682,0.000815761,0.00006549112,0.000046388723,0.0000066844145,0.0000065691006,0.00003193579,0.0000020167586,0.00015699076],"genre_scores_gemma":[0.9996997,0.000116010975,0.00006143073,0.00002321667,0.000014663923,0.000003613288,0.000037497313,7.1328606e-7,0.000043182736],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99934703,0.0003119808,0.00008857235,0.00007530513,0.00011274438,0.000064519234],"domain_scores_gemma":[0.99770737,0.0007564499,0.001028916,0.000076645105,0.000116115814,0.00031447603],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000744363,0.00022424696,0.0004862315,0.00060198735,0.00045044266,0.00046672084,0.00019463897,0.0004640478,0.00091702555],"category_scores_gemma":[0.0034728188,0.00030246604,0.00044946492,0.00067950925,0.0002555119,0.00029040745,0.0002441085,0.0006126556,0.00008794645],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019437014,0.000021997343,0.9983454,0.000007593528,0.0000360224,0.00009213542,0.000022874054,0.00003270853,0.00011591128,0.0000063834855,0.000033014992,0.001091626],"study_design_scores_gemma":[0.000020554338,0.00018149464,0.9985116,0.000009677125,0.00005598391,0.0006572012,0.00005453762,0.00034881715,0.00005436117,0.000020466905,0.00008192308,0.00000338394],"about_ca_topic_score_codex":0.001795073,"about_ca_topic_score_gemma":0.0026503645,"teacher_disagreement_score":0.001795073,"about_ca_system_score_codex":0.00018958667,"about_ca_system_score_gemma":0.00024566162,"threshold_uncertainty_score":0.0039365888},"labels":[],"label_agreement":null},{"id":"W2097829796","doi":"10.1046/j.1365-2893.2000.00013.x","title":"Hepatitis C and the British Columbia experience with hepatitis A vaccination","year":2000,"lang":"en","type":"article","venue":"Journal of Viral Hepatitis","topic":"HIV, Drug Use, Sexual Risk","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Hepatitis A; Outbreak; Hepatitis C virus; Hepatitis a virus; Virology; Medicine; Vaccination; Hepatitis C; Hepatitis; Hepatitis A vaccine; Environmental health; Immunology; Virus","score_opus":0.01151688928095262,"score_gpt":0.27702706888914796,"score_spread":0.26551017960819534,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2097829796","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.88876975,0.008903199,0.0000801359,0.016129116,0.00042518455,0.00009751008,0.00028815362,0.000025392113,0.085281596],"genre_scores_gemma":[0.9615447,0.0084889885,0.00009742094,0.004124576,0.00007946678,0.00003273881,0.00023495682,0.000014064091,0.025383143],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988211,0.0002916577,0.000039588744,0.00005483159,0.0003469157,0.00044585572],"domain_scores_gemma":[0.9970161,0.00030946627,0.00017293522,0.00004975103,0.00076542154,0.0016864066],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010100387,0.00015232775,0.00015753822,0.0005653393,0.0040814374,0.0014137641,0.0005621741,0.00089417933,0.005472689],"category_scores_gemma":[0.0040134164,0.00020794217,0.00015936318,0.0010821408,0.00084974465,0.0004440892,0.0009791488,0.0016939541,0.00050579995],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005839074,0.001535606,0.6230146,0.0003461814,0.000092270275,0.0066147046,0.029936627,0.0003148884,0.0015212442,0.0019394282,0.08579231,0.24830826],"study_design_scores_gemma":[0.000047083195,0.00049597886,0.82381886,0.00038634092,0.000042975596,0.0019487389,0.021495003,0.0002274363,0.00027477232,0.00020496175,0.150982,0.00007572976],"about_ca_topic_score_codex":0.8839329,"about_ca_topic_score_gemma":0.9396093,"teacher_disagreement_score":0.11606711,"about_ca_system_score_codex":0.008840575,"about_ca_system_score_gemma":0.013008958,"threshold_uncertainty_score":0.23350126},"labels":[],"label_agreement":null},{"id":"W2100256719","doi":"10.1111/j.1365-2893.2010.01321.x","title":"Molecular characterization of intrahepatic and extrahepatic hepatitis B virus (HBV) reservoirs in patients on suppressive antiviral therapy","year":2010,"lang":"en","type":"article","venue":"Journal of Viral Hepatitis","topic":"Hepatitis B Virus Studies","field":"Medicine","cited_by":74,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Memorial University of Newfoundland; University of Calgary","funders":"National Institute of Diabetes and Digestive and Kidney Diseases; University of California, San Francisco; American Association for the Study of Liver Diseases","keywords":"cccDNA; Virology; Hepatitis B virus; Viral quasispecies; Adefovir; Lamivudine; Biology; Peripheral blood mononuclear cell; Orthohepadnavirus; Virus; Hepatitis B; Liver transplantation; HBsAg; Molecular biology; Medicine; Hepatitis C virus; Transplantation; In vitro; Internal medicine","score_opus":0.008832522639236154,"score_gpt":0.2566557498223033,"score_spread":0.24782322718306718,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2100256719","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99955744,0.00019712553,0.000051091352,0.000012604673,0.0000013208747,0.0000027872763,0.000015661253,0.0000024828264,0.0001595184],"genre_scores_gemma":[0.9997353,0.0000776939,0.000057848203,0.000018832989,0.000009076699,0.0000035837381,0.000047658294,0.0000015147665,0.000048552873],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99979776,0.00005874559,0.00003017269,0.000034338525,0.000044007185,0.000035083343],"domain_scores_gemma":[0.99928826,0.00027172326,0.00019382274,0.000042838074,0.000058049416,0.00014537835],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002491375,0.00025039676,0.0003598893,0.00081732473,0.0003281244,0.0006418328,0.00013611614,0.00040104555,0.00073826674],"category_scores_gemma":[0.0018864692,0.00020659556,0.00014994417,0.00039189437,0.00026414718,0.0003865173,0.0001887665,0.00038391072,0.00017447295],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000709287,0.00006680964,0.9753685,0.000024469935,0.00002769955,0.001157939,0.0003971857,0.00009632109,0.013137952,0.000035802797,0.00006044653,0.00891757],"study_design_scores_gemma":[0.00003597595,0.0009552321,0.98834443,0.000012638517,0.00004977519,0.006874501,0.0004701714,0.0007268243,0.0020574273,0.00008183962,0.00038265917,0.000008454381],"about_ca_topic_score_codex":0.00034052203,"about_ca_topic_score_gemma":0.00027916997,"teacher_disagreement_score":0.00081732473,"about_ca_system_score_codex":0.00012092295,"about_ca_system_score_gemma":0.00009568835,"threshold_uncertainty_score":0.0024697185},"labels":[],"label_agreement":null},{"id":"W2100451620","doi":"10.1111/j.1365-2893.2009.01092.x","title":"Chronic hepatitis C and persistent occult hepatitis C virus infection are characterized by distinct immune cell cytokine expression profiles","year":2009,"lang":"en","type":"article","venue":"Journal of Viral Hepatitis","topic":"Hepatitis C virus research","field":"Medicine","cited_by":35,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Memorial University of Newfoundland","funders":"","keywords":"Hepatitis C virus; Immune system; Immunology; Virology; Peripheral blood mononuclear cell; Hepatitis C; Biology; Hepacivirus; Cytokine; Virus; Viral replication; Occult; Medicine; Pathology; In vitro","score_opus":0.013761526060327565,"score_gpt":0.27713380734680065,"score_spread":0.2633722812864731,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2100451620","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9972555,0.0015104389,0.00025117685,0.000017671833,0.000009156283,0.000016591812,0.000199501,0.00000809324,0.0007318892],"genre_scores_gemma":[0.99806577,0.0006249575,0.00039982534,0.000049278984,0.00002759275,0.00004981481,0.00036821645,0.0000050691992,0.00040954532],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9997863,0.00003648355,0.000019664756,0.000049656584,0.00004721295,0.000060664617],"domain_scores_gemma":[0.9996873,0.00007648131,0.000110323774,0.000022831782,0.00003844222,0.000064527536],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016660336,0.00021523653,0.00025182992,0.0004986511,0.00015259306,0.0003121042,0.00007559574,0.00026028196,0.0010670648],"category_scores_gemma":[0.0004316338,0.00011242165,0.00011749549,0.00037316242,0.0003009421,0.00013980115,0.00021985757,0.00019849927,0.0002243569],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0039081853,0.00017149339,0.38306236,0.0003957151,0.000069120375,0.0017929692,0.0008382695,0.00009234759,0.5761153,0.00032631957,0.00025017236,0.032977726],"study_design_scores_gemma":[0.000027609261,0.00046589077,0.9834446,0.00001558701,0.000025496747,0.0042068493,0.00029085355,0.00011011691,0.010171338,0.0001797365,0.0010527354,0.000009149744],"about_ca_topic_score_codex":0.0003383721,"about_ca_topic_score_gemma":0.00045016038,"teacher_disagreement_score":0.0010670648,"about_ca_system_score_codex":0.00016087804,"about_ca_system_score_gemma":0.00012755966,"threshold_uncertainty_score":0.0035697222},"labels":[],"label_agreement":null},{"id":"W2102025275","doi":"10.1046/j.1365-2893.2003.00397.x","title":"Targeted destruction of the polymerized human serum albumin binding site within the preS2 region of the HBV surface antigen while retaining full immunogenicity for this epitope","year":2003,"lang":"en","type":"article","venue":"Journal of Viral Hepatitis","topic":"Hepatitis B Virus Studies","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Provincial Health Services Authority","keywords":"Epitope; Immunogenicity; Virology; Antigen; Hepatitis B virus; Antibody; Epitope mapping; Conformational epitope; Chemistry; Biology; Virus; Immunology","score_opus":0.025721647244376113,"score_gpt":0.26744970095454634,"score_spread":0.24172805371017023,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2102025275","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9967918,0.00025645946,0.0024540853,0.000022156659,0.000013170774,0.00002048859,0.000034431738,0.00002724084,0.00038030007],"genre_scores_gemma":[0.99531156,0.00017528617,0.0032132766,0.000030255223,0.0000063025645,0.000013262923,0.00006571596,0.000008958912,0.0011753201],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99994445,0.000008659108,0.0000044990943,0.000013642763,0.000012194739,0.000016569653],"domain_scores_gemma":[0.99994004,0.00000748463,0.000026898184,0.0000061135033,0.0000056970857,0.000013644836],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010651232,0.00032043696,0.00014785497,0.000083771745,0.000078177945,0.00017789671,0.00010327786,0.00022408582,0.0006921643],"category_scores_gemma":[0.00006473471,0.000095563795,0.00025381037,0.0000697924,0.00013272617,0.000118182834,0.00013735935,0.0002249588,0.00022164558],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000503578,0.000016305918,0.00005686767,0.000012900494,0.000002792552,0.000029660088,0.000003801911,0.000046965677,0.9991598,0.000035628305,0.0000054083175,0.00057956413],"study_design_scores_gemma":[0.000013173109,0.00062301796,0.0013514514,0.0000020557002,0.000011418089,0.00017456737,0.0000058274477,0.0006566442,0.99614173,0.000015936668,0.0010009062,0.0000032600915],"about_ca_topic_score_codex":0.0002081977,"about_ca_topic_score_gemma":0.00025533926,"teacher_disagreement_score":0.0006921643,"about_ca_system_score_codex":0.0001239713,"about_ca_system_score_gemma":0.00014112996,"threshold_uncertainty_score":0.0023155212},"labels":[],"label_agreement":null},{"id":"W2103399712","doi":"10.1111/j.1365-2893.2005.00600.x","title":"Treatment of hepatitis C","year":2005,"lang":"en","type":"review","venue":"Journal of Viral Hepatitis","topic":"Hepatitis C virus research","field":"Medicine","cited_by":189,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Ribavirin; Medicine; Pegylated interferon; Hepatitis C; Internal medicine; Combination therapy; Intensive care medicine; Chronic hepatitis; Virology; Virus","score_opus":0.08876473411177735,"score_gpt":0.4253372981562146,"score_spread":0.33657256404443725,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2103399712","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00019316487,0.9972736,0.00014625456,0.00016476949,0.00022923085,0.000012838523,0.000016409449,0.000008576222,0.001955098],"genre_scores_gemma":[0.0015075863,0.9963014,0.00029729257,0.00035081027,0.0002279282,0.000013740678,0.000040205286,0.0000016122395,0.0012593556],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99957556,0.0000957846,0.000050388797,0.00005608061,0.00019017405,0.000032014315],"domain_scores_gemma":[0.9997464,0.00009452254,0.000062977,0.000013027383,0.000058928184,0.000024261233],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006254272,0.0009372632,0.0015653163,0.0019341119,0.0003250876,0.00057984155,0.000810346,0.0010145671,0.0045526247],"category_scores_gemma":[0.00080162863,0.00017286635,0.00057878473,0.001480186,0.00041561658,0.0006326854,0.00052808586,0.0011511402,0.0032017343],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00005966331,0.00006213749,0.00015858849,0.009998117,0.000108581065,0.00017142123,0.00003005386,0.00009268991,0.0012932466,0.0005949405,0.022044037,0.96538657],"study_design_scores_gemma":[0.00011812144,0.0003365942,0.0030515739,0.009099523,0.00024946165,0.007563677,0.000077028344,0.00008118074,0.0010504702,0.0010739346,0.9772742,0.000024285893],"about_ca_topic_score_codex":0.0013436741,"about_ca_topic_score_gemma":0.0027163478,"teacher_disagreement_score":0.0045526247,"about_ca_system_score_codex":0.000405492,"about_ca_system_score_gemma":0.0006821153,"threshold_uncertainty_score":0.01523006},"labels":[],"label_agreement":null},{"id":"W2103723704","doi":"10.1111/j.1365-2893.2005.00553.x","title":"Patient concerns regarding chronic hepatitis C infections","year":2005,"lang":"en","type":"article","venue":"Journal of Viral Hepatitis","topic":"Hepatitis C virus research","field":"Medicine","cited_by":39,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"","keywords":"Medicine; Cirrhosis; Marital status; Disease; Hepatitis C; Transmission (telecommunications); Viral hepatitis; Liver disease; Hepatitis C virus; Family medicine; Ethnic group; Internal medicine; Virus; Immunology; Population; Environmental health","score_opus":0.02393388098074745,"score_gpt":0.3313626379925439,"score_spread":0.30742875701179645,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2103723704","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99465203,0.0006165497,0.00036893893,0.0015119666,0.000028279743,0.000056687604,0.000056703284,0.000017509461,0.0026912491],"genre_scores_gemma":[0.9973405,0.00057319837,0.0005641172,0.000577556,0.000023973174,0.000030637428,0.000037050017,0.0000024105789,0.0008505148],"study_design_codex":"observational","study_design_gemma":"qualitative","domain_scores_codex":[0.9988329,0.0006874478,0.00008440858,0.000055733555,0.0002100556,0.00012950705],"domain_scores_gemma":[0.99521035,0.0026818793,0.001055264,0.00009303657,0.00042026292,0.0005392455],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015013968,0.0001591348,0.00021368862,0.0003636421,0.001211123,0.00063598,0.00020366297,0.0007257537,0.0021831028],"category_scores_gemma":[0.009490804,0.00009589379,0.00023195872,0.00022636377,0.00034626565,0.00045693596,0.0007064305,0.0007895274,0.00018003744],"study_design_candidate":"qualitative","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005075748,0.00044520287,0.7092926,0.00062836264,0.000058704125,0.004715935,0.1165404,0.00046162397,0.004652989,0.0005653001,0.0066971993,0.15543415],"study_design_scores_gemma":[0.000050851995,0.0024154675,0.79423314,0.0006645625,0.000095984775,0.019148896,0.1465992,0.0013853948,0.0020690176,0.00087453326,0.032316625,0.0001462506],"about_ca_topic_score_codex":0.0016647967,"about_ca_topic_score_gemma":0.0021894514,"teacher_disagreement_score":0.0021831028,"about_ca_system_score_codex":0.00051533786,"about_ca_system_score_gemma":0.00068894774,"threshold_uncertainty_score":0.007940233},"labels":[],"label_agreement":null},{"id":"W2111431831","doi":"10.1111/jvh.12430","title":"Chronic hepatitis C virus infection is associated with increased risk of preterm birth: a meta‐analysis of observational studies","year":2015,"lang":"en","type":"review","venue":"Journal of Viral Hepatitis","topic":"Hepatitis C virus research","field":"Medicine","cited_by":65,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Lunenfeld-Tanenbaum Research Institute","funders":"Nanfang Hospital","keywords":"Observational study; Medicine; Meta-analysis; Hepatitis a virus; Virology; Chronic hepatitis; Internal medicine; Virus","score_opus":0.22572006750610205,"score_gpt":0.4322159152598758,"score_spread":0.20649584775377375,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2111431831","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0076212888,0.99122953,0.0004011775,0.00014056965,0.00008394254,0.00007170816,0.00028913553,0.000011387093,0.00015126613],"genre_scores_gemma":[0.15993713,0.8366283,0.0014310837,0.0004635754,0.00019943605,0.00025760426,0.0008133263,0.000020709856,0.00024881694],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9959188,0.0019182441,0.0011896923,0.00042727747,0.0003915457,0.00015438187],"domain_scores_gemma":[0.9884729,0.008745849,0.0014554258,0.0003904565,0.0007797045,0.00015569049],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.007607007,0.0018531802,0.009438411,0.0034962576,0.0004721536,0.0018312382,0.0013748792,0.0013104348,0.002421159],"category_scores_gemma":[0.017968448,0.0009970175,0.024963131,0.00577435,0.00034174745,0.00079500006,0.0009153447,0.001430425,0.00017652771],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0032722147,0.000054468062,0.022125129,0.2078114,0.7379137,0.00030546344,0.0000993658,0.00080492103,0.00033951792,0.00015287272,0.0009593175,0.02616161],"study_design_scores_gemma":[0.0003058533,0.00019599378,0.012760519,0.010622404,0.9734596,0.00020528653,0.00004292514,0.0002786595,0.00013421549,0.00021894524,0.0017527,0.000022942017],"about_ca_topic_score_codex":0.0051510907,"about_ca_topic_score_gemma":0.009393176,"teacher_disagreement_score":0.009438411,"about_ca_system_score_codex":0.0012063668,"about_ca_system_score_gemma":0.0018065469,"threshold_uncertainty_score":0.040230215},"labels":[],"label_agreement":null},{"id":"W2112837294","doi":"10.1111/jvh.12436","title":"Clinical course of 161 untreated and tenofovir‐treated chronic hepatitis<scp>B</scp>pregnant patients in a low hepatitis<scp>B</scp>virus endemic region","year":2015,"lang":"en","type":"article","venue":"Journal of Viral Hepatitis","topic":"Hepatitis B Virus Studies","field":"Medicine","cited_by":56,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Alberta Children's Hospital; Alberta Health; Government of Alberta; University of Calgary","funders":"Public Health Agency; Canadian Institutes of Health Research; Centers for Disease Control and Prevention; Bristol-Myers Squibb","keywords":"Medicine; Hepatitis B virus; Gastroenterology; Hepatitis B; Internal medicine; Tenofovir; Viral load; Pregnancy; Immunology; Virus; Biology; Human immunodeficiency virus (HIV)","score_opus":0.02907699896041154,"score_gpt":0.30535829767616685,"score_spread":0.2762812987157553,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2112837294","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99954516,0.000086257176,0.000012741572,0.000013566568,0.000002361787,0.000008577225,0.00013640938,9.911772e-7,0.00019381248],"genre_scores_gemma":[0.99926955,0.00010049988,0.000029545106,0.00003566057,0.000008860887,0.000015817688,0.00032650956,8.7326794e-7,0.00021280348],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9997278,0.0000523437,0.00004149432,0.00007475484,0.00003176417,0.00007184662],"domain_scores_gemma":[0.9992694,0.00017237262,0.00023373337,0.000029862626,0.000031382435,0.00026325858],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00030056047,0.00022397132,0.00040117343,0.00031141227,0.0005290847,0.0004152354,0.00016479431,0.0004373267,0.0014266173],"category_scores_gemma":[0.0010250928,0.0002910269,0.00024227855,0.00041219825,0.00037223648,0.0003444241,0.0003995468,0.00047260118,0.00028345498],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012586482,0.00022647265,0.99317306,0.000026420872,0.000026646612,0.0012551913,0.0003656771,0.00007282497,0.0007535002,0.000029965733,0.00016131828,0.0026501613],"study_design_scores_gemma":[0.00011238382,0.0021506355,0.9941049,0.000011806281,0.000016994609,0.0024461355,0.00053831964,0.00015729928,0.00013698864,0.000027433129,0.0002864219,0.000010644717],"about_ca_topic_score_codex":0.002948789,"about_ca_topic_score_gemma":0.0028008537,"teacher_disagreement_score":0.002948789,"about_ca_system_score_codex":0.0005959453,"about_ca_system_score_gemma":0.0003282117,"threshold_uncertainty_score":0.0058632493},"labels":[],"label_agreement":null},{"id":"W2116187238","doi":"10.1111/jvh.12249","title":"Strategies to manage hepatitis<scp>C</scp>virus (<scp>HCV</scp>) disease burden","year":2014,"lang":"en","type":"article","venue":"Journal of Viral Hepatitis","topic":"Hepatitis C virus research","field":"Medicine","cited_by":181,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto General Hospital; Health Sciences Centre; University Health Network; Nova Scotia Health Authority; University of Calgary; University of Toronto; Western University; University of British Columbia; BC Centre for Disease Control; Calgary Laboratory Services; University of Manitoba; Queen Elizabeth II Health Sciences Centre; Université de Montréal","funders":"Bundesamt für Gesundheit; National Institute for Health and Care Research; Gilead Sciences","keywords":"Medicine; Hepatitis C virus; Disease; Hepatitis C; Burden of disease; Disease burden; Internal medicine; Mortality rate; Virus; Intensive care medicine; Immunology","score_opus":0.017995024039105963,"score_gpt":0.3051082130545049,"score_spread":0.28711318901539895,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2116187238","genre_codex":"methods","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.29785407,0.034936395,0.340698,0.12882893,0.0014763755,0.002760447,0.0039131045,0.0023532957,0.1871793],"genre_scores_gemma":[0.83144075,0.017140482,0.13555562,0.003988288,0.00020443149,0.0008733568,0.0010708126,0.00007473555,0.009651514],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99914145,0.0005271312,0.000033612512,0.000054934408,0.000118929645,0.00012385352],"domain_scores_gemma":[0.9991474,0.00028727058,0.00018259838,0.000035252568,0.00018700917,0.00016048334],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002305929,0.00086490077,0.00040147392,0.0009902909,0.0005721882,0.002298115,0.0012402406,0.0010488353,0.004277605],"category_scores_gemma":[0.0033113935,0.00019805046,0.000652856,0.0008532132,0.0003319017,0.0012519074,0.0011735813,0.0010058153,0.00069943216],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00031103982,0.001060405,0.026603997,0.0015599949,0.00045257516,0.0006030297,0.0011961684,0.39948106,0.0049820193,0.09305787,0.06154751,0.4091444],"study_design_scores_gemma":[0.00044845438,0.0018272742,0.018114254,0.002919096,0.0006853023,0.00058743206,0.008289451,0.5649967,0.0064444756,0.14362791,0.25183192,0.00022772187],"about_ca_topic_score_codex":0.011834566,"about_ca_topic_score_gemma":0.02004797,"teacher_disagreement_score":0.011834566,"about_ca_system_score_codex":0.0020397787,"about_ca_system_score_gemma":0.0060335454,"threshold_uncertainty_score":0.023531377},"labels":[],"label_agreement":null},{"id":"W2120204078","doi":"10.1111/j.1365-2893.2011.01530.x","title":"Virus-triggered autophagy in viral hepatitis - possible novel strategies for drug development","year":2011,"lang":"en","type":"review","venue":"Journal of Viral Hepatitis","topic":"Autophagy in Disease and Therapy","field":"Medicine","cited_by":54,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Research Manitoba; Children's Hospital Research Institute of Manitoba; University of Manitoba","funders":"","keywords":"Autophagy; Homeostasis; Biology; Hepatitis C virus; Disease; Drug development; Drug; Virus; Immunology; Virology; Medicine; Cell biology; Pharmacology; Genetics; Apoptosis; Pathology","score_opus":0.047604243975815426,"score_gpt":0.3409367641357718,"score_spread":0.29333252015995637,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2120204078","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0002362094,0.9979785,0.00022325179,0.00032108335,0.00017997921,0.000006569474,0.000010167609,0.000009898301,0.0010343448],"genre_scores_gemma":[0.0015450714,0.99664706,0.00037152067,0.00024816985,0.0001896932,0.000011458231,0.000029286193,0.0000021797894,0.0009556584],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9998864,0.000030196064,0.0000160647,0.000016151464,0.000037315873,0.000013882938],"domain_scores_gemma":[0.9998864,0.00004692356,0.000018437548,0.000005685377,0.00002407378,0.000018480854],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005084281,0.00065633404,0.0016510795,0.0019008731,0.00033858928,0.000849414,0.00076097436,0.0013279306,0.00331332],"category_scores_gemma":[0.00032456362,0.00025318316,0.0005282316,0.0013844953,0.0005673365,0.0015273985,0.00064803165,0.0019056303,0.0020026022],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016722732,0.0002213531,0.00016994761,0.010213053,0.00010629504,0.0011304031,0.000097893426,0.0009074983,0.0074179755,0.010302499,0.036898244,0.93236756],"study_design_scores_gemma":[0.00006412482,0.00027550364,0.00084865995,0.0022166665,0.00009742553,0.0036653895,0.000089190646,0.00026457434,0.0014834929,0.0063112904,0.98464984,0.000033866476],"about_ca_topic_score_codex":0.00049160497,"about_ca_topic_score_gemma":0.0015023326,"teacher_disagreement_score":0.00331332,"about_ca_system_score_codex":0.0006453681,"about_ca_system_score_gemma":0.0005341524,"threshold_uncertainty_score":0.011084199},"labels":[],"label_agreement":null},{"id":"W2120349387","doi":"10.1111/j.1365-2893.2007.00889.x","title":"Exploring differences in response to treatment with peginterferon alpha 2a (40kD) and ribavirin in chronic hepatitis C between genotypes 2 and 3","year":2007,"lang":"en","type":"article","venue":"Journal of Viral Hepatitis","topic":"Hepatitis C virus research","field":"Medicine","cited_by":36,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta; University of Calgary; University of Toronto; Dalhousie University; University of British Columbia; BC Centre for Disease Control","funders":"","keywords":"Ribavirin; Chronic hepatitis; Peginterferon alfa-2a; Genotype; Virology; Medicine; Alpha (finance); Gastroenterology; Biology; Genetics; Gene; Virus; Surgery","score_opus":0.09088054876083444,"score_gpt":0.33883364993056286,"score_spread":0.2479531011697284,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2120349387","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9996728,0.00016217392,0.000037024274,0.000021415932,0.0000025218797,0.000010644316,0.000020639543,8.2376494e-7,0.000071928014],"genre_scores_gemma":[0.99967146,0.000041054172,0.00007368253,0.000046049543,0.000010794534,0.000020202091,0.00006884972,8.775563e-7,0.00006700808],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984603,0.001157932,0.0000709638,0.0000909129,0.00010880653,0.000111158755],"domain_scores_gemma":[0.9976132,0.0014767497,0.00051714364,0.00008540787,0.00006202087,0.00024554023],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0028598527,0.00025039175,0.00043308246,0.00023020143,0.00016157275,0.00031367983,0.00022563826,0.0005084632,0.0008522406],"category_scores_gemma":[0.0033836032,0.00014883309,0.00067534996,0.00027684358,0.00027136074,0.0003154754,0.0002349254,0.00048343162,0.0001619678],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.074517205,0.0017555874,0.8963578,0.00008503946,0.00054546533,0.00013077036,0.00017472675,0.00049975625,0.0032363613,0.000044454493,0.00016783657,0.022485092],"study_design_scores_gemma":[0.002042194,0.019424733,0.9747155,0.000017822227,0.00022294311,0.00027282367,0.00013328902,0.0020291633,0.0006964734,0.00008957765,0.0003440344,0.000011488672],"about_ca_topic_score_codex":0.0005353645,"about_ca_topic_score_gemma":0.00073054095,"teacher_disagreement_score":0.0028598527,"about_ca_system_score_codex":0.00029237405,"about_ca_system_score_gemma":0.00024903181,"threshold_uncertainty_score":0.0151245},"labels":[],"label_agreement":null},{"id":"W2126038515","doi":"10.1111/j.1365-2893.2004.00520.x","title":"A multicentre study of the usefulness of liver biopsy in hepatitis C","year":2004,"lang":"en","type":"article","venue":"Journal of Viral Hepatitis","topic":"Hepatitis C virus research","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba; McGill University; Royal Victoria Hospital; University of Toronto; Toronto General Hospital; University of Alberta","funders":"National Institutes of Health; F. Hoffmann-La Roche","keywords":"Medicine; Liver biopsy; Biopsy; Internal medicine; Stage (stratigraphy); Gastroenterology; Hepatitis C; Liver disease; Hepatitis; Fibrosis; Prospective cohort study","score_opus":0.03652881888214431,"score_gpt":0.31080989815375715,"score_spread":0.2742810792716128,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2126038515","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99932957,0.00028221981,0.00006512082,0.000046950412,0.0000065536833,0.000020351828,0.00007152818,0.0000026615508,0.00017509029],"genre_scores_gemma":[0.9996965,0.000048406553,0.000067072666,0.000038241426,0.000011391739,0.000012679771,0.00007164621,0.000001577401,0.000052453448],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9953585,0.0028868308,0.00029454054,0.0006026945,0.00052232784,0.00033507645],"domain_scores_gemma":[0.9860088,0.0055901106,0.004131553,0.0015011004,0.0011505368,0.0016179131],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005114615,0.0005247446,0.00050936814,0.0006583281,0.0007160079,0.000818125,0.0004522363,0.001222447,0.0007795703],"category_scores_gemma":[0.023140376,0.00066357746,0.00046458776,0.00088684575,0.00068449025,0.0007793827,0.0006048353,0.000829147,0.0003270538],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00089799275,0.00010161471,0.9972928,0.000016993024,0.00007207321,0.0001180558,0.00031797768,0.000032024993,0.00017586657,0.0000138632595,0.00007794213,0.0008827021],"study_design_scores_gemma":[0.000074951626,0.0011295873,0.99788046,0.0000061516293,0.000035172598,0.00039247953,0.00013342623,0.00017916491,0.000036300204,0.000013101204,0.000110809146,0.000008294248],"about_ca_topic_score_codex":0.0044404976,"about_ca_topic_score_gemma":0.0035486089,"teacher_disagreement_score":0.005114615,"about_ca_system_score_codex":0.00055256055,"about_ca_system_score_gemma":0.00048761,"threshold_uncertainty_score":0.027049005},"labels":[],"label_agreement":null},{"id":"W2126206366","doi":"10.1111/j.1365-2893.2011.01445.x","title":"Granulocyte colony‐stimulating factor for hepatitis C therapy‐associated neutropenia: systematic review and economic evaluation","year":2011,"lang":"en","type":"review","venue":"Journal of Viral Hepatitis","topic":"Hepatitis C virus research","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"Novartis Pharmaceuticals Canada; Astellas Foundation for Research on Metabolic Disorders; F. Hoffmann-La Roche; Amgen","keywords":"Medicine; Neutropenia; Adverse effect; Pegylated interferon; Internal medicine; Ribavirin; Hepatitis C virus; Granulocyte colony-stimulating factor; Hepatitis C; Febrile neutropenia; Gastroenterology; Immunology; Virus; Chemotherapy","score_opus":0.13174327557101573,"score_gpt":0.41769939208295237,"score_spread":0.28595611651193664,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2126206366","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.001559567,0.99566454,0.0003056071,0.00036210738,0.00010546995,0.00058041344,0.00085998984,0.000016943242,0.0005453759],"genre_scores_gemma":[0.037609186,0.95831394,0.0012990956,0.0006214402,0.000090183355,0.0012449874,0.00059384713,0.000013031059,0.00021421007],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.99256366,0.0036026486,0.0018629113,0.00037628828,0.0013299731,0.00026463863],"domain_scores_gemma":[0.9809544,0.013584333,0.003286487,0.00023387965,0.0016705949,0.00027031315],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.010387456,0.0016440902,0.012101212,0.0078189215,0.0005230388,0.0026097442,0.001986095,0.0016454416,0.006334883],"category_scores_gemma":[0.04030831,0.00088393356,0.012216323,0.0089101335,0.0006709107,0.001664818,0.0012292243,0.001799877,0.00029039773],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008000112,0.000025614741,0.00059916475,0.9252471,0.03884994,0.00007660639,0.000042505882,0.0003608766,0.000077014396,0.00042056976,0.0018340158,0.03166652],"study_design_scores_gemma":[0.0024988824,0.0005213666,0.005908317,0.61729527,0.3541961,0.000411778,0.0001474079,0.00086030207,0.00026167964,0.0012968697,0.016524643,0.00007745821],"about_ca_topic_score_codex":0.0128276255,"about_ca_topic_score_gemma":0.025175372,"teacher_disagreement_score":0.0128276255,"about_ca_system_score_codex":0.0061842683,"about_ca_system_score_gemma":0.009045698,"threshold_uncertainty_score":0.05493474},"labels":[],"label_agreement":null},{"id":"W2131792659","doi":"10.1111/j.1365-2893.2009.01080.x","title":"Low uptake of treatment for hepatitis C virus infection in a large community‐based study of inner city residents","year":2009,"lang":"en","type":"article","venue":"Journal of Viral Hepatitis","topic":"Hepatitis C virus research","field":"Medicine","cited_by":171,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Toronto; Simon Fraser University; Actua; Centre for Addiction and Mental Health; AIDS Vancouver; University of British Columbia; BC Centre for Disease Control; University of Waterloo","funders":"","keywords":"Inner city; Virology; Hepatitis C virus; Medicine; Internal medicine; Virus; Geography","score_opus":0.06125686948558456,"score_gpt":0.38032338058063586,"score_spread":0.3190665110950513,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2131792659","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99946374,0.000084040636,0.000023684275,0.00003840497,0.0000029440569,0.000009519269,0.0001620774,0.0000018262673,0.00021370074],"genre_scores_gemma":[0.9993777,0.000092826325,0.000046049445,0.000054168202,0.0000067653423,0.000009908804,0.00021594955,0.0000027277188,0.00019377616],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989182,0.00025458445,0.00006681355,0.00025817959,0.00030548035,0.00019687212],"domain_scores_gemma":[0.99689627,0.00043182852,0.0006676559,0.00025971,0.0008098361,0.00093464536],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010470983,0.00034698838,0.000505486,0.0011884957,0.0015467928,0.0017030857,0.00093048095,0.00062769273,0.0011157633],"category_scores_gemma":[0.0032625657,0.00070064573,0.0003845501,0.0018224899,0.0007484019,0.00053579226,0.000735895,0.000828604,0.00033355912],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006981193,0.000053942207,0.99793017,0.000008996182,0.000041255553,0.00007060757,0.0007214367,0.00001163804,0.00016463663,0.0000104682695,0.00015772607,0.00075928535],"study_design_scores_gemma":[0.0000053027857,0.000029950528,0.9992065,0.0000060798357,0.000013772375,0.00006989055,0.0004687348,0.00007103749,0.00001456435,0.0000045313377,0.00010549686,0.000004261079],"about_ca_topic_score_codex":0.47074097,"about_ca_topic_score_gemma":0.50797826,"teacher_disagreement_score":0.47074097,"about_ca_system_score_codex":0.002209158,"about_ca_system_score_gemma":0.0022667442,"threshold_uncertainty_score":0.9360019},"labels":[],"label_agreement":null},{"id":"W2133941144","doi":"10.1111/j.1365-2893.2005.00618.x","title":"SEN virus infection in patients with hepatocellular carcinoma","year":2005,"lang":"en","type":"article","venue":"Journal of Viral Hepatitis","topic":"Animal Virus Infections Studies","field":"Agricultural and Biological Sciences","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of British Columbia","funders":"","keywords":"Hepatocellular carcinoma; HBsAg; Medicine; Hepatitis B virus; Virology; Antibody; Virus; Hepatitis C virus; Internal medicine; Gastroenterology; Immunology","score_opus":0.010563529657196799,"score_gpt":0.20124534880588166,"score_spread":0.19068181914868487,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2133941144","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9980981,0.00039803266,0.00003521857,0.000059611993,0.000007405624,0.000009394068,0.00007237547,0.00000311171,0.0013168857],"genre_scores_gemma":[0.9994716,0.00019717102,0.00003638372,0.000036807403,0.000010959844,0.000003916546,0.000079712474,6.979744e-7,0.00016279747],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99979776,0.000029330737,0.00001608026,0.00003026976,0.000060502956,0.00006600247],"domain_scores_gemma":[0.9995727,0.0000639691,0.00010611533,0.000021671269,0.00011038911,0.00012519155],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001404883,0.00020952178,0.00027471464,0.00047844343,0.00090272183,0.00039167833,0.00016877486,0.00029508705,0.0019393141],"category_scores_gemma":[0.0011529954,0.00017422292,0.00015717738,0.0006184322,0.00040969963,0.0002242166,0.00023087383,0.00032846496,0.00021358166],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007424634,0.000012423639,0.99725765,0.000010286463,0.0000068942527,0.0005636141,0.00013917804,0.00001214182,0.00051667314,0.000015014953,0.00007630409,0.0013155434],"study_design_scores_gemma":[0.000010025942,0.00014359043,0.9935488,0.000016157604,0.000024623852,0.004688253,0.0006458104,0.00009998201,0.00018493233,0.00002598578,0.00060474727,0.0000070200726],"about_ca_topic_score_codex":0.054936532,"about_ca_topic_score_gemma":0.04838155,"teacher_disagreement_score":0.054936532,"about_ca_system_score_codex":0.0006029311,"about_ca_system_score_gemma":0.0010302293,"threshold_uncertainty_score":0.1092335},"labels":[],"label_agreement":null},{"id":"W2138460161","doi":"10.1111/jvh.12388","title":"Clinical course of chronic hepatitis B (<scp>CHB</scp>) presented with normal <scp>ALT</scp> in Asian American patients","year":2015,"lang":"en","type":"article","venue":"Journal of Viral Hepatitis","topic":"Hepatitis B Virus Studies","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Genentech; Bristol-Myers Squibb Canada; Gilead Sciences; Roche; American Association for the Study of Liver Diseases; Novartis; Bristol-Myers Squibb","keywords":"Medicine; Internal medicine; Gastroenterology; Liver biopsy; Stage (stratigraphy); Hepatitis B virus; Hepatocellular carcinoma; Hepatitis B; Liver disease; Fibrosis; Biopsy; Immunology; Virus","score_opus":0.02096439274670802,"score_gpt":0.3179002201296275,"score_spread":0.29693582738291946,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2138460161","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9996431,0.00006153343,0.000017134229,0.000019437672,0.0000018098069,0.0000048852016,0.000055573546,0.0000014551016,0.00019507321],"genre_scores_gemma":[0.9997154,0.000045241588,0.00002991992,0.000023464134,0.0000071656555,0.0000051602583,0.00011270498,6.8426533e-7,0.000060201917],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9997694,0.00005930694,0.00003496958,0.000050602484,0.000030588428,0.000055140987],"domain_scores_gemma":[0.9992867,0.00009134862,0.00031591122,0.000037070517,0.000053561816,0.00021538281],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00030587602,0.00022119252,0.00025380528,0.0004892871,0.0005975831,0.0004246437,0.00018952866,0.00036175246,0.001327306],"category_scores_gemma":[0.0010294218,0.00026729112,0.00024759545,0.0006183756,0.00026983934,0.00047273227,0.0003113256,0.00040892145,0.00030822813],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001413666,0.000036090023,0.9982697,0.0000043725377,0.000008865555,0.00020427561,0.0000750059,0.000014473235,0.000280282,0.000010116471,0.00006060888,0.00089490355],"study_design_scores_gemma":[0.000012479128,0.00016723805,0.9981833,0.000004156118,0.000009409279,0.0011360483,0.0002421763,0.00010350806,0.000038368205,0.000018522343,0.00008084165,0.0000040124896],"about_ca_topic_score_codex":0.0031467208,"about_ca_topic_score_gemma":0.0038518035,"teacher_disagreement_score":0.0031467208,"about_ca_system_score_codex":0.00029792523,"about_ca_system_score_gemma":0.00027485768,"threshold_uncertainty_score":0.006256759},"labels":[],"label_agreement":null},{"id":"W2141766413","doi":"10.1111/jvh.12346","title":"Simeprevir with peginterferon/ribavirin for treatment of chronic hepatitis C virus genotype 1 infection: pooled safety analysis from Phase <scp>II</scp>b and <scp>III</scp> studies","year":2014,"lang":"en","type":"article","venue":"Journal of Viral Hepatitis","topic":"Hepatitis C virus research","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Salix Pharmaceuticals; Bristol-Myers Squibb Canada; Genentech; Vertex Pharmaceuticals; Janssen Biotech; Roche; GlaxoSmithKline; Novartis; Pfizer; AbbVie; Sanofi; Human Genome Sciences","keywords":"Simeprevir; Tolerability; Medicine; Internal medicine; Gastroenterology; Ribavirin; Rash; Placebo; Neutropenia; Adverse effect; Virology; Hepatitis C virus; Virus; Toxicity; Pathology","score_opus":0.028980802424859373,"score_gpt":0.3425990692856471,"score_spread":0.3136182668607877,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2141766413","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.23169029,0.7272644,0.008112055,0.0014808062,0.0010804738,0.005075511,0.019563556,0.0005020426,0.00523084],"genre_scores_gemma":[0.88001573,0.092730746,0.0057095373,0.0019270213,0.0009532949,0.0029381071,0.013367838,0.00015826689,0.0021995092],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.98434424,0.009995263,0.0026632487,0.0012339383,0.0014339286,0.00032945856],"domain_scores_gemma":[0.99064064,0.0038129322,0.0035495115,0.00062634883,0.0011916283,0.00017893962],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.024967488,0.0020074847,0.0051565254,0.0029974368,0.00025935032,0.0023370986,0.0007548831,0.0012503517,0.0047059353],"category_scores_gemma":[0.019538723,0.001013373,0.022676803,0.003298355,0.00035217192,0.001120228,0.0010948625,0.0011340561,0.0006802363],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.16890372,0.00017871804,0.012385814,0.04992495,0.68642175,0.00014944091,0.00010702593,0.0015690404,0.0033548633,0.00016295603,0.0044028857,0.07243881],"study_design_scores_gemma":[0.068793565,0.01241145,0.0657881,0.0043753763,0.8300537,0.00053095946,0.0001035022,0.0015693711,0.0021225044,0.00071846345,0.013382966,0.00015002902],"about_ca_topic_score_codex":0.0009677988,"about_ca_topic_score_gemma":0.0023674942,"teacher_disagreement_score":0.024967488,"about_ca_system_score_codex":0.0010743564,"about_ca_system_score_gemma":0.0011565865,"threshold_uncertainty_score":0.13204229},"labels":[],"label_agreement":null},{"id":"W2143057229","doi":"10.1111/jvh.12393","title":"Visits to primary care physicians among persons who inject drugs at high risk of hepatitis <scp>C</scp> virus infection: room for improvement","year":2015,"lang":"en","type":"article","venue":"Journal of Viral Hepatitis","topic":"Hepatitis C virus research","field":"Medicine","cited_by":43,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Montreal Police Service; Université de Sherbrooke; Université de Montréal; McGill University; Centre Hospitalier de l’Université de Montréal","funders":"Canadian Institutes of Health Research; Université de Sherbrooke","keywords":"Medicine; Logistic regression; Odds ratio; Hepatitis C; Cohort; Family medicine; Internal medicine","score_opus":0.014953127130666878,"score_gpt":0.28686619712652006,"score_spread":0.2719130699958532,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2143057229","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.58640486,0.11493447,0.006654387,0.27469453,0.0013973691,0.001397834,0.0037813543,0.0014454564,0.009289772],"genre_scores_gemma":[0.9149144,0.04603232,0.022480236,0.009860948,0.0014185985,0.0010434334,0.002862403,0.000063838175,0.0013237094],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9966917,0.0015978256,0.00030837586,0.00032583906,0.00043855933,0.0006378062],"domain_scores_gemma":[0.98086584,0.007747685,0.003046362,0.0006279132,0.003188942,0.004523259],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.010108058,0.0009583923,0.0018310472,0.0017241071,0.0019114946,0.002637351,0.0026042701,0.0026474418,0.0046862643],"category_scores_gemma":[0.02819222,0.00076480024,0.0014655447,0.0019674336,0.0009805374,0.0039441776,0.0017455302,0.0032251289,0.00068366097],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007082935,0.0023968427,0.65258723,0.0051558353,0.00046709809,0.0002868121,0.0026528707,0.0009973809,0.00043058017,0.00083624,0.03130189,0.30217886],"study_design_scores_gemma":[0.00035077528,0.0010946101,0.96773887,0.0043624663,0.00062566786,0.0002874398,0.008191983,0.0045951237,0.00015561291,0.0008734661,0.011645381,0.00007866054],"about_ca_topic_score_codex":0.15726188,"about_ca_topic_score_gemma":0.14238752,"teacher_disagreement_score":0.15726188,"about_ca_system_score_codex":0.0028240723,"about_ca_system_score_gemma":0.019354295,"threshold_uncertainty_score":0.312693},"labels":[],"label_agreement":null},{"id":"W2143641481","doi":"10.1111/j.1365-2893.2005.00636.x","title":"Silymarin treatment of viral hepatitis: a systematic review","year":2005,"lang":"en","type":"review","venue":"Journal of Viral Hepatitis","topic":"Drug-Induced Hepatotoxicity and Protection","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":189,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Milk Thistle; Silybum marianum; Medicine; Viral hepatitis; Viral load; Internal medicine; Hepatitis; Hepatitis B; Gastroenterology; Hepatitis C; Liver disease; Immunology; Virology; Pharmacology; Traditional medicine; Virus","score_opus":0.1469577002209933,"score_gpt":0.46104103941205554,"score_spread":0.31408333919106224,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2143641481","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00034441726,0.99929416,0.00003007188,0.000048854465,0.000027650409,0.000033129232,0.000041315725,0.000002757379,0.00017770308],"genre_scores_gemma":[0.0029477037,0.99663025,0.00012751517,0.00008889897,0.000021442393,0.00003820599,0.000038232014,9.984022e-7,0.00010668476],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9992912,0.0002483124,0.00019202723,0.00006459523,0.0001687733,0.000035077544],"domain_scores_gemma":[0.9975641,0.0016074199,0.0004701697,0.000028256896,0.00026173974,0.00006831908],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014836009,0.000900267,0.0044628917,0.003291257,0.0002954939,0.0009590353,0.0010904715,0.0010095937,0.0053698095],"category_scores_gemma":[0.0044957837,0.00044938826,0.0022587047,0.004665501,0.00034660602,0.00089318,0.0004939359,0.00050915504,0.0004536871],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005464361,0.00004254712,0.00030547046,0.8047113,0.0031834063,0.00022649777,0.00009207599,0.00014167177,0.00040997664,0.0002246085,0.004751739,0.18536426],"study_design_scores_gemma":[0.0016853986,0.0013378562,0.0097869905,0.76605535,0.06587157,0.0022852197,0.00039788536,0.0003008119,0.001238402,0.000877824,0.15009916,0.00006346921],"about_ca_topic_score_codex":0.004058399,"about_ca_topic_score_gemma":0.013252109,"teacher_disagreement_score":0.0053698095,"about_ca_system_score_codex":0.0011161907,"about_ca_system_score_gemma":0.0027086781,"threshold_uncertainty_score":0.017963827},"labels":[],"label_agreement":null},{"id":"W2144076650","doi":"10.1111/jvh.12384","title":"Factors associated with hepatitis C virus RNA levels in early chronic infection: the InC<sup>3</sup> study","year":2015,"lang":"en","type":"article","venue":"Journal of Viral Hepatitis","topic":"Hepatitis C virus research","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"National Center for Advancing Translational Sciences; National Institute on Drug Abuse; Canadian Institutes of Health Research; National Institutes of Health; National Institute of Allergy and Infectious Diseases; Rijksinstituut voor Volksgezondheid en Milieu; Department of Health and Ageing, Australian Government; National Institute of Diabetes and Digestive and Kidney Diseases; Australian Government","keywords":"Medicine; Hepatitis C virus; Odds ratio; Genotype; Chronic hepatitis; Internal medicine; Immunology; Chronic infection; Virus; Population; Interferon; Logistic regression; Gastroenterology; Virology; Immune system; Biology; Gene","score_opus":0.09150540897415632,"score_gpt":0.3413177435910063,"score_spread":0.24981233461684998,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2144076650","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99891984,0.00028449326,0.000080938575,0.000043904558,0.000006917819,0.000009075143,0.00028567022,0.0000023087375,0.00036684313],"genre_scores_gemma":[0.9990294,0.00010765921,0.00009988177,0.000060659688,0.000023920515,0.000016180986,0.0003983359,0.0000055778255,0.00025843992],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.999421,0.00025394929,0.000051986764,0.00012202353,0.00006018803,0.000090897505],"domain_scores_gemma":[0.9976908,0.0005132141,0.0008561354,0.00031157874,0.00022114941,0.000407221],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013726981,0.0005212151,0.00043820238,0.00034902027,0.00053158874,0.0010681043,0.00048427747,0.0007736141,0.0013892705],"category_scores_gemma":[0.0019657689,0.00040146188,0.0009534886,0.00080758514,0.00028562767,0.0003976577,0.0005656365,0.0010225977,0.0002893084],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012535906,0.00006127242,0.996977,0.000016008074,0.00014889802,0.000099259465,0.00009298962,0.000019776591,0.00034971503,0.00001801428,0.00013894818,0.0008246148],"study_design_scores_gemma":[0.00004950867,0.00035246194,0.9984285,0.0000123462805,0.00017601765,0.00029644047,0.00015950702,0.00012117793,0.00006653028,0.000028513174,0.00030331672,0.00000563524],"about_ca_topic_score_codex":0.003786853,"about_ca_topic_score_gemma":0.0039957743,"teacher_disagreement_score":0.003786853,"about_ca_system_score_codex":0.00023490368,"about_ca_system_score_gemma":0.0004231919,"threshold_uncertainty_score":0.0075296164},"labels":[],"label_agreement":null},{"id":"W2144935009","doi":"10.1046/j.1365-2893.2001.00288.x","title":"Historical features are poor predictors of liver fibrosis in Canadian patients with chronic hepatitis C","year":2001,"lang":"en","type":"article","venue":"Journal of Viral Hepatitis","topic":"Hepatitis C virus research","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Calgary","funders":"","keywords":"Medicine; Fibrosis; Cirrhosis; Liver biopsy; Internal medicine; Gastroenterology; Liver fibrosis; Chronic hepatitis; Biopsy; Predictive value; Hepatitis C; Alcohol consumption; Hepatic fibrosis; Alcohol; Immunology; Biology; Virus","score_opus":0.010407406627937453,"score_gpt":0.2480797741382426,"score_spread":0.23767236751030513,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2144935009","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9980578,0.00053573266,0.000053503645,0.00013438993,0.0000074086165,0.0000073245105,0.0003074011,0.000004950801,0.00089155784],"genre_scores_gemma":[0.99921083,0.00025391788,0.00009502817,0.00002914087,0.000010631547,0.000003135895,0.00027793995,0.0000015451816,0.00011785396],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99964845,0.00005312819,0.000033152803,0.0000417148,0.00014698447,0.000076630924],"domain_scores_gemma":[0.9981516,0.00031772017,0.00066218444,0.00005476778,0.0004747739,0.00033899027],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00044852291,0.00028857397,0.0002795993,0.00082081085,0.0011750086,0.00059646263,0.0004297444,0.00043270554,0.0014140098],"category_scores_gemma":[0.0043110535,0.00025863395,0.00027672297,0.0009898989,0.00042938814,0.00031396886,0.00036946352,0.0004248364,0.00018485663],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000498328,0.0000063193584,0.9982663,0.000005024422,0.000006712272,0.000050532664,0.000064907326,0.000024685596,0.00005577604,0.0000088904335,0.000095208896,0.0013659177],"study_design_scores_gemma":[0.0000044697426,0.000021216623,0.9991616,0.0000074752666,0.00000962138,0.0001880525,0.0001579189,0.00022108755,0.000025248137,0.000013329281,0.00018532357,0.000004632725],"about_ca_topic_score_codex":0.50187576,"about_ca_topic_score_gemma":0.64130557,"teacher_disagreement_score":0.49812424,"about_ca_system_score_codex":0.0019639716,"about_ca_system_score_gemma":0.0021337506,"threshold_uncertainty_score":0.997909},"labels":[],"label_agreement":null},{"id":"W2146563024","doi":"10.1111/j.1365-2893.2010.01319.x","title":"Rapid virological response as a predictor of sustained response in HCV-infected patients with persistently normal alanine aminotransferase levels: A multicenter study","year":2010,"lang":"en","type":"article","venue":"Journal of Viral Hepatitis","topic":"Hepatitis C virus research","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Hospital Foundation","funders":"","keywords":"Ribavirin; Medicine; Internal medicine; Gastroenterology; Alanine aminotransferase; Alanine transaminase; Viral load; Immunology; Hepatitis C virus; Virus","score_opus":0.017143314785509883,"score_gpt":0.2920755157901849,"score_spread":0.274932201004675,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2146563024","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9994672,0.00022612308,0.000058871847,0.00003768524,0.0000042186934,0.000017883996,0.000060681123,0.0000024115045,0.00012497413],"genre_scores_gemma":[0.9995098,0.000068524125,0.00013791877,0.000035337434,0.00002209781,0.000013892726,0.0001536422,0.0000020852895,0.000056725443],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9993363,0.000369726,0.00005372455,0.00008947642,0.00007275437,0.000077962315],"domain_scores_gemma":[0.9972572,0.0006264523,0.00086448446,0.0002188195,0.00019445586,0.00083857373],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00228156,0.0005385448,0.0006144605,0.00034791732,0.00030129953,0.0006367399,0.000339438,0.0005690481,0.00076002313],"category_scores_gemma":[0.002648942,0.00030186912,0.00054658507,0.00041239834,0.000310156,0.0005511876,0.00037422383,0.0006778936,0.0002424179],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008890941,0.00045370936,0.98472244,0.000021695107,0.00016927207,0.00013398059,0.00011751822,0.000107669264,0.0013021094,0.000019277968,0.00009532257,0.003966172],"study_design_scores_gemma":[0.00090169365,0.0077337744,0.9885274,0.000015085557,0.00017599024,0.0006238004,0.00015574484,0.0012863533,0.00027283002,0.00003511031,0.00025691895,0.000015333777],"about_ca_topic_score_codex":0.0007962582,"about_ca_topic_score_gemma":0.0005723624,"teacher_disagreement_score":0.00228156,"about_ca_system_score_codex":0.00023654975,"about_ca_system_score_gemma":0.0003444768,"threshold_uncertainty_score":0.0120661855},"labels":[],"label_agreement":null},{"id":"W2149727205","doi":"10.1046/j.1365-2893.2001.00286.x","title":"Pilot study of interferon‐α and ribavirin treatment in patients with chronic hepatitis C and normal transaminase values","year":2001,"lang":"en","type":"article","venue":"Journal of Viral Hepatitis","topic":"Hepatitis C virus research","field":"Medicine","cited_by":45,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University of Calgary","funders":"Fondation pour la Recherche Médicale; University of Calgary","keywords":"Ribavirin; Medicine; Internal medicine; Gastroenterology; Transaminase; Concomitant; Alanine transaminase; Interferon; Chronic hepatitis; Elevated transaminases; Hepatitis C; Alpha interferon; Immunology; Virus; Biology; Enzyme","score_opus":0.022120838383474527,"score_gpt":0.29604399577565016,"score_spread":0.27392315739217565,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2149727205","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9977379,0.0004307221,0.0001778887,0.0001628095,0.000079762394,0.0004305888,0.00008179786,0.000015994934,0.00088258245],"genre_scores_gemma":[0.99747366,0.00026670008,0.00043074315,0.00031875647,0.00021040467,0.00054767105,0.00025310495,0.000005326648,0.0004936849],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9980876,0.0012516355,0.000103670514,0.00013137615,0.0001433238,0.0002823407],"domain_scores_gemma":[0.9972241,0.001057074,0.00021599629,0.00020050464,0.00014120119,0.0011611399],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0030026112,0.0010470833,0.002207938,0.00040390663,0.0009474471,0.00072111527,0.0004956045,0.000996837,0.0026518335],"category_scores_gemma":[0.0038712,0.00053900084,0.0012036334,0.0003468885,0.0011147414,0.00078512065,0.00052725046,0.0017520649,0.0006776972],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.63650906,0.17302567,0.07230762,0.00043617582,0.0009139102,0.005009191,0.0014119138,0.00091404363,0.022330541,0.00031408208,0.0017098754,0.08511786],"study_design_scores_gemma":[0.089282,0.87257576,0.032974854,0.000025347763,0.00026816287,0.001098704,0.00022246753,0.00068927376,0.0012470552,0.00009206879,0.0014939174,0.000030401541],"about_ca_topic_score_codex":0.0010211635,"about_ca_topic_score_gemma":0.00087489653,"teacher_disagreement_score":0.0030026112,"about_ca_system_score_codex":0.0005075415,"about_ca_system_score_gemma":0.0012073744,"threshold_uncertainty_score":0.015879512},"labels":[],"label_agreement":null},{"id":"W2151615087","doi":"10.1046/j.1365-2893.2000.00205.x","title":"Statistical models for predicting response to interferon‐α and spontaneous seroconversion in children with chronic hepatitis B","year":2000,"lang":"en","type":"article","venue":"Journal of Viral Hepatitis","topic":"Hepatitis B Virus Studies","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Seroconversion; Medicine; Interferon; Chronic hepatitis; Immunology; Virology; Human immunodeficiency virus (HIV); Virus","score_opus":0.010020810156779256,"score_gpt":0.26147077712953415,"score_spread":0.2514499669727549,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2151615087","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.86657447,0.0017538604,0.12565407,0.0014533489,0.00010480951,0.00035570803,0.002261202,0.0005428731,0.0012997121],"genre_scores_gemma":[0.97605133,0.00039280995,0.020018935,0.000121380974,0.000080971666,0.0003342725,0.0019913209,0.000029596336,0.0009794056],"study_design_codex":"simulation_or_modeling","study_design_gemma":"observational","domain_scores_codex":[0.99679846,0.0024019778,0.00014967624,0.00023525517,0.0002013536,0.0002132197],"domain_scores_gemma":[0.97332776,0.023068013,0.00190379,0.0003770975,0.0009253885,0.0003979811],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.013974044,0.0014074396,0.0011832393,0.0019172473,0.0004531278,0.000945797,0.00097416824,0.0007858861,0.0014678779],"category_scores_gemma":[0.023070455,0.0005750648,0.0016998322,0.00080648664,0.00056940893,0.0006509728,0.0009916882,0.001467987,0.00031597508],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011239719,0.00021866724,0.13411848,0.000057045803,0.0005132274,0.00012657324,0.00012499843,0.8357114,0.00023259762,0.0017080178,0.0012682807,0.024796732],"study_design_scores_gemma":[0.000040321644,0.00014604625,0.004558439,0.0000130869885,0.000036994057,0.000021985246,0.000021058486,0.9935774,0.00006496208,0.0013606908,0.00015038265,0.000008610244],"about_ca_topic_score_codex":0.009450162,"about_ca_topic_score_gemma":0.0051799435,"teacher_disagreement_score":0.013974044,"about_ca_system_score_codex":0.00095221534,"about_ca_system_score_gemma":0.0011458462,"threshold_uncertainty_score":0.07390267},"labels":[],"label_agreement":null},{"id":"W2152583616","doi":"10.1111/j.1365-2893.2011.01505.x","title":"Inhibition of IκB kinase by thalidomide increases hepatitis C virus RNA replication","year":2011,"lang":"en","type":"article","venue":"Journal of Viral Hepatitis","topic":"Hepatitis C virus research","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Centre Hospitalier Universitaire Sainte-Justine","funders":"Canadian Institutes of Health Research","keywords":"Virology; Replication (statistics); Viral replication; Hepatitis C virus; RNA; Thalidomide; Hepatitis B virus; Biology; Medicine; Virus; Genetics; Immunology; Gene","score_opus":0.03780795160599469,"score_gpt":0.3125469292247264,"score_spread":0.2747389776187317,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2152583616","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99255484,0.0040765293,0.001125939,0.00009693809,0.000060573395,0.00003181988,0.00020301847,0.00009525072,0.0017550124],"genre_scores_gemma":[0.9947044,0.0019464251,0.0012685781,0.00005114086,0.000013455208,0.000032961856,0.00035148198,0.0000107037395,0.0016209215],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998841,0.000022435242,0.000012173298,0.000017785183,0.00002676332,0.000036664453],"domain_scores_gemma":[0.9999181,0.000017766326,0.000022020988,0.000008522621,0.000009768288,0.000023830993],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015209682,0.0003127935,0.00028041675,0.00014759648,0.00009841863,0.00028690058,0.00016268397,0.00017265699,0.0010613792],"category_scores_gemma":[0.00012217704,0.000113518276,0.00024204052,0.00013972518,0.0001566546,0.00018189097,0.0001282468,0.00050138234,0.00022658316],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003383554,0.00011615775,0.00014541407,0.000055033484,0.000009534136,0.000024465951,0.000017006292,0.000080113736,0.99683017,0.00005130678,0.000055694152,0.0022768355],"study_design_scores_gemma":[0.000071509756,0.0019472593,0.0033353462,0.000011243214,0.000023932083,0.00011352864,0.000024787934,0.0009520256,0.9913919,0.000024837722,0.0020976318,0.0000059118047],"about_ca_topic_score_codex":0.00072722975,"about_ca_topic_score_gemma":0.0009829163,"teacher_disagreement_score":0.0010613792,"about_ca_system_score_codex":0.00026775763,"about_ca_system_score_gemma":0.0002408839,"threshold_uncertainty_score":0.0035506487},"labels":[],"label_agreement":null},{"id":"W2159537180","doi":"10.1111/jvh.12432","title":"Disease burden of chronic hepatitis C among immigrants in Canada","year":2015,"lang":"en","type":"article","venue":"Journal of Viral Hepatitis","topic":"Hepatitis C virus research","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University Health Network; University of Toronto; Toronto Public Health","funders":"Canadian Institutes of Health Research; University of Toronto; Canadian Liver Foundation","keywords":"Medicine; Cirrhosis; Disease burden; Quality-adjusted life year; Hepatitis C; Liver disease; Cohort; Epidemiology; Chronic liver disease; Pegylated interferon; Hepatocellular carcinoma; Ribavirin; Demography; Internal medicine; Disease; Cost effectiveness; Chronic hepatitis; Immunology","score_opus":0.02099045651050379,"score_gpt":0.2891378608831087,"score_spread":0.2681474043726049,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2159537180","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9795161,0.0045501506,0.000807809,0.001678955,0.000030098088,0.00010339477,0.008131759,0.000038911094,0.0051427344],"genre_scores_gemma":[0.9952494,0.0015960567,0.0006647411,0.00017346615,0.000007981382,0.000020548903,0.0015736598,0.0000044782946,0.00070958445],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99947304,0.00009185868,0.000031317457,0.000071539675,0.00020911574,0.00012320663],"domain_scores_gemma":[0.9991418,0.0001256342,0.0001566347,0.000021623991,0.00036073753,0.00019349314],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00075266534,0.00040306232,0.00046313612,0.0008259742,0.0015435037,0.001406146,0.000601487,0.00039778472,0.0017335486],"category_scores_gemma":[0.0019678008,0.00019648441,0.0009165717,0.0017208561,0.0005278393,0.00020885898,0.0005961495,0.0005039962,0.00009446154],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00049220875,0.00008347196,0.9323222,0.000337426,0.0008062433,0.00045383594,0.00055643177,0.025755571,0.00048628417,0.001853821,0.006069131,0.030783454],"study_design_scores_gemma":[0.00014188145,0.00016186814,0.93321866,0.00048101877,0.00069553126,0.00036251073,0.0018060831,0.05345879,0.0002937187,0.0012395442,0.008032806,0.000107575375],"about_ca_topic_score_codex":0.99327576,"about_ca_topic_score_gemma":0.9924953,"teacher_disagreement_score":0.044093788,"about_ca_system_score_codex":0.044093788,"about_ca_system_score_gemma":0.035203602,"threshold_uncertainty_score":0.3199243},"labels":[],"label_agreement":null},{"id":"W2160138172","doi":"10.1111/j.1365-2893.2008.01045.x","title":"Genotype D amongst injection drug users with acute hepatitis B virus infection in British Columbia","year":2008,"lang":"en","type":"article","venue":"Journal of Viral Hepatitis","topic":"Hepatitis B Virus Studies","field":"Medicine","cited_by":34,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"BC Centre for Disease Control","funders":"British Columbia Centre for Disease Control; Public Health Agency of Canada","keywords":"Genotype; Hepatitis B virus; Transmission (telecommunications); Virology; Medicine; Biology; Demography; Virus; Gene; Genetics","score_opus":0.010313060521055203,"score_gpt":0.24082968831966475,"score_spread":0.23051662779860954,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2160138172","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99822694,0.0002245267,0.000043474716,0.000059013782,0.000003589148,0.000020515938,0.00043027045,0.000004908166,0.0009868718],"genre_scores_gemma":[0.99812037,0.0003351346,0.000090425216,0.000071404036,0.0000023073585,0.000009128208,0.00043919633,0.0000027342219,0.0009294338],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9996475,0.000028231863,0.000025358242,0.000049483016,0.00011929189,0.00013017148],"domain_scores_gemma":[0.99933904,0.00004805964,0.0001315543,0.000023199045,0.0002788893,0.00017922994],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017130705,0.00029344362,0.00029436185,0.0013887349,0.0020129902,0.00089719956,0.0006242251,0.00033981245,0.0015674051],"category_scores_gemma":[0.0009223252,0.00036972936,0.00015920492,0.00255652,0.00049636606,0.00021919173,0.0006227808,0.0003944011,0.0002601621],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000056347624,0.000026372452,0.99038154,0.000027002236,0.000012956901,0.0005229236,0.0010683059,0.000043264903,0.0006210796,0.000019075915,0.00057530316,0.00664573],"study_design_scores_gemma":[0.0000027695985,0.000020888518,0.9977386,0.000015914411,0.0000067366645,0.0002687102,0.0014070722,0.000085413965,0.000057997768,0.0000069948624,0.00038375775,0.0000052040923],"about_ca_topic_score_codex":0.96633166,"about_ca_topic_score_gemma":0.97875273,"teacher_disagreement_score":0.03366834,"about_ca_system_score_codex":0.006209523,"about_ca_system_score_gemma":0.0053885123,"threshold_uncertainty_score":0.06773317},"labels":[],"label_agreement":null},{"id":"W2166935665","doi":"10.1111/jvh.12468","title":"Peginterferon add‐on results in more HBsAg decline compared to monotherapy in HBeAg‐positive chronic hepatitis B patients","year":2015,"lang":"en","type":"article","venue":"Journal of Viral Hepatitis","topic":"Hepatitis B Virus Studies","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network","funders":"Foundation for Liver Research; Novartis; F. Hoffmann-La Roche; Abbott Fund; Roche; Merck; Gilead Sciences; Medtronic; Boehringer Ingelheim","keywords":"HBsAg; Medicine; Entecavir; Gastroenterology; PEG ratio; HBeAg; Combination therapy; Internal medicine; Discontinuation; Lamivudine; Hepatitis B virus; Peginterferon alfa-2a; Hepatitis B; Chronic hepatitis; Immunology; Virus","score_opus":0.03004416677783156,"score_gpt":0.32291296686259346,"score_spread":0.2928688000847619,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2166935665","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99709916,0.0021617548,0.00007028727,0.00007799288,0.00004248118,0.00006427356,0.00011238902,0.000006283136,0.00036533302],"genre_scores_gemma":[0.9986858,0.00046831765,0.00010913636,0.00012980847,0.000047741116,0.00005397399,0.00014275256,0.0000035341739,0.0003589651],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99772197,0.0015581868,0.00019998147,0.00022173455,0.00014384084,0.0001543362],"domain_scores_gemma":[0.99708027,0.0017312441,0.0005840136,0.00021741397,0.00009337713,0.00029362127],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003632858,0.00045430014,0.0018577584,0.00035689748,0.00016881574,0.00079155073,0.00022230824,0.00062336866,0.0022425607],"category_scores_gemma":[0.003246985,0.000384295,0.0032177947,0.00032416254,0.0003388765,0.00043753916,0.0002779488,0.0008215166,0.00023733503],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.8413712,0.003937632,0.05929421,0.0010362971,0.009666479,0.00022173049,0.00018923629,0.001042133,0.014581381,0.000111778005,0.00058007863,0.067967854],"study_design_scores_gemma":[0.14925979,0.31892422,0.4993099,0.00028638818,0.018146358,0.00058719254,0.00029095236,0.0025512201,0.006412017,0.0004914293,0.0036588775,0.000081623846],"about_ca_topic_score_codex":0.00046643437,"about_ca_topic_score_gemma":0.0009727459,"teacher_disagreement_score":0.003632858,"about_ca_system_score_codex":0.00039209786,"about_ca_system_score_gemma":0.0005195774,"threshold_uncertainty_score":0.019212604},"labels":[],"label_agreement":null},{"id":"W2168450731","doi":"10.1111/j.1365-2893.2010.01248.x","title":"Pegylated interferon plus optimized weight-based ribavirin dosing negate the influence of weight and body mass index on early viral kinetics and sustained virological response in chronic hepatitis C","year":2010,"lang":"en","type":"article","venue":"Journal of Viral Hepatitis","topic":"Hepatitis C virus research","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Mount Sinai Hospital; Toronto Western Hospital; University Health Network","funders":"National Medical Research Council; National Health and Medical Research Council; University Health Network","keywords":"Ribavirin; Medicine; Body mass index; Internal medicine; Gastroenterology; Viral load; Pegylated interferon; Dosing; Chronic hepatitis; Immunology; Virus","score_opus":0.010605427978216711,"score_gpt":0.28787421311950767,"score_spread":0.27726878514129094,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2168450731","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99919397,0.00037538563,0.00022437309,0.00002159952,0.0000040556906,0.000012071056,0.000015111257,0.000005443493,0.00014795404],"genre_scores_gemma":[0.999343,0.000111014,0.0003753238,0.000026073614,0.0000076000942,0.0000080949885,0.00004638657,0.0000013635356,0.00008117993],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99985456,0.000066357454,0.000017862712,0.000017606517,0.00003178256,0.000011698007],"domain_scores_gemma":[0.99982953,0.000045555815,0.000078692145,0.000013696754,0.000010156551,0.0000223365],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00038274226,0.0001526175,0.00020826043,0.00011369551,0.000073903444,0.0001433152,0.00010522107,0.00011497032,0.00040644288],"category_scores_gemma":[0.0008053239,0.00007650289,0.000105501575,0.00010720328,0.00011400122,0.00013072503,0.00007622711,0.00017010079,0.000098626355],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.025404511,0.001560494,0.6392165,0.0002582904,0.00042414595,0.0005011277,0.00012497585,0.003321978,0.099386,0.00014581687,0.0005588362,0.2290974],"study_design_scores_gemma":[0.00093377667,0.023001013,0.95411646,0.000042006526,0.00019733582,0.0020716651,0.00005593096,0.00460376,0.013509676,0.00010021238,0.0013554617,0.000012771912],"about_ca_topic_score_codex":0.00020082295,"about_ca_topic_score_gemma":0.00047697828,"teacher_disagreement_score":0.00040644288,"about_ca_system_score_codex":0.00014904753,"about_ca_system_score_gemma":0.0001316869,"threshold_uncertainty_score":0.0020241141},"labels":[],"label_agreement":null},{"id":"W2181253693","doi":"10.1111/jvh.12485","title":"Open‐label study of faldaprevir plus peginterferon and ribavirin in hepatitis <scp>C</scp> virus genotype 1‐infected patients who failed placebo plus peginterferon and ribavirin","year":2015,"lang":"en","type":"article","venue":"Journal of Viral Hepatitis","topic":"Hepatitis C virus research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"Gilead Sciences; Roche; Boehringer Ingelheim","keywords":"Ribavirin; Virology; Hepatitis C virus; Medicine; Genotype; Placebo; Open label; Hepatitis C; Internal medicine; Virus; Gastroenterology; Clinical trial; Biology; Gene; Pathology","score_opus":0.05525933149872614,"score_gpt":0.3410306568169238,"score_spread":0.28577132531819766,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2181253693","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99693656,0.0006669007,0.00023104185,0.0001868067,0.00012568873,0.0008807499,0.00029413129,0.000057874768,0.0006202431],"genre_scores_gemma":[0.9954668,0.0005761541,0.0006349587,0.00035066984,0.00025292693,0.00090850424,0.0005213888,0.000010137184,0.0012785849],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.999385,0.00028510607,0.000042407555,0.000114145296,0.0000486921,0.00012458165],"domain_scores_gemma":[0.998828,0.0002217639,0.00016150292,0.00008488364,0.00008075666,0.0006231372],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014888701,0.0014467259,0.0031682868,0.0005030255,0.0005762203,0.0008480602,0.0008251585,0.0016012258,0.0037337116],"category_scores_gemma":[0.0012027582,0.0007864435,0.0012321838,0.00037601922,0.0011732477,0.0014103344,0.00036459652,0.002900895,0.0008291759],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.91191036,0.046201374,0.002114298,0.00025606612,0.00049818883,0.00009310033,0.00012129749,0.0004015425,0.0074149515,0.0000797172,0.00046363383,0.030445395],"study_design_scores_gemma":[0.52688175,0.4639067,0.0067631756,0.000015337999,0.00017935026,0.00006644287,0.00004008694,0.0006936745,0.0007900858,0.00007009472,0.0005729381,0.000020444942],"about_ca_topic_score_codex":0.0014781514,"about_ca_topic_score_gemma":0.0027768842,"teacher_disagreement_score":0.0037337116,"about_ca_system_score_codex":0.0007340001,"about_ca_system_score_gemma":0.0010787669,"threshold_uncertainty_score":0.012490571},"labels":[],"label_agreement":null},{"id":"W2192613407","doi":"10.1111/jvh.12492","title":"Epidemiological characteristics of the carriers with coexistence of <scp>HB</scp>sAg and anti‐<scp>HB</scp>s based on a community cohort study","year":2015,"lang":"en","type":"article","venue":"Journal of Viral Hepatitis","topic":"Hepatitis B Virus Studies","field":"Medicine","cited_by":37,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Public Health Ontario; University of Toronto","funders":"Centers for Disease Control and Prevention; National Natural Science Foundation of China","keywords":"Serology; HBsAg; Epidemiology; Medicine; Cohort; Virology; Hepatitis B virus; Internal medicine; Immunology; Virus; Antibody","score_opus":0.04793896082211583,"score_gpt":0.30385966656315694,"score_spread":0.2559207057410411,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2192613407","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99967504,0.00005842212,0.000027556443,0.000011087125,0.000002773418,0.000006366733,0.00008828362,8.1725256e-7,0.00012963764],"genre_scores_gemma":[0.9996853,0.000043460943,0.000027181346,0.000008444755,0.000004681684,0.00000475492,0.0001279113,8.4599696e-7,0.00009750124],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9996433,0.00006277994,0.000043748456,0.00009571721,0.00007520837,0.00007921973],"domain_scores_gemma":[0.9990564,0.00010912148,0.00029037189,0.00008717863,0.0001629356,0.00029402622],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00064002565,0.0002638308,0.00034852698,0.00094675267,0.0007149176,0.00067599234,0.00026935973,0.0004932346,0.0012965038],"category_scores_gemma":[0.0015041485,0.00046393968,0.00046957075,0.0008539931,0.0002782044,0.00047952434,0.0003850104,0.0005220743,0.00021275424],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009461765,0.00005221477,0.99895966,0.0000029981948,0.000020620297,0.00011587834,0.000113956216,0.000009471366,0.00023961802,0.000007924966,0.000033054534,0.0003498462],"study_design_scores_gemma":[0.000006153195,0.00012893617,0.99900097,0.0000033127994,0.000022748665,0.00041207823,0.00022395054,0.00008375359,0.00003662802,0.000009542741,0.000067335255,0.0000046676228],"about_ca_topic_score_codex":0.009734468,"about_ca_topic_score_gemma":0.0076883603,"teacher_disagreement_score":0.009734468,"about_ca_system_score_codex":0.00024024467,"about_ca_system_score_gemma":0.00038123704,"threshold_uncertainty_score":0.019355655},"labels":[],"label_agreement":null},{"id":"W2205764163","doi":"10.1111/jvh.12494","title":"Protease inhibitors partially overcome the interferon nonresponse phenotype in patients with chronic hepatitis C","year":2015,"lang":"en","type":"article","venue":"Journal of Viral Hepatitis","topic":"Hepatitis C virus research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre for Global Health Research; Toronto Liver Centre; University of Toronto; University Health Network","funders":"Janssen Pharmaceuticals; University of Illinois at Chicago; University of Arkansas; Boehringer Ingelheim; Gilead Sciences; University of Arkansas for Medical Sciences; Merck; AbbVie; Bristol-Myers Squibb","keywords":"Telaprevir; Ribavirin; Boceprevir; Interferon; Hepatitis C virus; Staining; Medicine; Biomarker; Internal medicine; Hepatitis C; Alpha interferon; Immunology; Virology; Biology; Pathology; Virus","score_opus":0.022002266286612907,"score_gpt":0.29283231500097673,"score_spread":0.27083004871436384,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2205764163","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9980971,0.0011165126,0.00006998727,0.00007470269,0.000008088275,0.000013058489,0.000026995469,0.000009946414,0.00058355054],"genre_scores_gemma":[0.99952984,0.00015019464,0.000066296,0.000056388824,0.000011802089,0.0000045163424,0.000046054214,0.0000016249438,0.00013339032],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99981743,0.00007623441,0.000020200241,0.000020929665,0.000031235024,0.00003405946],"domain_scores_gemma":[0.99959165,0.00014274204,0.0001233288,0.00002464648,0.000032692722,0.000085023916],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004036916,0.00023083354,0.00048943475,0.0001900819,0.0001657147,0.00024776146,0.00011991891,0.0002570937,0.00064456166],"category_scores_gemma":[0.0012475977,0.00010914299,0.00025009137,0.0001755528,0.00011281642,0.00021408996,0.000123622,0.00031425574,0.000141106],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.014728875,0.00073059596,0.81025904,0.00021949821,0.00031529675,0.0015840145,0.00028646452,0.00046738074,0.032479372,0.000116264295,0.0009911035,0.13782203],"study_design_scores_gemma":[0.00037949102,0.006112867,0.9848128,0.000028705252,0.00016386666,0.0028114761,0.00017649874,0.0007278095,0.00326869,0.000102940096,0.0014054821,0.000009377913],"about_ca_topic_score_codex":0.00033674279,"about_ca_topic_score_gemma":0.0007369066,"teacher_disagreement_score":0.00064456166,"about_ca_system_score_codex":0.00015914846,"about_ca_system_score_gemma":0.00012269271,"threshold_uncertainty_score":0.0021562576},"labels":[],"label_agreement":null},{"id":"W2289412129","doi":"10.1111/jvh.12525","title":"<i><scp>HLA</scp>‐C</i> and <i><scp>KIR</scp></i> combined genotype as new response marker for <scp>HB</scp>eAg‐positive chronic hepatitis B patients treated with interferon‐based combination therapy","year":2016,"lang":"en","type":"article","venue":"Journal of Viral Hepatitis","topic":"Immune Cell Function and Interaction","field":"Immunology and Microbiology","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network","funders":"Cilag; F. Hoffmann-La Roche; Alnylam Pharmaceuticals; Gilead Sciences; Bristol-Myers Squibb","keywords":"Genotype; Medicine; Immunology; Human leukocyte antigen; SNP; Internal medicine; Gastroenterology; Single-nucleotide polymorphism; Antigen; Biology; Gene; Genetics","score_opus":0.006820369655337944,"score_gpt":0.21896902490829837,"score_spread":0.21214865525296042,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2289412129","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9995141,0.00014442057,0.00010762231,0.000016633894,0.0000043412883,0.0000044092753,0.000037458758,0.0000036663664,0.00016743911],"genre_scores_gemma":[0.99975556,0.000021254355,0.00008461041,0.000014999799,0.000006638782,0.0000032180021,0.00004914456,0.000001596488,0.00006297037],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9996526,0.00015267321,0.000037429025,0.000064040134,0.000054153552,0.000039081744],"domain_scores_gemma":[0.99909186,0.00027520166,0.00035411416,0.000054298227,0.000072289564,0.00015221054],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004900297,0.00032439627,0.000505149,0.000465684,0.00019659742,0.00040115602,0.0001432402,0.0003639964,0.0011112584],"category_scores_gemma":[0.0009924013,0.00010066139,0.0004270241,0.00039505833,0.00019560585,0.00015630097,0.00015731156,0.0003837029,0.00021549649],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00421982,0.00011702164,0.9704019,0.000027366894,0.00024966212,0.00025778532,0.0000896934,0.00029883636,0.015298713,0.000021480071,0.00014568705,0.008872051],"study_design_scores_gemma":[0.00007160378,0.0006510186,0.99526995,0.000009236004,0.00016459222,0.0007452452,0.000076148885,0.0013639058,0.0013720596,0.000054107386,0.00021371864,0.000008427115],"about_ca_topic_score_codex":0.00046829684,"about_ca_topic_score_gemma":0.0005963868,"teacher_disagreement_score":0.0011112584,"about_ca_system_score_codex":0.00014390718,"about_ca_system_score_gemma":0.00009738127,"threshold_uncertainty_score":0.0037175417},"labels":[],"label_agreement":null},{"id":"W2508631962","doi":"10.1111/jvh.12579","title":"Prevalence and risk factors for viral blipping in chronic hepatitis B patients treated with nucleos (t) ide analogues","year":2016,"lang":"en","type":"article","venue":"Journal of Viral Hepatitis","topic":"Hepatitis B Virus Studies","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Mount Sinai Hospital; Toronto General Hospital; Public Health Ontario; University of Toronto","funders":"","keywords":"Medicine; Entecavir; Internal medicine; HBsAg; Gastroenterology; Lamivudine; Viral load; HBeAg; Viral hepatitis; Hepatitis B; Clinical significance; Hepatitis B virus; Creatinine; Proportional hazards model; Immunology; Virus","score_opus":0.014152145221737649,"score_gpt":0.2608634613009652,"score_spread":0.24671131607922756,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2508631962","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9995376,0.0002318756,0.000026008702,0.00001584029,0.0000033027115,0.0000033494598,0.00007384141,0.000001036042,0.00010709296],"genre_scores_gemma":[0.99973446,0.00008776828,0.000027446296,0.00001145027,0.0000072759303,0.0000029392452,0.0000815141,6.1317496e-7,0.000046637793],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9996736,0.00009200188,0.000047833386,0.000072665665,0.000052279105,0.000061646264],"domain_scores_gemma":[0.99876046,0.00020104695,0.000681531,0.00008221417,0.00007362479,0.00020115454],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00056347926,0.0002032335,0.00029799907,0.00044462632,0.00038263027,0.0005359453,0.00024083247,0.0004003133,0.00092820707],"category_scores_gemma":[0.001487106,0.00035852275,0.0005854568,0.0007216285,0.00020913141,0.00039836153,0.00035135334,0.0006799388,0.00010740404],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000080931684,0.000014825623,0.99943036,0.0000031720474,0.000019283221,0.000022923427,0.000014423884,0.000007374253,0.000062828854,0.0000032052571,0.000016035016,0.00032464621],"study_design_scores_gemma":[0.0000052160776,0.00009082312,0.9994624,0.0000053213093,0.000020653275,0.00014874301,0.00008168147,0.00010797111,0.000023773155,0.000008625205,0.00004275974,0.0000019081829],"about_ca_topic_score_codex":0.0033978166,"about_ca_topic_score_gemma":0.004089161,"teacher_disagreement_score":0.0033978166,"about_ca_system_score_codex":0.00018094388,"about_ca_system_score_gemma":0.00024363463,"threshold_uncertainty_score":0.0067560673},"labels":[],"label_agreement":null},{"id":"W2521531894","doi":"10.1111/jvh.12615","title":"Analysis of resistance‐associated substitutions in acute hepatitis C virus infection by deep sequencing across six genotypes and three continents","year":2016,"lang":"en","type":"article","venue":"Journal of Viral Hepatitis","topic":"Hepatitis C virus research","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"National Institute on Drug Abuse; National Institute of Allergy and Infectious Diseases; University of New South Wales","keywords":"NS3; NS5B; NS5A; Virology; Hepatitis C virus; Genotype; Ribavirin; Population; Biology; Deep sequencing; Medicine; Hepacivirus; Virus; Genome; Genetics; Gene; Environmental health","score_opus":0.019892182873816545,"score_gpt":0.32140015806416883,"score_spread":0.3015079751903523,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2521531894","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99873215,0.0002248103,0.00034961596,0.000019028985,0.0000027925657,0.000006502602,0.0004494643,0.000004069174,0.00021156811],"genre_scores_gemma":[0.9968093,0.00015991475,0.00112808,0.000060839186,0.0000039065753,0.000014014339,0.0016896818,0.0000069643693,0.00012723438],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9995604,0.00011959313,0.00004376177,0.000118352,0.00008487365,0.0000730672],"domain_scores_gemma":[0.99923384,0.00020703793,0.0002457649,0.000082683895,0.00012512668,0.00010565168],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008453489,0.00024358444,0.0003811438,0.0008525999,0.00034749866,0.0005046033,0.00024677222,0.00027107474,0.00047485583],"category_scores_gemma":[0.0012766734,0.00016584639,0.00041672602,0.00087676,0.00029427934,0.00014309399,0.00078431464,0.00027256488,0.00012177704],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00057884504,0.00005701452,0.9230555,0.00013998624,0.0004388424,0.00043749643,0.0012784684,0.0008340399,0.052807465,0.00018645162,0.00037113056,0.019814586],"study_design_scores_gemma":[0.000011280374,0.00006926212,0.9952093,0.000020493591,0.00008158635,0.00049877615,0.00048223278,0.0011256249,0.0011876656,0.00008785939,0.0012162651,0.000009593672],"about_ca_topic_score_codex":0.0025397385,"about_ca_topic_score_gemma":0.0039018295,"teacher_disagreement_score":0.0025397385,"about_ca_system_score_codex":0.00020403713,"about_ca_system_score_gemma":0.0002409698,"threshold_uncertainty_score":0.005049944},"labels":[],"label_agreement":null},{"id":"W2547009557","doi":"10.1111/jvh.12616","title":"Phylogenetic analysis of full‐length, early infection, hepatitis C virus genomes among people with intravenous drug use: the InC<sup>3</sup> Study","year":2016,"lang":"en","type":"article","venue":"Journal of Viral Hepatitis","topic":"Hepatitis C virus research","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"National Institute on Drug Abuse; National Institute of Allergy and Infectious Diseases; Rijksinstituut voor Volksgezondheid en Milieu; National Health and Medical Research Council; Medical Research Council; Fonds de Recherche du Québec - Santé; National Institutes of Health; Canadian Institutes of Health Research; University of New South Wales; Styrelsen för Internationellt Utvecklingssamarbete","keywords":"Phylogenetic tree; Hepatitis C virus; Molecular epidemiology; Genome; Biology; Phylogenetics; Virology; Evolutionary biology; Genetics; Virus; Genotype; Gene","score_opus":0.013055118956338567,"score_gpt":0.269022471669071,"score_spread":0.25596735271273247,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2547009557","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9996463,0.000027202717,0.000064453554,0.000009926905,7.7659564e-7,0.000004043045,0.00017012145,8.428379e-7,0.00007625415],"genre_scores_gemma":[0.9991829,0.000030256251,0.0002210071,0.000019818875,0.0000025878642,0.000008549263,0.00045629387,0.0000022587947,0.00007635878],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9995708,0.00014867164,0.000033105116,0.0001062568,0.00006427878,0.0000769816],"domain_scores_gemma":[0.99890983,0.00024716838,0.00026553308,0.00015121959,0.00020725265,0.00021903272],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00065178325,0.00018542471,0.00024688072,0.00080053584,0.0006464497,0.00045074357,0.00028387472,0.00041621033,0.0009378917],"category_scores_gemma":[0.0018017303,0.00022412962,0.0003623798,0.0008539899,0.00027127226,0.00025030033,0.0004994306,0.0005058086,0.0002148527],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019909415,0.00003562824,0.99664366,0.000007729103,0.000037919883,0.000056519053,0.00030537628,0.000041754614,0.0013310777,0.000017236744,0.00008786829,0.001236139],"study_design_scores_gemma":[0.000006586749,0.000105030675,0.9982961,0.0000042282018,0.00002791662,0.00035578213,0.00043979217,0.00031739002,0.00023676547,0.000020265697,0.000187328,0.0000028696147],"about_ca_topic_score_codex":0.00880568,"about_ca_topic_score_gemma":0.010663014,"teacher_disagreement_score":0.00880568,"about_ca_system_score_codex":0.00028163637,"about_ca_system_score_gemma":0.0003157471,"threshold_uncertainty_score":0.017508864},"labels":[],"label_agreement":null},{"id":"W2554587175","doi":"10.1111/jvh.12650","title":"Role of primary T‐cell immunodeficiency and hepatitis B coinfection on spontaneous clearance of hepatitis C: The BC Hepatitis Testers Cohort","year":2016,"lang":"en","type":"article","venue":"Journal of Viral Hepatitis","topic":"Hepatitis C virus research","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Ontario HIV Treatment Network; BC Centre for Disease Control; University of British Columbia","funders":"Canadian Institutes of Health Research","keywords":"Coinfection; Medicine; Virology; Hepatitis C; Hepatitis; Cohort; Hepatitis B; Hepatitis A; Immunology; Human immunodeficiency virus (HIV); Internal medicine","score_opus":0.008161408965611678,"score_gpt":0.24690461486346602,"score_spread":0.23874320589785433,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2554587175","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99662566,0.0007336377,0.00010210657,0.00014043524,0.000020817257,0.000015506821,0.0014930184,0.000007283069,0.0008616344],"genre_scores_gemma":[0.99846834,0.00019780891,0.00004996882,0.000035762434,0.000010137502,0.000008229785,0.00085959147,0.000007190986,0.00036294863],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99912256,0.00015605184,0.000054973192,0.00020302729,0.00024256515,0.00022066479],"domain_scores_gemma":[0.99754024,0.00025261348,0.0006038007,0.00039876305,0.0005564253,0.00064810005],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001498291,0.00049109187,0.0006825569,0.0007457038,0.0013603022,0.001411787,0.0010580024,0.0005352777,0.002131663],"category_scores_gemma":[0.003039736,0.000455523,0.0010220045,0.0010759337,0.00035839717,0.00038344474,0.0008159481,0.0011066587,0.00030666322],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016484852,0.000013753126,0.99842393,0.0000063044154,0.00009363432,0.00008133626,0.00008831147,0.000032973912,0.000101818776,0.00002386044,0.00027449703,0.00069473917],"study_design_scores_gemma":[0.00001298902,0.000041884472,0.998454,0.000015245616,0.00008045305,0.00028659657,0.00025352725,0.00035634678,0.000038762635,0.000031671796,0.00042103758,0.000007484769],"about_ca_topic_score_codex":0.383663,"about_ca_topic_score_gemma":0.34521064,"teacher_disagreement_score":0.383663,"about_ca_system_score_codex":0.0012496321,"about_ca_system_score_gemma":0.0025322323,"threshold_uncertainty_score":0.76285964},"labels":[],"label_agreement":null},{"id":"W2560230732","doi":"10.1111/jvh.12641","title":"Time to viral suppression is not related to achievement of <scp>SVR</scp>12 in <scp>HCV GT</scp>1‐infected patients treated with ombitasvir/paritaprevir/ritonavir and dasabuvir with or without ribavirin","year":2016,"lang":"en","type":"article","venue":"Journal of Viral Hepatitis","topic":"Hepatitis C virus research","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"National Institute on Drug Abuse; AbbVie","keywords":"Ombitasvir; Paritaprevir; Dasabuvir; Ritonavir; Medicine; Ribavirin; Virology; Internal medicine; Gastroenterology; Hepatitis C virus; Viral load; Virus","score_opus":0.013586254011132443,"score_gpt":0.28386933062461717,"score_spread":0.2702830766134847,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2560230732","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99953103,0.00014627742,0.000038275593,0.000023004888,0.0000032089076,0.000003905328,0.00003212455,0.0000028030956,0.00021938203],"genre_scores_gemma":[0.9997904,0.000025998934,0.000019557225,0.000017592161,0.0000052677474,0.000002794152,0.000068746755,0.0000011674293,0.00006853793],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9996203,0.00013189613,0.000045388013,0.00006286004,0.00005303214,0.00008648327],"domain_scores_gemma":[0.99694496,0.0010592609,0.0012101016,0.00011892764,0.00010632683,0.0005604487],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008661217,0.00014951415,0.00034752602,0.00020907457,0.0001774845,0.00045845078,0.00012206595,0.00038448776,0.0013895703],"category_scores_gemma":[0.0027149725,0.00020685377,0.00039127414,0.00021635626,0.00019562712,0.00028691918,0.00016266163,0.0007118895,0.00024883955],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.02147699,0.00037373358,0.95626324,0.00003947468,0.0002308854,0.00021896741,0.00013908252,0.00046946015,0.004344346,0.000044925273,0.0002602399,0.016138641],"study_design_scores_gemma":[0.00045512617,0.0060843746,0.9900137,0.000015188952,0.00014688984,0.0006015264,0.00006323313,0.0015352227,0.0006671267,0.00006062541,0.00034494232,0.000011897572],"about_ca_topic_score_codex":0.0005551946,"about_ca_topic_score_gemma":0.0007755613,"teacher_disagreement_score":0.0013895703,"about_ca_system_score_codex":0.00017285085,"about_ca_system_score_gemma":0.00020731185,"threshold_uncertainty_score":0.0046485662},"labels":[],"label_agreement":null},{"id":"W2582003424","doi":"10.1111/jvh.12684","title":"Shift in disparities in hepatitis C treatment from interferon to <scp>DAA</scp> era: A population‐based cohort study","year":2017,"lang":"en","type":"article","venue":"Journal of Viral Hepatitis","topic":"Hepatitis C virus research","field":"Medicine","cited_by":47,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"BC Centre for Disease Control; University of British Columbia","funders":"Canadian Institutes of Health Research; Merck; Boehringer Ingelheim","keywords":"Medicine; Internal medicine; Sofosbuvir; Pegylated interferon; Hepatitis C; Hepatitis C virus; Ledipasvir; Ribavirin; Boceprevir; Telaprevir; Gastroenterology; Population; Ombitasvir; Odds ratio; Cohort; Virology; Virus","score_opus":0.03185741129124091,"score_gpt":0.3480021526909063,"score_spread":0.31614474139966536,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2582003424","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.995112,0.0006457303,0.00008883992,0.00029666704,0.000026288846,0.00002517292,0.0029842097,0.0000050049366,0.00081605854],"genre_scores_gemma":[0.99836856,0.00023928835,0.00006639996,0.00014604488,0.000011778039,0.000013386881,0.00094377337,0.0000038850517,0.00020683733],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985933,0.00023480202,0.00010667706,0.0003922123,0.00024165874,0.00043140393],"domain_scores_gemma":[0.997829,0.00013782112,0.0005989603,0.00022920677,0.00064805464,0.00055698334],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001217455,0.00035931848,0.0004953409,0.0010626444,0.0016209672,0.0012048847,0.001031679,0.00076562306,0.0017002724],"category_scores_gemma":[0.0027210785,0.00049046613,0.00078777404,0.0028812743,0.0005762714,0.00061342394,0.0011570829,0.0011569248,0.0003019327],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008258023,0.00003803415,0.9973949,0.0000110596,0.00013043162,0.000044815697,0.00035951473,0.000031359108,0.00007511891,0.000074371026,0.00076254865,0.000995262],"study_design_scores_gemma":[0.000011418085,0.000025617152,0.9984648,0.000023199273,0.000046807538,0.00006299574,0.000599731,0.00022070511,0.00001792805,0.00003679913,0.0004803287,0.000009702286],"about_ca_topic_score_codex":0.735284,"about_ca_topic_score_gemma":0.75677425,"teacher_disagreement_score":0.735284,"about_ca_system_score_codex":0.00391308,"about_ca_system_score_gemma":0.0039561153,"threshold_uncertainty_score":0.53255},"labels":[],"label_agreement":null},{"id":"W2588513563","doi":"10.1111/jvh.12697","title":"Endemic prevalence of hepatitis B and C in Mongolia: A nationwide survey amongst Mongolian adults","year":2017,"lang":"en","type":"article","venue":"Journal of Viral Hepatitis","topic":"Hepatitis B Virus Studies","field":"Medicine","cited_by":50,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Grand Challenges Canada","keywords":"Medicine; Population; Hepatitis B virus; Hepatitis B; Hepatitis C; Demography; Hepatitis C virus; Inner mongolia; Virology; Environmental health; Virus; Geography; China","score_opus":0.02259305661452256,"score_gpt":0.29871559047339946,"score_spread":0.2761225338588769,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2588513563","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9995005,0.00010369566,0.000022943388,0.000024263756,0.0000012943278,0.0000066087223,0.00015286499,0.0000010120375,0.00018673122],"genre_scores_gemma":[0.9993247,0.000106990425,0.000082786966,0.00004683659,0.0000024914668,0.000010371583,0.000260324,3.3213541e-7,0.00016524164],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9998388,0.000046972546,0.000022880802,0.000026691607,0.000027669646,0.00003692773],"domain_scores_gemma":[0.9997174,0.00003038498,0.0000900674,0.000016214595,0.000063621446,0.00008225222],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00044534044,0.00011390495,0.0001362834,0.0004249474,0.0003412199,0.00024281393,0.00013813443,0.00024610307,0.00063684065],"category_scores_gemma":[0.0003923076,0.00017458611,0.00013696228,0.00038659837,0.00015538618,0.00028117868,0.00023916754,0.00015226414,0.000115917566],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00001348076,0.00002090872,0.99779725,0.000017481389,0.000012276233,0.00003992747,0.00056264485,0.0000137368415,0.0003442004,0.000009007672,0.00008570482,0.0010834533],"study_design_scores_gemma":[0.0000014848731,0.00004202549,0.9991708,0.00000665578,0.0000042799743,0.00009359157,0.00046152537,0.000023206421,0.00001664703,0.0000029757211,0.00017586214,0.0000010589366],"about_ca_topic_score_codex":0.028859071,"about_ca_topic_score_gemma":0.03925098,"teacher_disagreement_score":0.028859071,"about_ca_system_score_codex":0.00032741914,"about_ca_system_score_gemma":0.00044873203,"threshold_uncertainty_score":0.057382226},"labels":[],"label_agreement":null},{"id":"W2606603910","doi":"10.1111/jvh.12716","title":"<scp>NK</scp> cells in self‐limited <scp>HCV</scp> infection exhibit a more extensively differentiated, but not memory‐like, repertoire","year":2017,"lang":"en","type":"article","venue":"Journal of Viral Hepatitis","topic":"Immune Cell Function and Interaction","field":"Immunology and Microbiology","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University Health Network","funders":"Rijksinstituut voor Volksgezondheid en Milieu; Virgo Consortium; Stichting Sanquin Bloedvoorziening; Universiteit van Amsterdam","keywords":"Immunology; Biology; Phenotype; Immune system; Cell; Interleukin 21; Janus kinase 3; Population; Innate immune system; Natural killer cell; Cytotoxic T cell; T cell; Medicine; In vitro; Genetics; Gene","score_opus":0.012309827046355956,"score_gpt":0.23697697390559988,"score_spread":0.22466714685924394,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2606603910","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9993894,0.00009748837,0.000086393644,0.000009391181,0.0000018148465,0.0000044111393,0.00006075735,0.000008060728,0.0003422991],"genre_scores_gemma":[0.9994288,0.00003120249,0.00007040884,0.0000150175365,0.0000035963458,0.0000056467366,0.00014194087,0.0000029383439,0.00030048395],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9999323,0.000008373216,0.000009175836,0.000016603379,0.000011920831,0.000021620368],"domain_scores_gemma":[0.9998073,0.000032727417,0.00006212788,0.000020528281,0.000019421777,0.000057960493],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011027543,0.00010241493,0.00013944713,0.00020949323,0.00018890658,0.00030724617,0.00007320421,0.00016162869,0.0021388156],"category_scores_gemma":[0.00019667335,0.000074342744,0.00010227918,0.00011586851,0.0002088323,0.00015731307,0.00019131305,0.00028977546,0.00036179056],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016165347,0.00008720874,0.2765417,0.00009158741,0.000031486838,0.0033435184,0.00049330585,0.0001623987,0.7082014,0.00013688325,0.00028189126,0.009012059],"study_design_scores_gemma":[0.000027270733,0.00040943315,0.95778483,0.000013207404,0.000022735607,0.007118385,0.00030997436,0.00044463773,0.032634176,0.00008020506,0.0011459733,0.000009139562],"about_ca_topic_score_codex":0.0009520792,"about_ca_topic_score_gemma":0.0009177449,"teacher_disagreement_score":0.0021388156,"about_ca_system_score_codex":0.00014283061,"about_ca_system_score_gemma":0.000107824366,"threshold_uncertainty_score":0.007155061},"labels":[],"label_agreement":null},{"id":"W2610278579","doi":"10.1111/jvh.12719","title":"Efficacy of 12 or 18 weeks of elbasvir plus grazoprevir with ribavirin in treatment‐naïve, noncirrhotic <scp>HCV</scp> genotype 3‐infected patients","year":2017,"lang":"en","type":"article","venue":"Journal of Viral Hepatitis","topic":"Hepatitis C virus research","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hillsborough Hospital","funders":"Merck","keywords":"Medicine; Ribavirin; Tolerability; NS5A; Internal medicine; Gastroenterology; Potency; Virology; Hepatitis C virus; Adverse effect; Hepacivirus; Virus; Chemistry; In vitro","score_opus":0.04107651794239327,"score_gpt":0.33570293041657584,"score_spread":0.2946264124741826,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2610278579","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99883443,0.0006416812,0.00005730235,0.000061203435,0.000018425684,0.00006871037,0.00004980157,0.000014704255,0.00025359387],"genre_scores_gemma":[0.99824286,0.00032045034,0.00028965904,0.00011606396,0.00005863482,0.00016453907,0.00014026849,0.000004660658,0.0006627748],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99961853,0.00018311356,0.000031370146,0.000062617786,0.000024758197,0.00007959641],"domain_scores_gemma":[0.999482,0.00008699446,0.0001253049,0.000037805523,0.000024845163,0.00024297567],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009368802,0.0007715461,0.0014267464,0.00020060937,0.00028684395,0.00035176525,0.00039929512,0.00086944655,0.0022457873],"category_scores_gemma":[0.00096937834,0.00039092722,0.0009810415,0.00015382472,0.00036302742,0.0006692736,0.00024711882,0.0011573127,0.00047448304],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.835901,0.026134653,0.017582184,0.00029116432,0.0005957071,0.000291681,0.0002569722,0.0012460845,0.018122341,0.00006293112,0.000619161,0.098896116],"study_design_scores_gemma":[0.20241946,0.6726578,0.11560763,0.00008357002,0.0007476605,0.00037900862,0.00013796143,0.0020949477,0.00403483,0.00011517647,0.0016555807,0.00006637832],"about_ca_topic_score_codex":0.0008015743,"about_ca_topic_score_gemma":0.0015992298,"teacher_disagreement_score":0.0022457873,"about_ca_system_score_codex":0.00037120102,"about_ca_system_score_gemma":0.00042534457,"threshold_uncertainty_score":0.0075128675},"labels":[],"label_agreement":null},{"id":"W2620280314","doi":"10.1111/jvh.12727","title":"Prediction of long‐term clinical outcome in a diverse chronic hepatitis B population: Role of the PAGE‐B score","year":2017,"lang":"en","type":"article","venue":"Journal of Viral Hepatitis","topic":"Liver Disease Diagnosis and Treatment","field":"Medicine","cited_by":44,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute for Work & Health; University of Toronto; Institute of Health Services and Policy Research; University Health Network","funders":"Foundation for Liver Research","keywords":"Medicine; Internal medicine; Hepatocellular carcinoma; Liver biopsy; Gastroenterology; Biopsy; Milan criteria; Stage (stratigraphy); Liver transplantation; Hepatitis B; Population; Chronic hepatitis; Hepatitis C; Transplantation; Oncology; Immunology","score_opus":0.0561928007277373,"score_gpt":0.3431533523911885,"score_spread":0.2869605516634512,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2620280314","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9990896,0.00033608908,0.0001519822,0.000049330618,0.0000054612424,0.0000036061065,0.00011489528,0.0000032350958,0.0002456664],"genre_scores_gemma":[0.99951065,0.000102547856,0.000072739094,0.000013621858,0.000012941727,0.0000037562315,0.00022410454,0.000001511872,0.00005813453],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99940085,0.00028962665,0.000048134396,0.000104404804,0.00009658739,0.000060367434],"domain_scores_gemma":[0.99732083,0.0008524766,0.0009075587,0.00015228598,0.00025456256,0.00051228947],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002093182,0.00049652316,0.0004896776,0.0009640166,0.000367244,0.00094874925,0.00043502264,0.0006712465,0.0007137011],"category_scores_gemma":[0.0052928645,0.00016732742,0.00038319937,0.0008150852,0.000400967,0.00068972755,0.00078452466,0.00075961737,0.00026836383],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010446507,0.000013498913,0.9985979,0.0000033070069,0.000040310035,0.000019107834,0.000019407908,0.0000728713,0.00005746234,0.0000076055244,0.00003676646,0.0010272219],"study_design_scores_gemma":[0.000007638666,0.0001501315,0.9984144,0.0000055647306,0.000027683269,0.00011257914,0.00008790461,0.0010325589,0.00003103393,0.00005642052,0.00006889304,0.000005043479],"about_ca_topic_score_codex":0.0023183112,"about_ca_topic_score_gemma":0.0018496801,"teacher_disagreement_score":0.0023183112,"about_ca_system_score_codex":0.00015859932,"about_ca_system_score_gemma":0.00020826283,"threshold_uncertainty_score":0.011069953},"labels":[],"label_agreement":null},{"id":"W2622579634","doi":"10.1111/jvh.12732","title":"Prevalence of hepatitis B antiviral drug resistance variants in North American patients with chronic hepatitis B not receiving antiviral treatment","year":2017,"lang":"en","type":"article","venue":"Journal of Viral Hepatitis","topic":"Hepatitis B Virus Studies","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"National Center for Advancing Translational Sciences; National Center for Research Resources; National Institute on Alcohol Abuse and Alcoholism; National Institutes of Health; National Institute of Diabetes and Digestive and Kidney Diseases; Gilead Sciences","keywords":"Medicine; Antiviral treatment; Chronic hepatitis; Drug resistance; Drug; Antiviral drug; Virology; Hepatitis B; Antiviral therapy; Hepatitis C; Hepatitis; Immunology; Pharmacology; Virus; Biology; Genetics","score_opus":0.011923265706360433,"score_gpt":0.26654468292745215,"score_spread":0.2546214172210917,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2622579634","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9993393,0.00012397743,0.000022938397,0.000027169683,0.0000041610897,0.0000045024003,0.00013323396,0.0000014220508,0.0003433458],"genre_scores_gemma":[0.99952316,0.00009569777,0.00004726512,0.000049875136,0.000011453288,0.000008181581,0.00015909788,0.0000011956438,0.00010418442],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9995958,0.00010093031,0.000045429726,0.00011776037,0.00009243884,0.000047620662],"domain_scores_gemma":[0.99896777,0.00018767995,0.0004136702,0.0000648719,0.00015212069,0.00021396247],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00041264607,0.0001869012,0.00030248333,0.0006629198,0.0006163589,0.00043728127,0.00025722658,0.0004087213,0.0016417854],"category_scores_gemma":[0.0013343666,0.00029601413,0.00018779635,0.0008274923,0.00030847627,0.0003790666,0.00023162478,0.00031341022,0.00021492688],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00003852246,0.000022810398,0.99883956,0.0000045150223,0.000011428266,0.00005168481,0.00009407599,0.0000071383724,0.00022781648,0.0000059147196,0.00006635771,0.0006302248],"study_design_scores_gemma":[0.000005831337,0.000044148856,0.9992899,0.0000040612467,0.0000074438126,0.00029294498,0.00017141206,0.00003786038,0.0000222369,0.0000060388857,0.0001159424,0.0000021937533],"about_ca_topic_score_codex":0.011242102,"about_ca_topic_score_gemma":0.0128603205,"teacher_disagreement_score":0.011242102,"about_ca_system_score_codex":0.0002707893,"about_ca_system_score_gemma":0.0002502934,"threshold_uncertainty_score":0.022353292},"labels":[],"label_agreement":null},{"id":"W2644043742","doi":"10.1111/jvh.12738","title":"<scp>HB</scp>sAg loss after peginterferon‐nucleotide combination treatment in chronic hepatitis B patients: 5 years of follow‐up","year":2017,"lang":"en","type":"article","venue":"Journal of Viral Hepatitis","topic":"Hepatitis B Virus Studies","field":"Medicine","cited_by":26,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto Western Hospital; University Health Network","funders":"Janssen Pharmaceuticals; Innogenetics; MedImmune; Abbott Fund; Roche; AbbVie; Merck; Bristol-Myers Squibb; Gilead Sciences; Medtronic; Boehringer Ingelheim","keywords":"Medicine; HBsAg; HBeAg; Adefovir; Internal medicine; Gastroenterology; Chronic hepatitis; Immunology; Hepatitis B virus; Virus; Lamivudine","score_opus":0.014536731288873705,"score_gpt":0.2779753366387037,"score_spread":0.26343860534983,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2644043742","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99884784,0.0006349143,0.00008070513,0.000027693965,0.0000064851088,0.00000738361,0.00008100161,0.000005270848,0.0003087004],"genre_scores_gemma":[0.99957234,0.00007076242,0.000027348264,0.00001962329,0.0000057628363,0.0000036392332,0.00016756007,5.551822e-7,0.000132442],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99958163,0.000082625316,0.000044736797,0.000061156585,0.000096323536,0.00013358732],"domain_scores_gemma":[0.99849725,0.00022121065,0.0006749262,0.00008657521,0.00022984613,0.0002901886],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012915375,0.0002017155,0.00047583636,0.0005723016,0.00060773554,0.0006896934,0.00019910432,0.0005439358,0.0006316572],"category_scores_gemma":[0.0018420534,0.00011809654,0.0007752059,0.00046741206,0.00023836596,0.0005140888,0.0002853718,0.00060903066,0.00019380562],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0022002053,0.00024986657,0.97686017,0.000027700511,0.00016105268,0.0005011528,0.00023084652,0.00021247017,0.0014475223,0.000019001842,0.00013219561,0.017957892],"study_design_scores_gemma":[0.000050027356,0.0031478524,0.99412954,0.00001633371,0.00021194849,0.00063715567,0.00011979601,0.00044046895,0.0006124393,0.000024400786,0.00059741864,0.000012701478],"about_ca_topic_score_codex":0.0032856772,"about_ca_topic_score_gemma":0.0025020572,"teacher_disagreement_score":0.0032856772,"about_ca_system_score_codex":0.00042925266,"about_ca_system_score_gemma":0.00026335104,"threshold_uncertainty_score":0.0068303943},"labels":[],"label_agreement":null},{"id":"W2738751588","doi":"10.1111/jvh.12758","title":"Drug use and phylogenetic clustering of hepatitis C virus infection among people who use drugs in Vancouver, Canada: A latent class analysis approach","year":2017,"lang":"en","type":"article","venue":"Journal of Viral Hepatitis","topic":"Hepatitis C virus research","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"BC Centre for Disease Control; Simon Fraser University; AIDS Vancouver; St. Paul's Hospital; University of British Columbia","funders":"National Institute of Allergy and Infectious Diseases; National Institute on Drug Abuse; National Health and Medical Research Council; National Institutes of Health; International AIDS Society; Canadian Institutes of Health Research; Ministry of Health, British Columbia; Simon Fraser University; University of British Columbia; World Health Organization; Department of Health and Aged Care, Australian Government; UNICEF; U.S. President’s Emergency Plan for AIDS Relief; Michael Smith Health Research BC","keywords":"Latent class model; Drug; Phylogenetic tree; Medicine; Drug class; Virology; Cluster analysis; Injection drug use; Hepatitis C virus; Class (philosophy); Virus; Biology; Pharmacology; Genetics; Computer science; Artificial intelligence; Machine learning; Gene","score_opus":0.02270081102480592,"score_gpt":0.27440464096603495,"score_spread":0.25170382994122903,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2738751588","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9946137,0.00042392328,0.002907549,0.00023983962,0.00000991172,0.000060531405,0.0009765165,0.000014275081,0.0007537768],"genre_scores_gemma":[0.99715483,0.00017878911,0.0012551337,0.000028272658,0.0000033147508,0.000019320845,0.00078231335,0.0000054878506,0.00057249435],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99876237,0.00038892988,0.000054606124,0.0002467751,0.00020317506,0.00034417736],"domain_scores_gemma":[0.9978302,0.0005501622,0.00044035394,0.00021668604,0.000580758,0.00038182034],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0019401929,0.00056133454,0.0005543565,0.0017061715,0.0024292863,0.0019053682,0.0011115628,0.0004869177,0.0014782541],"category_scores_gemma":[0.004852821,0.00039331565,0.0012414148,0.0019682578,0.0009002953,0.00044841025,0.0014933825,0.0010890175,0.00015374494],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012469031,0.000029075523,0.99152,0.000019700707,0.00014863849,0.00003208034,0.000653195,0.0011255731,0.00011096004,0.00039463805,0.0003357328,0.005505833],"study_design_scores_gemma":[0.00002121455,0.000058108995,0.96322995,0.00008429416,0.00018339949,0.00009659849,0.0029631774,0.031290337,0.00012774956,0.0007814184,0.001134308,0.000029549316],"about_ca_topic_score_codex":0.9575937,"about_ca_topic_score_gemma":0.94897866,"teacher_disagreement_score":0.04240632,"about_ca_system_score_codex":0.010205075,"about_ca_system_score_gemma":0.011360371,"threshold_uncertainty_score":0.08531207},"labels":[],"label_agreement":null},{"id":"W2749525663","doi":"10.1111/jvh.12782","title":"Efficacy and safety results of patients with <scp>HCV</scp> genotype 2 or 3 infection treated with ombitasvir/paritaprevir/ritonavir and sofosbuvir with or without ribavirin (<scp>QUARTZ II</scp>‐<scp>III</scp>)","year":2017,"lang":"en","type":"article","venue":"Journal of Viral Hepatitis","topic":"Hepatitis C virus research","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta Hospital; Alberta Hospital Edmonton","funders":"AbbVie","keywords":"Ombitasvir; Sofosbuvir; Paritaprevir; Ritonavir; Ribavirin; Medicine; Cirrhosis; Gastroenterology; Internal medicine; Hepatitis C; Hepatitis C virus; Virology; Viral load; Virus","score_opus":0.02093166805568696,"score_gpt":0.2985401554194128,"score_spread":0.27760848736372584,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2749525663","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9979005,0.00075383746,0.00009606172,0.000087431246,0.00001572905,0.00010709032,0.00016821246,0.000007625347,0.00086354074],"genre_scores_gemma":[0.99877053,0.00028099125,0.00015023805,0.0001340623,0.00004473133,0.00010103209,0.0003119555,0.0000022727993,0.00020405948],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99955195,0.00027611223,0.000036913367,0.000039357456,0.000039468487,0.000056182285],"domain_scores_gemma":[0.99932003,0.00019114133,0.000186479,0.000047047404,0.00005289485,0.00020246641],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010662184,0.00038811713,0.00075595116,0.00014399106,0.0002333291,0.00029854593,0.00015629502,0.0005192871,0.0011836834],"category_scores_gemma":[0.0010772018,0.00017530072,0.0010114455,0.00017761892,0.00037603232,0.00029323972,0.00011715203,0.0008452704,0.00020364084],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.72919047,0.015876997,0.07986001,0.00048136155,0.0013050716,0.00074436347,0.0003767961,0.0017902919,0.03063373,0.00016644695,0.0014263284,0.13814814],"study_design_scores_gemma":[0.15317564,0.5821309,0.25090972,0.000078969046,0.0013961954,0.0010823631,0.00012447864,0.002193498,0.006165079,0.00021217982,0.0024649287,0.00006598621],"about_ca_topic_score_codex":0.0003146905,"about_ca_topic_score_gemma":0.00053007586,"teacher_disagreement_score":0.0011836834,"about_ca_system_score_codex":0.00028739913,"about_ca_system_score_gemma":0.0004291293,"threshold_uncertainty_score":0.005638778},"labels":[],"label_agreement":null},{"id":"W2767655913","doi":"10.1111/jvh.12825","title":"Intrapatient viral diversity and treatment outcome in patients with genotype 3a hepatitis C virus infection on sofosbuvir‐containing regimens","year":2017,"lang":"en","type":"article","venue":"Journal of Viral Hepatitis","topic":"Hepatitis C virus research","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto Liver Centre; University of Toronto","funders":"National Institute of Allergy and Infectious Diseases; National Institute on Drug Abuse; Biotechnology and Biological Sciences Research Council; Medical Research Council","keywords":"Sofosbuvir; Hepatitis C virus; NS5B; Ribavirin; Internal medicine; Virology; NS5A; Medicine; Viral load; Biology; Immunology; Virus; Hepacivirus","score_opus":0.03820688759225106,"score_gpt":0.31148254359654215,"score_spread":0.2732756560042911,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2767655913","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99960643,0.00010982129,0.00003913335,0.00002855264,0.0000028179743,0.0000038334756,0.000027808406,0.0000014815661,0.00018002508],"genre_scores_gemma":[0.99983156,0.000026594606,0.000020993772,0.00001521726,0.000006485481,0.0000032122612,0.00005898853,7.1035095e-7,0.00003619606],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9996828,0.00011098197,0.000034988097,0.000037651225,0.000062045656,0.00007150544],"domain_scores_gemma":[0.9985178,0.0004323695,0.000449298,0.00006061377,0.00012878657,0.0004110533],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005731666,0.00023112072,0.0004621223,0.00046669366,0.00044550071,0.00048021274,0.00016335033,0.00043640053,0.00053260685],"category_scores_gemma":[0.0025997842,0.00015016709,0.00038444746,0.00047795888,0.00026187254,0.0005324343,0.00033429547,0.0007735209,0.00011396621],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016477705,0.00018063009,0.9911108,0.000012279073,0.00010159939,0.00020678081,0.00015807738,0.00036450854,0.0010374761,0.00002054762,0.00008177376,0.0050778436],"study_design_scores_gemma":[0.00003611831,0.0012703658,0.9968527,0.0000058046794,0.000037079742,0.00026548302,0.00014347928,0.0010691638,0.00016494343,0.00006677059,0.00007876418,0.000009354382],"about_ca_topic_score_codex":0.0009010797,"about_ca_topic_score_gemma":0.0011864953,"teacher_disagreement_score":0.0009010797,"about_ca_system_score_codex":0.00032704385,"about_ca_system_score_gemma":0.00019193282,"threshold_uncertainty_score":0.0030312538},"labels":[],"label_agreement":null},{"id":"W2772783926","doi":"10.1111/jvh.12837","title":"Trends in hepatocellular carcinoma incidence and survival among people with hepatitis C: An international study","year":2017,"lang":"en","type":"article","venue":"Journal of Viral Hepatitis","topic":"Hepatitis C virus research","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"BC Centre for Disease Control; University of British Columbia","funders":"National Health and Medical Research Council; Scottish Government; NSW Ministry of Health; Department of Health and Aged Care, Australian Government; Seventh Framework Programme; University of Sydney; Canadian Institutes of Health Research; Cancer Institute NSW","keywords":"Medicine; Hepatocellular carcinoma; Incidence (geometry); Internal medicine; Proportional hazards model; Hepatitis C; Hepatitis C virus; Demography; Immunology; Virus","score_opus":0.031534039559084015,"score_gpt":0.33764214387609737,"score_spread":0.30610810431701335,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2772783926","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9936447,0.0015213116,0.0000907597,0.00015717669,0.0000139795775,0.00001403124,0.002773819,0.000007235335,0.0017768972],"genre_scores_gemma":[0.99701047,0.00086917874,0.00007561742,0.000048687532,0.000017077573,0.000011075641,0.0017561092,0.0000029438686,0.00020867134],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99955314,0.00006718455,0.00005841026,0.0001286001,0.00008993184,0.00010274546],"domain_scores_gemma":[0.9979513,0.00012536967,0.0006918703,0.000107706845,0.00077190774,0.0003517018],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006867694,0.00020195587,0.00031303454,0.001796982,0.00044310294,0.0007536185,0.00026578517,0.00027471647,0.00082583574],"category_scores_gemma":[0.0016174166,0.00016389859,0.00042130792,0.0037879164,0.00036238309,0.0006204359,0.00062550645,0.00047991987,0.0001775373],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00005639879,0.0000094145735,0.9974171,0.000020303929,0.00005245177,0.000024324947,0.00021104928,0.000027254886,0.00006769946,0.000023506364,0.00016897859,0.0019214809],"study_design_scores_gemma":[0.0000015611855,0.000012839641,0.99936765,0.000009420309,0.000013347282,0.000044944696,0.00021473634,0.00003680649,0.000011202876,0.0000043984496,0.00028104236,0.000002140375],"about_ca_topic_score_codex":0.1748335,"about_ca_topic_score_gemma":0.15520369,"teacher_disagreement_score":0.1748335,"about_ca_system_score_codex":0.00118919,"about_ca_system_score_gemma":0.0009879675,"threshold_uncertainty_score":0.34763175},"labels":[],"label_agreement":null},{"id":"W2773970116","doi":"10.1111/jvh.12846","title":"Estimating chronic hepatitis C prognosis using transient elastography‐based liver stiffness: A systematic review and meta‐analysis","year":2017,"lang":"en","type":"review","venue":"Journal of Viral Hepatitis","topic":"Liver Disease Diagnosis and Treatment","field":"Medicine","cited_by":50,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Waterloo; Queen's University; Public Health Ontario; University of Toronto; Centre for Global Health Research; Toronto Public Health","funders":"Canadian Institutes of Health Research; Public Health Agency of Canada","keywords":"Transient elastography; Cirrhosis; Medicine; Fibrosis; Internal medicine; Liver biopsy; Meta-analysis; Hepatitis C; Gastroenterology; Biopsy; Pathology; Liver fibrosis","score_opus":0.09517543472396635,"score_gpt":0.3740154189432479,"score_spread":0.2788399842192816,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2773970116","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0058658444,0.991958,0.0006184292,0.00019666573,0.00008494445,0.00019229072,0.0008073684,0.000026912097,0.0002494902],"genre_scores_gemma":[0.19504437,0.79831374,0.0025546777,0.00080677576,0.0002456171,0.0009134934,0.0017102179,0.00003415294,0.00037697097],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9936052,0.002971596,0.0017548745,0.00075211714,0.0006816919,0.00023449637],"domain_scores_gemma":[0.9814466,0.014451625,0.002044216,0.00055091974,0.001315235,0.00019138848],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.010817994,0.002569889,0.0129475435,0.005736534,0.00067141606,0.0027099948,0.0018578935,0.0019324401,0.0035715322],"category_scores_gemma":[0.02918121,0.0013366472,0.034280557,0.007424324,0.0005834831,0.0016298519,0.0013079814,0.0018263741,0.00037361038],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001831456,0.00003342881,0.010503696,0.34368357,0.62588,0.00015874306,0.000088151246,0.0009385893,0.00021284532,0.00014873559,0.00093452807,0.015586211],"study_design_scores_gemma":[0.00031736388,0.000119758675,0.0043569156,0.018254438,0.97499824,0.000084982144,0.000032417083,0.00030320237,0.00009072982,0.00017289893,0.0012472259,0.000021864447],"about_ca_topic_score_codex":0.008532939,"about_ca_topic_score_gemma":0.019636355,"teacher_disagreement_score":0.0129475435,"about_ca_system_score_codex":0.0020465166,"about_ca_system_score_gemma":0.003214806,"threshold_uncertainty_score":0.057211697},"labels":[],"label_agreement":null},{"id":"W2778790736","doi":"10.1111/jvh.12853","title":"Efficacy and safety of 6 or 8 weeks of simeprevir, daclatasvir, sofosbuvir for <scp>HCV</scp> genotype 1 infection","year":2017,"lang":"en","type":"article","venue":"Journal of Viral Hepatitis","topic":"Hepatitis C virus research","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto General Hospital","funders":"Janssen Research and Development","keywords":"Daclatasvir; Sofosbuvir; Simeprevir; Medicine; Internal medicine; Tolerability; Regimen; Gastroenterology; Cirrhosis; Adverse effect; Discontinuation; Hepatitis C virus; Ribavirin; Virology; Virus","score_opus":0.04462316308482335,"score_gpt":0.3649741482884431,"score_spread":0.32035098520361976,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2778790736","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9987232,0.00048409196,0.00012791513,0.0000560118,0.000023015578,0.00011578056,0.000121509984,0.000015135341,0.00033330318],"genre_scores_gemma":[0.99783546,0.00028122068,0.00038926178,0.00012274414,0.00005832407,0.0002694263,0.00029214143,0.0000055624373,0.00074594095],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99947554,0.00031295815,0.000031303414,0.00006193869,0.000047705384,0.0000705726],"domain_scores_gemma":[0.99949276,0.00010422309,0.00014315841,0.00004831442,0.000027902252,0.00018358883],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011424077,0.00055393815,0.0010412966,0.000180677,0.00021645467,0.00025130104,0.00030800284,0.0007740894,0.0020608273],"category_scores_gemma":[0.0009757864,0.00026330308,0.00059204537,0.000113748974,0.00033051174,0.00052183174,0.00017045066,0.00137958,0.00038935212],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.7901098,0.04087618,0.010655465,0.00034279976,0.00034604763,0.00015561824,0.0001517561,0.0013397809,0.05250097,0.00008096075,0.0009484658,0.10249208],"study_design_scores_gemma":[0.19634782,0.74344045,0.04887984,0.000036052083,0.0002100934,0.00028798886,0.000046491547,0.0017755234,0.007858164,0.00010508874,0.0009779681,0.000034480723],"about_ca_topic_score_codex":0.00021422513,"about_ca_topic_score_gemma":0.00046887482,"teacher_disagreement_score":0.0020608273,"about_ca_system_score_codex":0.00022743683,"about_ca_system_score_gemma":0.00033126917,"threshold_uncertainty_score":0.0068941712},"labels":[],"label_agreement":null},{"id":"W2782793576","doi":"10.1111/jvh.12860","title":"Deep sequencing shows low‐level oncogenic hepatitis B virus variants persists post–liver transplant despite potent anti‐<scp>HBV</scp> prophylaxis","year":2018,"lang":"en","type":"article","venue":"Journal of Viral Hepatitis","topic":"Hepatitis B Virus Studies","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Public Health Agency of Canada; University of Calgary","funders":"Canadian Institutes of Health Research","keywords":"cccDNA; Virology; HBsAg; Viral quasispecies; Hepatitis B virus; Hepatitis B immune globulin; Medicine; Hepatocellular carcinoma; Peripheral blood mononuclear cell; Liver disease; Immunology; Biology; Virus; Hepatitis C virus; Internal medicine","score_opus":0.026527118647823273,"score_gpt":0.25820195808777674,"score_spread":0.23167483943995346,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2782793576","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99787223,0.00025982797,0.0011057298,0.00004071042,0.0000037493269,0.0000043493365,0.00017768188,0.000027001384,0.00050864276],"genre_scores_gemma":[0.9986885,0.00008863462,0.00059362606,0.00006415788,0.000003670416,0.0000046124387,0.00030663467,0.0000047213193,0.00024536648],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9998814,0.000018553712,0.00001062326,0.000028779445,0.000030918796,0.000029837318],"domain_scores_gemma":[0.9997856,0.000058632377,0.000052069998,0.00002399384,0.00003215103,0.000047577498],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001977331,0.000111577094,0.00018770361,0.00019172631,0.000113844464,0.0003385967,0.000079966434,0.00019060478,0.0008904745],"category_scores_gemma":[0.00036970436,0.00011385846,0.00012340376,0.00015448146,0.00014946482,0.00010645648,0.00014679715,0.00023111631,0.00029206453],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00071790227,0.000054276352,0.116298534,0.000064516134,0.000059645652,0.0007998787,0.0001961698,0.00031380076,0.85405475,0.000113486196,0.00031448365,0.027012503],"study_design_scores_gemma":[0.00004775655,0.000861847,0.8216571,0.00003180902,0.00011931438,0.0077657904,0.0003487406,0.0070959623,0.15707456,0.00065736537,0.004320374,0.000019452515],"about_ca_topic_score_codex":0.0006294019,"about_ca_topic_score_gemma":0.000966408,"teacher_disagreement_score":0.0008904745,"about_ca_system_score_codex":0.00011842199,"about_ca_system_score_gemma":0.00009168964,"threshold_uncertainty_score":0.002978921},"labels":[],"label_agreement":null},{"id":"W2783785638","doi":"10.1111/jvh.12856","title":"Development of a recombinant murine tumour model using hepatoma cells expressing hepatitis C virus nonstructural antigens","year":2018,"lang":"en","type":"article","venue":"Journal of Viral Hepatitis","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"National Research Council Canada; Ottawa Hospital","funders":"National Research Council Canada","keywords":"Virology; Hepatitis C virus; Antigen; Recombinant DNA; Immune system; Virus; Biology; Vaccination; Population; Immunology; Medicine; Gene","score_opus":0.025406869781014734,"score_gpt":0.30388171757036053,"score_spread":0.2784748477893458,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2783785638","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9563729,0.0018944979,0.03584831,0.0003355726,0.0002117924,0.00066325115,0.0010626364,0.000516056,0.0030949162],"genre_scores_gemma":[0.95040345,0.00235509,0.0376192,0.00009634955,0.000035798934,0.00061265,0.0015152651,0.00009080477,0.007271452],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.999752,0.000049934726,0.000030197736,0.000052780575,0.00006668782,0.000048380352],"domain_scores_gemma":[0.9997167,0.00006543321,0.00007561168,0.000051268875,0.000028493982,0.00006258907],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00039283396,0.0006246834,0.0002840033,0.00051006925,0.00019987754,0.00034623858,0.0005924648,0.00059513445,0.0010196277],"category_scores_gemma":[0.00016726457,0.00027739868,0.0003580031,0.00018673981,0.0004219848,0.00039666877,0.00029918816,0.0011505142,0.00059126044],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002022727,0.0001782191,0.0001325511,0.000042761403,0.000004944821,0.00004900048,0.00002722049,0.0002060632,0.9977604,0.00044687136,0.000049596907,0.00089995994],"study_design_scores_gemma":[0.000067812114,0.0019833194,0.0006116801,0.000010377906,0.00002218677,0.00028521044,0.00001729114,0.0019382675,0.99182117,0.00009815438,0.0031355408,0.000008943039],"about_ca_topic_score_codex":0.00082558824,"about_ca_topic_score_gemma":0.0007724841,"teacher_disagreement_score":0.0010196277,"about_ca_system_score_codex":0.00037646663,"about_ca_system_score_gemma":0.00040097177,"threshold_uncertainty_score":0.003410995},"labels":[],"label_agreement":null},{"id":"W2791741379","doi":"10.1111/jvh.12894","title":"The burden of hepatitis C virus in Cameroon: Spatial epidemiology and historical perspective","year":2018,"lang":"en","type":"article","venue":"Journal of Viral Hepatitis","topic":"Hepatitis C virus research","field":"Medicine","cited_by":31,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Sherbrooke","funders":"Agence Nationale de Recherches sur le Sida et les Hépatites Virales","keywords":"Medicine; Cohort; Demography; Epidemiology; Population; Hepatitis C; Logistic regression; Environmental health; Immunology; Internal medicine","score_opus":0.045373459725036404,"score_gpt":0.3587749477966967,"score_spread":0.3134014880716603,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2791741379","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9699374,0.017443959,0.0022258533,0.0037895113,0.00012703719,0.000041829615,0.0020344178,0.00002101084,0.0043791085],"genre_scores_gemma":[0.9930535,0.0055159954,0.00079760485,0.00008457128,0.00005989017,0.0000151365,0.00029501447,0.0000034596994,0.00017471347],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9996556,0.00017219552,0.000016349955,0.000059257905,0.000023059816,0.00007346953],"domain_scores_gemma":[0.99913436,0.00030727257,0.00028753513,0.000049098195,0.00015213808,0.00006968027],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010394724,0.0003261378,0.00017399318,0.0025173116,0.00064754015,0.0010460932,0.00028959016,0.00028293979,0.0026630482],"category_scores_gemma":[0.0026341507,0.00022620306,0.00025372568,0.0038731107,0.00085319486,0.0012369992,0.0007505571,0.00035155338,0.000096615324],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009932581,0.000035833003,0.9395608,0.0003352003,0.00012852268,0.0011257536,0.0030102648,0.003262486,0.00080153736,0.005598729,0.002340176,0.04370137],"study_design_scores_gemma":[0.0000059707177,0.000059501832,0.97703093,0.0003715947,0.00007310082,0.0010732057,0.0050667077,0.003984474,0.00017841965,0.0012540023,0.010868012,0.000033954893],"about_ca_topic_score_codex":0.08515615,"about_ca_topic_score_gemma":0.07399772,"teacher_disagreement_score":0.08515615,"about_ca_system_score_codex":0.0018336069,"about_ca_system_score_gemma":0.00088703673,"threshold_uncertainty_score":0.16932094},"labels":[],"label_agreement":null},{"id":"W2794154499","doi":"10.1111/jvh.12875","title":"Hepatitis C: The beginning of the end—key elements for successful European and national strategies to eliminate HCV in Europe","year":2018,"lang":"en","type":"review","venue":"Journal of Viral Hepatitis","topic":"Hepatitis C virus research","field":"Medicine","cited_by":89,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Infection and Immunity","funders":"AbbVie; Gilead Sciences","keywords":"European union; Summit; Manifesto; Public health; Hepatitis C; Political science; Medicine; Virology; Environmental health; Economic growth; Public administration; Business; Geography; International trade; Economics; Law","score_opus":0.06459612109104892,"score_gpt":0.3943094733706154,"score_spread":0.32971335227956644,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2794154499","genre_codex":"commentary","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0042308955,0.21029194,0.0031276827,0.7300502,0.01609894,0.000085520405,0.00010717837,0.00013900222,0.03586876],"genre_scores_gemma":[0.14781322,0.3021153,0.029631658,0.46903628,0.023588503,0.00033542153,0.0006592699,0.00037789505,0.026442451],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9871336,0.005869265,0.0010341662,0.00067264255,0.0028392267,0.0024511018],"domain_scores_gemma":[0.9739214,0.0076481765,0.0011163491,0.0012211754,0.003226027,0.012866923],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.05023796,0.0007779966,0.0016156211,0.0012399501,0.0029090908,0.014639883,0.002223556,0.010113771,0.010193762],"category_scores_gemma":[0.025019495,0.00047227246,0.0010523063,0.0011000165,0.0065827984,0.013267669,0.010547293,0.0106413,0.0035247598],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00032330435,0.0004430118,0.0030865176,0.0026085756,0.00012363576,0.0006677456,0.0038909807,0.0005998742,0.001254314,0.1959703,0.4000007,0.39103094],"study_design_scores_gemma":[0.00005516785,0.000233575,0.0035592641,0.005067677,0.000033859487,0.0005331467,0.0038776896,0.00014563208,0.00037357764,0.048195355,0.9378536,0.000071364324],"about_ca_topic_score_codex":0.0031983866,"about_ca_topic_score_gemma":0.0032692885,"teacher_disagreement_score":0.05023796,"about_ca_system_score_codex":0.004535636,"about_ca_system_score_gemma":0.025276331,"threshold_uncertainty_score":0.26568693},"labels":[],"label_agreement":null},{"id":"W2802560552","doi":"10.1111/jvh.12920","title":"Younger age and language barriers are associated with nonadherence to clinical follow‐up in hepatitis B treatment","year":2018,"lang":"en","type":"article","venue":"Journal of Viral Hepatitis","topic":"Hepatitis B Virus Studies","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto General Hospital; University of Toronto","funders":"Foundation for Liver Research","keywords":"Family medicine; Medicine; Psychology","score_opus":0.031183487596938834,"score_gpt":0.3355747015587564,"score_spread":0.30439121396181756,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2802560552","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.993634,0.0014217885,0.000064448344,0.001636094,0.00006430419,0.0000119789,0.00014573122,0.0000041511316,0.003017491],"genre_scores_gemma":[0.9986645,0.00037183697,0.00005509875,0.0002259053,0.000043363514,0.000005921697,0.00007499585,0.000004630022,0.00055374944],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99868745,0.0004917309,0.00020943655,0.000108539716,0.00029730567,0.00020557558],"domain_scores_gemma":[0.983356,0.006624995,0.0075111375,0.0004524759,0.0005931616,0.0014623028],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012259814,0.00012057534,0.00028240753,0.0004907507,0.00059111253,0.0010711873,0.00042767526,0.0007647984,0.009675954],"category_scores_gemma":[0.019796204,0.00020394532,0.00047189713,0.0007019584,0.0002879899,0.0007485114,0.00049081224,0.001495105,0.00042101849],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014320562,0.00017828449,0.9916019,0.000041550604,0.000053934098,0.00015701294,0.0004000445,0.00003996614,0.000079720914,0.000087476335,0.00078839716,0.0064285244],"study_design_scores_gemma":[0.0000074143554,0.000069490365,0.99817,0.00007291576,0.000031335087,0.00027721887,0.00052780984,0.0002136312,0.00003096382,0.000095061536,0.00049762416,0.0000065043114],"about_ca_topic_score_codex":0.007852939,"about_ca_topic_score_gemma":0.0071302676,"teacher_disagreement_score":0.009675954,"about_ca_system_score_codex":0.00032449156,"about_ca_system_score_gemma":0.00051406375,"threshold_uncertainty_score":0.032369256},"labels":[],"label_agreement":null},{"id":"W2805832713","doi":"10.1111/jvh.12942","title":"Safety and efficacy of vesatolimod (GS‐9620) in patients with chronic hepatitis B who are not currently on antiviral treatment","year":2018,"lang":"en","type":"article","venue":"Journal of Viral Hepatitis","topic":"Hepatitis B Virus Studies","field":"Medicine","cited_by":93,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto Liver Centre","funders":"Gilead Sciences","keywords":"Medicine; HBsAg; Internal medicine; HBeAg; Adverse effect; Placebo; Seroconversion; Gastroenterology; Hepatitis B; Hepatitis B virus; Immunology; Antibody; Virus; Pathology","score_opus":0.012914301300578987,"score_gpt":0.2726024275393045,"score_spread":0.25968812623872556,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2805832713","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9936047,0.005166394,0.00016527424,0.00010190187,0.000034683828,0.00021209655,0.00011337108,0.000016479004,0.00058507867],"genre_scores_gemma":[0.9968413,0.0015895681,0.00037433216,0.0003006421,0.00009485989,0.00024734603,0.00024103653,0.0000037493917,0.00030731526],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99960095,0.00023483374,0.000037397975,0.0000485746,0.00004452646,0.000033723063],"domain_scores_gemma":[0.9994173,0.00020671308,0.00014955386,0.000030260378,0.000035070727,0.0001612223],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001087563,0.00043399562,0.0014865637,0.00022031188,0.00022416616,0.00039698635,0.00031449881,0.0007497153,0.0016882827],"category_scores_gemma":[0.0011222392,0.0002615494,0.0006253073,0.00020755571,0.00034351985,0.00047357593,0.00022550662,0.000771176,0.00029413882],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.7084165,0.015148355,0.027041778,0.0016977997,0.0012361502,0.00033126093,0.00024667737,0.0008600892,0.037824985,0.00014209226,0.00090221415,0.206152],"study_design_scores_gemma":[0.35138527,0.5682063,0.071407236,0.00010738972,0.0006913832,0.00062735885,0.00013212423,0.0011775432,0.0034927737,0.00015187725,0.0025844756,0.000036282196],"about_ca_topic_score_codex":0.00013927079,"about_ca_topic_score_gemma":0.00031913575,"teacher_disagreement_score":0.0016882827,"about_ca_system_score_codex":0.00018008845,"about_ca_system_score_gemma":0.00030730563,"threshold_uncertainty_score":0.0057516694},"labels":[],"label_agreement":null},{"id":"W2806844008","doi":"10.1111/jvh.12936","title":"Hepatitis C among vulnerable populations: A seroprevalence study of homeless, people who inject drugs and prisoners in London","year":2018,"lang":"en","type":"article","venue":"Journal of Viral Hepatitis","topic":"Hepatitis C virus research","field":"Medicine","cited_by":32,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Infection and Immunity","funders":"National Institute for Health and Care Research; Wellcome Trust","keywords":"Medicine; Prison; Seroprevalence; Hepatitis C; Imprisonment; Transmission (telecommunications); Substance abuse; Drug; Psychiatry; Family medicine; Internal medicine; Immunology; Psychology","score_opus":0.022256771351357212,"score_gpt":0.3304150852127518,"score_spread":0.3081583138613946,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2806844008","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9993187,0.00015253518,0.000019642292,0.00004327625,0.0000023581329,0.00003369969,0.00015187185,0.0000014118759,0.00027653025],"genre_scores_gemma":[0.9990884,0.00021253496,0.000063257656,0.00007924344,0.000006229574,0.00003728335,0.00014790484,0.000001373631,0.00036389777],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99958235,0.000100319485,0.000074582334,0.000072246665,0.00009888905,0.00007153331],"domain_scores_gemma":[0.9992749,0.00006518063,0.00030122665,0.000036370806,0.00011039465,0.00021182263],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004238708,0.00029240138,0.00038319625,0.0012662937,0.00082032476,0.00088472397,0.00040770875,0.00044890703,0.0012627924],"category_scores_gemma":[0.0009588329,0.00046878099,0.00034712037,0.0008869971,0.000553906,0.0006322083,0.0010421368,0.00042584358,0.00042400582],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007442441,0.00009697521,0.9921057,0.000057468074,0.000025896716,0.00050106767,0.0045092846,0.0000121001,0.0007055443,0.000020486068,0.0002029934,0.0016880614],"study_design_scores_gemma":[0.0000113211145,0.0001280249,0.9962674,0.000025850975,0.000010203186,0.0004289692,0.0028413902,0.000025996322,0.000039795068,0.000007891437,0.00020811452,0.000005129696],"about_ca_topic_score_codex":0.060592942,"about_ca_topic_score_gemma":0.09602024,"teacher_disagreement_score":0.060592942,"about_ca_system_score_codex":0.0009864296,"about_ca_system_score_gemma":0.0006482052,"threshold_uncertainty_score":0.12048054},"labels":[],"label_agreement":null},{"id":"W2883668852","doi":"10.1111/jvh.12977","title":"Estimating the impact of early hepatitis C virus clearance on hepatocellular carcinoma risk","year":2018,"lang":"en","type":"article","venue":"Journal of Viral Hepatitis","topic":"Hepatitis C virus research","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Child and Family Research Institute; BC Cancer Agency; BC Centre for Disease Control; University of British Columbia","funders":"Canadian Institutes of Health Research; British Columbia Centre for Disease Control; Provincial Health Services Authority; Michael Smith Health Research BC","keywords":"Medicine; Hepatocellular carcinoma; Internal medicine; Hepatitis C virus; Hazard ratio; Incidence (geometry); Hepatitis C; Gastroenterology; Population; Confidence interval; Proportional hazards model; Immunology; Virus","score_opus":0.02861234463262334,"score_gpt":0.33705895714977546,"score_spread":0.3084466125171521,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2883668852","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9913702,0.0028801702,0.0035649962,0.000285143,0.000020830164,0.0000323693,0.0010128042,0.000038081005,0.0007953854],"genre_scores_gemma":[0.9978928,0.00039775122,0.00094513496,0.000034595214,0.000025624042,0.000011492483,0.00049278507,0.000007117243,0.00019267085],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9965321,0.0022564018,0.00016431537,0.00046020167,0.00034205074,0.00024501933],"domain_scores_gemma":[0.9826988,0.011616581,0.0034671926,0.0011359095,0.0005293723,0.0005520615],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0060809045,0.0007531863,0.00063508324,0.00090336107,0.00020750685,0.0009254378,0.00068731187,0.000608089,0.0010808654],"category_scores_gemma":[0.02074693,0.00047152978,0.0018568486,0.0008786258,0.00030892715,0.00075822556,0.0008303975,0.0011568812,0.00025552165],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00039843016,0.000030945695,0.9915165,0.000033208216,0.00062877673,0.000025295349,0.000023875678,0.0013520122,0.000082302504,0.000077783014,0.0000890381,0.0057418724],"study_design_scores_gemma":[0.000031645133,0.00047171552,0.979157,0.000044959263,0.0009117689,0.00018437937,0.0000782381,0.017986776,0.00031786037,0.000401491,0.00039508444,0.000019129438],"about_ca_topic_score_codex":0.011594482,"about_ca_topic_score_gemma":0.0066774716,"teacher_disagreement_score":0.011594482,"about_ca_system_score_codex":0.00045966357,"about_ca_system_score_gemma":0.0006656459,"threshold_uncertainty_score":0.03215933},"labels":[],"label_agreement":null},{"id":"W2888185171","doi":"10.1111/jvh.12985","title":"Real‐world impact of direct acting antiviral therapy on health‐related quality of life in <scp>HIV</scp>/Hepatitis C co‐infected individuals","year":2018,"lang":"en","type":"article","venue":"Journal of Viral Hepatitis","topic":"Hepatitis C virus research","field":"Medicine","cited_by":35,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"St. Paul's Hospital; HIV Legal Network; University Health Network; University of Ottawa; Regina Qu'Appelle Health Region; Centre Hospitalier de l’Université de Montréal; McGill University; Alberta Hip and Knee Clinic; McGill University Health Centre","funders":"Canadian Institutes of Health Research; Canadian HIV Trials Network, Canadian Institutes of Health Research","keywords":"Medicine; Quality of life (healthcare); Hepatitis C; Cohort; Internal medicine; Human immunodeficiency virus (HIV); Viral load; Antiviral therapy; Clinical trial; Immunology; Chronic hepatitis; Virus","score_opus":0.06605167108538555,"score_gpt":0.416898689276676,"score_spread":0.35084701819129044,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2888185171","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9984491,0.00032478714,0.000075535965,0.000095685406,0.0000046055357,0.000018827188,0.0006654003,0.0000025093243,0.0003635168],"genre_scores_gemma":[0.99917066,0.00007322423,0.00018493982,0.000028603052,0.000004118213,0.000013401596,0.00046535832,9.3442253e-7,0.000058685346],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9980324,0.0012713914,0.000096401236,0.0001592884,0.00022163015,0.0002188687],"domain_scores_gemma":[0.997433,0.001010755,0.00092765794,0.00015620094,0.00016733831,0.00030501626],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003021462,0.00025476754,0.0003775229,0.00033403552,0.0004318134,0.0011120738,0.0004282472,0.00031609257,0.0012175982],"category_scores_gemma":[0.00622402,0.00017062027,0.0010258895,0.00058761804,0.00043715208,0.0003416385,0.0006177759,0.0005704587,0.00008579858],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017095556,0.00035946842,0.9859643,0.0000829211,0.0009024611,0.00006842678,0.0001566557,0.0017255488,0.00022506203,0.00009730082,0.00029679306,0.008411454],"study_design_scores_gemma":[0.000051893046,0.0004978749,0.9960155,0.000016713291,0.00016467358,0.00004930417,0.00010885004,0.0027325952,0.00007572271,0.00005559845,0.00021861416,0.0000126532195],"about_ca_topic_score_codex":0.095051266,"about_ca_topic_score_gemma":0.1578172,"teacher_disagreement_score":0.095051266,"about_ca_system_score_codex":0.0025379222,"about_ca_system_score_gemma":0.0014852597,"threshold_uncertainty_score":0.18899602},"labels":[],"label_agreement":null},{"id":"W2890807462","doi":"10.1111/jvh.12997","title":"Long‐term follow‐up of patients treated with entecavir and peginterferon add‐on therapy for <scp>HB</scp>eAg‐positive chronic hepatitis B infection: <scp>ARES</scp> long‐term follow‐up","year":2018,"lang":"en","type":"article","venue":"Journal of Viral Hepatitis","topic":"Hepatitis B Virus Studies","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto Western Hospital; University of Toronto; University Health Network","funders":"Bristol-Myers Squibb","keywords":"Entecavir; Medicine; Internal medicine; Gastroenterology; Peginterferon alfa-2a; Clinical endpoint; Chronic hepatitis; Clinical trial; Immunology; Virus","score_opus":0.015727983318895748,"score_gpt":0.27578360970140137,"score_spread":0.2600556263825056,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2890807462","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9982407,0.0007372873,0.000077547855,0.00006310274,0.000019959518,0.000024244384,0.00036522286,0.000004025672,0.00046777024],"genre_scores_gemma":[0.9984688,0.00013106661,0.000038497034,0.00009003206,0.000029674195,0.00003159434,0.0007800774,0.0000015865095,0.00042873525],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9993358,0.00018613531,0.00008121876,0.00011782442,0.00010586662,0.00017300433],"domain_scores_gemma":[0.9970235,0.0005720274,0.0008856481,0.00019510159,0.00035264413,0.0009709962],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014383962,0.00028483686,0.0008892929,0.00043842592,0.00076975604,0.00057990843,0.0003032008,0.00086430553,0.0015110436],"category_scores_gemma":[0.0021061753,0.00026761417,0.0010571787,0.00042613334,0.000277432,0.00079959916,0.00040539636,0.0014834363,0.00040531426],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.014044601,0.0009956146,0.9692759,0.00006108483,0.00065767806,0.00069966307,0.00022981242,0.00021429882,0.0020124563,0.000027855356,0.0004719381,0.011309158],"study_design_scores_gemma":[0.00041394704,0.006601196,0.9902773,0.000024859391,0.00048569372,0.0006194068,0.00015895307,0.000279649,0.00035900707,0.000030081761,0.00072583486,0.000024084258],"about_ca_topic_score_codex":0.0015735616,"about_ca_topic_score_gemma":0.0019226376,"teacher_disagreement_score":0.0015735616,"about_ca_system_score_codex":0.00040815384,"about_ca_system_score_gemma":0.00031713882,"threshold_uncertainty_score":0.007607043},"labels":[],"label_agreement":null},{"id":"W2900758126","doi":"10.1111/jvh.13043","title":"Applying core theory and spatial analysis to identify hepatitis C virus infection “core areas” in British Columbia, Canada","year":2018,"lang":"en","type":"article","venue":"Journal of Viral Hepatitis","topic":"HIV, Drug Use, Sexual Risk","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Public Health Ontario; University of Toronto; BC Centre for Disease Control; University of British Columbia","funders":"Canadian Institutes of Health Research; British Columbia Centre for Disease Control; BC Cancer Agency; Provincial Health Services Authority; Hologic","keywords":"Geography; Demography; Downtown; Hepatitis C; Cartography; Medicine; Virology; Archaeology","score_opus":0.021442678423611337,"score_gpt":0.3194305612134829,"score_spread":0.29798788278987154,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2900758126","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94732744,0.002356115,0.015838336,0.0012532263,0.00006190008,0.00034602074,0.015001528,0.00023792376,0.017577505],"genre_scores_gemma":[0.98126054,0.0008036583,0.009823237,0.00010576293,0.0000074652016,0.00012768252,0.0043128813,0.000048008515,0.0035107408],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99906605,0.00018431357,0.00005584964,0.00018130678,0.00024772718,0.00026481863],"domain_scores_gemma":[0.99663675,0.0004792008,0.00020600413,0.0001571855,0.0022521021,0.00026873744],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010609976,0.00038318054,0.00041383872,0.0046714637,0.002222822,0.0022670988,0.0011589089,0.0002481461,0.0025924463],"category_scores_gemma":[0.006162929,0.0003538894,0.0005910669,0.008473541,0.0007308181,0.00044028595,0.0015309586,0.00042298704,0.00028806218],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000102953694,0.000040654315,0.88526964,0.00024401056,0.00021678692,0.00030315245,0.0030410558,0.009408761,0.00049239385,0.0031916557,0.013646247,0.08404267],"study_design_scores_gemma":[0.00002133014,0.000022186754,0.9347586,0.0002570109,0.00013914822,0.0001141689,0.010361641,0.039332025,0.0003258156,0.0018953009,0.012722586,0.00005014713],"about_ca_topic_score_codex":0.9960175,"about_ca_topic_score_gemma":0.9972687,"teacher_disagreement_score":0.024177656,"about_ca_system_score_codex":0.024177656,"about_ca_system_score_gemma":0.035511434,"threshold_uncertainty_score":0.17542201},"labels":[],"label_agreement":null},{"id":"W2905838688","doi":"10.1111/jvh.13051","title":"Genomic variability of within‐host hepatitis C variants in acute infection","year":2018,"lang":"en","type":"article","venue":"Journal of Viral Hepatitis","topic":"Hepatitis C virus research","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal","funders":"National Institute on Drug Abuse; National Institute of Allergy and Infectious Diseases; Rijksinstituut voor Volksgezondheid en Milieu; National Health and Medical Research Council; Medical Research Council; National Institutes of Health; Canadian Institutes of Health Research; University of New South Wales","keywords":"Nonsynonymous substitution; Biology; Viral quasispecies; Genetics; Single-nucleotide polymorphism; Virology; Viral load; Genotype; SNP; Genetic variation; Hepatitis C virus; Virus; Genome; Gene","score_opus":0.02022682742282716,"score_gpt":0.32425549487518623,"score_spread":0.30402866745235907,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2905838688","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99932563,0.00017159175,0.00023092506,0.0000051169973,0.000001316705,0.0000015655777,0.00012966477,0.0000020688028,0.00013213721],"genre_scores_gemma":[0.9996257,0.000035393576,0.00011472814,0.000004499857,0.0000022625732,0.0000016544233,0.00016037193,0.0000018850839,0.000053549895],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9996655,0.00011184515,0.000029172796,0.00008209748,0.00006674886,0.000044687593],"domain_scores_gemma":[0.9990133,0.00040993805,0.00032958676,0.00009133496,0.000082678256,0.00007313649],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00048021827,0.00009090845,0.00021428886,0.00040206936,0.00016066081,0.0003610916,0.00010961902,0.00020293781,0.0008320926],"category_scores_gemma":[0.0012111565,0.000076078315,0.00014279658,0.0005365474,0.00019447778,0.00017080877,0.00021536012,0.0001917713,0.00011547649],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00061861705,0.000031024516,0.9764688,0.00002494174,0.000112933645,0.00015338555,0.00016929241,0.00029933787,0.015365077,0.000078303354,0.000063395906,0.0066149794],"study_design_scores_gemma":[0.0000026604073,0.000059504328,0.9980604,0.0000033618805,0.000016289809,0.00031970593,0.000057251444,0.0004384071,0.00081963243,0.00007556332,0.00014373807,0.0000035793178],"about_ca_topic_score_codex":0.00055909035,"about_ca_topic_score_gemma":0.000715348,"teacher_disagreement_score":0.0008320926,"about_ca_system_score_codex":0.00012294404,"about_ca_system_score_gemma":0.0000865173,"threshold_uncertainty_score":0.0027835965},"labels":[],"label_agreement":null},{"id":"W2911954308","doi":"10.1111/jvh.13067","title":"Sofosbuvir/Velpatasvir/Voxilaprevir for patients with HCV who previously received a Sofosbuvir/Velpatasvir‐containing regimen: Results from a retreatment study","year":2019,"lang":"en","type":"article","venue":"Journal of Viral Hepatitis","topic":"Hepatitis C virus research","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"Gilead Sciences","keywords":"Regimen; Medicine; Sofosbuvir; Hepatitis C virus; Internal medicine; Gastroenterology; Virus; Immunology; Ribavirin","score_opus":0.01914237510934283,"score_gpt":0.2974786450502149,"score_spread":0.278336269940872,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2911954308","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9992091,0.00043840715,0.00004451202,0.0000401683,0.000013157878,0.00005830691,0.000024491526,0.0000041032117,0.00016778072],"genre_scores_gemma":[0.9991511,0.00024810174,0.00011931205,0.0000881798,0.000037710055,0.000036664074,0.00011133946,0.0000023332932,0.00020525092],"study_design_codex":"observational","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99938846,0.00032552207,0.00005334947,0.000058420414,0.00008006024,0.000094180665],"domain_scores_gemma":[0.9993087,0.00022397253,0.000107475294,0.000053587875,0.00006504678,0.00024122102],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017597777,0.0005676286,0.0011443469,0.00026559064,0.00039563022,0.00046616347,0.00032029094,0.0005489133,0.0009007307],"category_scores_gemma":[0.0017764524,0.00024532035,0.0011294478,0.00023966038,0.00031251422,0.00052918785,0.00014611983,0.000920996,0.000263781],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.32786244,0.036694817,0.3338622,0.0007152222,0.002645781,0.0025021983,0.0021509207,0.0023241423,0.043571483,0.000101153455,0.0012220108,0.24634762],"study_design_scores_gemma":[0.055238254,0.4333765,0.49267495,0.000098571014,0.0019962946,0.0019263274,0.00061377004,0.0042039524,0.0068223835,0.000066649176,0.0029066475,0.000075719865],"about_ca_topic_score_codex":0.0011507976,"about_ca_topic_score_gemma":0.001678216,"teacher_disagreement_score":0.0017597777,"about_ca_system_score_codex":0.0003728962,"about_ca_system_score_gemma":0.0004665062,"threshold_uncertainty_score":0.009306729},"labels":[],"label_agreement":null},{"id":"W2917824734","doi":"10.1111/jvh.13084","title":"Sustained off‐treatment viral control is associated with high hepatitis B surface antigen seroclearance rates in Caucasian patients with nucleos(t)ide analogue–induced <scp>HB</scp>eAg seroconversion","year":2019,"lang":"en","type":"article","venue":"Journal of Viral Hepatitis","topic":"Hepatitis B Virus Studies","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto General Hospital; University of Toronto; University Health Network","funders":"","keywords":"Seroconversion; Virology; Medicine; Antigen; Immunology; Virus","score_opus":0.007113304482053324,"score_gpt":0.23128351596715147,"score_spread":0.22417021148509814,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2917824734","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9989778,0.00019076635,0.000026392105,0.000060290284,0.000010766693,0.0000022222482,0.000048978272,0.0000028463294,0.00067994057],"genre_scores_gemma":[0.99960154,0.00006584173,0.000020912437,0.000034213106,0.000021156868,0.0000016544179,0.00007594926,0.0000029025116,0.00017570994],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99966156,0.00012155167,0.000053867647,0.00005956183,0.000040774008,0.00006268196],"domain_scores_gemma":[0.99721354,0.00065559486,0.0012198909,0.00017520844,0.00016124833,0.00057451543],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005455743,0.00021920721,0.00034274327,0.00052600686,0.00051198626,0.00085981976,0.00025819885,0.00055302976,0.004219521],"category_scores_gemma":[0.0025901122,0.0003014702,0.00036945156,0.00079073425,0.00035563894,0.0004113533,0.00027099723,0.0008561225,0.000567359],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00059880083,0.00006075725,0.9964509,0.000008765575,0.0000395427,0.00024759816,0.000071140355,0.000012037148,0.00068992807,0.000022811082,0.00013769811,0.0016600188],"study_design_scores_gemma":[0.000016892203,0.00019043154,0.9981331,0.000006159645,0.000036782694,0.0009948221,0.00018984926,0.00011735828,0.00009959469,0.000029492992,0.00018171086,0.0000037491056],"about_ca_topic_score_codex":0.0024349957,"about_ca_topic_score_gemma":0.002499915,"teacher_disagreement_score":0.004219521,"about_ca_system_score_codex":0.00014119847,"about_ca_system_score_gemma":0.00022960654,"threshold_uncertainty_score":0.014115751},"labels":[],"label_agreement":null},{"id":"W2924489617","doi":"10.1111/jvh.13097","title":"Relationship between hepatitis B core‐related antigen levels and sustained <scp>HB</scp>eAg seroconversion in patients treated with nucleo(s)tide analogues","year":2019,"lang":"en","type":"article","venue":"Journal of Viral Hepatitis","topic":"Hepatitis B Virus Studies","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network","funders":"Fujirebio Europe; Bristol-Myers Squibb","keywords":"Seroconversion; Medicine; Internal medicine; Antigen; Hazard ratio; Gastroenterology; Hepatitis B; Hepatitis B virus; Virology; Immunology; Antibody; Confidence interval; Virus","score_opus":0.02228793486487363,"score_gpt":0.2614412727985077,"score_spread":0.23915333793363408,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2924489617","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99937433,0.00037075116,0.00003433544,0.000027032438,0.0000051360107,0.000002612415,0.000031754364,0.0000019995173,0.00015199899],"genre_scores_gemma":[0.9997708,0.000067352776,0.000020978146,0.00001311969,0.000008812631,0.0000016891938,0.000057679594,9.1483133e-7,0.000058651975],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99971765,0.000098463795,0.000037392212,0.00005406419,0.000044751763,0.00004761711],"domain_scores_gemma":[0.99807906,0.00064501713,0.0006781352,0.00012177906,0.00011616383,0.0003598576],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00053883134,0.00019814736,0.000484844,0.00024770643,0.0002576959,0.0005263022,0.0001999225,0.0004272708,0.0009029666],"category_scores_gemma":[0.0021630318,0.00027273802,0.0005820964,0.0003788811,0.00025199662,0.0002715124,0.0002016432,0.00081229856,0.00014936224],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013643466,0.00005209185,0.9956922,0.00000867088,0.00008489763,0.00010531668,0.00003143787,0.00007724785,0.0003658303,0.000010228989,0.000049741815,0.0021579762],"study_design_scores_gemma":[0.00004892358,0.00060610584,0.9981316,0.0000059719573,0.00006297237,0.0003820247,0.0000461767,0.0004893935,0.000091662536,0.000024742973,0.0001062095,0.000004189225],"about_ca_topic_score_codex":0.0015595477,"about_ca_topic_score_gemma":0.001789936,"teacher_disagreement_score":0.0015595477,"about_ca_system_score_codex":0.00022563525,"about_ca_system_score_gemma":0.00025990998,"threshold_uncertainty_score":0.0031009316},"labels":[],"label_agreement":null},{"id":"W2939003214","doi":"10.1111/jvh.13104","title":"Age, race and viral genotype are associated with the prevalence of hepatitis B e antigen in children and adults with chronic hepatitis B","year":2019,"lang":"en","type":"article","venue":"Journal of Viral Hepatitis","topic":"Hepatitis B Virus Studies","field":"Medicine","cited_by":28,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto General Hospital; University of Toronto","funders":"National Center for Advancing Translational Sciences; National Institutes of Health; National Institute of Diabetes and Digestive and Kidney Diseases; Gilead Sciences; National Center for Research Resources; Roche","keywords":"HBeAg; Medicine; Genotype; Cohort; Hepatitis B virus; Hepatitis B; Immunology; Serology; Internal medicine; Virology; Virus; HBsAg; Antibody; Biology; Gene","score_opus":0.005595835323454534,"score_gpt":0.22866011245685397,"score_spread":0.22306427713339944,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2939003214","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.999003,0.00038006788,0.00003419471,0.000073668445,0.000011106966,0.000004111283,0.00015724196,0.000002542033,0.00033412068],"genre_scores_gemma":[0.99930954,0.00021890335,0.00006900513,0.00003461857,0.000019926008,0.000008563369,0.00017555678,0.0000024731655,0.0001614671],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9995215,0.00011583355,0.00006115588,0.00009759782,0.00009506614,0.0001088282],"domain_scores_gemma":[0.99791056,0.00032155268,0.0011704694,0.00010149271,0.00013747424,0.00035842077],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00063670654,0.0002683541,0.00037807197,0.0005427493,0.00046383706,0.00054818,0.00030687056,0.000623314,0.0020657768],"category_scores_gemma":[0.0030565916,0.0003798427,0.0005101794,0.0007539449,0.00030720604,0.0004889558,0.00046775944,0.0006454351,0.00036215983],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000047633606,0.000016320455,0.999246,0.000004760874,0.000013395004,0.000045109,0.00005222964,0.000010142244,0.0000912058,0.000006851299,0.000044552777,0.0004219142],"study_design_scores_gemma":[0.0000026232615,0.00003349376,0.99951684,0.0000045212696,0.000013231843,0.00019039895,0.00008001442,0.000036772337,0.000016535041,0.000007794811,0.00009630187,0.0000013962829],"about_ca_topic_score_codex":0.0058569005,"about_ca_topic_score_gemma":0.0060120616,"teacher_disagreement_score":0.0058569005,"about_ca_system_score_codex":0.00024252354,"about_ca_system_score_gemma":0.00032861275,"threshold_uncertainty_score":0.011645615},"labels":[],"label_agreement":null},{"id":"W2943994554","doi":"10.1111/jvh.13119","title":"Perceived barriers related to testing, management and treatment of HCV infection among physicians prescribing opioid agonist therapy: The C‐SCOPE Study","year":2019,"lang":"en","type":"article","venue":"Journal of Viral Hepatitis","topic":"Hepatitis C virus research","field":"Medicine","cited_by":72,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Merck Canada Inc. (Canada)","funders":"Merck Sharp and Dohme; Department of Health and Ageing, Australian Government","keywords":"Opioid; Medicine; Scope (computer science); Agonist; Intensive care medicine; Internal medicine; Receptor","score_opus":0.024889504192536622,"score_gpt":0.3058115625959304,"score_spread":0.2809220584033938,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2943994554","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.998767,0.00016227085,0.00005083699,0.00023241786,0.0000041498643,0.000048270867,0.00012084307,0.0000010080498,0.0006131389],"genre_scores_gemma":[0.9992149,0.00016315069,0.00013250756,0.00015964467,0.000009032047,0.000056212313,0.00011582617,0.000001428666,0.00014720642],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99775827,0.0008265204,0.00030292844,0.00013394331,0.00060762605,0.0003706619],"domain_scores_gemma":[0.9825435,0.005798037,0.007374837,0.0004200116,0.0013908781,0.002472604],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004228155,0.00019219708,0.0003527218,0.00086957705,0.0007865679,0.0009274601,0.00038964456,0.0005813855,0.0024845388],"category_scores_gemma":[0.016716896,0.00027575274,0.0006613299,0.00082318287,0.0005045535,0.00082356896,0.0012583457,0.00073333835,0.0001683494],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000901541,0.00021029274,0.99198383,0.000080313825,0.000051183466,0.000055796154,0.0037538784,0.000040399696,0.00013849471,0.000055271732,0.00023306983,0.0033073816],"study_design_scores_gemma":[0.000013141744,0.00022934313,0.99145156,0.00009486731,0.000021942597,0.000088270615,0.0073515372,0.0001445634,0.00004322405,0.000018548832,0.00053372467,0.0000092123],"about_ca_topic_score_codex":0.014189271,"about_ca_topic_score_gemma":0.023774521,"teacher_disagreement_score":0.014189271,"about_ca_system_score_codex":0.0010253931,"about_ca_system_score_gemma":0.0020679347,"threshold_uncertainty_score":0.028213382},"labels":[],"label_agreement":null},{"id":"W2945358100","doi":"10.1111/jvh.13129","title":"Hepatitis E during pregnancy: Maternal and foetal case‐fatality rates and adverse outcomes—A systematic review","year":2019,"lang":"en","type":"review","venue":"Journal of Viral Hepatitis","topic":"Hepatitis Viruses Studies and Epidemiology","field":"Medicine","cited_by":74,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Case fatality rate; Medicine; Obstetrics; Pregnancy; Adverse effect; Hepatitis E; Intensive care medicine; Internal medicine; Epidemiology; Biology","score_opus":0.060634703763913105,"score_gpt":0.3758537019380733,"score_spread":0.3152189981741602,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2945358100","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0012949009,0.997575,0.00007492939,0.00014155346,0.00007225853,0.00023902954,0.00042166904,0.00000653518,0.00017417886],"genre_scores_gemma":[0.017198207,0.9812599,0.00030111053,0.00031376633,0.000067858986,0.00049958023,0.000265136,0.00000450454,0.00008995808],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.99296075,0.0020989052,0.002925988,0.00046507688,0.0013064562,0.0002428545],"domain_scores_gemma":[0.9703333,0.021383313,0.005531861,0.00036083377,0.0021295783,0.00026121255],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0072378702,0.0012950408,0.007409036,0.010697708,0.0005380056,0.002460507,0.0014728899,0.0017109694,0.0039102854],"category_scores_gemma":[0.044303164,0.0010699613,0.008393735,0.009629904,0.00071005564,0.0019723433,0.0015200699,0.0011252069,0.00027963746],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018076369,0.000011749988,0.0011134946,0.9690129,0.008140125,0.000081158854,0.00014164874,0.00006266664,0.000065795626,0.00008957425,0.00092402974,0.020176146],"study_design_scores_gemma":[0.00020663503,0.0001922877,0.006760105,0.90859836,0.073834956,0.00049067696,0.00024599012,0.00008175953,0.00010821342,0.00016376945,0.009278632,0.000038677965],"about_ca_topic_score_codex":0.012246419,"about_ca_topic_score_gemma":0.030762102,"teacher_disagreement_score":0.012246419,"about_ca_system_score_codex":0.003936755,"about_ca_system_score_gemma":0.009747498,"threshold_uncertainty_score":0.038277984},"labels":[],"label_agreement":null},{"id":"W2945683743","doi":"10.1111/jvh.13125","title":"Persistence of <scp>HB</scp>sAg‐specific antibodies and immune memory two to three decades after hepatitis B vaccination in adults","year":2019,"lang":"en","type":"article","venue":"Journal of Viral Hepatitis","topic":"Hepatitis B Virus Studies","field":"Medicine","cited_by":48,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre hospitalier de l'Université Laval; Centre hospitalier universitaire de Québec","funders":"GlaxoSmithKline","keywords":"Immunogenicity; Vaccination; Medicine; Immunology; Immunization; Booster dose; Antibody; Immune system; Hepatitis B; Hepatitis B vaccine; Virology; Hepatitis B virus; HBsAg; Virus","score_opus":0.012804609847132171,"score_gpt":0.2617573074249085,"score_spread":0.24895269757777633,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2945683743","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9995022,0.00021199469,0.000045905563,0.000010952279,0.000003895815,0.000014610443,0.00004179984,0.0000028773702,0.00016577027],"genre_scores_gemma":[0.9993357,0.000058152298,0.00005037123,0.000051099945,0.0000072793428,0.000020831942,0.00012225073,9.230908e-7,0.0003533349],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99981767,0.000052004074,0.000014762477,0.000030012236,0.00002787924,0.000057648802],"domain_scores_gemma":[0.99936646,0.00011186598,0.00022923111,0.000034784625,0.00008487807,0.00017290637],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009967919,0.00020827235,0.00033190107,0.00017780937,0.00016943013,0.00031293847,0.00011660125,0.00043361518,0.0010127559],"category_scores_gemma":[0.00097224244,0.000166357,0.00023706749,0.00011742079,0.00012805055,0.00033187767,0.00020365286,0.0003415131,0.0002545927],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.015565084,0.0031305314,0.9196767,0.00012784114,0.00014564898,0.00033659398,0.00056635885,0.00011864621,0.02032404,0.00004336955,0.0004242738,0.03954093],"study_design_scores_gemma":[0.00028336432,0.05687191,0.93755096,0.0000320854,0.00010250011,0.00063950743,0.0002477289,0.00019154145,0.0030738278,0.00004032629,0.0009581539,0.000008066911],"about_ca_topic_score_codex":0.00042040268,"about_ca_topic_score_gemma":0.00034967888,"teacher_disagreement_score":0.0010127559,"about_ca_system_score_codex":0.000107345055,"about_ca_system_score_gemma":0.00016995147,"threshold_uncertainty_score":0.0052716136},"labels":[],"label_agreement":null},{"id":"W2946475694","doi":"10.1111/jvh.13132","title":"Efficacy and safety of a two‐drug direct‐acting antiviral agent regimen ruzasvir 180 mg and uprifosbuvir 450 mg for 12 weeks in adults with chronic hepatitis C virus genotype 1, 2, 3, 4, 5 or 6","year":2019,"lang":"en","type":"article","venue":"Journal of Viral Hepatitis","topic":"Hepatitis C virus research","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto Liver Centre; University of Toronto","funders":"Merck Sharp and Dohme","keywords":"Tolerability; Medicine; Regimen; Ribavirin; Adverse effect; Internal medicine; Hepatitis C virus; Drug; Hepatitis C; Gastroenterology; Cirrhosis; Pharmacology; Virology; Virus","score_opus":0.01534624440452465,"score_gpt":0.29956091935133894,"score_spread":0.2842146749468143,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2946475694","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99823856,0.00082256197,0.000110923145,0.00005712563,0.000011661571,0.00016438811,0.00012288945,0.000016622478,0.00045532148],"genre_scores_gemma":[0.9985024,0.0003494987,0.00025290632,0.000076416814,0.00003154949,0.00013677459,0.00020696293,0.0000034443608,0.00044022297],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9993376,0.00036171364,0.000057693756,0.00008791025,0.00009130555,0.000063773165],"domain_scores_gemma":[0.999619,0.00008263463,0.0001036771,0.000035231693,0.000032545413,0.00012690433],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011631271,0.00054629677,0.00094229804,0.00020353096,0.00021374118,0.00031646347,0.0003832675,0.00084918295,0.0016660921],"category_scores_gemma":[0.0009756767,0.00034013946,0.00065316004,0.00013804977,0.00037793376,0.00046026727,0.0002289758,0.0010480663,0.0003676185],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.619681,0.04504845,0.026286917,0.00069847127,0.0012154621,0.00023994443,0.00044665302,0.0013644868,0.07105951,0.00013775204,0.000966153,0.23285516],"study_design_scores_gemma":[0.12694027,0.77502525,0.08498951,0.00004128314,0.0006285818,0.00034393714,0.00007865192,0.0016236696,0.008338319,0.000069433656,0.0018802774,0.00004073639],"about_ca_topic_score_codex":0.00051052717,"about_ca_topic_score_gemma":0.0009461666,"teacher_disagreement_score":0.0016660921,"about_ca_system_score_codex":0.00040256695,"about_ca_system_score_gemma":0.00039532242,"threshold_uncertainty_score":0.006151259},"labels":[],"label_agreement":null},{"id":"W2947135426","doi":"10.1111/jvh.13146","title":"Low compliance with hepatocellular carcinoma screening guidelines in hepatitis B/C virus co‐infected HIV patients with cirrhosis","year":2019,"lang":"en","type":"article","venue":"Journal of Viral Hepatitis","topic":"Hepatitis C virus research","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Infection and Immunity","funders":"Seventh Framework Programme; Agence Nationale de Recherches sur le Sida et les Hépatites Virales; European Commission; Augustinus Fonden; Styrelsen för Internationellt Utvecklingssamarbete","keywords":"Medicine; Hepatocellular carcinoma; Cirrhosis; Internal medicine; Hepatitis C; Hepatitis B virus; Hepatitis C virus; Observational study; Incidence (geometry); Hepatitis B; Epidemiology; Gastroenterology; Virology; Virus","score_opus":0.03428191584304353,"score_gpt":0.30802785572219,"score_spread":0.27374593987914647,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2947135426","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9996088,0.00012275491,0.000034791596,0.000027327336,0.00000211692,0.0000057774587,0.00008503121,0.0000015725105,0.000111801804],"genre_scores_gemma":[0.99979013,0.000025667205,0.000041199746,0.000018426106,0.0000023499713,0.000005950933,0.00007947534,5.773898e-7,0.000036066413],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9979259,0.0011341022,0.00026173607,0.00024173179,0.00020622183,0.00023022847],"domain_scores_gemma":[0.99374914,0.0022762385,0.0028239635,0.00037353116,0.00032053897,0.00045656378],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0026220034,0.00015982991,0.00030747592,0.00067349273,0.00045647033,0.00086103764,0.0003092684,0.0005079001,0.000974235],"category_scores_gemma":[0.011062187,0.00032905012,0.0005016422,0.0010602155,0.00029243928,0.00042875457,0.0006033093,0.0005257602,0.00010681634],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000086694025,0.000028352355,0.9991154,0.0000070607575,0.000026305097,0.000025091405,0.000076173696,0.00003285078,0.000023027034,0.000007770301,0.000023794473,0.00054743],"study_design_scores_gemma":[0.000007970798,0.00016378437,0.99899274,0.0000129475975,0.000029289853,0.00008881852,0.00016648599,0.00041464288,0.000041559382,0.000017451366,0.00006038959,0.000003930931],"about_ca_topic_score_codex":0.0076209214,"about_ca_topic_score_gemma":0.009452094,"teacher_disagreement_score":0.0076209214,"about_ca_system_score_codex":0.00051479146,"about_ca_system_score_gemma":0.00059833424,"threshold_uncertainty_score":0.01515317},"labels":[],"label_agreement":null},{"id":"W2947243310","doi":"10.1111/jvh.13117","title":"Hepatitis B core‐related antigen monitoring during peginterferon alfa treatment for HBeAg‐negative chronic hepatitis B","year":2019,"lang":"en","type":"article","venue":"Journal of Viral Hepatitis","topic":"Hepatitis B Virus Studies","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Toronto Western Hospital; University Health Network","funders":"Fujirebio Europe; Roche; National Science Foundation","keywords":"Medicine; Chronic hepatitis; Internal medicine; Gastroenterology; HBeAg; Hepatitis B; Antigen; Hepatitis B virus; Immunology; HBsAg; Virus","score_opus":0.025324806295111902,"score_gpt":0.30469062024816,"score_spread":0.2793658139530481,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2947243310","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9994413,0.00028593765,0.00006444383,0.000020951642,0.0000030541448,0.000009453557,0.0000182508,0.0000048216075,0.0001516816],"genre_scores_gemma":[0.9996464,0.00006824124,0.00009332427,0.000024247936,0.00000813972,0.000008775121,0.000052890082,0.0000011591068,0.000096845986],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99959105,0.00018838991,0.000032117718,0.00005500999,0.000081366205,0.000052011826],"domain_scores_gemma":[0.99942917,0.00015766785,0.0002126192,0.000027996082,0.000047937854,0.00012459417],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00080986123,0.00028624188,0.00060594257,0.000295156,0.00024787392,0.00032929334,0.00012293209,0.0003158814,0.00036058525],"category_scores_gemma":[0.0014207663,0.0001860623,0.00025511463,0.0002590461,0.00020625818,0.0002443185,0.00011677996,0.00045360991,0.00016752283],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.012608449,0.0007784247,0.9067641,0.00009306463,0.00014063012,0.0005133159,0.00047757386,0.0005182616,0.03189461,0.000022015669,0.00034551497,0.045844126],"study_design_scores_gemma":[0.00028694462,0.006504075,0.9865051,0.000015586163,0.00010712393,0.0007624257,0.00011547586,0.0011137251,0.004015686,0.00003057125,0.00053116865,0.000012070535],"about_ca_topic_score_codex":0.0010033036,"about_ca_topic_score_gemma":0.0016615243,"teacher_disagreement_score":0.0010033036,"about_ca_system_score_codex":0.00032865035,"about_ca_system_score_gemma":0.0001986227,"threshold_uncertainty_score":0.004283011},"labels":[],"label_agreement":null},{"id":"W2947594352","doi":"10.1111/jvh.13147","title":"Metabolic syndrome and liver steatosis occur at lower body mass index in US Asian patients with chronic hepatitis B","year":2019,"lang":"en","type":"article","venue":"Journal of Viral Hepatitis","topic":"Liver Disease Diagnosis and Treatment","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital","funders":"National Institute of Diabetes and Digestive and Kidney Diseases; National Heart, Lung, and Blood Institute","keywords":"Steatosis; Metabolic syndrome; Body mass index; Liver steatosis; Chronic hepatitis; Internal medicine; Medicine; Gastroenterology; Fatty liver; Obesity; Virology; Disease","score_opus":0.0037935660453478812,"score_gpt":0.2097693988871236,"score_spread":0.2059758328417757,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2947594352","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9994531,0.00010990984,0.000026941683,0.000031320596,0.0000034841146,0.0000039688157,0.000066926776,0.0000018044259,0.00030245437],"genre_scores_gemma":[0.9996288,0.00007236118,0.000041848896,0.000041214156,0.000009696622,0.0000056775957,0.000106544045,0.0000012121915,0.00009265177],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9997179,0.00006716397,0.000044848246,0.000051411513,0.000059146925,0.000059617927],"domain_scores_gemma":[0.99901664,0.0001201097,0.0004722142,0.00007156282,0.0000919423,0.00022756154],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004311705,0.00029374144,0.0004459709,0.0009152989,0.00060581666,0.00067110255,0.00022005301,0.00047625907,0.0020763918],"category_scores_gemma":[0.0015887385,0.00045918726,0.00047445836,0.0012152814,0.00029072684,0.00052547915,0.00045588418,0.0006881934,0.00029373358],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007640918,0.000019281,0.99917895,0.0000031314437,0.000017511122,0.00009485817,0.00005393816,0.000007886216,0.00016262877,0.000005165902,0.000024941262,0.0003553286],"study_design_scores_gemma":[0.000007137816,0.00005968196,0.99899894,0.0000039962233,0.000017303912,0.0005638869,0.00019068962,0.00006671695,0.000028577608,0.0000110633555,0.000049790255,0.0000023336588],"about_ca_topic_score_codex":0.0066459905,"about_ca_topic_score_gemma":0.0073112454,"teacher_disagreement_score":0.0066459905,"about_ca_system_score_codex":0.00025042158,"about_ca_system_score_gemma":0.00030326933,"threshold_uncertainty_score":0.013214588},"labels":[],"label_agreement":null},{"id":"W2952804340","doi":"10.1111/jvh.13159","title":"Deferred treatment with a fixed‐dose combination of sofosbuvir‐velpatasvir for chronic hepatitis C virus genotype 1, 2, 4 and 6 infection","year":2019,"lang":"en","type":"article","venue":"Journal of Viral Hepatitis","topic":"Hepatitis C virus research","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; University of Alberta","funders":"Gilead Sciences","keywords":"Genotype; Fixed-dose combination; Virology; Sofosbuvir; Medicine; Virus; Chronic hepatitis; Internal medicine; Biology; Ribavirin; Genetics; Gene","score_opus":0.021699968799874153,"score_gpt":0.30862028692575816,"score_spread":0.28692031812588403,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2952804340","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99713933,0.0014729933,0.00043852287,0.000104325525,0.00007450904,0.00021679305,0.00009426077,0.00004364753,0.00041566172],"genre_scores_gemma":[0.99797326,0.0004489215,0.00067287585,0.00016316144,0.00007263636,0.000190174,0.00017483332,0.0000042241863,0.00029974745],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99953854,0.00019494811,0.00004145534,0.00007183808,0.00008149378,0.00007168424],"domain_scores_gemma":[0.9994019,0.0001386807,0.00013285517,0.0000656928,0.000034944795,0.00022598352],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015267107,0.0005974977,0.0021212627,0.00035367857,0.00029182294,0.0003425275,0.0007308944,0.0005351357,0.0014902616],"category_scores_gemma":[0.0012567629,0.00030607847,0.0007853987,0.00018883184,0.00047753923,0.00037861225,0.00022433014,0.0012516809,0.00023693348],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.6846932,0.03221274,0.014041958,0.0007365175,0.0016584964,0.000417788,0.00022950023,0.002693947,0.037564468,0.00042666975,0.0018212369,0.22350349],"study_design_scores_gemma":[0.3494576,0.613682,0.026001623,0.00006718888,0.00061265065,0.00059769605,0.000040847364,0.002937057,0.0044662044,0.00024541657,0.0018467993,0.000045024157],"about_ca_topic_score_codex":0.00055102323,"about_ca_topic_score_gemma":0.001330078,"teacher_disagreement_score":0.0021212627,"about_ca_system_score_codex":0.00041256717,"about_ca_system_score_gemma":0.0005991794,"threshold_uncertainty_score":0.008074105},"labels":[],"label_agreement":null},{"id":"W2963753270","doi":"10.1111/jvh.13180","title":"Kinetics of hepatitis B surface antigen quasispecies during REP 2139‐Ca therapy in HBeAg‐positive chronic HBV infection","year":2019,"lang":"en","type":"article","venue":"Journal of Viral Hepatitis","topic":"Hepatitis B Virus Studies","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Quebec Rehabilitation Research Network","funders":"","keywords":"Viral quasispecies; HBsAg; Virology; HBeAg; Population; Immunology; Medicine; Entecavir; Seroconversion; Hepatitis B virus; Biology; Virus; Hepatitis C virus","score_opus":0.011822478141709225,"score_gpt":0.27239599971128076,"score_spread":0.26057352156957153,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2963753270","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99963045,0.00013672098,0.000052083917,0.0000052095165,0.0000010852881,0.00001052254,0.000030659405,0.000004010168,0.00012930861],"genre_scores_gemma":[0.9995757,0.0000355307,0.0000687817,0.000013179362,0.000003525744,0.000014256934,0.00010591425,0.0000021252342,0.00018105912],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9997917,0.00006630097,0.000022543145,0.000041001633,0.000039737413,0.000038799724],"domain_scores_gemma":[0.9993374,0.0001717475,0.00022862907,0.00004666064,0.00007902362,0.00013657927],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00043836137,0.00017856476,0.0003115961,0.00030162977,0.00018905145,0.00026427413,0.00008649923,0.00027217277,0.0008309259],"category_scores_gemma":[0.0010086424,0.00017919038,0.00016774533,0.00015288565,0.00014927424,0.00027672033,0.00013385889,0.0002616609,0.0002413706],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.011919853,0.00081958185,0.2990498,0.00013773068,0.0001211331,0.00069834344,0.0008791513,0.00089412753,0.6562495,0.00012049664,0.0002820146,0.028828295],"study_design_scores_gemma":[0.00020515051,0.01248872,0.94041467,0.000013218753,0.00009463948,0.0012073106,0.00024657862,0.0030610587,0.041247908,0.000088478155,0.0009061961,0.000026075419],"about_ca_topic_score_codex":0.00048512465,"about_ca_topic_score_gemma":0.00048178085,"teacher_disagreement_score":0.0008309259,"about_ca_system_score_codex":0.00019157866,"about_ca_system_score_gemma":0.00008863667,"threshold_uncertainty_score":0.0027797222},"labels":[],"label_agreement":null},{"id":"W2969950817","doi":"10.1111/jvh.13194","title":"Sexual behaviour as a risk factor for hepatitis C virus infection among people who inject drugs in Montreal, Canada","year":2019,"lang":"en","type":"article","venue":"Journal of Viral Hepatitis","topic":"HIV, Drug Use, Sexual Risk","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Institut National de Santé Publique du Québec; Université de Montréal; Université de Sherbrooke; Centre Hospitalier de l’Université de Montréal","funders":"Canadian Institutes of Health Research","keywords":"Medicine; Hazard ratio; Seroconversion; Demography; Incidence (geometry); Hepatitis C; Cohort; Confidence interval; Hepatitis C virus; Men who have sex with men; Rate ratio; Cohort study; Needle sharing; Proportional hazards model; Heroin; Internal medicine; Condom; Human immunodeficiency virus (HIV); Immunology; Drug; Psychiatry; Virus","score_opus":0.011614459158976704,"score_gpt":0.28566978180335256,"score_spread":0.2740553226443759,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2969950817","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98740757,0.0024888252,0.00025910483,0.0009549544,0.000037470967,0.0001224326,0.005390812,0.000031287687,0.0033075819],"genre_scores_gemma":[0.9962429,0.0008122559,0.00024496642,0.00013118812,0.000012568509,0.000023811635,0.0010825689,0.000006337074,0.0014434102],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9993917,0.000072836156,0.00003253575,0.00010068476,0.00018756934,0.00021470587],"domain_scores_gemma":[0.9984066,0.00009255967,0.00034269283,0.000044506607,0.00062690646,0.0004868578],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00062995637,0.00044566937,0.00039066197,0.001404439,0.0025671804,0.0014865594,0.0013339135,0.00039971634,0.0032430952],"category_scores_gemma":[0.0019326435,0.00038972497,0.0008724541,0.002657962,0.00065957627,0.00043404318,0.00091889815,0.00074810354,0.00019660378],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000027165614,0.000020299085,0.9961212,0.000020264697,0.00003851193,0.000046164547,0.00028083075,0.00007455559,0.000089830566,0.000051887466,0.0007274012,0.0025017967],"study_design_scores_gemma":[0.0000059057493,0.00002029539,0.9984724,0.000033485285,0.000026803127,0.000036694975,0.00043514985,0.0002758351,0.000028019955,0.000014433068,0.00064217055,0.000008837654],"about_ca_topic_score_codex":0.99678814,"about_ca_topic_score_gemma":0.9976404,"teacher_disagreement_score":0.026555963,"about_ca_system_score_codex":0.026555963,"about_ca_system_score_gemma":0.025289163,"threshold_uncertainty_score":0.19267792},"labels":[],"label_agreement":null},{"id":"W2970398492","doi":"10.1111/jvh.13196","title":"Evaluation of a hepatitis C virus core antigen assay from venepuncture and dried blood spot collected samples: A cohort study","year":2019,"lang":"en","type":"article","venue":"Journal of Viral Hepatitis","topic":"Hepatitis C virus research","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal","funders":"Merck Sharp and Dohme; Medical Research Council; Abbott Diagnostics; Department of Health and Aged Care, Australian Government; Merck","keywords":"Medicine; Dried blood spot; Hepatitis C virus; Venipuncture; Hepatitis C; Internal medicine; Cohort; Window period; Viral load; Hepacivirus; Virology; Virus; Immunology; Antibody; Biology; Surgery; Serology","score_opus":0.04461566110911272,"score_gpt":0.34016766279436217,"score_spread":0.2955520016852494,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2970398492","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99922013,0.00009172156,0.00026952734,0.0000127268295,0.000015004695,0.00006164545,0.00017145684,0.000004198932,0.00015349766],"genre_scores_gemma":[0.998818,0.00009382864,0.0003973589,0.0000413647,0.00001739493,0.00006116199,0.00031980523,0.000006182228,0.00024497294],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99698824,0.0012846042,0.00015759222,0.0007333456,0.0006232608,0.00021298103],"domain_scores_gemma":[0.9927371,0.0018556251,0.0015191018,0.001527401,0.00151554,0.0008452834],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0061911824,0.00080136623,0.0005190953,0.00076613325,0.0008397616,0.0013906864,0.000798437,0.0008398748,0.00087800605],"category_scores_gemma":[0.010751602,0.00071136013,0.00091666344,0.00058369973,0.0005681181,0.00076321955,0.0006929018,0.0011108922,0.000443293],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0023141988,0.0006013608,0.99164385,0.000035913992,0.0003423393,0.00024499214,0.00064562325,0.00005413968,0.0017287367,0.00003666441,0.00013534423,0.002216817],"study_design_scores_gemma":[0.00020282883,0.004654344,0.99139506,0.00002017603,0.00025060616,0.0010121065,0.00046324113,0.00084469875,0.0006048355,0.000038782797,0.0004811365,0.00003216722],"about_ca_topic_score_codex":0.0073847314,"about_ca_topic_score_gemma":0.0055134427,"teacher_disagreement_score":0.0073847314,"about_ca_system_score_codex":0.0006474757,"about_ca_system_score_gemma":0.0007061121,"threshold_uncertainty_score":0.0327425},"labels":[],"label_agreement":null},{"id":"W2970907004","doi":"10.1111/jvh.13197","title":"Consistent high prevalence of undiagnosed blood‐borne virus infection in patients attending large urban emergency departments in England","year":2019,"lang":"en","type":"article","venue":"Journal of Viral Hepatitis","topic":"Hepatitis C virus research","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Infection and Immunity","funders":"Gilead Sciences","keywords":"Medicine; Epidemiology; Human immunodeficiency virus (HIV); Emergency department; Family medicine; Environmental health; Virology; Emergency medicine; Internal medicine; Nursing","score_opus":0.013156862725124615,"score_gpt":0.2915969702303248,"score_spread":0.2784401075052002,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2970907004","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99689037,0.00078238634,0.00010058266,0.0007046015,0.0000144222295,0.000017480646,0.00051515445,0.000006580623,0.0009685384],"genre_scores_gemma":[0.9991696,0.00027102485,0.00006849505,0.00017492475,0.000014334452,0.000007034431,0.00011116571,0.000001240453,0.00018240226],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99890447,0.00033735597,0.00023560386,0.0001663708,0.00018245442,0.00017376117],"domain_scores_gemma":[0.9953112,0.0009363016,0.0021368032,0.00017937394,0.00074263825,0.00069377007],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00065375166,0.00012462413,0.00041815682,0.0007003136,0.0004223613,0.00097456184,0.0004401334,0.00044626583,0.0033521722],"category_scores_gemma":[0.004226011,0.0003169526,0.0001694972,0.0006523429,0.00066255406,0.0007491901,0.00095000287,0.00066421373,0.00025807924],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00005479036,0.000019028104,0.9954757,0.00008309304,0.000014549503,0.00034766042,0.0012711076,0.0000268848,0.00039380512,0.000047079648,0.00040444246,0.0018618533],"study_design_scores_gemma":[0.0000030879364,0.00004237214,0.9976985,0.0000445005,0.0000047317594,0.0004916928,0.0013955304,0.000034158787,0.000032737968,0.000019366365,0.0002263744,0.0000069971024],"about_ca_topic_score_codex":0.048758414,"about_ca_topic_score_gemma":0.107210025,"teacher_disagreement_score":0.048758414,"about_ca_system_score_codex":0.00087476603,"about_ca_system_score_gemma":0.0008928835,"threshold_uncertainty_score":0.09694922},"labels":[],"label_agreement":null},{"id":"W2981575069","doi":"10.1111/jvh.13226","title":"Long‐term morbidity and mortality in a Canadian post‐transfusion hepatitis C cohort: Over 15 years of follow‐up","year":2019,"lang":"en","type":"article","venue":"Journal of Viral Hepatitis","topic":"Hepatitis C virus research","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Institute for Clinical Evaluative Sciences; Institute of Health Services and Policy Research; University of Ottawa; Public Health Ontario; University Health Network; University of Toronto; University of Waterloo","funders":"","keywords":"Medicine; Cohort; Population; Mortality rate; Hepatitis C; Blood transfusion; Standardized mortality ratio; Hepatitis C virus; Demography; Cohort study; Cause of death; Pediatrics; Internal medicine; Immunology; Disease; Environmental health; Virus","score_opus":0.018448782207660164,"score_gpt":0.3130967553922834,"score_spread":0.2946479731846232,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2981575069","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9926725,0.0007070079,0.00009358113,0.00014403241,0.000008178775,0.000025118105,0.005492812,0.000009410338,0.00084727915],"genre_scores_gemma":[0.9951683,0.0005399792,0.000116283605,0.000057106947,0.0000064359556,0.000013950737,0.0036677553,0.000003338204,0.00042684967],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9994143,0.000022809252,0.000034619952,0.0001055797,0.00023034023,0.0001923317],"domain_scores_gemma":[0.99880135,0.000040465588,0.00021481737,0.000053789994,0.0006113447,0.0002782779],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00067767623,0.00041894423,0.00048933865,0.0015257972,0.0022268316,0.0010225669,0.0010127163,0.00053065544,0.0010922878],"category_scores_gemma":[0.0014628739,0.0003669275,0.00083937316,0.0032238336,0.00045267257,0.0005000031,0.0008258133,0.00080620195,0.00021859421],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009571322,0.000018476876,0.9963714,0.000020384003,0.000097741744,0.000108453154,0.00034994402,0.00008684994,0.00016197753,0.000032800668,0.000504699,0.0021516865],"study_design_scores_gemma":[0.0000030940764,0.000017663335,0.9991105,0.000012828457,0.000033165532,0.00007102206,0.00025085526,0.00012646016,0.000023677598,0.000010469043,0.00033103046,0.000009290089],"about_ca_topic_score_codex":0.9760862,"about_ca_topic_score_gemma":0.9760528,"teacher_disagreement_score":0.0239138,"about_ca_system_score_codex":0.010931701,"about_ca_system_score_gemma":0.010637747,"threshold_uncertainty_score":0.079315424},"labels":[],"label_agreement":null},{"id":"W2982065785","doi":"10.1111/jvh.13220","title":"Using the barriers and facilitators to linkage to HIV care to inform hepatitis C virus (HCV) linkage to care strategies for people released from prison: Findings from a systematic review","year":2019,"lang":"en","type":"review","venue":"Journal of Viral Hepatitis","topic":"HIV/AIDS Research and Interventions","field":"Medicine","cited_by":35,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"HIV Legal Network; McGill University; McGill University Health Centre","funders":"","keywords":"Medicine; Prison; Hepatitis C; Receipt; Family medicine; Health care; Social support; Stigma (botany); MEDLINE; Nursing; Systematic review; Psychiatry; Psychology; Virology; Business; Political science; Social psychology","score_opus":0.04025520643935951,"score_gpt":0.3751487145698361,"score_spread":0.3348935081304766,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2982065785","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.004009028,0.9932231,0.00033970372,0.0006412218,0.00008125799,0.00078355824,0.0004701502,0.00000832446,0.0004436982],"genre_scores_gemma":[0.03455795,0.9615351,0.0014933354,0.00057650736,0.000047963607,0.0013736294,0.00029197335,0.000005846797,0.000117670585],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.98038554,0.007155054,0.0076618833,0.0010193903,0.003172091,0.0006060326],"domain_scores_gemma":[0.91131014,0.068227984,0.012840977,0.000887066,0.0060773874,0.0006565294],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.024016215,0.0016759599,0.008816021,0.016275056,0.0011017885,0.005184686,0.0019793392,0.0021671134,0.0031516547],"category_scores_gemma":[0.102138765,0.0014503767,0.010628922,0.015935102,0.0013714574,0.00517734,0.0025895024,0.0016615093,0.00024075051],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012310974,0.000025670719,0.0029680545,0.9439307,0.0109364325,0.00012134522,0.0013435195,0.000106978885,0.00009121254,0.00027334224,0.0006770087,0.039402533],"study_design_scores_gemma":[0.00010757408,0.00010760927,0.0055917646,0.9256229,0.059385527,0.00018839244,0.0013621735,0.00007790816,0.00010750936,0.00024633275,0.0071657947,0.000036576334],"about_ca_topic_score_codex":0.019598948,"about_ca_topic_score_gemma":0.05961859,"teacher_disagreement_score":0.024016215,"about_ca_system_score_codex":0.0064462335,"about_ca_system_score_gemma":0.028130634,"threshold_uncertainty_score":0.12701142},"labels":[],"label_agreement":null},{"id":"W2982321079","doi":"10.1111/jvh.13228","title":"Loss to follow‐up: A significant barrier in the treatment cascade with direct‐acting therapies","year":2019,"lang":"en","type":"article","venue":"Journal of Viral Hepatitis","topic":"Hepatitis C virus research","field":"Medicine","cited_by":34,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Simon Fraser University; BC Centre for Disease Control; University of British Columbia","funders":"Canadian Institutes of Health Research","keywords":"Ombitasvir; Sofosbuvir; Paritaprevir; Ledipasvir; Medicine; Dasabuvir; Ribavirin; Ritonavir; Internal medicine; Hepatitis C; Discontinuation; Hepatitis C virus; Cohort; Gastroenterology; Viral load; Virology; Virus","score_opus":0.02395805420574037,"score_gpt":0.313854947509243,"score_spread":0.2898968933035026,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2982321079","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.90725964,0.0069944467,0.007624467,0.061490994,0.00034831153,0.0007279499,0.0019033594,0.00015392348,0.013496789],"genre_scores_gemma":[0.9900969,0.0010253845,0.0016803208,0.005171098,0.00028066855,0.00022674586,0.0003563616,0.000036265326,0.0011262097],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9695384,0.017035883,0.0033077698,0.002324178,0.0051290304,0.0026648461],"domain_scores_gemma":[0.86246926,0.077011295,0.041901283,0.0068425504,0.0049325456,0.0068430915],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.026388405,0.0002791766,0.0011164795,0.00081825245,0.0024372751,0.003801873,0.001456837,0.0010794809,0.008758299],"category_scores_gemma":[0.13577849,0.0004163847,0.0013057714,0.0012738087,0.00089737144,0.0026478437,0.0030204195,0.0039950246,0.0006427143],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014097394,0.0008733554,0.82308275,0.0004726926,0.0008580628,0.0007810806,0.0038663843,0.0009914273,0.0002943781,0.0037515492,0.006841748,0.15677689],"study_design_scores_gemma":[0.00023483609,0.0012012953,0.9655696,0.0017718744,0.0006451686,0.0015527706,0.0026809215,0.007210756,0.0004515641,0.004569761,0.014020284,0.00009130658],"about_ca_topic_score_codex":0.030760212,"about_ca_topic_score_gemma":0.021726638,"teacher_disagreement_score":0.030760212,"about_ca_system_score_codex":0.0037558237,"about_ca_system_score_gemma":0.0065771514,"threshold_uncertainty_score":0.13955688},"labels":[],"label_agreement":null},{"id":"W2995694266","doi":"10.1111/jvh.13223","title":"Liver safety assessment in clinical trials of new agents for chronic hepatitis B","year":2019,"lang":"en","type":"review","venue":"Journal of Viral Hepatitis","topic":"Hepatitis B Virus Studies","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Arbutus Biopharma (Canada); Toronto Liver Centre; University Health Network","funders":"Janssen Pharmaceuticals; Gilead Sciences; Novartis; GlaxoSmithKline","keywords":"Medicine; Clinical trial; Chronic hepatitis; Internal medicine; Intensive care medicine; Virology; Virus","score_opus":0.28872929134994224,"score_gpt":0.5224618920925622,"score_spread":0.23373260074261998,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2995694266","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00013184031,0.99879897,0.00012697652,0.00023006495,0.00011180277,0.00004688835,0.00002230786,0.000005512359,0.0005255387],"genre_scores_gemma":[0.00348056,0.9943811,0.0008662254,0.0006195155,0.00018185837,0.0001383317,0.000060559392,0.0000036587314,0.0002682456],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.9948478,0.0027743662,0.0011075399,0.00025089062,0.0009236252,0.000095804855],"domain_scores_gemma":[0.98176986,0.01344264,0.0025954067,0.0002646315,0.001702184,0.0002252881],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.010037901,0.0008661988,0.0033969467,0.0022714497,0.00026236987,0.0013633403,0.0014826774,0.0021454552,0.0032963317],"category_scores_gemma":[0.016511273,0.00040215542,0.0018110626,0.0023728183,0.00057106116,0.0013004637,0.00070992776,0.0016582949,0.00081521296],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00052902394,0.000057641704,0.0002482367,0.110184394,0.0006756367,0.00011545368,0.0000788431,0.0002499917,0.0006006547,0.0017087609,0.008468993,0.8770824],"study_design_scores_gemma":[0.0011585071,0.0022678,0.005493797,0.21244249,0.0066370238,0.00202034,0.0003331597,0.00045085727,0.0015727299,0.0044762455,0.76305515,0.000091822294],"about_ca_topic_score_codex":0.0007346639,"about_ca_topic_score_gemma":0.0015963811,"teacher_disagreement_score":0.010037901,"about_ca_system_score_codex":0.0010839676,"about_ca_system_score_gemma":0.0033381553,"threshold_uncertainty_score":0.053086102},"labels":[],"label_agreement":null},{"id":"W3006299716","doi":"10.1111/jvh.13272","title":"Serum hepatitis B virus RNA predicts response to peginterferon treatment in HBeAg‐positive chronic hepatitis B","year":2020,"lang":"en","type":"article","venue":"Journal of Viral Hepatitis","topic":"Hepatitis B Virus Studies","field":"Medicine","cited_by":29,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University Health Network","funders":"Virgo Consortium; F. Hoffmann-La Roche; Gilead Sciences; Foundation for Liver Research; Bristol-Myers Squibb","keywords":"Medicine; HBeAg; Lamivudine; Discontinuation; Gastroenterology; Internal medicine; cccDNA; Hepatitis B virus; Hepatitis B; Chronic hepatitis; Peginterferon alfa-2a; Immunology; Virology; Virus; HBsAg; Ribavirin","score_opus":0.020355493614961282,"score_gpt":0.2869564212684183,"score_spread":0.266600927653457,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3006299716","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9996277,0.00015827698,0.00009790708,0.000020865631,0.0000037076857,0.0000036814822,0.000031170926,0.0000022127826,0.000054428943],"genre_scores_gemma":[0.9996873,0.000041153377,0.000097216216,0.000010531702,0.0000075244434,0.0000041318876,0.00009804673,8.5913683e-7,0.00005321317],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99938595,0.00036730425,0.00004748524,0.00008107865,0.00006485748,0.000053303265],"domain_scores_gemma":[0.9979213,0.0011398476,0.0005484569,0.00010129441,0.0001044401,0.00018471458],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0019099095,0.00042137603,0.0005655656,0.00033144068,0.00016807707,0.0004919228,0.00025607602,0.00046456454,0.0006866421],"category_scores_gemma":[0.0040677707,0.00032766175,0.00061733276,0.00026900324,0.0002709869,0.00027905338,0.00023119983,0.0007565597,0.00014562202],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004452715,0.00019946741,0.9868264,0.000017879163,0.00019761677,0.000030321906,0.000037059453,0.00073912827,0.00094827515,0.00001205646,0.000086831176,0.0064523215],"study_design_scores_gemma":[0.00045663037,0.0024291235,0.9815217,0.000014429145,0.00026238913,0.00015672811,0.00007505188,0.014153482,0.00059835525,0.00009428458,0.00022756642,0.00001021945],"about_ca_topic_score_codex":0.00096724863,"about_ca_topic_score_gemma":0.0012205406,"teacher_disagreement_score":0.0019099095,"about_ca_system_score_codex":0.00021351915,"about_ca_system_score_gemma":0.0002328091,"threshold_uncertainty_score":0.010100722},"labels":[],"label_agreement":null},{"id":"W3010758680","doi":"10.1111/jvh.13295","title":"The impact of SVR from direct‐acting antiviral‐ and interferon‐based treatments for HCV on hepatocellular carcinoma risk","year":2020,"lang":"en","type":"article","venue":"Journal of Viral Hepatitis","topic":"Hepatitis C virus research","field":"Medicine","cited_by":52,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Toronto General Hospital; University of Toronto; BC Centre for Disease Control; University of British Columbia","funders":"Institute of Infection and Immunity; Canadian Institutes of Health Research","keywords":"Medicine; Hepatocellular carcinoma; Internal medicine; Incidence (geometry); Gastroenterology; Interferon; Hepatitis C; Cohort; Hazard ratio; Population; Hepatitis C virus; Oncology; Immunology; Confidence interval; Virus","score_opus":0.04240718566342806,"score_gpt":0.3364812395723933,"score_spread":0.29407405390896524,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3010758680","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9970203,0.0007473156,0.000117782925,0.00029879343,0.000007478214,0.000010585107,0.0011685813,0.000007912803,0.00062129926],"genre_scores_gemma":[0.99894994,0.00014370302,0.000074389005,0.000041669115,0.000007839272,0.000003879241,0.00057880295,0.0000031739805,0.0001966142],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99825066,0.0007064335,0.000085702726,0.00023979967,0.00038043613,0.0003369391],"domain_scores_gemma":[0.9943001,0.0020011906,0.0015151398,0.00043088556,0.00063861196,0.0011140034],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002926448,0.00026067038,0.0003879672,0.00034642234,0.0003163395,0.0007307596,0.00053928245,0.0003331517,0.0009258576],"category_scores_gemma":[0.009932094,0.00021676632,0.001027201,0.00051038415,0.0003610491,0.0003352932,0.00054434687,0.00083274534,0.00014185635],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000683215,0.000044347988,0.99466527,0.000016249047,0.00032359172,0.000027852144,0.000038087557,0.0003579464,0.000104469196,0.000050520994,0.00016876038,0.00351979],"study_design_scores_gemma":[0.00002095874,0.00014744732,0.9982936,0.0000068417276,0.00015339145,0.000048138052,0.00004642398,0.0009848768,0.000058905265,0.000038658953,0.00019602962,0.000004753166],"about_ca_topic_score_codex":0.24879606,"about_ca_topic_score_gemma":0.30855706,"teacher_disagreement_score":0.24879606,"about_ca_system_score_codex":0.0031327398,"about_ca_system_score_gemma":0.0032659743,"threshold_uncertainty_score":0.49469578},"labels":[],"label_agreement":null},{"id":"W3010933403","doi":"10.1111/jvh.13294","title":"Measuring hepatitis C virus elimination as a public health threat: Beyond global targets","year":2020,"lang":"en","type":"article","venue":"Journal of Viral Hepatitis","topic":"Hepatitis C virus research","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Infection and Immunity","funders":"Gilead Sciences; Bristol-Myers Squibb","keywords":"Hepatitis C; Incidence (geometry); Hepatitis C virus; Medicine; Public health; Environmental health; Baseline (sea); Global health; Virology; Political science; Virus; Pathology","score_opus":0.08677338192503313,"score_gpt":0.3447218099450807,"score_spread":0.2579484280200476,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3010933403","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00029643092,0.097461104,0.0016298533,0.8196329,0.07788483,0.00004703053,0.00016775145,0.000044010696,0.002836201],"genre_scores_gemma":[0.007822283,0.11149425,0.0028897945,0.72952455,0.14399967,0.00014270854,0.00015925603,0.00007353667,0.0038939335],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.98106533,0.010427994,0.0019803995,0.0015813677,0.0043008155,0.0006441552],"domain_scores_gemma":[0.9203307,0.05550412,0.0028385764,0.0010620002,0.018738084,0.0015265605],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.022409594,0.0011633986,0.0017093038,0.0018506037,0.0020761755,0.004751365,0.003487114,0.015224239,0.0025719714],"category_scores_gemma":[0.07341091,0.00046689858,0.0020000127,0.0017924792,0.007243053,0.0061454526,0.0023661386,0.020691322,0.0014131643],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007708621,0.000025464737,0.0008732284,0.0025935716,0.00009573171,0.0002163126,0.0010060896,0.00041713542,0.00027789053,0.028628692,0.9121206,0.05366822],"study_design_scores_gemma":[0.0000435276,0.00008757443,0.0014670426,0.0054004416,0.000100227684,0.00030523978,0.00086056656,0.00048663205,0.00025960637,0.032176152,0.9587227,0.00009027113],"about_ca_topic_score_codex":0.018378148,"about_ca_topic_score_gemma":0.031473506,"teacher_disagreement_score":0.022409594,"about_ca_system_score_codex":0.005702102,"about_ca_system_score_gemma":0.01154696,"threshold_uncertainty_score":0.11851466},"labels":[],"label_agreement":null},{"id":"W3012226782","doi":"10.1111/jvh.13292","title":"New hepatitis C diagnoses in Ontario, Canada are associated with the local prescription patterns of a controlled‐release opioid","year":2020,"lang":"en","type":"article","venue":"Journal of Viral Hepatitis","topic":"Opioid Use Disorder Treatment","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Ottawa; London Health Sciences Centre; Western University","funders":"","keywords":"Hydromorphone; Medicine; Incidence (geometry); Medical prescription; Hepatitis C; Opioid; Oxycodone; Internal medicine; Rate ratio; Methadone; Population; Hepatitis C virus; Poisson regression; Emergency medicine; Anesthesia; Pharmacology; Virology; Environmental health; Virus","score_opus":0.008500649430252328,"score_gpt":0.2102716070525585,"score_spread":0.20177095762230618,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3012226782","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98559827,0.0016856467,0.0002088729,0.0007525497,0.00002305131,0.00008358012,0.007577316,0.00004168432,0.0040290575],"genre_scores_gemma":[0.9955206,0.0010346636,0.00023811747,0.00010845566,0.000009759343,0.000018286923,0.001606687,0.000007906651,0.0014555226],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99925643,0.00003523275,0.00005876868,0.00010934128,0.00033837816,0.0002018222],"domain_scores_gemma":[0.9966556,0.00015966078,0.0012536801,0.000094462186,0.001228862,0.0006077512],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00042262048,0.00031645832,0.00031586058,0.0017671755,0.0022383598,0.00096546655,0.00093861803,0.00027423183,0.0027070234],"category_scores_gemma":[0.0024842622,0.00043497182,0.00062472,0.0043669986,0.0006947162,0.00038615728,0.00090303674,0.0004550599,0.00019193116],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000032507203,0.000011551152,0.9957694,0.000042953074,0.000030874446,0.00008110669,0.000381065,0.000078991485,0.000107055836,0.00004320384,0.0009205386,0.0025008102],"study_design_scores_gemma":[0.000003881689,0.000008032821,0.9984371,0.00002585665,0.000018011473,0.000058249694,0.0005544349,0.0001895935,0.000033050288,0.000014949363,0.0006506275,0.000006223471],"about_ca_topic_score_codex":0.9966581,"about_ca_topic_score_gemma":0.9983115,"teacher_disagreement_score":0.030659994,"about_ca_system_score_codex":0.030659994,"about_ca_system_score_gemma":0.043265656,"threshold_uncertainty_score":0.2224549},"labels":[],"label_agreement":null},{"id":"W3014424706","doi":"10.1111/jvh.13297","title":"High incidence of Hepatitis C virus infection observed in the PROUD study of HIV pre‐exposure prophylaxis","year":2020,"lang":"en","type":"article","venue":"Journal of Viral Hepatitis","topic":"HIV/AIDS Research and Interventions","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Medical Research Council","keywords":"Medicine; Men who have sex with men; Pre-exposure prophylaxis; Incidence (geometry); Hepatitis C; Sexual health clinic; Transmission (telecommunications); Cohort; Human immunodeficiency virus (HIV); Sexual transmission; Demography; Internal medicine; Virology","score_opus":0.03282720399102692,"score_gpt":0.31268522179301655,"score_spread":0.27985801780198966,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3014424706","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9907962,0.004060836,0.00037023818,0.00040015593,0.00010130614,0.00037403253,0.0009305777,0.000013649149,0.0029530479],"genre_scores_gemma":[0.9976108,0.0006049392,0.00021384796,0.0003150294,0.00012044411,0.0001816362,0.00042982338,0.0000069248754,0.0005166649],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9947188,0.0032922574,0.00032274713,0.0006904699,0.0006228481,0.0003528301],"domain_scores_gemma":[0.9955798,0.0010180948,0.0017322365,0.00052606623,0.00035566377,0.0007880795],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0046770032,0.00061980996,0.001103519,0.0010632388,0.0016958332,0.0024181423,0.0007628971,0.0012115851,0.0020519823],"category_scores_gemma":[0.0075066504,0.0011441496,0.000629147,0.001240608,0.0009320395,0.0015195422,0.001403022,0.0019075124,0.00029781446],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009796455,0.0009961223,0.97971374,0.00024909727,0.0008896024,0.00031040655,0.00084924226,0.000052933145,0.0006661204,0.0004064337,0.001121574,0.004948341],"study_design_scores_gemma":[0.0018177358,0.0047271037,0.98569995,0.00014518268,0.0005251896,0.0014215502,0.00095872075,0.0003193238,0.00019860933,0.0005098148,0.0036158583,0.00006104254],"about_ca_topic_score_codex":0.0025026726,"about_ca_topic_score_gemma":0.0026891362,"teacher_disagreement_score":0.0046770032,"about_ca_system_score_codex":0.00031730847,"about_ca_system_score_gemma":0.000455115,"threshold_uncertainty_score":0.024734616},"labels":[],"label_agreement":null},{"id":"W3081171819","doi":"10.1111/jvh.13373","title":"Estimating chronic hepatitis C prevalence in British Columbia and Ontario, Canada, using population‐based cohort studies","year":2020,"lang":"en","type":"article","venue":"Journal of Viral Hepatitis","topic":"Hepatitis C virus research","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"BC Centre for Disease Control; University of British Columbia; Public Health Ontario; University of Guelph; University Health Network; University of Toronto; University of Waterloo","funders":"Canadian Liver Foundation","keywords":"Medicine; Cohort; Population; Retrospective cohort study; Hepatitis C; Natural history; Cohort study; Demography; Disease burden; Subclinical infection; Hepatitis C virus; Environmental health; Internal medicine; Immunology; Virus","score_opus":0.035962498560340735,"score_gpt":0.3156574725540833,"score_spread":0.27969497399374255,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3081171819","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96877456,0.0034704278,0.0022351202,0.0008262417,0.00005479571,0.000318973,0.019832633,0.0000732861,0.004414115],"genre_scores_gemma":[0.9846466,0.0020898508,0.0031166007,0.00029525434,0.000017801634,0.00019820002,0.007430549,0.00002033495,0.0021849377],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986798,0.00019594359,0.00012508126,0.0002682444,0.0004658651,0.00026499716],"domain_scores_gemma":[0.99533623,0.0003302341,0.0007642428,0.0002845767,0.0027169227,0.00056784705],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0020641123,0.00065646577,0.0005886744,0.0030618238,0.0033206928,0.0017619603,0.0017571261,0.0004668685,0.0009781981],"category_scores_gemma":[0.0055459314,0.0007531149,0.0009320954,0.005905739,0.00070858444,0.00044125313,0.0010388646,0.00050737243,0.0002045863],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008482933,0.00003162446,0.98698694,0.0001044213,0.00028963538,0.00009404125,0.0005032015,0.0013755753,0.00018721199,0.00022463704,0.0030302987,0.007087588],"study_design_scores_gemma":[0.000031461313,0.000019490482,0.9927279,0.00009158685,0.00016488353,0.00005981455,0.0007816178,0.0026810141,0.00007636854,0.0000743496,0.003270506,0.000021010223],"about_ca_topic_score_codex":0.998818,"about_ca_topic_score_gemma":0.9991228,"teacher_disagreement_score":0.043003224,"about_ca_system_score_codex":0.043003224,"about_ca_system_score_gemma":0.051625084,"threshold_uncertainty_score":0.31201166},"labels":[],"label_agreement":null},{"id":"W3081354703","doi":"10.1111/jvh.13378","title":"Life after hepatitis C cure in HIV‐infected people who inject drugs and men who have sex with men treated with direct‐acting antivirals in France: Health perceptions and experiences from qualitative and quantitative findings (ANRS CO13 HEPAVIH)","year":2020,"lang":"en","type":"article","venue":"Journal of Viral Hepatitis","topic":"Hepatitis C virus research","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"British Columbia Centre on Substance Use; University of British Columbia","funders":"Sidaction; National Institute on Drug Abuse; Schering-Plough; Roche","keywords":"Men who have sex with men; Medicine; Hepatitis C; Qualitative research; Human immunodeficiency virus (HIV); Quality of life (healthcare); Cohort; Gerontology; Family medicine; Internal medicine; Nursing","score_opus":0.02136681035605176,"score_gpt":0.34295642243666447,"score_spread":0.3215896120806127,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3081354703","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99755126,0.00058601215,0.00015133181,0.0005049298,0.000014597188,0.000029037921,0.0001538641,0.0000036900328,0.0010053597],"genre_scores_gemma":[0.9984675,0.00045344964,0.0001358808,0.00021482873,0.000008994642,0.000059916976,0.00009121283,0.0000031766224,0.00056490226],"study_design_codex":"qualitative","study_design_gemma":"observational","domain_scores_codex":[0.99772996,0.0016114718,0.00006209442,0.00009985493,0.00016216174,0.00033453162],"domain_scores_gemma":[0.9978847,0.0011849002,0.00033372373,0.000040925843,0.00023288741,0.0003228881],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0031329305,0.00034982708,0.0003254923,0.0011433859,0.0025791493,0.00220679,0.00042799828,0.0007618825,0.0011373466],"category_scores_gemma":[0.0030100986,0.00025680216,0.000455592,0.00084253517,0.0018280745,0.0013256636,0.0016696403,0.00080686976,0.000115654584],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006913848,0.00006996413,0.0565848,0.00017749025,0.000023173421,0.0008554451,0.931349,0.00007234519,0.0010616459,0.0004086917,0.0005908758,0.008737401],"study_design_scores_gemma":[0.000005012951,0.00016252273,0.09022541,0.00018612917,0.0000090596395,0.00036856934,0.9034745,0.000075591626,0.0002419195,0.000067777924,0.005160627,0.000022853083],"about_ca_topic_score_codex":0.057992477,"about_ca_topic_score_gemma":0.060299493,"teacher_disagreement_score":0.057992477,"about_ca_system_score_codex":0.0042727115,"about_ca_system_score_gemma":0.0021341608,"threshold_uncertainty_score":0.115309894},"labels":[],"label_agreement":null},{"id":"W3084259013","doi":"10.1111/jvh.13401","title":"Maintained virological suppression and renal function with reduced dose tenofovir disoproxil fumarate in renally impaired chronic hepatitis B patients","year":2020,"lang":"en","type":"article","venue":"Journal of Viral Hepatitis","topic":"Hepatitis B Virus Studies","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre; University of Toronto; University Health Network; Centre for Global Health Research; Toronto General Hospital; Health Sciences Centre","funders":"","keywords":"Medicine; Renal function; Tenofovir; Urology; Internal medicine; Kidney disease; Dialysis; Kidney; Gastroenterology; Pharmacology; Human immunodeficiency virus (HIV); Immunology","score_opus":0.0127172482292829,"score_gpt":0.24093377155432524,"score_spread":0.22821652332504233,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3084259013","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.999752,0.000080513084,0.000022403416,0.000010830031,0.000001899808,0.0000029470973,0.00005262692,0.0000012781179,0.00007539386],"genre_scores_gemma":[0.9998017,0.000022738433,0.00002805121,0.000013854451,0.000003758956,0.0000023824934,0.00008100802,4.9403826e-7,0.000046011723],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99965024,0.000093790644,0.00003398732,0.0000739999,0.000059121267,0.000088853245],"domain_scores_gemma":[0.99897516,0.00017959527,0.00033782513,0.00007310581,0.00012327767,0.00031103246],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005457558,0.00025700594,0.00041863046,0.00038476993,0.0005481296,0.00059789495,0.0001883474,0.00037248532,0.0008130663],"category_scores_gemma":[0.0019252864,0.00024874657,0.00039170537,0.00038337088,0.00021481543,0.00045962803,0.00024501624,0.0005386054,0.0001491664],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010504294,0.00017106612,0.995404,0.000007958276,0.00003353142,0.00015411338,0.00011232718,0.000042786563,0.0010424,0.000008417527,0.000052159085,0.0019206041],"study_design_scores_gemma":[0.00007290218,0.0018901417,0.9964624,0.000006944188,0.000038322665,0.0006592346,0.00013137593,0.0002968606,0.00024222404,0.000014794571,0.00017847524,0.0000064073356],"about_ca_topic_score_codex":0.0033226712,"about_ca_topic_score_gemma":0.0027203553,"teacher_disagreement_score":0.0033226712,"about_ca_system_score_codex":0.0003291775,"about_ca_system_score_gemma":0.00026556102,"threshold_uncertainty_score":0.0066066384},"labels":[],"label_agreement":null},{"id":"W3088941285","doi":"10.1111/jvh.13412","title":"The case for simplifying and using absolute targets for viral hepatitis elimination goals","year":2020,"lang":"en","type":"article","venue":"Journal of Viral Hepatitis","topic":"Hepatitis B Virus Studies","field":"Medicine","cited_by":46,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Shengjing Hospital; College of Medicine, King Saud University; Yonsei University College of Medicine; Weill Cornell Medical College; Sorbonne Université; Alfaisal University; King Abdullah International Medical Research Center; Kaohsiung Medical University Chung-Ho Memorial Hospital; Humanitas University; Qassim University; School of Medicine, Stanford University; Institut National de la Santé et de la Recherche Médicale; National Taiwan University; Academia Sinica; Universidade Estadual de Campinas; Universidad de Cantabria; Universitat de Barcelona; Göteborgs Universitet; Hamad Medical Corporation; Università di Pisa; Universidade Federal de Goiás; National Yang-Ming University; National Taiwan University Hospital; Chinese University of Hong Kong; Kaohsiung Medical University; Wayne State University; Queen Mary University of London; I-Shou University; Fundació Institut de Recerca Hospital Universitari Vall d’Hebron; University of Hong Kong; Macquarie University; University of Toronto; Sultan Qaboos University; Örebro Universitet; Trimbos-instituut; Cairo University; Odense Universitetshospital; Northwestern University; Instituto de Higiene e Medicina Tropical, Universidade Nova de Lisboa; Yonsei University; Burnet Institute; Weill Cornell Medicine - Qatar; Feinberg School of Medicine; Ain Shams University; Theodor Bilharz Research Institute; Johns Hopkins University; Università degli Studi di Palermo; National Center for Global Health and Medicine; Università degli Studi di Milano; King Faisal Specialist Hospital and Research Centre; Universidad del Rosario; China Medical University; Universidade Nova de Lisboa; University of Dundee; University College London; Saint Louis University; Istituto Superiore di Sanità; University of Ottawa; National and Kapodistrian University of Athens; Hallym University; King Saud University","keywords":"Absolute (philosophy); Viral hepatitis; Virology; Computer science; Medicine; Philosophy","score_opus":0.04923049613192292,"score_gpt":0.33216916521148987,"score_spread":0.28293866907956694,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3088941285","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00068085716,0.00629814,0.005426101,0.9679615,0.009321079,0.000066596636,0.00010538551,0.00021649826,0.009923927],"genre_scores_gemma":[0.024893405,0.0048275744,0.036648374,0.92195827,0.0053187325,0.00039985907,0.00021465051,0.0004002335,0.0053388313],"study_design_codex":"not_applicable","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.87116647,0.06679369,0.0110573685,0.010060943,0.032238014,0.008683644],"domain_scores_gemma":[0.7581848,0.12202751,0.014465872,0.02433935,0.057154357,0.023828166],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.15692224,0.0020111918,0.002309774,0.0031804556,0.005840055,0.017261112,0.00795861,0.032338474,0.011590771],"category_scores_gemma":[0.22601259,0.0013463405,0.0032466252,0.0025625778,0.022273201,0.04043578,0.013290823,0.067888364,0.0054153665],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009249315,0.00024099572,0.0020022623,0.0011276336,0.000107481756,0.0003437855,0.0031997813,0.00079602527,0.0005928276,0.19750345,0.7159093,0.07808394],"study_design_scores_gemma":[0.00009573948,0.00015548708,0.0017527601,0.0032659168,0.000106943015,0.0003336821,0.0026795294,0.0008491214,0.0006696061,0.13419786,0.855665,0.00022828284],"about_ca_topic_score_codex":0.017299008,"about_ca_topic_score_gemma":0.015452405,"teacher_disagreement_score":0.15692224,"about_ca_system_score_codex":0.01074857,"about_ca_system_score_gemma":0.047864005,"threshold_uncertainty_score":0.829894},"labels":[],"label_agreement":null},{"id":"W3092819238","doi":"10.1111/jvh.13419","title":"Cost‐effectiveness analysis of sofosbuvir and velpatasvir in chronic hepatitis C patients with decompensated cirrhosis","year":2020,"lang":"en","type":"article","venue":"Journal of Viral Hepatitis","topic":"Hepatitis C virus research","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; University of Toronto; University of Waterloo","funders":"Canadian Institutes of Health Research","keywords":"Cirrhosis; Medicine; Sofosbuvir; Chronic hepatitis; Internal medicine; Gastroenterology; Intensive care medicine; Virology; Ribavirin; Virus","score_opus":0.03347749955496587,"score_gpt":0.32914820685684276,"score_spread":0.2956707073018769,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3092819238","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9730334,0.006266336,0.011163231,0.0013543188,0.00007906835,0.000574869,0.0016100612,0.00006520617,0.0058534723],"genre_scores_gemma":[0.99753356,0.00045741783,0.0011260802,0.00006321097,0.000011221554,0.000086320004,0.0003389064,0.0000037559835,0.0003794044],"study_design_codex":"simulation_or_modeling","study_design_gemma":"not_applicable","domain_scores_codex":[0.99852186,0.0010383631,0.00005254623,0.00008416996,0.00012035698,0.00018279304],"domain_scores_gemma":[0.99648654,0.0028426903,0.00025367062,0.000050944687,0.00014984675,0.00021643595],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0036805803,0.0010795168,0.0014274102,0.0013171523,0.00027324137,0.0014567953,0.00096454157,0.0011050227,0.0038389843],"category_scores_gemma":[0.007314426,0.00058398076,0.0034318552,0.0007603959,0.00042212583,0.0009148691,0.0008157258,0.0010523219,0.00014511871],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0098496005,0.0007106827,0.014685487,0.00071079895,0.0021499076,0.00051685545,0.000051500763,0.9485893,0.000514865,0.0034736837,0.0007866079,0.01796066],"study_design_scores_gemma":[0.002079981,0.004452194,0.01418528,0.00032025028,0.0029346214,0.0003605856,0.00016767204,0.9701728,0.00047970656,0.003718997,0.0010655618,0.000062310406],"about_ca_topic_score_codex":0.010301754,"about_ca_topic_score_gemma":0.005530219,"teacher_disagreement_score":0.010301754,"about_ca_system_score_codex":0.0047850017,"about_ca_system_score_gemma":0.0027250112,"threshold_uncertainty_score":0.0347178},"labels":[],"label_agreement":null},{"id":"W3094920525","doi":"10.1111/jvh.13429","title":"HIV influences clustering and intracellular replication of hepatitis C virus","year":2020,"lang":"en","type":"article","venue":"Journal of Viral Hepatitis","topic":"Hepatitis C virus research","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Institute of Allergy and Infectious Diseases; National Institutes of Health; NIH Office of the Director; National Institute on Drug Abuse; Danone Institute of Canada","keywords":"Coinfection; Hepatitis C virus; RNA; Intracellular; Virology; Biology; Hepacivirus; Hepatitis C; Human immunodeficiency virus (HIV); Immunology; Virus; Genetics; Gene","score_opus":0.034759943952570746,"score_gpt":0.3173842233898246,"score_spread":0.2826242794372538,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3094920525","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9951692,0.00050461484,0.0029868174,0.0000735236,0.0000065894783,0.000013702281,0.00008287872,0.000020733856,0.0011418046],"genre_scores_gemma":[0.99905723,0.000075308926,0.0006457426,0.0000100875295,0.0000023932487,0.0000040439354,0.000033056313,0.0000028569614,0.00016921562],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9997563,0.000081063234,0.000010687725,0.000052462936,0.000044892677,0.00005458743],"domain_scores_gemma":[0.9993044,0.0003210078,0.00017254068,0.00005043829,0.00009530863,0.000056318608],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00029616908,0.00015335182,0.00024312273,0.00042040547,0.00032071353,0.00075509795,0.00017594897,0.00031192304,0.001000148],"category_scores_gemma":[0.001770689,0.00022393651,0.0002704575,0.0002883699,0.00027045672,0.000281703,0.00032843612,0.0001953183,0.00017552033],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014520389,0.00029150935,0.4137931,0.00033359873,0.00044334994,0.0008790526,0.00071585504,0.08360085,0.44706678,0.0068099746,0.0013495927,0.04326427],"study_design_scores_gemma":[0.00005457198,0.00053020753,0.53857464,0.000069690606,0.00022745742,0.0010369862,0.0010365453,0.38446957,0.06607475,0.005536359,0.002290432,0.000098805125],"about_ca_topic_score_codex":0.00837917,"about_ca_topic_score_gemma":0.004942582,"teacher_disagreement_score":0.00837917,"about_ca_system_score_codex":0.0007284835,"about_ca_system_score_gemma":0.00029829328,"threshold_uncertainty_score":0.01666075},"labels":[],"label_agreement":null},{"id":"W3096397297","doi":"10.1111/jvh.13434","title":"Association of hepatitis C infection and risk of kidney cancer: A systematic review and meta‐analysis of observational studies","year":2020,"lang":"en","type":"review","venue":"Journal of Viral Hepatitis","topic":"Hepatitis C virus research","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Natural Science Foundation of Guangdong Province; National Natural Science Foundation of China","keywords":"Medicine; Meta-analysis; Internal medicine; Odds ratio; Observational study; Confidence interval; Publication bias; Cohort study; Kidney cancer; Hepatitis C; Hepatitis C virus; Cancer; Oncology; Immunology; Virus","score_opus":0.15077468811208952,"score_gpt":0.4380203041096482,"score_spread":0.2872456159975587,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3096397297","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.005651066,0.99280715,0.00044167528,0.00015595305,0.00012077546,0.00022694195,0.0004531659,0.000014643526,0.00012865041],"genre_scores_gemma":[0.15843989,0.8365433,0.0023508254,0.0005216302,0.00023637936,0.0009052351,0.0008006267,0.00001868664,0.00018345744],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9911175,0.0040952857,0.0027606636,0.00075448025,0.0010110071,0.00026109323],"domain_scores_gemma":[0.97875434,0.0151332775,0.0035231924,0.000577397,0.0017960948,0.00021565113],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.013000719,0.0021376386,0.016096001,0.007400821,0.0006365424,0.002823661,0.0016415603,0.0016610799,0.002269393],"category_scores_gemma":[0.029699147,0.0013137751,0.027752783,0.010049109,0.0005876329,0.0012452798,0.0011703199,0.0016014536,0.00018060034],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010613197,0.000028130607,0.008683711,0.4184693,0.56095386,0.00015813082,0.0000801076,0.00055614876,0.00021947539,0.000106361316,0.0005424569,0.009140963],"study_design_scores_gemma":[0.0002484307,0.00014837022,0.0072318837,0.028875416,0.9616318,0.00013030991,0.000051016275,0.00025568248,0.00013144358,0.00016020691,0.00111084,0.000024594474],"about_ca_topic_score_codex":0.006080824,"about_ca_topic_score_gemma":0.013298793,"teacher_disagreement_score":0.016096001,"about_ca_system_score_codex":0.0021695243,"about_ca_system_score_gemma":0.0034523013,"threshold_uncertainty_score":0.06875515},"labels":[],"label_agreement":null},{"id":"W3113135622","doi":"10.1111/jvh.13453","title":"Distinct Hepatitis B and HIV co‐infected populations in Canada","year":2020,"lang":"en","type":"article","venue":"Journal of Viral Hepatitis","topic":"Hepatitis B Virus Studies","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of British Columbia; Canadian Science Centre for Human and Animal Health; University of Manitoba; Vancouver Infectious Diseases Centre; Saskatchewan Science Centre; University of Saskatchewan; University of Alberta; University of Calgary; Dalhousie University; University of Toronto; McGill University; University of Ottawa","funders":"","keywords":"Medicine; Internal medicine; Cohort; Hepatitis B; Hepatitis B virus; Hepatocellular carcinoma; Cirrhosis; Human immunodeficiency virus (HIV); Population; Immunology; Environmental health; Virus","score_opus":0.032040168792296535,"score_gpt":0.2841499652360542,"score_spread":0.25210979644375764,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3113135622","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99012274,0.0019714576,0.00012401982,0.0005768656,0.000025770085,0.00007559967,0.0025186078,0.000012236056,0.0045727845],"genre_scores_gemma":[0.9970186,0.0011686201,0.00012905427,0.00017779996,0.0000072478997,0.000015149763,0.0007269439,0.0000031338827,0.0007534938],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9993771,0.000035473702,0.000030848318,0.000090125475,0.00018499585,0.0002814661],"domain_scores_gemma":[0.9993766,0.000027303042,0.00010653718,0.000014772494,0.00020826925,0.00026654915],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00030159383,0.0002844249,0.00037878682,0.001140513,0.0039073653,0.0011661174,0.00064686907,0.00033309867,0.00303919],"category_scores_gemma":[0.0009870031,0.0002678674,0.0004012834,0.003367547,0.00059685647,0.0003406709,0.00097623037,0.0005404235,0.000186485],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001346686,0.000045892197,0.9851665,0.00007729348,0.000060558574,0.00047091252,0.0012001342,0.000118155476,0.00041577045,0.00043289195,0.0015610729,0.010316212],"study_design_scores_gemma":[0.000014693618,0.000039452767,0.9942339,0.00006848835,0.00004032259,0.00041559324,0.0029243873,0.00026553156,0.00006656084,0.000095978954,0.0018181326,0.00001692377],"about_ca_topic_score_codex":0.99335843,"about_ca_topic_score_gemma":0.9948767,"teacher_disagreement_score":0.017186435,"about_ca_system_score_codex":0.017186435,"about_ca_system_score_gemma":0.03446502,"threshold_uncertainty_score":0.12469691},"labels":[],"label_agreement":null},{"id":"W3115353623","doi":"10.1111/jvh.13460","title":"Improvement in cognitive impairment following a 12‐week aerobic exercise intervention in individuals with non‐cirrhotic chronic hepatitis C","year":2020,"lang":"en","type":"article","venue":"Journal of Viral Hepatitis","topic":"Liver Disease Diagnosis and Treatment","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Toronto Rehabilitation Institute; University of Toronto","funders":"","keywords":"Cardiorespiratory fitness; Aerobic exercise; Medicine; Physical therapy; Montreal Cognitive Assessment; Cognition; Quality of life (healthcare); Depression (economics); Anthropometry; Internal medicine; Cognitive impairment; Psychiatry","score_opus":0.01351760131970038,"score_gpt":0.2672399341006473,"score_spread":0.2537223327809469,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3115353623","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9995338,0.000113279275,0.000024183777,0.00001957351,0.000008804644,0.0000725347,0.000033269,0.000004832412,0.00018975972],"genre_scores_gemma":[0.99931526,0.000097280914,0.00010669352,0.000035683024,0.000014978987,0.0001245359,0.00007756163,6.146763e-7,0.00022730611],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9998111,0.00006289795,0.000017980583,0.000024700325,0.000023069388,0.000060213533],"domain_scores_gemma":[0.9996673,0.000052410862,0.00006812211,0.000015265556,0.00003835287,0.00015845044],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005002748,0.0005123143,0.00082164776,0.00032135812,0.00039518962,0.00023744366,0.00018107539,0.00034852352,0.0012097774],"category_scores_gemma":[0.0008129033,0.00017383843,0.0005033603,0.00025867933,0.0001656948,0.00014043378,0.00031660288,0.0003919605,0.00014546963],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.28612584,0.16116856,0.27331138,0.0017374544,0.0021373408,0.0004571006,0.0015644607,0.0017354232,0.022338273,0.000059176207,0.0018608036,0.24750428],"study_design_scores_gemma":[0.008964339,0.10684914,0.88173777,0.000045904064,0.00025412926,0.00004728553,0.00017652899,0.00066894945,0.0008884451,0.000023023973,0.00032647495,0.000018150033],"about_ca_topic_score_codex":0.003736093,"about_ca_topic_score_gemma":0.0059589697,"teacher_disagreement_score":0.003736093,"about_ca_system_score_codex":0.00026301004,"about_ca_system_score_gemma":0.00040352537,"threshold_uncertainty_score":0.007428646},"labels":[],"label_agreement":null},{"id":"W3119993225","doi":"10.1111/jvh.13467","title":"Risk factors for difficult‐to‐treat hepatitis C virus genotype 4r in Rwanda and implications for elimination in sub‐Saharan Africa","year":2021,"lang":"en","type":"article","venue":"Journal of Viral Hepatitis","topic":"Hepatitis C virus research","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Medicine; Internal medicine; Sofosbuvir; Hepatitis C virus; Genotype; Cirrhosis; Ledipasvir; Hepatitis C; Odds ratio; Logistic regression; Multivariate analysis; Virology; Virus; Ribavirin; Biology","score_opus":0.033311035798428576,"score_gpt":0.3308294903170017,"score_spread":0.2975184545185731,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3119993225","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99749595,0.0010406428,0.000053122152,0.0006139594,0.000024058822,0.000014337531,0.0001192873,0.0000036192473,0.0006350266],"genre_scores_gemma":[0.99923253,0.00044354307,0.00006333633,0.000060325736,0.000026810694,0.000011701403,0.0000433067,0.0000023055543,0.00011608411],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9992625,0.00041377012,0.00004539358,0.00006917016,0.000056073637,0.00015307161],"domain_scores_gemma":[0.9979937,0.00033681127,0.001277257,0.000059933856,0.00008381377,0.0002485725],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00078335067,0.0003755306,0.00037721463,0.00074303127,0.0005907135,0.00086239167,0.00031718687,0.00039873217,0.00213621],"category_scores_gemma":[0.0042831944,0.000378101,0.00041577607,0.00086785736,0.00053007127,0.0004910275,0.00048962625,0.00081887643,0.00019660697],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000073977055,0.000057018842,0.996727,0.000024358867,0.000035617155,0.00023374915,0.00024807543,0.000023893557,0.00013781156,0.00005497392,0.00029404392,0.0020894462],"study_design_scores_gemma":[0.00001340644,0.000084508654,0.9982381,0.00006416896,0.000039532748,0.00046295335,0.000643045,0.000100864854,0.000026616997,0.00003502748,0.00028595945,0.000005739517],"about_ca_topic_score_codex":0.011022045,"about_ca_topic_score_gemma":0.00944106,"teacher_disagreement_score":0.011022045,"about_ca_system_score_codex":0.00040950265,"about_ca_system_score_gemma":0.00077583705,"threshold_uncertainty_score":0.021915734},"labels":[],"label_agreement":null},{"id":"W3126254847","doi":"10.1111/jvh.13482","title":"Impact of direct‐acting antiviral regimens on mortality and morbidity outcomes in patients with chronic hepatitis c: Systematic review and meta‐analysis","year":2021,"lang":"en","type":"review","venue":"Journal of Viral Hepatitis","topic":"Hepatitis C virus research","field":"Medicine","cited_by":40,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute for Clinical Evaluative Sciences; University of Toronto; Toronto General Hospital; Queen's University; University Health Network","funders":"","keywords":"Medicine; Internal medicine; Meta-analysis; Decompensation; Hazard ratio; Cirrhosis; Gastroenterology; Confidence interval; Hepatocellular carcinoma; Proportional hazards model; Publication bias; Hepatitis C","score_opus":0.08816738161005287,"score_gpt":0.4238348621550416,"score_spread":0.33566748054498874,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3126254847","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0044457633,0.994013,0.00043224482,0.0001501473,0.00012650518,0.00019112612,0.00039412736,0.000019714449,0.00022743025],"genre_scores_gemma":[0.1508405,0.8443306,0.0018748365,0.00072478387,0.00024948615,0.0008387179,0.0007768429,0.000026749254,0.00033740155],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99301815,0.0035796254,0.0018699886,0.0006153614,0.0007094496,0.00020745081],"domain_scores_gemma":[0.98694813,0.009636468,0.0019561315,0.000351959,0.0009493264,0.0001579643],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.011224095,0.0026268098,0.01697704,0.0047518113,0.00046455298,0.0028141849,0.0017692257,0.0019190385,0.002828777],"category_scores_gemma":[0.025601018,0.0014640563,0.03654919,0.005860647,0.00054358,0.0013903454,0.0012081163,0.0017973217,0.0002700759],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014858765,0.000020205829,0.002445514,0.28028268,0.70554614,0.00007646981,0.00004785929,0.00064707507,0.00013563927,0.000095302996,0.00043522843,0.0087819435],"study_design_scores_gemma":[0.0003818475,0.00014247136,0.0023163348,0.016230198,0.97944176,0.000064889064,0.000023172594,0.00018778388,0.000078879246,0.00012465646,0.0009925121,0.000015512867],"about_ca_topic_score_codex":0.007232907,"about_ca_topic_score_gemma":0.013805936,"teacher_disagreement_score":0.01697704,"about_ca_system_score_codex":0.002434433,"about_ca_system_score_gemma":0.0027908431,"threshold_uncertainty_score":0.05935937},"labels":[],"label_agreement":null},{"id":"W3139139960","doi":"10.1111/jvh.13500","title":"Effectiveness and Renal Safety of Tenofovir Alafenamide Fumarate among Chronic Hepatitis B Patients: Real‐World Study","year":2021,"lang":"en","type":"article","venue":"Journal of Viral Hepatitis","topic":"Hepatitis B Virus Studies","field":"Medicine","cited_by":31,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Calgary; McGill University; University of Ottawa; Vancouver Infectious Diseases Centre; Toronto General Hospital; McMaster University; St. Paul's Hospital; University of Toronto; Western University; Regina Qu'Appelle Health Region; University of Alberta; University Health Network","funders":"Gilead Sciences","keywords":"Tenofovir alafenamide; Renal function; Medicine; Internal medicine; Kidney disease; Adverse effect; Tenofovir; Gastroenterology; Hepatitis B; Chronic hepatitis; Creatinine; Urology; Immunology; Viral load; Human immunodeficiency virus (HIV); Antiretroviral therapy","score_opus":0.008905847415190871,"score_gpt":0.27195863191429587,"score_spread":0.263052784499105,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3139139960","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9990452,0.00045167538,0.000045857363,0.000029447709,0.0000037485397,0.00002530222,0.00018450881,0.0000018063215,0.0002126101],"genre_scores_gemma":[0.9995394,0.00011753326,0.000058145077,0.000029926008,0.000013814762,0.000016095584,0.00017731091,6.5349764e-7,0.00004720012],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986009,0.0007965606,0.000098428776,0.00017690418,0.00022178919,0.00010541312],"domain_scores_gemma":[0.9959571,0.0010210042,0.0017628723,0.0002320163,0.00043778494,0.00058930414],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0019887346,0.00028365746,0.00051322486,0.00030637535,0.00042914686,0.000740385,0.00024970394,0.00051660405,0.0010704405],"category_scores_gemma":[0.004516314,0.00017427825,0.0006329954,0.00047888578,0.00043769914,0.0005594813,0.00027056815,0.0004573907,0.00016481914],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.017302496,0.0024349166,0.9636075,0.00023332344,0.0006600471,0.00021059124,0.00031949315,0.00041835025,0.0011986232,0.0000632998,0.00036527752,0.013186108],"study_design_scores_gemma":[0.0022480192,0.023813164,0.96915025,0.000045549903,0.00042716681,0.0007301641,0.0004064797,0.0012506803,0.00068481354,0.000057135047,0.0011426196,0.000043984666],"about_ca_topic_score_codex":0.0026528551,"about_ca_topic_score_gemma":0.0023679424,"teacher_disagreement_score":0.0026528551,"about_ca_system_score_codex":0.0007821151,"about_ca_system_score_gemma":0.00039974262,"threshold_uncertainty_score":0.010517597},"labels":[],"label_agreement":null},{"id":"W3186417867","doi":"10.1111/jvh.13574","title":"Global cascade of care for chronic hepatitis C virus infection: A systematic review and meta‐analysis","year":2021,"lang":"en","type":"review","venue":"Journal of Viral Hepatitis","topic":"Hepatitis C virus research","field":"Medicine","cited_by":49,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Hepatitis C virus; Hepatitis C; Population; Meta-analysis; Health care; Family medicine; Environmental health; Internal medicine; Virus; Immunology; Political science","score_opus":0.0625517778424757,"score_gpt":0.4171279216271097,"score_spread":0.354576143784634,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3186417867","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0059732976,0.99169266,0.00042592656,0.00021782982,0.000116375944,0.00042137204,0.0008173696,0.000027617785,0.0003076352],"genre_scores_gemma":[0.17902328,0.813783,0.0024857824,0.00093697413,0.00020999697,0.0017980221,0.0013591741,0.00002964728,0.00037415663],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9911767,0.0044700587,0.0021723523,0.0009167833,0.0009294576,0.00033467685],"domain_scores_gemma":[0.981914,0.012989848,0.0028191332,0.00054126536,0.0014416601,0.00029412794],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.012399931,0.0020677221,0.015034625,0.005725915,0.00078135903,0.0029499833,0.0017910106,0.0018278272,0.0041833543],"category_scores_gemma":[0.031785384,0.0012575106,0.03405967,0.007260399,0.00057871745,0.0018635826,0.0015566138,0.0020031312,0.00027765534],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00183837,0.000036113466,0.0064007184,0.4573862,0.5182329,0.00012956258,0.00011333287,0.00062525144,0.000117453375,0.0001803498,0.0010782214,0.013861565],"study_design_scores_gemma":[0.0008493305,0.00024436373,0.0057432083,0.043801498,0.9466473,0.000114310555,0.00006969442,0.00023120012,0.00007615589,0.00019384021,0.001999863,0.000029199618],"about_ca_topic_score_codex":0.013187759,"about_ca_topic_score_gemma":0.029249309,"teacher_disagreement_score":0.015034625,"about_ca_system_score_codex":0.0032974852,"about_ca_system_score_gemma":0.005213897,"threshold_uncertainty_score":0.065577865},"labels":[],"label_agreement":null},{"id":"W3192372167","doi":"10.1111/jvh.13591","title":"Hepatitis B e antigen loss in adults and children with chronic hepatitis B living in North America: A prospective cohort study","year":2021,"lang":"en","type":"article","venue":"Journal of Viral Hepatitis","topic":"Hepatitis B Virus Studies","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto General Hospital; Toronto Liver Centre; University of Toronto","funders":"National Center for Advancing Translational Sciences; National Center for Research Resources; National Institute of Diabetes and Digestive and Kidney Diseases","keywords":"HBeAg; Medicine; HBsAg; Cohort; Hepatitis B virus; Hepatitis B; Internal medicine; Gastroenterology; Prospective cohort study; Immunology; Virus","score_opus":0.005400379761502039,"score_gpt":0.24295231565172165,"score_spread":0.2375519358902196,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3192372167","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99852896,0.00021133934,0.000035340116,0.000046496385,0.000007759987,0.000026123307,0.000895452,0.0000023315959,0.0002461189],"genre_scores_gemma":[0.9979067,0.00027085716,0.00009841646,0.00008237052,0.000015090638,0.000049624716,0.0013265029,0.0000031400652,0.0002472713],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9992648,0.00014169268,0.000073841955,0.00025496536,0.00013408286,0.00013063403],"domain_scores_gemma":[0.99846196,0.00015100309,0.00055781787,0.00020325193,0.00021210453,0.00041385996],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009121964,0.0004126272,0.00060848903,0.00064397283,0.0010877759,0.0009848329,0.0005169681,0.00065680995,0.0013605101],"category_scores_gemma":[0.0013724209,0.0007162177,0.0006696768,0.001563246,0.00033910712,0.0008515149,0.0006947099,0.0011726225,0.00033035234],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008733107,0.000045510384,0.9991002,0.000006917043,0.000052868694,0.00007052976,0.0001453126,0.000008434213,0.0000695534,0.0000069771936,0.0001136046,0.00029281902],"study_design_scores_gemma":[0.00001478403,0.00006996644,0.99918455,0.000007959869,0.000028631152,0.00015041216,0.00030718895,0.00003968818,0.000010449998,0.000006009347,0.00017671578,0.0000035552732],"about_ca_topic_score_codex":0.033610214,"about_ca_topic_score_gemma":0.04205719,"teacher_disagreement_score":0.033610214,"about_ca_system_score_codex":0.00066317,"about_ca_system_score_gemma":0.00076809234,"threshold_uncertainty_score":0.066829205},"labels":[],"label_agreement":null},{"id":"W3195949386","doi":"10.1111/jvh.13599","title":"Mean HBsAg decline at week 24 of PEG‐IFN‐based treatment predicts subsequent rate of HBsAg clearance — suggesting a valuable endpoint for early development HBV trials","year":2021,"lang":"en","type":"article","venue":"Journal of Viral Hepatitis","topic":"Hepatitis B Virus Studies","field":"Medicine","cited_by":37,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Toronto Liver Centre; Toronto General Hospital","funders":"Janssen Research and Development","keywords":"HBsAg; Medicine; Internal medicine; HBeAg; Gastroenterology; Hepatitis B virus; Immunology; Virus","score_opus":0.10551527617482388,"score_gpt":0.3395841333538411,"score_spread":0.2340688571790172,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3195949386","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9710504,0.013571843,0.008395549,0.00047637083,0.00009706631,0.00037816213,0.0015478814,0.0000958091,0.0043869205],"genre_scores_gemma":[0.99732685,0.00031927237,0.0010615207,0.00013149354,0.000042284675,0.00012345563,0.00051447796,0.000011964832,0.00046867295],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.98977494,0.007920192,0.000878615,0.0004435979,0.0007477374,0.000235042],"domain_scores_gemma":[0.9538506,0.028294524,0.011458246,0.002981491,0.0020763762,0.001338698],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.02143177,0.00069559197,0.0012377223,0.00077770086,0.00021161845,0.0013881775,0.0004162006,0.0008793066,0.0022578968],"category_scores_gemma":[0.025280196,0.00028837816,0.0012507358,0.00063856214,0.00042117303,0.0013397378,0.0005829542,0.0017179381,0.00063711044],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.09450087,0.0011314078,0.8033013,0.0009901132,0.0027362371,0.00010648751,0.00019539261,0.003221214,0.011025963,0.00049999857,0.0015988902,0.08069216],"study_design_scores_gemma":[0.0020726346,0.03053346,0.9345463,0.0003587408,0.0017033785,0.0006378885,0.00018409546,0.011053436,0.012230237,0.0020558808,0.0045354646,0.00008860458],"about_ca_topic_score_codex":0.0001546713,"about_ca_topic_score_gemma":0.00019095623,"teacher_disagreement_score":0.02143177,"about_ca_system_score_codex":0.00032235967,"about_ca_system_score_gemma":0.00029465219,"threshold_uncertainty_score":0.11334342},"labels":[],"label_agreement":null},{"id":"W3197061720","doi":"10.1111/jvh.13608","title":"Farnesoid X receptor agonist for the treatment of chronic hepatitis B: A safety study","year":2021,"lang":"en","type":"article","venue":"Journal of Viral Hepatitis","topic":"Hepatitis B Virus Studies","field":"Medicine","cited_by":48,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Infection and Immunity","funders":"","keywords":"Farnesoid X receptor; Medicine; Internal medicine; Entecavir; Placebo; HBsAg; Gastroenterology; Agonist; HBeAg; Pegylated interferon; Hepatitis B; Adverse effect; Hepatitis B virus; Viral load; Partial agonist; Pharmacology; Receptor; Lamivudine; Chronic hepatitis; Immunology; Nuclear receptor; Virus; Biology; Ribavirin; Transcription factor; Pathology","score_opus":0.025232566213175496,"score_gpt":0.31024622699669097,"score_spread":0.2850136607835155,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3197061720","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9633532,0.024973154,0.0010660697,0.0010042745,0.0002869077,0.002734006,0.0021114491,0.00009001472,0.004380943],"genre_scores_gemma":[0.9825832,0.009472033,0.0007886961,0.0015580727,0.0006726594,0.0014980695,0.0014491567,0.000014704355,0.0019633828],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.99932575,0.0004091799,0.00005688308,0.00007270532,0.000078455916,0.000057087636],"domain_scores_gemma":[0.9988506,0.0004061603,0.0002608995,0.000078896745,0.000121775025,0.00028161632],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002047404,0.0007063302,0.001510246,0.00027473923,0.0003524791,0.0005694276,0.00040150186,0.0013900719,0.005146027],"category_scores_gemma":[0.0011496772,0.00028088287,0.0013874817,0.00035140896,0.00046974313,0.0005282749,0.00019654361,0.0015729399,0.00058330654],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.831386,0.016932147,0.006756148,0.0031811309,0.0027457566,0.00032322633,0.0001552469,0.00048299102,0.021413978,0.0003304657,0.003099069,0.11319382],"study_design_scores_gemma":[0.7077243,0.26067343,0.020533131,0.0002322369,0.0016123072,0.00037794324,0.000058035752,0.00044804768,0.0023923921,0.00017551724,0.005746696,0.000025876203],"about_ca_topic_score_codex":0.00034719304,"about_ca_topic_score_gemma":0.00071312493,"teacher_disagreement_score":0.005146027,"about_ca_system_score_codex":0.00031281292,"about_ca_system_score_gemma":0.0008078888,"threshold_uncertainty_score":0.017215192},"labels":[],"label_agreement":null},{"id":"W3199012128","doi":"10.1111/jvh.13613","title":"Effects of on‐treatment ALT flares on serum HBsAg and HBV RNA in patients with chronic HBV infection","year":2021,"lang":"en","type":"article","venue":"Journal of Viral Hepatitis","topic":"Hepatitis B Virus Studies","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto Liver Centre; University of Toronto; University Health Network","funders":"","keywords":"HBsAg; Medicine; Gastroenterology; Internal medicine; Hepatitis B virus; Flare; Combination therapy; PEG ratio; Immunology; Virology; Virus","score_opus":0.005875427593792785,"score_gpt":0.2430034346520854,"score_spread":0.23712800705829262,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3199012128","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99777883,0.0016415117,0.00007210215,0.00003953484,0.000014784449,0.000073134084,0.00009062811,0.0000034541467,0.00028609022],"genre_scores_gemma":[0.9991716,0.00025460095,0.000119929035,0.000055356955,0.000029475514,0.000059301678,0.00018560153,0.0000015682426,0.0001226833],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.998387,0.0011420952,0.00013794527,0.00011937689,0.00009261013,0.000121027246],"domain_scores_gemma":[0.99663,0.0018264326,0.00080986036,0.00019794055,0.00011387949,0.0004218085],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004385313,0.00048389792,0.0014328607,0.00032973595,0.00021171513,0.00057832705,0.00023948538,0.0005907006,0.0011910847],"category_scores_gemma":[0.0033401977,0.00028478497,0.0025152508,0.00028855802,0.0003424875,0.0005242294,0.00036758606,0.00074382796,0.00009234572],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.67828417,0.0035490922,0.25779805,0.0005655443,0.0065231933,0.00010290216,0.00011273119,0.0011353933,0.0044366955,0.00006988107,0.00045917125,0.046963252],"study_design_scores_gemma":[0.054513365,0.2055436,0.726456,0.00014796594,0.0063154083,0.00032068725,0.00016350574,0.0024645452,0.0022424525,0.00020904068,0.0015661838,0.000057307738],"about_ca_topic_score_codex":0.00038105497,"about_ca_topic_score_gemma":0.00087051955,"teacher_disagreement_score":0.004385313,"about_ca_system_score_codex":0.00033789972,"about_ca_system_score_gemma":0.00038840604,"threshold_uncertainty_score":0.023191988},"labels":[],"label_agreement":null},{"id":"W3212334906","doi":"10.1111/jvh.13630","title":"Electronic nose versus quadrupole mass spectrometry for identifying viral hepatitis C patients","year":2021,"lang":"en","type":"article","venue":"Journal of Viral Hepatitis","topic":"Hepatitis C virus research","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"NOSM University; Lakehead University","funders":"","keywords":"Medicine; Gastroenterology; Hepatitis C; Internal medicine; Hepatitis","score_opus":0.03286927990297579,"score_gpt":0.35024153320887347,"score_spread":0.3173722533058977,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3212334906","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9861037,0.004827325,0.005251287,0.00029145676,0.0001110846,0.0001398494,0.00073101884,0.00015054419,0.0023937614],"genre_scores_gemma":[0.989146,0.00072750635,0.008455588,0.00045128106,0.000028050743,0.000037057605,0.00024904025,0.0000073678566,0.0008980052],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9994475,0.00016449117,0.000049752267,0.00012901299,0.00015626749,0.000052868923],"domain_scores_gemma":[0.99964416,0.000134187,0.00007015688,0.000013035969,0.000114821545,0.00002354789],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00080742704,0.00037561884,0.00031451593,0.0009321687,0.00020683423,0.00043441492,0.00022040453,0.00051055104,0.001692267],"category_scores_gemma":[0.00084015215,0.000109767345,0.00021688749,0.00042127963,0.00018141394,0.00019924485,0.00025079097,0.0002195088,0.00042458458],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0028785302,0.0005460734,0.5393013,0.0005920481,0.0002989543,0.00063227455,0.00022544831,0.0004841492,0.33232525,0.00024735727,0.0017753222,0.120693326],"study_design_scores_gemma":[0.00015729737,0.0033460455,0.7924571,0.00021089241,0.00042031336,0.006372436,0.0010585644,0.016206907,0.17341642,0.0005213339,0.0057461397,0.00008648118],"about_ca_topic_score_codex":0.0015496903,"about_ca_topic_score_gemma":0.0027704097,"teacher_disagreement_score":0.001692267,"about_ca_system_score_codex":0.00023833233,"about_ca_system_score_gemma":0.00023550424,"threshold_uncertainty_score":0.0056611896},"labels":[],"label_agreement":null},{"id":"W3215309323","doi":"10.1111/jvh.13637","title":"The impact of the first, second and third waves of covid‐19 on hepatitis B and C testing in Ontario, Canada","year":2021,"lang":"en","type":"article","venue":"Journal of Viral Hepatitis","topic":"Hepatitis B Virus Studies","field":"Medicine","cited_by":37,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Western University; University of Toronto; Public Health Ontario; Toronto Liver Centre; University Health Network","funders":"","keywords":"Medicine; Pandemic; HBsAg; Asymptomatic; Virology; Hepatitis B virus; Hepatitis C virus; Hepatitis C; Coronavirus disease 2019 (COVID-19); Virus; Internal medicine; Disease; Infectious disease (medical specialty)","score_opus":0.021125514917991337,"score_gpt":0.26862758609142856,"score_spread":0.24750207117343723,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3215309323","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97690946,0.0018829476,0.0001875164,0.003026249,0.000037417183,0.000077332224,0.01109703,0.000030098829,0.00675202],"genre_scores_gemma":[0.99445033,0.00086503866,0.0002662058,0.00038088628,0.000011675939,0.000027157366,0.0024038765,0.000010046033,0.0015848157],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99805754,0.00016756514,0.00012016433,0.00016521353,0.00082285417,0.00066665176],"domain_scores_gemma":[0.99405503,0.0006779819,0.0016734299,0.00015016137,0.0021349613,0.0013084755],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011240799,0.0002634221,0.0002881495,0.0010374552,0.0013520205,0.0013348814,0.00090538396,0.0003744701,0.0013989373],"category_scores_gemma":[0.0054010516,0.00030824606,0.0005439117,0.0023086513,0.0008766564,0.00039959993,0.00088694924,0.00065035705,0.00012848107],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017381713,0.000022155638,0.98379654,0.000110504385,0.00006817288,0.0001283346,0.0010743767,0.0009470483,0.0003816832,0.00018271798,0.0030192493,0.010095386],"study_design_scores_gemma":[0.0000035185626,0.000010484151,0.9982487,0.000025444764,0.000008542198,0.000015264797,0.00048871466,0.0002293725,0.000051518255,0.000008138128,0.00090478605,0.000005638063],"about_ca_topic_score_codex":0.99623555,"about_ca_topic_score_gemma":0.99732274,"teacher_disagreement_score":0.049086165,"about_ca_system_score_codex":0.049086165,"about_ca_system_score_gemma":0.05715394,"threshold_uncertainty_score":0.35614675},"labels":[],"label_agreement":null},{"id":"W4230885083","doi":"10.1111/jvh.33_12922","title":"O‐038: Prevention and care cascade for hepatitis C among people who inject drugs in British Columbia, Canada","year":2018,"lang":"en","type":"article","venue":"Journal of Viral Hepatitis","topic":"Hepatitis C virus research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Citation; Medicine; Hepatitis C; Library science; Family medicine; Virology; Computer science","score_opus":0.009710912138667614,"score_gpt":0.28190408984064474,"score_spread":0.27219317770197715,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4230885083","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9653971,0.0019284706,0.00016123304,0.010048205,0.00015926908,0.0004302064,0.004867718,0.000046737314,0.016960965],"genre_scores_gemma":[0.985405,0.0013873971,0.00048795663,0.0025981476,0.000033129603,0.00011486398,0.0011989843,0.000020640597,0.00875378],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987092,0.00014498629,0.00007737455,0.000093499,0.00022455592,0.000750411],"domain_scores_gemma":[0.9970669,0.00016637481,0.0002647403,0.00003365442,0.0009723525,0.0014959247],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005146386,0.00028834847,0.00048256424,0.00084010325,0.0060008476,0.0015950098,0.0015345949,0.0009972873,0.007665852],"category_scores_gemma":[0.0025128864,0.0005751865,0.00083488855,0.0016726379,0.0006386227,0.0006795789,0.0017860798,0.0022742979,0.00048058783],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00029948633,0.00061248837,0.94323885,0.00020248842,0.00008728159,0.0005411455,0.0034787469,0.0004549724,0.00031969816,0.00054789183,0.018102465,0.032114368],"study_design_scores_gemma":[0.00006685273,0.000093696646,0.98321265,0.00029021117,0.00007777406,0.00015466656,0.010952687,0.00071488664,0.00010952075,0.0001229603,0.004171299,0.000032783642],"about_ca_topic_score_codex":0.9977616,"about_ca_topic_score_gemma":0.9990085,"teacher_disagreement_score":0.051171977,"about_ca_system_score_codex":0.051171977,"about_ca_system_score_gemma":0.099402025,"threshold_uncertainty_score":0.37128037},"labels":[],"label_agreement":null},{"id":"W4235713874","doi":"10.1111/jvh.107_12923","title":"P1‐137: Lack of prenatal HBV and HCV screening and follow‐up in Ontario, Canada","year":2018,"lang":"en","type":"article","venue":"Journal of Viral Hepatitis","topic":"HIV, Drug Use, Sexual Risk","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Citation; Medicine; Prenatal screening; Library science; Family medicine; Hepatitis C; Virology; Pediatrics; Prenatal diagnosis; Computer science; Pregnancy; Biology; Genetics; Fetus","score_opus":0.04091567410141984,"score_gpt":0.31186985189441147,"score_spread":0.27095417779299164,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4235713874","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9610907,0.0017541877,0.00026434968,0.007402079,0.00011210726,0.00024434968,0.015221336,0.000044834887,0.013866232],"genre_scores_gemma":[0.9909416,0.0008062011,0.000356737,0.001038667,0.000019288074,0.00006929824,0.001813597,0.000022000882,0.004932619],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9975382,0.000186004,0.00025172246,0.00023943526,0.0007964539,0.0009880973],"domain_scores_gemma":[0.99241054,0.0004707915,0.0012089012,0.00018886596,0.0033216928,0.0023992043],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008462726,0.0002721048,0.00057611126,0.0010949716,0.006348425,0.0015659975,0.0023169,0.0008392692,0.0043470706],"category_scores_gemma":[0.0044003343,0.0007343209,0.000635092,0.003958213,0.00083506515,0.00059773546,0.0014504899,0.001410439,0.00031347715],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001092849,0.00009552117,0.9754742,0.0001955041,0.000079765734,0.00072587054,0.0033198774,0.00021818024,0.000375164,0.0005056225,0.010218381,0.008682651],"study_design_scores_gemma":[0.0000168943,0.000038476912,0.9898493,0.00020539177,0.00003934994,0.00024547154,0.0055152224,0.00034485562,0.00010605433,0.000046566078,0.003571299,0.000021227761],"about_ca_topic_score_codex":0.9988557,"about_ca_topic_score_gemma":0.9994461,"teacher_disagreement_score":0.06922945,"about_ca_system_score_codex":0.06922945,"about_ca_system_score_gemma":0.14279662,"threshold_uncertainty_score":0.50229716},"labels":[],"label_agreement":null},{"id":"W4236041872","doi":"10.1111/jvh.26_12923","title":"P1‐044: Hepatitis B virus therapy with nucleos(t)ide analogues significantly reduces fibrosis in a ‘Real‐world’ Canadian cohort","year":2018,"lang":"en","type":"article","venue":"Journal of Viral Hepatitis","topic":"Hepatitis B Virus Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Cohort; Citation; Medicine; Chronic hepatitis; Virology; Hepatitis B; Library science; Internal medicine; Family medicine; Virus; Computer science","score_opus":0.020559682903340693,"score_gpt":0.28348560671111683,"score_spread":0.26292592380777613,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4236041872","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98007476,0.0032831705,0.0002307587,0.0018767958,0.000113179805,0.00008080763,0.0073839966,0.000027466574,0.00692894],"genre_scores_gemma":[0.9949057,0.0010327253,0.00023227079,0.00038873227,0.00003045745,0.000021766604,0.001716235,0.000011989291,0.0016600935],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99932945,0.0001365619,0.000029332074,0.00013365172,0.00018120227,0.00018990395],"domain_scores_gemma":[0.99893755,0.000120566685,0.00017029989,0.00008863034,0.00036425283,0.00031873301],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00097399973,0.00048088038,0.00047471104,0.0002638859,0.0013735573,0.0010326637,0.0010814093,0.0007658398,0.004684525],"category_scores_gemma":[0.0028869621,0.00031801107,0.0010688611,0.0010136917,0.0007507392,0.0003287184,0.00032111525,0.0010101136,0.00033620116],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.021100301,0.00047290747,0.91444176,0.0004919603,0.0023513646,0.0005606422,0.0009760008,0.0007497344,0.0035230701,0.0011304836,0.021612776,0.032589033],"study_design_scores_gemma":[0.0016655299,0.0010786316,0.98568743,0.00011883037,0.0015269556,0.00032071627,0.0009351111,0.0005693584,0.0004027328,0.00018046143,0.007460501,0.000053741456],"about_ca_topic_score_codex":0.94164515,"about_ca_topic_score_gemma":0.950768,"teacher_disagreement_score":0.058354855,"about_ca_system_score_codex":0.007820257,"about_ca_system_score_gemma":0.013621458,"threshold_uncertainty_score":0.11739701},"labels":[],"label_agreement":null},{"id":"W4237915162","doi":"10.1111/jvh.56_12923","title":"P1‐080: Prevalence of baseline NS5A resistance associated sequences (RAS) in treatment naïve patients with genotype 1 and 3 in Canada","year":2018,"lang":"en","type":"article","venue":"Journal of Viral Hepatitis","topic":"Hepatitis C virus research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Genotype; Citation; NS5A; Baseline (sea); Medicine; Family medicine; Library science; Genetics; Biology; Political science; Computer science; Gene; Hepacivirus; Law","score_opus":0.013124837023297458,"score_gpt":0.2706368240545586,"score_spread":0.2575119870312611,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4237915162","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99033386,0.0004377561,0.00008050711,0.00039577924,0.000015881373,0.000032493026,0.0056680655,0.000012386852,0.0030232405],"genre_scores_gemma":[0.9970509,0.00029706256,0.00007566969,0.00017097499,0.0000051910906,0.000009332163,0.0010940934,0.000008017683,0.0012886162],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9993405,0.000037274945,0.00004298576,0.00013422506,0.00016594573,0.00027905306],"domain_scores_gemma":[0.99841464,0.0000902228,0.00025636723,0.000028306597,0.00053209584,0.0006783037],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00026285337,0.0003031144,0.00042351458,0.0012615552,0.002145737,0.0011387343,0.001498989,0.0006552578,0.0053455927],"category_scores_gemma":[0.0014313011,0.00041821503,0.0006144348,0.0028602458,0.00074287306,0.00040747327,0.0006464654,0.0010037425,0.00043534144],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012363699,0.00003224288,0.9953431,0.000021629638,0.000032317595,0.0001792552,0.00043222387,0.00009149838,0.00025476646,0.00014717146,0.0011018472,0.002240422],"study_design_scores_gemma":[0.000012049405,0.00003138487,0.9969785,0.00002604273,0.000025141679,0.00016782033,0.0018536157,0.00024435905,0.000058009937,0.000037183225,0.00055298273,0.000012897299],"about_ca_topic_score_codex":0.9937763,"about_ca_topic_score_gemma":0.99537164,"teacher_disagreement_score":0.018350637,"about_ca_system_score_codex":0.018350637,"about_ca_system_score_gemma":0.023976626,"threshold_uncertainty_score":0.13314384},"labels":[],"label_agreement":null},{"id":"W4237983440","doi":"10.1111/jvh.218_12923","title":"P2‐099: A tale of two provinces: Comparison of the successes and challenges of structured, stepwise development in two Canadian provincial research and evaluation imbedded HCV elimination strategies","year":2018,"lang":"en","type":"article","venue":"Journal of Viral Hepatitis","topic":"Hepatitis C virus research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Citation; Library science; Citation impact; Computer science; Political science; Operations research; Medicine; Mathematics","score_opus":0.09450903020911175,"score_gpt":0.4338179707006881,"score_spread":0.33930894049157634,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4237983440","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":"evaluation","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":"evaluation","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.83667564,0.0066761593,0.006511768,0.071744405,0.00072993495,0.0029814465,0.0035735213,0.00048090538,0.07062622],"genre_scores_gemma":[0.9791976,0.001308395,0.01011122,0.0040912577,0.000027456235,0.00034934393,0.00065882644,0.00006492129,0.0041909763],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9784066,0.0069957445,0.0007038677,0.00061000185,0.0057880552,0.0074957595],"domain_scores_gemma":[0.9715408,0.0053402716,0.0013321427,0.0014379844,0.01315191,0.0071968785],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.01884279,0.0006384076,0.00058683695,0.001966669,0.00818705,0.005872026,0.0029906116,0.0015975556,0.0018433997],"category_scores_gemma":[0.029830145,0.0005856077,0.00089439616,0.0034984148,0.0035878993,0.001521665,0.0043381043,0.0025417833,0.00021238171],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.007800061,0.0020910187,0.3451639,0.0034637193,0.0012438634,0.0023228314,0.032388605,0.011848987,0.012968549,0.084348105,0.083305344,0.41305497],"study_design_scores_gemma":[0.0014070953,0.0036090068,0.77485085,0.0014504397,0.0014494553,0.00061984477,0.07552433,0.009858467,0.007330338,0.0077653215,0.11565161,0.00048335613],"about_ca_topic_score_codex":0.98352605,"about_ca_topic_score_gemma":0.99281114,"teacher_disagreement_score":0.9811572,"about_ca_system_score_codex":0.14204729,"about_ca_system_score_gemma":0.42127457,"threshold_uncertainty_score":0.99510354},"labels":[],"label_agreement":null},{"id":"W4238473073","doi":"10.1111/jvh.141_12923","title":"P2‐005: Hepatitis D virus infection in Canada: molecular epidemiology and clinical association","year":2018,"lang":"en","type":"article","venue":"Journal of Viral Hepatitis","topic":"Hepatitis C virus research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Citation; Epidemiology; Association (psychology); Medicine; Virology; Clinical epidemiology; Molecular epidemiology; Library science; Family medicine; Biology; Computer science; Psychology; Internal medicine; Genetics","score_opus":0.039458968157309614,"score_gpt":0.3813092814373231,"score_spread":0.34185031328001353,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4238473073","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97526574,0.0024170305,0.00024881677,0.0028937336,0.00007613912,0.00008638446,0.010774707,0.00003048109,0.008206985],"genre_scores_gemma":[0.99354035,0.0009949895,0.00021900503,0.0005050904,0.000024934816,0.000014557296,0.0016004782,0.000012856659,0.0030876603],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99908066,0.00006517056,0.000072521725,0.00013697079,0.0002954503,0.0003491669],"domain_scores_gemma":[0.99635386,0.00020215772,0.0004984579,0.00006669646,0.0016440504,0.0012347128],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000597277,0.0003896748,0.00032665182,0.0025973446,0.0036686205,0.0017469982,0.0013423797,0.00092027284,0.0061941403],"category_scores_gemma":[0.0024188291,0.0004334891,0.0006065455,0.005672769,0.00089392887,0.0005122623,0.00092673436,0.0010690407,0.00048115116],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006909158,0.000032651056,0.99326926,0.000023656281,0.000030203051,0.00015080025,0.00023474976,0.00006910435,0.00019433953,0.00021909147,0.0020576129,0.0036494187],"study_design_scores_gemma":[0.000013742912,0.00002591825,0.99512625,0.00007058075,0.0000306186,0.00024059796,0.001687597,0.00032184913,0.00008654104,0.00009230009,0.0022891043,0.000014944047],"about_ca_topic_score_codex":0.9954926,"about_ca_topic_score_gemma":0.995445,"teacher_disagreement_score":0.024952164,"about_ca_system_score_codex":0.024952164,"about_ca_system_score_gemma":0.05904162,"threshold_uncertainty_score":0.18104148},"labels":[],"label_agreement":null},{"id":"W4239695775","doi":"10.1111/jvh.202_12923","title":"P2‐083: A high demand for hepatitis C education among healthcare providers in British Columbia","year":2018,"lang":"en","type":"article","venue":"Journal of Viral Hepatitis","topic":"Hepatitis C virus research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Citation; Library science; Health care; Hepatitis C; Medicine; Family medicine; Political science; World Wide Web; Computer science; Virology; Law","score_opus":0.017338735525286086,"score_gpt":0.3257864348980294,"score_spread":0.3084476993727433,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4239695775","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98170567,0.00033839088,0.000067846195,0.0078075747,0.000036642326,0.000063841326,0.0011103554,0.00002048376,0.008849195],"genre_scores_gemma":[0.98668694,0.00048702044,0.00019308645,0.003486269,0.000012268552,0.000035679677,0.00030753922,0.00002332992,0.008767973],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99926215,0.00007273406,0.00004419675,0.0000689568,0.0001494105,0.00040253575],"domain_scores_gemma":[0.9961152,0.00046461445,0.0003340931,0.00005011906,0.00085888535,0.0021769668],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003686037,0.00017033644,0.0002632614,0.0007002642,0.004306616,0.0019063352,0.001097343,0.0013589679,0.01185707],"category_scores_gemma":[0.0018932996,0.00046202447,0.00021565272,0.0016051901,0.0007196475,0.00051590404,0.0014218803,0.0021180685,0.00076233526],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00029463434,0.00042398344,0.8974991,0.000316092,0.000061588325,0.0074157403,0.013282491,0.00022074989,0.0039138775,0.0012667801,0.034035757,0.041269265],"study_design_scores_gemma":[0.00002802605,0.00006395935,0.93081987,0.00031483668,0.00002410786,0.0010433061,0.054423448,0.00074023823,0.00028820013,0.00013602631,0.012077663,0.000040295134],"about_ca_topic_score_codex":0.96873003,"about_ca_topic_score_gemma":0.99096125,"teacher_disagreement_score":0.031269968,"about_ca_system_score_codex":0.017605247,"about_ca_system_score_gemma":0.035540134,"threshold_uncertainty_score":0.12773561},"labels":[],"label_agreement":null},{"id":"W4241502674","doi":"10.1111/jvh.227_12923","title":"P2‐110: Limited HCV awareness and hepatitis C virus stigma are common in a medium sized Canadian province before implementation of an elimination strategy but 2 years after DAA implementation","year":2018,"lang":"en","type":"article","venue":"Journal of Viral Hepatitis","topic":"Hepatitis C virus research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Stigma (botany); Citation; Hepatitis C; Hepatitis C virus; Medicine; Library science; Computer science; Virology; Family medicine; Virus; Psychiatry","score_opus":0.02135677046272398,"score_gpt":0.3606023659270675,"score_spread":0.3392455954643435,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4241502674","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97824574,0.00030777472,0.00020013099,0.004692859,0.00007882869,0.0001710313,0.0043107797,0.000032725962,0.011960179],"genre_scores_gemma":[0.9926502,0.00020393317,0.00026882492,0.001005004,0.000014350303,0.000045598863,0.0008095629,0.000011063439,0.0049915793],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990651,0.000053375363,0.0000327941,0.00007708345,0.00023429345,0.0005374032],"domain_scores_gemma":[0.99827254,0.000091575,0.00026143875,0.00004232586,0.0006207921,0.0007112392],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00043633336,0.0003503773,0.00032464255,0.0007383972,0.00652367,0.0015052144,0.0015539149,0.0009103141,0.006966427],"category_scores_gemma":[0.002076965,0.0003768742,0.0006771946,0.0017071319,0.0012452174,0.0006941027,0.0011787271,0.0015624543,0.000480384],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002704769,0.00027095765,0.93885666,0.00023332561,0.000056976573,0.0021314868,0.01090152,0.00019187956,0.00096898834,0.0007941666,0.028981648,0.01634189],"study_design_scores_gemma":[0.000022310393,0.00009336369,0.95689857,0.00015206178,0.00003193303,0.00090513425,0.031744957,0.00028799265,0.0002930408,0.00016014276,0.0093537625,0.000056830657],"about_ca_topic_score_codex":0.9956477,"about_ca_topic_score_gemma":0.99774903,"teacher_disagreement_score":0.028968226,"about_ca_system_score_codex":0.028968226,"about_ca_system_score_gemma":0.06248902,"threshold_uncertainty_score":0.21018022},"labels":[],"label_agreement":null},{"id":"W4241917971","doi":"10.1111/jvh.21_12935","title":"LBP‐016: Lost to follow‐up among Ledipasvir/sofosbuvir treated patients in Canada: The BC Hepatitis Testers Cohort","year":2018,"lang":"en","type":"article","venue":"Journal of Viral Hepatitis","topic":"Hepatitis C virus research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Sofosbuvir; Medicine; Cohort; Hepatitis C; Family medicine; Virology; Internal medicine; Chronic hepatitis; Ribavirin","score_opus":0.014942555951787435,"score_gpt":0.27382128668839417,"score_spread":0.2588787307366067,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4241917971","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9915531,0.00035445302,0.00007389623,0.0003443838,0.000023191003,0.000039754115,0.006285761,0.000011211784,0.0013142496],"genre_scores_gemma":[0.9928033,0.00040439377,0.000081902544,0.00031262988,0.000015337548,0.000032154596,0.0041342485,0.000014407482,0.0022016084],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989404,0.00005830535,0.000048002225,0.00016803324,0.00026101206,0.0005242612],"domain_scores_gemma":[0.9983265,0.0000580118,0.00035379533,0.0000972082,0.00054898264,0.00061549165],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000533863,0.0005273482,0.0007719432,0.001189583,0.0033867722,0.0023191024,0.0018833957,0.00090858195,0.0031009864],"category_scores_gemma":[0.0014761216,0.00079104624,0.00087410276,0.0035572064,0.00072743354,0.00081667694,0.0010551679,0.0020951738,0.0006634049],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003056933,0.00007325104,0.99600804,0.000013078118,0.00007420063,0.0001491943,0.0003233174,0.000054929555,0.00017882226,0.000063965555,0.0011319567,0.0016234049],"study_design_scores_gemma":[0.00003743959,0.0000652414,0.99657995,0.00003879159,0.00007381033,0.00014654643,0.0017320545,0.0003433822,0.000050960734,0.000040198316,0.00087323715,0.000018579778],"about_ca_topic_score_codex":0.97181726,"about_ca_topic_score_gemma":0.97313744,"teacher_disagreement_score":0.028182745,"about_ca_system_score_codex":0.014496493,"about_ca_system_score_gemma":0.017561253,"threshold_uncertainty_score":0.105179906},"labels":[],"label_agreement":null},{"id":"W4241941786","doi":"10.1111/jvh.231_12923","title":"P2‐114: Gaps in care before introduction of a coordinated elimination strategy: a Canadian provincial baseline","year":2018,"lang":"en","type":"article","venue":"Journal of Viral Hepatitis","topic":"Hepatitis C virus research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Baseline (sea); Citation; Library science; Viral hepatitis; Medicine; Political science; Computer science; Law; Virology","score_opus":0.011348818777393055,"score_gpt":0.30285923349892,"score_spread":0.29151041472152694,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4241941786","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.6339664,0.0045083016,0.0035982565,0.14374116,0.0015985662,0.0054500583,0.11955082,0.00033435866,0.08725209],"genre_scores_gemma":[0.9417957,0.0014000384,0.007579942,0.014668108,0.00014436766,0.0031827053,0.016111163,0.000077013865,0.0150408745],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.98807657,0.0013653665,0.00043219162,0.0006201481,0.0031470736,0.006358697],"domain_scores_gemma":[0.97140414,0.002796267,0.001274096,0.00064519997,0.0153481355,0.008532017],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.010203804,0.00061230885,0.0010858529,0.0014484649,0.008271798,0.0032616993,0.0033447251,0.0031458358,0.008136915],"category_scores_gemma":[0.027388083,0.0006113141,0.002270288,0.0042116665,0.0011350574,0.00204528,0.0034594876,0.005418428,0.0004500446],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0031768244,0.0019998297,0.4075929,0.0021415893,0.0007031775,0.000895142,0.0102717,0.0058963,0.00095774233,0.020122716,0.45855606,0.08768599],"study_design_scores_gemma":[0.00082370033,0.00072079746,0.87230945,0.0013928433,0.0005352983,0.00018429612,0.02448903,0.0049926946,0.00064241095,0.0033848386,0.09030279,0.00022190512],"about_ca_topic_score_codex":0.9971317,"about_ca_topic_score_gemma":0.99847084,"teacher_disagreement_score":0.19697991,"about_ca_system_score_codex":0.19697991,"about_ca_system_score_gemma":0.50560546,"threshold_uncertainty_score":0.93138945},"labels":[],"label_agreement":null},{"id":"W4243205864","doi":"10.1111/jvh.189_12923","title":"P2‐067: Emergence among men in Quebec, Canada of a hepatitis C virus genotype 4D lineage circulating in European HIV‐infected men","year":2018,"lang":"en","type":"article","venue":"Journal of Viral Hepatitis","topic":"Hepatitis C virus research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Human immunodeficiency virus (HIV); Genotype; Lineage (genetic); Virology; Men who have sex with men; Hepatitis C virus; Citation; Hepatitis C; Medicine; Demography; Political science; Genealogy; Biology; History; Virus; Genetics; Sociology; Gene; Law","score_opus":0.016547126223810306,"score_gpt":0.28476228072225823,"score_spread":0.2682151544984479,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4243205864","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99702674,0.00023753825,0.0001116571,0.00023271181,0.000014511707,0.000034719706,0.00092692557,0.000008010244,0.00140722],"genre_scores_gemma":[0.9978765,0.00014807565,0.00009544485,0.000269533,0.000008657566,0.000008738742,0.00031129512,0.0000061208184,0.0012755749],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99963,0.000029833544,0.000012143202,0.000067876514,0.000073008625,0.00018706523],"domain_scores_gemma":[0.99941564,0.000030768064,0.000093939045,0.000020296766,0.00021863157,0.00022082344],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00024290329,0.00034102463,0.00029622135,0.00063008006,0.0031188417,0.0010782568,0.00081561116,0.0007085091,0.0035669536],"category_scores_gemma":[0.00058968604,0.0003290978,0.00031040743,0.001629823,0.0007842201,0.00034422893,0.000595463,0.0008821578,0.00027703552],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014949191,0.000041977473,0.9905184,0.000019819094,0.000025356887,0.0005160573,0.0013327297,0.00007024469,0.0015476132,0.00014831526,0.0012494174,0.0043806555],"study_design_scores_gemma":[0.0000082384095,0.000071259325,0.99470973,0.000024401641,0.000014620035,0.00051752036,0.0032565044,0.00024107775,0.0001041749,0.000023001945,0.0010191632,0.000010347777],"about_ca_topic_score_codex":0.95259804,"about_ca_topic_score_gemma":0.9609405,"teacher_disagreement_score":0.047401965,"about_ca_system_score_codex":0.005453983,"about_ca_system_score_gemma":0.006198874,"threshold_uncertainty_score":0.09536219},"labels":[],"label_agreement":null},{"id":"W4244280002","doi":"10.1111/jvh.62_12923","title":"P1‐088: Z‐PROFILE: real‐world utilization and effectiveness of Elbasvir/Grazoprevir in adult patients with chronic hepatitis C in Canada – final study results","year":2018,"lang":"en","type":"article","venue":"Journal of Viral Hepatitis","topic":"Hepatitis C virus research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Chronic hepatitis; Citation; Hepatitis C; Internal medicine; Family medicine; Library science; Virology; Computer science","score_opus":0.02106948965505111,"score_gpt":0.31090515612353575,"score_spread":0.28983566646848463,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4244280002","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96616656,0.00058566843,0.00015769052,0.00030871714,0.000011780051,0.00034737086,0.030142821,0.00002975921,0.0022496448],"genre_scores_gemma":[0.98188674,0.0005112403,0.0005133607,0.0002442747,0.000016506185,0.00019208864,0.015124239,0.000017505647,0.0014940212],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99846196,0.0002174486,0.000118149685,0.0001784737,0.0005431429,0.00048077235],"domain_scores_gemma":[0.9974322,0.00020584282,0.0004440927,0.00010847857,0.0012916428,0.0005177203],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013407539,0.0007098043,0.00078567193,0.00067661173,0.00079006166,0.001267469,0.0010232467,0.00050529157,0.0021703215],"category_scores_gemma":[0.0030487769,0.000436235,0.0015843908,0.0023950224,0.00046940162,0.00056862953,0.000651669,0.0007400058,0.00042618474],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004731193,0.0004430657,0.9761928,0.00020379701,0.00077330787,0.00006948698,0.00037649684,0.0010518922,0.00024403523,0.00009844505,0.0040746853,0.011740829],"study_design_scores_gemma":[0.00037419228,0.0003207747,0.9962949,0.000044451288,0.0003228155,0.000049725997,0.00040731166,0.0006700909,0.000134833,0.00001612408,0.0013398947,0.00002488721],"about_ca_topic_score_codex":0.96431535,"about_ca_topic_score_gemma":0.96985424,"teacher_disagreement_score":0.035684645,"about_ca_system_score_codex":0.019943524,"about_ca_system_score_gemma":0.026127711,"threshold_uncertainty_score":0.14470106},"labels":[],"label_agreement":null},{"id":"W4245262142","doi":"10.1111/jvh.234_12923","title":"P2‐119: Evaluation of hepatitis C screening strategies in different community settings in a Canadian metropolitan area","year":2018,"lang":"en","type":"article","venue":"Journal of Viral Hepatitis","topic":"Hepatitis C virus research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Metropolitan area; Citation; Library science; Viral hepatitis; Hepatitis C; Medicine; Hepatitis; Family medicine; Computer science; Virology; Pathology","score_opus":0.07029392440580737,"score_gpt":0.38031151971677674,"score_spread":0.3100175953109694,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4245262142","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9946345,0.00023650366,0.000114115996,0.00030626348,0.000019920992,0.0011067175,0.001091179,0.000022818911,0.0024679801],"genre_scores_gemma":[0.99494416,0.00034286614,0.0013834583,0.00036169877,0.000012493282,0.00061094324,0.0008896682,0.000009783876,0.0014449701],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9972428,0.0006433799,0.00015346223,0.0002542714,0.00086191145,0.0008441659],"domain_scores_gemma":[0.9943046,0.00042011615,0.00038348747,0.00012979198,0.0030528475,0.0017092176],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002879995,0.000792331,0.000758896,0.0012100218,0.005302237,0.0015476798,0.0026326878,0.0007520324,0.0025107695],"category_scores_gemma":[0.0066162827,0.0005352316,0.0013020297,0.002205668,0.0008856855,0.00070599606,0.0016700769,0.0007475797,0.00032677737],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006145003,0.008530242,0.85325384,0.0011720944,0.00047030477,0.00062125956,0.010796022,0.0017215835,0.0028205346,0.00056707463,0.0058437595,0.10805831],"study_design_scores_gemma":[0.0005381393,0.0057386644,0.9738009,0.00019962675,0.00031604053,0.00012893323,0.013338622,0.0017014237,0.0010875406,0.00007025498,0.0029990613,0.00008068643],"about_ca_topic_score_codex":0.9879183,"about_ca_topic_score_gemma":0.99405307,"teacher_disagreement_score":0.04924769,"about_ca_system_score_codex":0.04924769,"about_ca_system_score_gemma":0.10217986,"threshold_uncertainty_score":0.35731864},"labels":[],"label_agreement":null},{"id":"W4245762639","doi":"10.1111/jvh.177_12923","title":"P2‐055: Screening for hepatitis C in Ontario, Canada: exploring antibody positivity in the federal and provincial correctional systems","year":2018,"lang":"en","type":"article","venue":"Journal of Viral Hepatitis","topic":"Hepatitis C virus research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Citation; Library science; Medicine; Hepatitis C; Viral hepatitis; Political science; Family medicine; Computer science; Virology","score_opus":0.058835494303464554,"score_gpt":0.32052933474097545,"score_spread":0.26169384043751087,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4245762639","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9849294,0.00042134122,0.00014997923,0.0019833231,0.00003273182,0.00018539985,0.004823885,0.000019264924,0.0074546714],"genre_scores_gemma":[0.99520844,0.00030591196,0.00032266742,0.0004184253,0.000006728096,0.000048515805,0.0008810395,0.000008270966,0.0028000192],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99832886,0.00015527052,0.00009927831,0.000114602684,0.00053164153,0.00077036343],"domain_scores_gemma":[0.9946272,0.000266792,0.00071744353,0.000095642674,0.0030720152,0.0012209545],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00089932134,0.00032122762,0.00030722975,0.0013524585,0.005123379,0.0014833651,0.0015922232,0.00059883686,0.0025317422],"category_scores_gemma":[0.004061999,0.0003944987,0.00060230243,0.0038467513,0.00086675497,0.0005688857,0.0011879768,0.0008252819,0.00029381484],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00004368058,0.00005089963,0.98864347,0.000056555014,0.000018824803,0.00010349023,0.0020627547,0.00009567959,0.00020567342,0.00012438266,0.0030303404,0.005564416],"study_design_scores_gemma":[0.000004939257,0.00003108923,0.99189866,0.000047097583,0.000015685375,0.000051515286,0.0060765436,0.00019104761,0.00008401347,0.000020477846,0.0015712414,0.000007734729],"about_ca_topic_score_codex":0.99839145,"about_ca_topic_score_gemma":0.99916923,"teacher_disagreement_score":0.04780173,"about_ca_system_score_codex":0.04780173,"about_ca_system_score_gemma":0.09841001,"threshold_uncertainty_score":0.34682745},"labels":[],"label_agreement":null},{"id":"W4248569107","doi":"10.1111/jvh.170_12923","title":"P2‐046: Estimating the number of people who inject drugs and the coverage of harm reduction services in Canada","year":2018,"lang":"en","type":"article","venue":"Journal of Viral Hepatitis","topic":"HIV, Drug Use, Sexual Risk","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Harm reduction; Citation; Harm; Medicine; Hepatitis C; Library science; Family medicine; Computer science; Political science; Virology; Human immunodeficiency virus (HIV); Law","score_opus":0.010331557507445903,"score_gpt":0.2939610406917841,"score_spread":0.28362948318433817,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4248569107","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.92038876,0.0025861047,0.0013312328,0.0043820534,0.00012367101,0.00028262177,0.06238987,0.00015022272,0.008365561],"genre_scores_gemma":[0.9833382,0.0009450421,0.0017110772,0.00033746893,0.000025787816,0.000057129077,0.009425152,0.00002610063,0.004134056],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99782026,0.00038397423,0.00015864667,0.00026738827,0.00070678006,0.0006629237],"domain_scores_gemma":[0.9909328,0.0017572207,0.00072774955,0.00017665183,0.0048241867,0.0015813907],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0023091808,0.0007812298,0.0009895477,0.0031616916,0.002254081,0.0025005192,0.0033602908,0.0014227573,0.005018904],"category_scores_gemma":[0.012117406,0.00078249787,0.0025164606,0.0059283287,0.0007749733,0.0009281324,0.0012495457,0.0018835677,0.00046988804],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00022355748,0.00013476373,0.96365887,0.00018621584,0.00055247435,0.0001665572,0.00023563807,0.014647212,0.000077358265,0.0010784441,0.010982634,0.008056329],"study_design_scores_gemma":[0.00010494192,0.00009324581,0.9197458,0.00017380105,0.00036147123,0.00012770743,0.002273007,0.071259335,0.00025521702,0.0004665262,0.005071007,0.00006799017],"about_ca_topic_score_codex":0.99932146,"about_ca_topic_score_gemma":0.99893993,"teacher_disagreement_score":0.060678996,"about_ca_system_score_codex":0.060678996,"about_ca_system_score_gemma":0.09525686,"threshold_uncertainty_score":0.44025898},"labels":[],"label_agreement":null},{"id":"W4249706211","doi":"10.1111/jvh.127_12923","title":"P1‐163: Assessing the diagnostic accuracy of viral hepatitis B and C health administrative diagnosis and billing codes using linked laboratory and administrative health databases in Ontario, Canada","year":2018,"lang":"en","type":"article","venue":"Journal of Viral Hepatitis","topic":"Hepatitis C virus research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Citation; Viral hepatitis; Library science; Hepatitis C; Medicine; Family medicine; Database; Political science; Computer science; Virology","score_opus":0.14156108011796043,"score_gpt":0.43382868701110616,"score_spread":0.29226760689314574,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4249706211","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.93985164,0.0013408877,0.00053372036,0.0013937362,0.000069511705,0.0002578089,0.05080549,0.00007007922,0.00567721],"genre_scores_gemma":[0.9855531,0.0007185051,0.00088448124,0.00022156084,0.000017799035,0.00008851111,0.011058368,0.000027266422,0.0014305072],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9951623,0.00059368083,0.0005921173,0.0006630442,0.0020756302,0.00091335276],"domain_scores_gemma":[0.97629195,0.0029182488,0.004416556,0.00074266904,0.01308962,0.0025409746],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003319194,0.0006945096,0.00092823495,0.0031732046,0.0029882751,0.002393985,0.003510137,0.0008104665,0.0023237283],"category_scores_gemma":[0.019012747,0.00094398565,0.0014370367,0.0103709465,0.0011169253,0.0008726735,0.0019043981,0.0012491192,0.00044095964],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015549788,0.00004675514,0.9881098,0.0001229883,0.00018910045,0.0000615404,0.0005755104,0.00057752157,0.00010620905,0.000253388,0.0050108116,0.0047907135],"study_design_scores_gemma":[0.000025771084,0.000018891153,0.9958003,0.00007650386,0.000073268944,0.000042877135,0.000976827,0.0015969052,0.00007385909,0.000045184002,0.0012511895,0.000018433666],"about_ca_topic_score_codex":0.9985489,"about_ca_topic_score_gemma":0.99891114,"teacher_disagreement_score":0.061205026,"about_ca_system_score_codex":0.061205026,"about_ca_system_score_gemma":0.101582244,"threshold_uncertainty_score":0.44407564},"labels":[],"label_agreement":null},{"id":"W4250550282","doi":"10.1111/jvh.174_12923","title":"P2‐051: Can we afford not to screen for and treat HCV infection in Canada","year":2018,"lang":"en","type":"article","venue":"Journal of Viral Hepatitis","topic":"Hepatitis C virus research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Citation; Hepatitis C; Medicine; Correct name; Library science; Computer science; World Wide Web; Virology; Biology","score_opus":0.030692945915890668,"score_gpt":0.3332224881548479,"score_spread":0.3025295422389572,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4250550282","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.34497908,0.0076832124,0.00044373717,0.49766433,0.0030096748,0.00030709643,0.013518147,0.00011840864,0.13227639],"genre_scores_gemma":[0.86137974,0.004003897,0.0008539194,0.08380602,0.00060071907,0.000115644645,0.00208861,0.00012312527,0.047028385],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99744946,0.0002068504,0.00011464334,0.00013678028,0.00061820797,0.001474072],"domain_scores_gemma":[0.98809683,0.00080567115,0.0004841757,0.00009481883,0.0028917077,0.0076268064],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009429834,0.00020234384,0.0004054383,0.0006524303,0.0066488055,0.002489074,0.0020728635,0.0028701213,0.01618732],"category_scores_gemma":[0.0077048903,0.00042445326,0.0007995341,0.0013982388,0.0012202105,0.00084049685,0.0013945883,0.004083894,0.0008153625],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00072012347,0.00036043633,0.3538001,0.0005064484,0.0001934511,0.0014915997,0.0027635756,0.0008982938,0.0007194288,0.010299176,0.5456816,0.08256571],"study_design_scores_gemma":[0.00044804454,0.0002402464,0.72912115,0.0018527369,0.00036884763,0.0010110026,0.021857934,0.0021990845,0.00060961954,0.003400994,0.23867139,0.00021890146],"about_ca_topic_score_codex":0.99744034,"about_ca_topic_score_gemma":0.9988757,"teacher_disagreement_score":0.06852322,"about_ca_system_score_codex":0.06852322,"about_ca_system_score_gemma":0.22073048,"threshold_uncertainty_score":0.49717307},"labels":[],"label_agreement":null},{"id":"W4250981492","doi":"10.1111/jvh.09_12922","title":"O‐012: Is hepatitis C elimination possible among HIV‐infected population in Canada?","year":2018,"lang":"en","type":"article","venue":"Journal of Viral Hepatitis","topic":"Hepatitis C virus research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Human immunodeficiency virus (HIV); Citation; Hepatitis C; Population; Viral hepatitis; Medicine; Virology; Library science; Family medicine; Computer science; Environmental health","score_opus":0.014698275641492613,"score_gpt":0.2949417462772432,"score_spread":0.28024347063575056,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4250981492","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8862246,0.006747125,0.00015580119,0.07236593,0.00029014843,0.00012614446,0.0031285223,0.00003559636,0.030926147],"genre_scores_gemma":[0.9841456,0.0030524351,0.0002600701,0.0060768146,0.00007838774,0.000019802106,0.00046778366,0.000009551676,0.00588955],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99927324,0.0000632687,0.000025629652,0.000042505526,0.00013851559,0.00045683043],"domain_scores_gemma":[0.9978405,0.0001354199,0.00022300155,0.000020921336,0.0006643986,0.001115745],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00044509687,0.00019724877,0.00020945567,0.00035949392,0.003162019,0.0012832597,0.0011666473,0.0011990458,0.0062821633],"category_scores_gemma":[0.002986592,0.000192056,0.0003799014,0.0010565917,0.000734386,0.00070814596,0.00060382707,0.0012367635,0.00028238277],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000580615,0.00029091255,0.90009546,0.00031626117,0.00007448302,0.00080396293,0.0018693794,0.0004267114,0.00048780092,0.0023189632,0.03157165,0.06116381],"study_design_scores_gemma":[0.00008619322,0.00012962577,0.9713515,0.00038971004,0.00010349718,0.00029273581,0.0110358,0.000620992,0.00022294372,0.0004198053,0.015314713,0.00003246413],"about_ca_topic_score_codex":0.99614966,"about_ca_topic_score_gemma":0.9976611,"teacher_disagreement_score":0.029520515,"about_ca_system_score_codex":0.029520515,"about_ca_system_score_gemma":0.10626977,"threshold_uncertainty_score":0.21418732},"labels":[],"label_agreement":null},{"id":"W4252306638","doi":"10.1111/jvh.12332_8","title":"O213: Daclatasvir vs telaprevir in combination with peginterferon alfa/ribavirin in treatment‐naive patients with HCV genotype 1: phase 3 COMMAND‐3 results","year":2014,"lang":"en","type":"article","venue":"Journal of Viral Hepatitis","topic":"Hepatitis C virus research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta Hospital","funders":"","keywords":"Telaprevir; Daclatasvir; Ribavirin; Medicine; Internal medicine; Virology; Genotype; Gastroenterology; Chronic hepatitis; Biology; Genetics; Gene","score_opus":0.01766427547604496,"score_gpt":0.30684666925407456,"score_spread":0.28918239377802957,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4252306638","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9949799,0.0016478985,0.00018258081,0.0002978159,0.00009704509,0.00043585396,0.00080900267,0.00005042711,0.0014995112],"genre_scores_gemma":[0.99316376,0.001322015,0.0008272469,0.0005253286,0.00015062097,0.00046751043,0.0016221541,0.000027488146,0.0018939049],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9992993,0.00040373468,0.000038887723,0.00007398733,0.000059156675,0.00012488439],"domain_scores_gemma":[0.99933785,0.00018162541,0.000117202675,0.000046911595,0.00003421178,0.00028216754],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016312343,0.0009992536,0.002086678,0.00032745753,0.00033470304,0.0007885705,0.00072146277,0.000950117,0.0031625046],"category_scores_gemma":[0.0011693221,0.00039343268,0.0019540938,0.00042188985,0.00062688894,0.0008827476,0.00024277317,0.0020714367,0.00076095475],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9013963,0.019010948,0.0033378387,0.0003531758,0.0013045486,0.00009891018,0.00013684381,0.0018158058,0.01092568,0.00010594809,0.0017746175,0.05973949],"study_design_scores_gemma":[0.5980926,0.37370023,0.019664317,0.000039039805,0.0010831549,0.00021672799,0.00008063233,0.0019886666,0.0031411503,0.00018765916,0.001752877,0.00005292634],"about_ca_topic_score_codex":0.001567011,"about_ca_topic_score_gemma":0.0039010043,"teacher_disagreement_score":0.0031625046,"about_ca_system_score_codex":0.0007546465,"about_ca_system_score_gemma":0.0012334924,"threshold_uncertainty_score":0.010579646},"labels":[],"label_agreement":null},{"id":"W4252574644","doi":"10.1111/jvh.172_12923","title":"P2‐049: Relationship of hydromorphone controlled release prescribing and hepatitis C incidence in Ontario, Canada","year":2018,"lang":"en","type":"article","venue":"Journal of Viral Hepatitis","topic":"Hepatitis C virus research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Hydromorphone; Incidence (geometry); Citation; Hepatitis; Medicine; Hepatitis C; Library science; Viral hepatitis; Family medicine; Virology; Internal medicine; Computer science; Mathematics","score_opus":0.025247815494569555,"score_gpt":0.2798805814071877,"score_spread":0.25463276591261813,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4252574644","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.979978,0.0012163342,0.0001296101,0.0021175386,0.000052748397,0.000077524695,0.009017598,0.000022652255,0.007387934],"genre_scores_gemma":[0.9944799,0.000626866,0.0001432108,0.00031016394,0.000017148304,0.000021087284,0.0011781688,0.000013072456,0.0032103285],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99908626,0.00008327051,0.000087622175,0.000106603075,0.00030880028,0.00032737784],"domain_scores_gemma":[0.99462247,0.00040636025,0.0012246576,0.00010692478,0.0021329666,0.0015066859],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00038625096,0.00022347708,0.00041897656,0.00090265437,0.0025311196,0.0013052914,0.0015275606,0.00061970315,0.00506548],"category_scores_gemma":[0.0030499408,0.00047598677,0.00083280326,0.0032812222,0.00065069,0.00035984966,0.0006489401,0.0011510799,0.00030847685],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017739674,0.00006483247,0.99225336,0.000054649314,0.000074634234,0.00018085625,0.00045448184,0.00017546886,0.00017595044,0.00016452315,0.002953383,0.0032705811],"study_design_scores_gemma":[0.000026395477,0.000030863706,0.9968831,0.00005639155,0.000041789826,0.00008909358,0.0011431472,0.00033454222,0.00005694082,0.000026201984,0.0012999219,0.000011524491],"about_ca_topic_score_codex":0.9974558,"about_ca_topic_score_gemma":0.99858487,"teacher_disagreement_score":0.036471464,"about_ca_system_score_codex":0.036471464,"about_ca_system_score_gemma":0.05517303,"threshold_uncertainty_score":0.26462024},"labels":[],"label_agreement":null},{"id":"W4280511675","doi":"10.1111/jvh.13706","title":"Internet‐guided <scp>HCV‐RNA</scp> testing: A promising tool to achieve hepatitis C micro‐elimination among men who have sex with men","year":2022,"lang":"en","type":"article","venue":"Journal of Viral Hepatitis","topic":"Hepatitis C virus research","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Infection and Immunity","funders":"Roche Diagnostics; AbbVie; Gilead Sciences","keywords":"Men who have sex with men; Test (biology); Medicine; Hepatitis C virus; Population; Service (business); Hepatitis C; Transmission (telecommunications); Virology; Environmental health; Computer science; Biology; Business; Virus; Human immunodeficiency virus (HIV)","score_opus":0.03095591414636701,"score_gpt":0.29899713575838444,"score_spread":0.26804122161201743,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4280511675","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98893446,0.00042630328,0.0021887552,0.0005540336,0.00002714351,0.00027074083,0.00015125592,0.0002543207,0.0071930205],"genre_scores_gemma":[0.98541117,0.0006750452,0.009818777,0.00030234375,0.000049464306,0.00014146462,0.00024002405,0.000042929703,0.003318727],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9994142,0.0003785143,0.00001391253,0.000031230913,0.00011623395,0.000045809422],"domain_scores_gemma":[0.9992003,0.00042515254,0.00009268088,0.000028293203,0.000088518565,0.00016510481],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010846887,0.00016584164,0.00012790094,0.0002386764,0.000238403,0.00064486614,0.0002946853,0.00023863568,0.003990883],"category_scores_gemma":[0.001906287,0.000062015,0.00013666836,0.00017371068,0.00020162953,0.0005467031,0.0003363751,0.00016978513,0.00082698656],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012098282,0.0062415306,0.12681445,0.0007393063,0.000044004617,0.0006250802,0.002549735,0.0006176054,0.012525347,0.00050873356,0.009693437,0.83843094],"study_design_scores_gemma":[0.0008260875,0.033368535,0.77887094,0.0009968433,0.0004358235,0.0041515063,0.008906575,0.037128467,0.04031095,0.0017557425,0.0930324,0.00021609172],"about_ca_topic_score_codex":0.002425693,"about_ca_topic_score_gemma":0.0031122037,"teacher_disagreement_score":0.003990883,"about_ca_system_score_codex":0.00015243003,"about_ca_system_score_gemma":0.00036886366,"threshold_uncertainty_score":0.013350844},"labels":[],"label_agreement":null},{"id":"W4281606944","doi":"10.1111/jvh.13717","title":"International multicenter validation of <scp>GES</scp> score for <scp>HCC</scp> risk stratification in chronic hepatitis C patients","year":2022,"lang":"en","type":"article","venue":"Journal of Viral Hepatitis","topic":"Hepatitis C virus research","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"University of Texas MD Anderson Cancer Center; Agence Nationale de la Recherche","keywords":"Medicine; Hepatocellular carcinoma; Internal medicine; Hepatitis C virus; Cohort; Framingham Risk Score; Genotype; Risk stratification; Ethnic group; Oncology; Disease; Virus; Immunology; Gene; Biology","score_opus":0.0253754238937506,"score_gpt":0.3154956025338403,"score_spread":0.2901201786400897,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4281606944","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9938909,0.00035360127,0.0021586579,0.000113918286,0.000044209246,0.00026479043,0.0011618718,0.00004826977,0.0019638475],"genre_scores_gemma":[0.9958721,0.00007048077,0.0016922017,0.000050691087,0.000023583392,0.00010921138,0.0019427721,0.000010669396,0.00022824493],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9970515,0.001703957,0.00022364316,0.00033657718,0.00052255305,0.00016177566],"domain_scores_gemma":[0.9950369,0.0010481866,0.0011977375,0.0006806116,0.0015636839,0.00047285183],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.010142449,0.00083678216,0.0004775595,0.0012795689,0.00038445476,0.0007187592,0.00048479592,0.0005061315,0.00081015454],"category_scores_gemma":[0.012577484,0.00016880431,0.00075814925,0.00092759926,0.0004907175,0.00044059556,0.0010126068,0.0004211658,0.00047958767],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018877276,0.0001923179,0.980856,0.000034269902,0.00037039534,0.0000496712,0.000103066384,0.0013124332,0.00066878065,0.00012381832,0.0012018619,0.013199701],"study_design_scores_gemma":[0.00036052158,0.00141609,0.98484933,0.00003414116,0.00021130155,0.00027151665,0.00013301898,0.009805204,0.00075732917,0.00021115248,0.0019283136,0.000022095766],"about_ca_topic_score_codex":0.002092916,"about_ca_topic_score_gemma":0.0019950857,"teacher_disagreement_score":0.010142449,"about_ca_system_score_codex":0.00035574017,"about_ca_system_score_gemma":0.0007160389,"threshold_uncertainty_score":0.053638995},"labels":[],"label_agreement":null},{"id":"W4283167288","doi":"10.1111/jvh.13723","title":"Impact of <scp>COVID</scp>‐19 lockdown restrictions on hepatitis C testing in Australian primary care services providing care for people who inject drugs","year":2022,"lang":"en","type":"article","venue":"Journal of Viral Hepatitis","topic":"HIV, Drug Use, Sexual Risk","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Simon Fraser University","funders":"National Health and Medical Research Council; NSW Ministry of Health","keywords":"Medicine; Coronavirus disease 2019 (COVID-19); Antibody; Population; Hepatitis C; Virology; Immunology; Internal medicine; Environmental health","score_opus":0.02915872468763862,"score_gpt":0.3339948161098864,"score_spread":0.30483609142224777,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4283167288","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9889727,0.000706205,0.0005226219,0.0022585276,0.000041956002,0.00011885633,0.0031528987,0.000033075954,0.0041931663],"genre_scores_gemma":[0.9962341,0.0002580468,0.0005128713,0.0007996041,0.000026461365,0.0001002924,0.0012640232,0.000013533031,0.0007911138],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9889187,0.0044468245,0.0011754977,0.00082769635,0.0024771276,0.0021542355],"domain_scores_gemma":[0.9721429,0.012159539,0.008835698,0.0012642154,0.0025086096,0.0030890491],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.009056269,0.00018767497,0.00041067213,0.00084852136,0.00083095906,0.0017807846,0.0011264822,0.00057278323,0.0030390685],"category_scores_gemma":[0.046000607,0.00041487673,0.0011099746,0.0013966804,0.0008004351,0.0009208548,0.0023922964,0.0015419187,0.00021488918],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009177603,0.00031910776,0.94555014,0.0006422092,0.00040731815,0.0003819617,0.0036018759,0.004807753,0.00087016606,0.0014836034,0.0036223226,0.037395786],"study_design_scores_gemma":[0.000016624304,0.00019783588,0.99365884,0.00013684077,0.000054999626,0.00006507617,0.00069986767,0.0022205897,0.00015597242,0.000114634866,0.0026653153,0.000013547764],"about_ca_topic_score_codex":0.47641128,"about_ca_topic_score_gemma":0.43467325,"teacher_disagreement_score":0.47641128,"about_ca_system_score_codex":0.008875646,"about_ca_system_score_gemma":0.010653516,"threshold_uncertainty_score":0.94727653},"labels":[],"label_agreement":null},{"id":"W4293761195","doi":"10.1111/jvh.13738","title":"Safety analysis of glecaprevir/pibrentasvir in patients with markers of advanced liver disease in clinical and real‐world cohorts","year":2022,"lang":"en","type":"article","venue":"Journal of Viral Hepatitis","topic":"Hepatitis C virus research","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University Health Network","funders":"AbbVie","keywords":"Internal medicine; Disease; Medicine; Liver disease","score_opus":0.013668682661485531,"score_gpt":0.32213102874582594,"score_spread":0.3084623460843404,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4293761195","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9962921,0.0013597322,0.0003225607,0.000121261255,0.000021661332,0.00016288488,0.001009761,0.000011842971,0.0006982467],"genre_scores_gemma":[0.99762976,0.00026645118,0.00022390501,0.00011432361,0.000037379792,0.00010220009,0.0014586286,0.000004753078,0.00016259978],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99513173,0.003090551,0.00030129572,0.000585517,0.000673403,0.00021745478],"domain_scores_gemma":[0.9913338,0.0026611448,0.0034197553,0.0009104461,0.00092573656,0.0007490476],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.008062911,0.0006259734,0.00081164006,0.0005224586,0.00030835127,0.0011661224,0.0004915836,0.00076765293,0.0020959796],"category_scores_gemma":[0.009539293,0.0002418885,0.0017375504,0.0006404128,0.00061950117,0.0008621501,0.00048254928,0.001025247,0.00030895896],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.38561568,0.0046114274,0.5462911,0.0007676352,0.01090861,0.00041309203,0.00035101385,0.0034599814,0.0064053475,0.00053025276,0.0021628607,0.038482904],"study_design_scores_gemma":[0.04377728,0.13138305,0.7952861,0.00017058366,0.005156196,0.0020014234,0.00055667275,0.009177163,0.0050163707,0.0007929522,0.0064800438,0.00020215318],"about_ca_topic_score_codex":0.00037189884,"about_ca_topic_score_gemma":0.00043042924,"teacher_disagreement_score":0.008062911,"about_ca_system_score_codex":0.0006800295,"about_ca_system_score_gemma":0.00069751637,"threshold_uncertainty_score":0.042641282},"labels":[],"label_agreement":null},{"id":"W4294045143","doi":"10.1111/jvh.13742","title":"Early virologic relapse predicts alanine aminotransferase flares after nucleos(t)ide analogue withdrawal in patients with chronic hepatitis B","year":2022,"lang":"en","type":"article","venue":"Journal of Viral Hepatitis","topic":"Hepatitis B Virus Studies","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Centre for Global Health Research; Toronto Liver Centre; University Health Network","funders":"National Natural Science Foundation of China; University Health Network","keywords":"Medicine; Internal medicine; Cumulative incidence; Gastroenterology; HBsAg; Proportional hazards model; Chronic hepatitis; Incidence (geometry); Hepatitis B; Alanine aminotransferase; Prospective cohort study; Cohort; Hepatitis B virus; Immunology; Virus","score_opus":0.005679702206272041,"score_gpt":0.21389297940996016,"score_spread":0.20821327720368812,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4294045143","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9985967,0.0009845137,0.0000991662,0.00006444965,0.000006651843,0.000019328441,0.00003900247,0.0000032713629,0.00018677922],"genre_scores_gemma":[0.99954766,0.00015751085,0.00008785379,0.000027545182,0.000014454179,0.000011087467,0.000070642534,9.804986e-7,0.00008237828],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990478,0.000603584,0.00009650577,0.00008921376,0.000098372395,0.00006458523],"domain_scores_gemma":[0.99431133,0.0029071197,0.0019973062,0.00021920151,0.00020175117,0.0003633735],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003109774,0.00029071353,0.00042072398,0.00022283473,0.00014052769,0.00046303394,0.00023750504,0.0004649652,0.0013581507],"category_scores_gemma":[0.007388354,0.00021220036,0.0008210107,0.00023584938,0.00025647966,0.0003977159,0.00029410093,0.00060981157,0.00020476036],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0056679295,0.00019105269,0.98289734,0.000085448046,0.00016703275,0.00004089864,0.00004047389,0.00012300716,0.00027821792,0.000013142454,0.00007108498,0.010424427],"study_design_scores_gemma":[0.00042306713,0.0038010485,0.9934186,0.0000618113,0.00025959848,0.00024935766,0.000074915246,0.001192255,0.00025114685,0.00006262101,0.00019765265,0.000007982588],"about_ca_topic_score_codex":0.00040836824,"about_ca_topic_score_gemma":0.00057991344,"teacher_disagreement_score":0.003109774,"about_ca_system_score_codex":0.00015955567,"about_ca_system_score_gemma":0.00031484893,"threshold_uncertainty_score":0.016446233},"labels":[],"label_agreement":null},{"id":"W4302362273","doi":"10.1111/jvh.13753","title":"A randomized phase 1b trial of the active site polymerase inhibitor nucleotide <scp>ATI</scp>‐2173 in patients with chronic hepatitis B virus infection","year":2022,"lang":"en","type":"article","venue":"Journal of Viral Hepatitis","topic":"Hepatitis B Virus Studies","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Altasciences (Canada)","funders":"","keywords":"Tolerability; Medicine; Placebo; Adverse effect; Internal medicine; Hepatitis B virus; Immunology; Pharmacology; Virology; Gastroenterology; Virus; Pathology","score_opus":0.008560298899872632,"score_gpt":0.26004819006172597,"score_spread":0.2514878911618533,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4302362273","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9885075,0.002954531,0.00043705216,0.0004436522,0.0004620397,0.0043423865,0.00082644174,0.000106786945,0.0019196306],"genre_scores_gemma":[0.98903894,0.0016961253,0.0011320558,0.00091069296,0.00034554474,0.0035022912,0.0010297709,0.000018889064,0.002325616],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99951875,0.0002922834,0.000024961026,0.000071707706,0.0000289299,0.000063361476],"domain_scores_gemma":[0.9994248,0.0001537291,0.00012830015,0.000044777924,0.00004569725,0.00020267023],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015613181,0.0011787163,0.0019998213,0.00031179967,0.000379909,0.00065944274,0.00048114653,0.001184267,0.005930749],"category_scores_gemma":[0.0010870674,0.0005269118,0.0010633554,0.00025494734,0.0006563241,0.0005752822,0.00027304477,0.0018961403,0.00068455713],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.97680396,0.005325872,0.0005717773,0.00038974234,0.00045991156,0.000038751103,0.000036329075,0.00021679029,0.0038535534,0.000101655736,0.0008191159,0.01138239],"study_design_scores_gemma":[0.9231198,0.07405388,0.0014722248,0.000015136301,0.00018395369,0.0000295346,0.000013442734,0.0002819589,0.00030217023,0.00007426024,0.00044469867,0.000008894244],"about_ca_topic_score_codex":0.00059849763,"about_ca_topic_score_gemma":0.0013550107,"teacher_disagreement_score":0.005930749,"about_ca_system_score_codex":0.0004543235,"about_ca_system_score_gemma":0.00091466034,"threshold_uncertainty_score":0.01984036},"labels":[],"label_agreement":null},{"id":"W4307497565","doi":"10.1111/jvh.13761","title":"Hepatitis C virus‐specific immune responses following direct‐acting antivirals administered during recent hepatitis C virus infection","year":2022,"lang":"en","type":"article","venue":"Journal of Viral Hepatitis","topic":"Hepatitis C virus research","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto General Hospital; University of Toronto; University Health Network","funders":"Department of Health and Aged Care, Australian Government","keywords":"ELISPOT; Medicine; Immune system; Hepatitis C virus; Immunology; Interferon; Virus; Virology; T cell","score_opus":0.04178207000462755,"score_gpt":0.33471341554755885,"score_spread":0.2929313455429313,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4307497565","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99954635,0.00023150313,0.000036157413,0.000005441644,0.0000035202916,0.000006287058,0.000011682027,0.0000011475831,0.00015789866],"genre_scores_gemma":[0.9996313,0.000092693896,0.000038765764,0.000021875017,0.000010359698,0.000008381446,0.00004870605,5.942618e-7,0.00014725329],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9997689,0.00010113839,0.00002260834,0.000033470496,0.000030004276,0.000043857806],"domain_scores_gemma":[0.9995023,0.00018048349,0.00013813756,0.000032624954,0.00004871765,0.00009777389],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005155214,0.00015418963,0.00034988497,0.0001636197,0.00015063792,0.00022642141,0.000086910826,0.0002100092,0.0006661205],"category_scores_gemma":[0.0011284256,0.00010156444,0.00012255053,0.000113518276,0.00016378018,0.00017719703,0.00014144182,0.0002626825,0.00014260785],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.013877666,0.0012145995,0.7407958,0.0004664075,0.00017619292,0.0018134174,0.0011160788,0.00048000354,0.16856408,0.00009543043,0.0002921979,0.0711081],"study_design_scores_gemma":[0.000101032136,0.008001903,0.97531545,0.0000244186,0.00006905377,0.0016981671,0.0002423968,0.00028487848,0.013484455,0.000037554735,0.00073211105,0.000008493066],"about_ca_topic_score_codex":0.00018226735,"about_ca_topic_score_gemma":0.0002963521,"teacher_disagreement_score":0.0006661205,"about_ca_system_score_codex":0.00015561051,"about_ca_system_score_gemma":0.00009341207,"threshold_uncertainty_score":0.002726376},"labels":[],"label_agreement":null},{"id":"W4310638951","doi":"10.1111/jvh.13780","title":"Integrated supervised consumption services and hepatitis C testing and treatment among people who inject drugs in Toronto, Canada: A cross‐sectional analysis","year":2022,"lang":"en","type":"article","venue":"Journal of Viral Hepatitis","topic":"Hepatitis C virus research","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Western University; Public Health Ontario; University of Toronto; Regent Park Community Health Centre; St. Michael's Hospital","funders":"Canadian Institutes of Health Research; St. Michael's Hospital Foundation; Public Health Agency of Canada","keywords":"Medicine; Hepatitis C; Harm reduction; Confidence interval; Cross-sectional study; Internal medicine; Family medicine; Human immunodeficiency virus (HIV); Pathology","score_opus":0.021863103675477804,"score_gpt":0.3006898689686396,"score_spread":0.2788267652931618,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4310638951","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9795212,0.001229595,0.00019179388,0.0004152223,0.000020759482,0.00014761578,0.016966736,0.000017765704,0.001489229],"genre_scores_gemma":[0.99243635,0.0007711078,0.00026813208,0.00018777068,0.000012013431,0.00008886634,0.005234082,0.0000073108836,0.0009942034],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99853396,0.00016586276,0.00015812824,0.00022088336,0.00044826185,0.00047293084],"domain_scores_gemma":[0.9956501,0.0003092687,0.001088133,0.00020884142,0.0017232097,0.0010204633],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011312017,0.0005669792,0.0007061653,0.0012634589,0.0025517715,0.001516272,0.0015863744,0.00067867315,0.003451399],"category_scores_gemma":[0.003229344,0.0007890122,0.0016701228,0.004841459,0.0008266305,0.0005960924,0.0016125937,0.0011728951,0.00036136297],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000538663,0.00003133298,0.9972561,0.000059716065,0.00012794179,0.000039884962,0.00046840645,0.00011263991,0.00005332767,0.000047297264,0.000779828,0.0009696485],"study_design_scores_gemma":[0.0000104918945,0.000028917324,0.99797004,0.000055338278,0.000076280136,0.000034145996,0.0010121063,0.000326989,0.000025393234,0.000010951103,0.00043881286,0.000010475469],"about_ca_topic_score_codex":0.99465275,"about_ca_topic_score_gemma":0.9956905,"teacher_disagreement_score":0.03433607,"about_ca_system_score_codex":0.03433607,"about_ca_system_score_gemma":0.031968918,"threshold_uncertainty_score":0.24912685},"labels":[],"label_agreement":null},{"id":"W4366241054","doi":"10.1111/jvh.13837","title":"A population‐based study of reported hepatitis C diagnoses from 1998 to 2018 in immigrants and nonimmigrants in Quebec, Canada","year":2023,"lang":"en","type":"article","venue":"Journal of Viral Hepatitis","topic":"Hepatitis C virus research","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"BC Centre for Disease Control; Public Health Ontario; Toronto General Hospital; University Health Network; University of Toronto; McGill University Health Centre; Institut National de Santé Publique du Québec; Institute for Clinical Evaluative Sciences; Centre Hospitalier de l’Université de Montréal; McGill University; Jewish General Hospital","funders":"Canadian Institutes of Health Research; Canada Research Chairs; Public Health Agency of Canada","keywords":"Medicine; Demography; Immigration; Poisson regression; Population; Hepatitis C; Cohort; Relative risk; Cohort study; Epidemiology; Geography; Internal medicine; Environmental health; Confidence interval","score_opus":0.027263776189639804,"score_gpt":0.3194647766665211,"score_spread":0.2922010004768813,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4366241054","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97259057,0.001098992,0.00022262985,0.00036006837,0.00002729788,0.00015686794,0.023779051,0.000024869727,0.0017397023],"genre_scores_gemma":[0.9906364,0.00063875644,0.00027436492,0.00025851297,0.0000141588125,0.000094182884,0.0066075334,0.000008716339,0.0014673832],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99927,0.000059456564,0.000068365334,0.0001736662,0.00019794093,0.00023052913],"domain_scores_gemma":[0.99755776,0.00012507713,0.00045998147,0.00007465136,0.001237815,0.0005446942],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00076779455,0.0005299758,0.00051266403,0.0016712196,0.00286389,0.0012309321,0.0014097568,0.0005611781,0.0023761166],"category_scores_gemma":[0.0017981816,0.0004569399,0.0007614434,0.0045382613,0.0005547979,0.000539512,0.0007581341,0.0008079007,0.00040085425],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000084801686,0.00004478035,0.99450433,0.0000466936,0.0000864022,0.00006959942,0.0003969132,0.000082041624,0.00012333502,0.00004309171,0.0021593382,0.00235868],"study_design_scores_gemma":[0.000012512406,0.000022532146,0.9980696,0.000037898593,0.000026385771,0.00004892348,0.0005652235,0.0002308489,0.000028415772,0.000007407567,0.0009413638,0.0000088496045],"about_ca_topic_score_codex":0.9946355,"about_ca_topic_score_gemma":0.9952232,"teacher_disagreement_score":0.029045397,"about_ca_system_score_codex":0.029045397,"about_ca_system_score_gemma":0.019293291,"threshold_uncertainty_score":0.21074009},"labels":[],"label_agreement":null},{"id":"W4381309765","doi":"10.1111/jvh.13863","title":"Contribution of alcohol use in <scp>HIV</scp>/hepatitis C virus co‐infection to all‐cause and cause‐specific mortality: A collaboration of cohort studies","year":2023,"lang":"en","type":"article","venue":"Journal of Viral Hepatitis","topic":"Hepatitis C virus research","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Heritage Medical Research Clinic; University of Calgary","funders":"National Institute of Allergy and Infectious Diseases; National Institute on Alcohol Abuse and Alcoholism; Merck Sharp and Dohme; European Regional Development Fund; Stichting HIV Monitoring; Ministère des Affaires Sociales et de la Santé; Institut National de la Santé et de la Recherche Médicale; National Institute for Health and Care Research; Alberta Health; Ministerie van Volksgezondheid, Welzijn en Sport; Ministerio de Sanidad, Política Social e Igualdad; ViiV Healthcare; Wellcome Trust; Office of Research and Development; Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung; Janssen Pharmaceuticals; Gilead Sciences; U.S. Department of Veterans Affairs","keywords":"Human immunodeficiency virus (HIV); Cohort; Virology; Hepatitis C virus; Medicine; Alcohol; Cohort study; Hepatitis C; Hepatitis virus; Virus; Environmental health; Biology; Internal medicine","score_opus":0.0977917006218127,"score_gpt":0.40795897450794394,"score_spread":0.31016727388613125,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4381309765","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9816714,0.010475489,0.00090282096,0.00030504417,0.00010435933,0.00008589007,0.004948002,0.00002419962,0.0014827154],"genre_scores_gemma":[0.9952141,0.0021892807,0.00038986278,0.00007249608,0.000043148382,0.000050489944,0.0016022215,0.000010134921,0.00042826912],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99744654,0.0011192745,0.0002987661,0.0005456899,0.0003719577,0.00021777216],"domain_scores_gemma":[0.99334174,0.0015102123,0.001695058,0.0014706877,0.0014752713,0.00050718937],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0058064978,0.00044785897,0.00055704615,0.0013384771,0.0007381947,0.001693687,0.00062278734,0.0004887904,0.00096736697],"category_scores_gemma":[0.0086622415,0.00050559966,0.0026757163,0.001962855,0.00024374522,0.00043668182,0.0013596513,0.0007480547,0.00013301517],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017208148,0.000008856808,0.99436635,0.000067834975,0.0022749777,0.000033491804,0.00009024755,0.000049260998,0.000077098135,0.000049303668,0.00025670277,0.002553745],"study_design_scores_gemma":[0.000020024409,0.000050578554,0.9965462,0.00006880415,0.0016222433,0.00016353776,0.00015097446,0.0003004064,0.0000786721,0.00007592247,0.0009113547,0.000011322965],"about_ca_topic_score_codex":0.04186436,"about_ca_topic_score_gemma":0.053877037,"teacher_disagreement_score":0.04186436,"about_ca_system_score_codex":0.00052597973,"about_ca_system_score_gemma":0.0013794269,"threshold_uncertainty_score":0.0832414},"labels":[],"label_agreement":null},{"id":"W4381470523","doi":"10.1111/jvh.13866","title":"Migrants and hepatitis: A tale of two worlds","year":2023,"lang":"en","type":"letter","venue":"Journal of Viral Hepatitis","topic":"Hepatitis C virus research","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Computer science; Data science; Computational biology; Biology","score_opus":0.030806352099571232,"score_gpt":0.33826777231802446,"score_spread":0.30746142021845324,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4381470523","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.008668564,0.103737324,0.00071415165,0.8521067,0.02394262,0.000030145316,0.000100910685,0.00008122262,0.01061833],"genre_scores_gemma":[0.106089205,0.23464277,0.0018136444,0.5644276,0.07328181,0.000114607705,0.00021309135,0.00023596839,0.019181322],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.994735,0.0029660629,0.00023566544,0.00042281952,0.00079554005,0.0008449781],"domain_scores_gemma":[0.992361,0.00344215,0.00048311436,0.00040176112,0.00082810654,0.0024838897],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0061250967,0.0011905953,0.0016660675,0.0028533547,0.011901051,0.0169004,0.0018689121,0.011186309,0.011759664],"category_scores_gemma":[0.010225604,0.00087016507,0.0009932356,0.0020572403,0.016164243,0.02366283,0.014473615,0.018989155,0.0018879961],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00025288734,0.00022067536,0.011060038,0.0011409897,0.00021029857,0.002514364,0.084620304,0.00009870813,0.000370077,0.058791768,0.64318335,0.19753644],"study_design_scores_gemma":[0.000035651832,0.00017398123,0.005175617,0.00410483,0.00006851457,0.0032626414,0.11570224,0.000087992405,0.000094854375,0.05579692,0.81535524,0.00014144075],"about_ca_topic_score_codex":0.010151377,"about_ca_topic_score_gemma":0.019001102,"teacher_disagreement_score":0.0169004,"about_ca_system_score_codex":0.0028701036,"about_ca_system_score_gemma":0.005665238,"threshold_uncertainty_score":0.03934002},"labels":[],"label_agreement":null},{"id":"W4387296246","doi":"10.1111/jvh.13889","title":"Does hepatitis delta virus have a preference for hepatitis B virus genotype? A systematic review of the literature","year":2023,"lang":"en","type":"review","venue":"Journal of Viral Hepatitis","topic":"Hepatitis B Virus Studies","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Hepatitis D virus; Virology; Genotype; Hepatitis B virus; Hepatitis D; Virus; Hepatitis C virus; Biology; Hepatitis B; Medicine; Genetics; Gene; HBsAg","score_opus":0.056307676486900334,"score_gpt":0.342132905956778,"score_spread":0.28582522946987765,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387296246","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0014070556,0.99781203,0.000029758192,0.0002143665,0.00007011671,0.000040208426,0.00026928357,0.0000026106432,0.00015451774],"genre_scores_gemma":[0.012504715,0.98645884,0.00014440552,0.0004301594,0.00006700817,0.000095588424,0.00022926752,0.0000030734584,0.00006701955],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9954537,0.0009969161,0.0023508852,0.00038688452,0.00066492776,0.00014662993],"domain_scores_gemma":[0.9689566,0.023214594,0.004825059,0.0003164651,0.0023580156,0.0003293459],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0042736772,0.0009800429,0.0060371323,0.017300086,0.0005927684,0.002201294,0.0012815021,0.00161672,0.0040847748],"category_scores_gemma":[0.022870708,0.00083751965,0.0036591075,0.02128303,0.0009980449,0.0025825985,0.0012011685,0.0007113205,0.0003176702],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002464248,0.000012404208,0.0034486528,0.9368714,0.0038909803,0.00030608257,0.00043990221,0.00004903209,0.00020357456,0.00023904415,0.0026602934,0.051632147],"study_design_scores_gemma":[0.00013846644,0.00018752382,0.016092023,0.92654145,0.028938662,0.0016913051,0.001032758,0.000047849204,0.00014743273,0.00026145778,0.024877254,0.000043882566],"about_ca_topic_score_codex":0.010165267,"about_ca_topic_score_gemma":0.022441305,"teacher_disagreement_score":0.017300086,"about_ca_system_score_codex":0.0032878593,"about_ca_system_score_gemma":0.0075798626,"threshold_uncertainty_score":0.023855269},"labels":[],"label_agreement":null},{"id":"W4391053435","doi":"10.1111/jvh.13918","title":"Addition of PEG‐interferon to long‐term nucleos(t)ide analogue therapy enhances HBsAg decline and clearance in HBeAg‐negative chronic hepatitis B","year":2024,"lang":"en","type":"article","venue":"Journal of Viral Hepatitis","topic":"Hepatitis B Virus Studies","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Toronto; Toronto General Hospital; University Health Network","funders":"F. Hoffmann-La Roche","keywords":"HBsAg; Medicine; HBeAg; Gastroenterology; Internal medicine; PEG ratio; Combination therapy; Chronic hepatitis; Hepatitis B virus; Immunology; Virus","score_opus":0.017378658277352577,"score_gpt":0.312825760864917,"score_spread":0.2954471025875644,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4391053435","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99817157,0.0010384707,0.00013320729,0.000080220925,0.00007056144,0.00017124097,0.000049996197,0.000018144867,0.0002665067],"genre_scores_gemma":[0.9982205,0.0005461552,0.00035514927,0.00011820293,0.0000865329,0.00017671811,0.000091564805,0.0000040513137,0.00040116065],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99947923,0.00032455407,0.000042084757,0.000054454966,0.0000338642,0.00006584968],"domain_scores_gemma":[0.9992532,0.00027819516,0.00016446265,0.00004900355,0.000036985624,0.00021816057],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011634489,0.00051306345,0.0010925236,0.0001648855,0.00018193416,0.00048550163,0.00038449967,0.0007491055,0.0020182915],"category_scores_gemma":[0.001216377,0.00038047676,0.0008136809,0.00016086132,0.00047912047,0.0005378182,0.00020618014,0.0011475354,0.00026894195],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.8817431,0.023207206,0.0039762375,0.0005549409,0.0007240362,0.00007356033,0.00010787526,0.000539737,0.024270685,0.000060686492,0.0004401585,0.06430193],"study_design_scores_gemma":[0.45359355,0.51813847,0.02053611,0.00007535879,0.00057582767,0.000119277734,0.00005430582,0.0012432439,0.0046878234,0.000084552354,0.0008646963,0.000026713582],"about_ca_topic_score_codex":0.00055133924,"about_ca_topic_score_gemma":0.0013115623,"teacher_disagreement_score":0.0020182915,"about_ca_system_score_codex":0.00028326074,"about_ca_system_score_gemma":0.00045316303,"threshold_uncertainty_score":0.006751895},"labels":[],"label_agreement":null},{"id":"W4391650026","doi":"10.1111/jvh.13925","title":"Test characteristics for combining non‐invasive liver fibrosis staging modalities in individuals with Hepatitis C virus","year":2024,"lang":"en","type":"article","venue":"Journal of Viral Hepatitis","topic":"Liver Disease Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University Health Network","funders":"National Institute on Drug Abuse; Center for AIDS Research, University of Washington; National Institutes of Health; Charles A. King Trust; Novo Nordisk; Gilead Sciences; National Institute of Allergy and Infectious Diseases; Pfizer; Patrick and Catherine Weldon Donaghue Medical Research Foundation","keywords":"Medicine; Cirrhosis; Transient elastography; Internal medicine; Fibrosis; Liver biopsy; Population; Gastroenterology; Biopsy; Radiology; Liver fibrosis","score_opus":0.014074495795338933,"score_gpt":0.2634079338953853,"score_spread":0.24933343810004638,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4391650026","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.93347555,0.0016111367,0.05844768,0.0008107039,0.00006644973,0.0007977926,0.0023518484,0.00021680183,0.0022221538],"genre_scores_gemma":[0.98210216,0.00016236471,0.015604235,0.00013862994,0.000014826207,0.0005039848,0.0011133588,0.000026947397,0.0003334052],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.980048,0.015172867,0.00089128653,0.0018838797,0.0015251983,0.00047877157],"domain_scores_gemma":[0.8533981,0.12822868,0.010280376,0.0045061023,0.0025978165,0.0009888582],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.038928997,0.00086369505,0.001079268,0.0015892007,0.00034872026,0.0018899919,0.0009231234,0.0016084878,0.002310792],"category_scores_gemma":[0.12968946,0.00058225676,0.0031571863,0.0012151946,0.0008164568,0.0014666931,0.001054672,0.0013631671,0.00043149345],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008317287,0.0005359344,0.6596814,0.00031710905,0.0030302058,0.00041499865,0.00044510336,0.21960774,0.0013034649,0.00385833,0.0017882702,0.10070019],"study_design_scores_gemma":[0.0021328027,0.009230457,0.24982864,0.0005560624,0.004924516,0.0016910043,0.0004907603,0.6999624,0.005171535,0.02015637,0.0055894726,0.00026601707],"about_ca_topic_score_codex":0.002112597,"about_ca_topic_score_gemma":0.0018648836,"teacher_disagreement_score":0.038928997,"about_ca_system_score_codex":0.001185591,"about_ca_system_score_gemma":0.0011394694,"threshold_uncertainty_score":0.20587867},"labels":[],"label_agreement":null},{"id":"W4392040631","doi":"10.1111/jvh.13931","title":"Real‐world hepatitis C prevalence and treatment uptake at opioid agonist therapy clinics in Ontario, Canada","year":2024,"lang":"en","type":"article","venue":"Journal of Viral Hepatitis","topic":"Hepatitis C virus research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Toronto; York University; University Health Network","funders":"","keywords":"Medicine; Agonist; Hepatitis C; Opioid; Internal medicine; Pharmacology; Family medicine; Receptor","score_opus":0.03530417547312426,"score_gpt":0.3291556698091861,"score_spread":0.29385149433606184,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4392040631","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9807777,0.0012697512,0.00013148757,0.0022876752,0.000028063538,0.00014023809,0.008671591,0.000033163284,0.0066603315],"genre_scores_gemma":[0.995789,0.0007107226,0.00018130105,0.00031742614,0.000008517022,0.000035550904,0.0013853,0.000009001398,0.0015631535],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9977639,0.0001807068,0.00013973212,0.00026709586,0.0008774842,0.000771094],"domain_scores_gemma":[0.9922456,0.00046543588,0.0016179188,0.00014857147,0.0031428582,0.0023796114],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008242127,0.0003019794,0.00043322434,0.0013264535,0.004022996,0.0017514803,0.0017229215,0.00055591244,0.0036321345],"category_scores_gemma":[0.003814726,0.00051250553,0.00065577414,0.004690116,0.0011771646,0.00076980516,0.0010918389,0.00090221147,0.00037508426],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000084277526,0.00005452628,0.9865595,0.000107884945,0.000050688064,0.00015225435,0.0024661664,0.00020055722,0.00022492059,0.00018597698,0.003539473,0.00637368],"study_design_scores_gemma":[0.000010425748,0.000025395175,0.99505734,0.00006460687,0.000014947231,0.000058965754,0.0032010367,0.0002971131,0.000036230907,0.000018585815,0.0011995368,0.000015867134],"about_ca_topic_score_codex":0.9983347,"about_ca_topic_score_gemma":0.9990657,"teacher_disagreement_score":0.07585587,"about_ca_system_score_codex":0.07585587,"about_ca_system_score_gemma":0.0631283,"threshold_uncertainty_score":0.55037546},"labels":[],"label_agreement":null},{"id":"W4392810368","doi":"10.1111/jvh.13937","title":"Performance of <scp>HCV</scp> core antigen and <scp>PCR</scp> testing in a predominantly genotype 3 population","year":2024,"lang":"en","type":"article","venue":"Journal of Viral Hepatitis","topic":"Hepatitis C virus research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Centre for Disease Control","funders":"","keywords":"Medicine; Genotype; Internal medicine; Hepatitis C virus; Population; Antibody; Antigen; Immunology; Gastroenterology; Hepatitis C; Virology; Polymerase chain reaction; Biology; Virus; Gene","score_opus":0.037227753346706305,"score_gpt":0.31554309972679767,"score_spread":0.27831534638009137,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4392810368","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.999418,0.00006298015,0.000105879764,0.000012276511,0.0000018252401,0.000008222174,0.000044156073,0.0000021184183,0.00034466223],"genre_scores_gemma":[0.9996164,0.000036176298,0.00018265289,0.0000153909,0.000005443593,0.000005096557,0.00007251813,9.679846e-7,0.00006531786],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989322,0.0004400338,0.00010438839,0.00022483774,0.0001787687,0.00011972206],"domain_scores_gemma":[0.99740607,0.0010116076,0.00092211977,0.000126585,0.0003096966,0.00022388852],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015207083,0.00039664248,0.00031633102,0.0005378592,0.0004711104,0.0006496506,0.00016791286,0.00035557212,0.0016806921],"category_scores_gemma":[0.0037123992,0.0002913142,0.0003751279,0.00039296187,0.0004423395,0.0005505287,0.0003120905,0.0002923668,0.000650899],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00022892602,0.000056310688,0.99660397,0.000007854085,0.000019391518,0.00012871172,0.000088974564,0.00007337928,0.00066475617,0.000008694294,0.000035666733,0.0020833707],"study_design_scores_gemma":[0.00002230465,0.0018645772,0.9949222,0.000008098186,0.000034337314,0.0011634325,0.00026299816,0.0008011978,0.0006781984,0.000035028086,0.00019739495,0.000010267485],"about_ca_topic_score_codex":0.0030128146,"about_ca_topic_score_gemma":0.0027441345,"teacher_disagreement_score":0.0030128146,"about_ca_system_score_codex":0.0003717758,"about_ca_system_score_gemma":0.00033173247,"threshold_uncertainty_score":0.008042395},"labels":[],"label_agreement":null},{"id":"W4394809659","doi":"10.1111/jvh.13939","title":"An updated assessment of hepatitis delta prevalence among adults in Canada: A meta‐analysis","year":2024,"lang":"en","type":"article","venue":"Journal of Viral Hepatitis","topic":"Hepatitis B Virus Studies","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Toronto Liver Centre; University Health Network","funders":"","keywords":"Medicine; Seroprevalence; Demography; Hepatitis D virus; Meta-analysis; HBsAg; Hepatitis D; Prevalence; Epidemiology; Hepatitis B virus; Virology; Internal medicine; Immunology; Virus; Serology","score_opus":0.019207641634244713,"score_gpt":0.31201870455119124,"score_spread":0.29281106291694653,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4394809659","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.019042486,0.9685624,0.0012936628,0.0005504063,0.00036104428,0.00043230777,0.008536685,0.00008068343,0.0011403064],"genre_scores_gemma":[0.4519291,0.52906585,0.0051905494,0.00215103,0.00041040246,0.0012970471,0.008561349,0.00009700607,0.001297657],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9947461,0.0017853276,0.0012730815,0.00081844494,0.0010093977,0.00036762506],"domain_scores_gemma":[0.9920471,0.0036869948,0.0010809214,0.00049125974,0.0024466945,0.00024706023],"candidate_categories":["metaepi_broad"],"consensus_categories":[],"category_scores_codex":[0.0085296,0.0022136907,0.0105472645,0.005433464,0.0011711835,0.003105893,0.001852174,0.0015545357,0.003527821],"category_scores_gemma":[0.020455359,0.0011932191,0.03592798,0.007986246,0.0005224703,0.0009876179,0.0012222024,0.0018793894,0.00029106188],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0037172374,0.000035222583,0.027848763,0.10325358,0.84072536,0.00021369211,0.00009090493,0.0014531479,0.0002503055,0.00021454587,0.003530222,0.018667065],"study_design_scores_gemma":[0.0008772442,0.00008064499,0.016709218,0.007887358,0.9709349,0.00011285328,0.000028915618,0.00041423403,0.00008174702,0.00014129347,0.0026959314,0.000035634926],"about_ca_topic_score_codex":0.36459425,"about_ca_topic_score_gemma":0.4942841,"teacher_disagreement_score":0.9894527,"about_ca_system_score_codex":0.008468906,"about_ca_system_score_gemma":0.012284356,"threshold_uncertainty_score":0.7249441},"labels":[],"label_agreement":null},{"id":"W4398166628","doi":"10.1111/jvh.13954","title":"Epidemiology, linkage to care and natural history of women of childbearing age with chronic hepatitis B: A population‐based study","year":2024,"lang":"en","type":"article","venue":"Journal of Viral Hepatitis","topic":"Hepatitis B Virus Studies","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Calgary","funders":"Gilead Sciences","keywords":"Medicine; Epidemiology; Poisson regression; Incidence (geometry); Population; Hepatitis B; Pregnancy; Rochester Epidemiology Project; Logistic regression; Psychological intervention; Demography; Obstetrics; Pediatrics; Internal medicine; Environmental health; Population based study","score_opus":0.01966700906849523,"score_gpt":0.298766914491631,"score_spread":0.2790999054231358,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4398166628","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99625814,0.00074173766,0.000095032236,0.00010130958,0.000005848775,0.00005257536,0.0021805705,0.0000065207178,0.0005582825],"genre_scores_gemma":[0.9976318,0.000582902,0.00013083614,0.000058739308,0.000011060835,0.000033399585,0.0013701328,0.000002216995,0.00017892425],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99930847,0.0000972554,0.00005270607,0.00013480624,0.0002406137,0.00016620269],"domain_scores_gemma":[0.9986186,0.000115534385,0.0006041267,0.00007990692,0.000286111,0.0002957387],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006995015,0.00032093926,0.00033069865,0.0016014491,0.00094150344,0.000872943,0.0010733384,0.0005120658,0.0009695551],"category_scores_gemma":[0.0019475392,0.00045798993,0.00053470634,0.004021586,0.0005023044,0.0003940999,0.0006447392,0.00057807105,0.0001557952],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00001863562,0.000013591657,0.9992168,0.000008177014,0.000026258615,0.000024629204,0.00007754496,0.000023264174,0.000030623403,0.000008745758,0.0001072639,0.0004443644],"study_design_scores_gemma":[0.000003776554,0.00001896937,0.99950576,0.000010481537,0.000014642159,0.000051029205,0.0001718982,0.000089209214,0.0000065555955,0.0000052104065,0.000120051445,0.0000023072514],"about_ca_topic_score_codex":0.7704477,"about_ca_topic_score_gemma":0.74753195,"teacher_disagreement_score":0.7704477,"about_ca_system_score_codex":0.0050670896,"about_ca_system_score_gemma":0.0045382036,"threshold_uncertainty_score":0.46180838},"labels":[],"label_agreement":null},{"id":"W4398783669","doi":"10.1111/jvh.13961","title":"Factors affecting quality of life in hepatitis B patients in Herat, Afghanistan: A case–control study","year":2024,"lang":"en","type":"article","venue":"Journal of Viral Hepatitis","topic":"Hepatitis B Virus Studies","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Psychological intervention; Medicine; Demography; Hepatitis B; Residence; Logistic regression; Quality of life (healthcare); Family history; Environmental health; Hepatitis C; Gerontology; Multivariate analysis; Immunology; Internal medicine; Psychiatry","score_opus":0.037325076563529784,"score_gpt":0.3380228199455912,"score_spread":0.3006977433820614,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4398783669","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.999338,0.00020420892,0.0000514183,0.000038341772,0.000005574363,0.00004206829,0.0001090222,0.0000019293054,0.00020943434],"genre_scores_gemma":[0.99935347,0.00014906802,0.000080134516,0.000039763432,0.000017787277,0.000060980623,0.00017784536,0.0000012136308,0.000119857905],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990902,0.00030092118,0.00008367747,0.00019053034,0.00014458114,0.00019005289],"domain_scores_gemma":[0.99906725,0.00026145307,0.00028008598,0.00009159495,0.00014253822,0.00015700751],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009778735,0.00067545846,0.0006284557,0.0017166336,0.0015133375,0.00089274487,0.00058883487,0.00087145163,0.0016754383],"category_scores_gemma":[0.0018917558,0.00059099,0.00056642067,0.0020399564,0.000688778,0.00064052205,0.00052036846,0.0006635921,0.00022421169],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00045543708,0.00083055353,0.9953479,0.00003176899,0.00011906937,0.0005679629,0.00055705506,0.00003153878,0.00026073822,0.00003490212,0.00017807682,0.0015849284],"study_design_scores_gemma":[0.00015437789,0.0007730682,0.9962314,0.000016391485,0.00009928594,0.000927681,0.0011346074,0.00024256682,0.000053069987,0.000030706444,0.0003244405,0.0000123686],"about_ca_topic_score_codex":0.018829672,"about_ca_topic_score_gemma":0.015554969,"teacher_disagreement_score":0.018829672,"about_ca_system_score_codex":0.0010478193,"about_ca_system_score_gemma":0.00055624155,"threshold_uncertainty_score":0.03744012},"labels":[],"label_agreement":null},{"id":"W4399977267","doi":"10.1111/jvh.13980","title":"Impact of <scp>COVID</scp>‐19 pandemic on hepatocellular carcinoma surveillance in British Columbia, Canada: An interrupted time series study","year":2024,"lang":"en","type":"article","venue":"Journal of Viral Hepatitis","topic":"COVID-19 and healthcare impacts","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"St. Paul's Hospital; BC Centre for Disease Control; University of British Columbia","funders":"BC Cancer Agency; British Columbia Centre for Disease Control; Ministry of Health, British Columbia","keywords":"Hepatocellular carcinoma; Medicine; Pandemic; Cirrhosis; Cohort; Confidence interval; Internal medicine; Demography; Hepatitis C; Coronavirus disease 2019 (COVID-19); Cohort study; Infectious disease (medical specialty); Disease","score_opus":0.0325084989666425,"score_gpt":0.3319542213789906,"score_spread":0.2994457224123481,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399977267","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9882699,0.0010003822,0.00051334215,0.00069151394,0.000028083126,0.000041384967,0.008321927,0.000023712546,0.001109741],"genre_scores_gemma":[0.9932522,0.000516959,0.00034304356,0.00015205042,0.00001810586,0.00003139806,0.0050642616,0.000009217852,0.0006127754],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981731,0.00045598295,0.0001754908,0.00027983348,0.00042825117,0.0004873364],"domain_scores_gemma":[0.9935456,0.0012709881,0.0018526033,0.0005383527,0.0019356749,0.0008567605],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0025393434,0.00043263167,0.00067510805,0.0009459133,0.0007675085,0.0014215918,0.0012426913,0.00058242155,0.0016462432],"category_scores_gemma":[0.0081989225,0.000304395,0.00063535594,0.0033429626,0.000692846,0.00032042686,0.0007459049,0.0009875868,0.00017583005],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00035239264,0.000061816354,0.9886671,0.00009133747,0.0003818332,0.00017571589,0.00054441363,0.0027188652,0.0001487706,0.000291773,0.0017747972,0.00479121],"study_design_scores_gemma":[0.000021037564,0.000063439664,0.9893846,0.00008937142,0.00013707923,0.00006495537,0.0006670929,0.00795535,0.00007562485,0.00006770775,0.0014489745,0.000024793248],"about_ca_topic_score_codex":0.9747472,"about_ca_topic_score_gemma":0.94645196,"teacher_disagreement_score":0.025252819,"about_ca_system_score_codex":0.013313681,"about_ca_system_score_gemma":0.0131980395,"threshold_uncertainty_score":0.09659797},"labels":[],"label_agreement":null},{"id":"W4401395414","doi":"10.1111/jvh.13979","title":"Assessment of HBV variants and novel viral and immune biomarkers in chronic hepatitis B patients with metabolic dysfunction associated steatotic liver disease","year":2024,"lang":"en","type":"article","venue":"Journal of Viral Hepatitis","topic":"Liver Disease Diagnosis and Treatment","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Public Health Agency of Canada; University of Lethbridge; University of Alberta; University of Calgary","funders":"GlaxoSmithKline Biologicals; Canadian Institutes of Health Research; Wellcome Trust","keywords":"Medicine; Disease; Viral hepatitis; Immunology; Immune system; Chronic hepatitis; Liver disease; Immune Dysfunction; Liver dysfunction; Hepatitis B; Virology; Internal medicine; Virus","score_opus":0.006639283390826784,"score_gpt":0.24508794603160533,"score_spread":0.23844866264077855,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4401395414","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99934894,0.00020522227,0.000084995656,0.000013276474,0.0000032601463,0.0000066938146,0.00009380396,0.0000022643057,0.00024161523],"genre_scores_gemma":[0.9996929,0.00003041511,0.0000855257,0.00001309156,0.000004474914,0.000004519212,0.00008609313,8.769904e-7,0.000082095044],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99970454,0.0001074909,0.00004975956,0.000055432083,0.000042875545,0.000039795916],"domain_scores_gemma":[0.99930394,0.00013702517,0.00026671213,0.000050866645,0.00010167175,0.0001397872],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006206103,0.000382011,0.0003511695,0.0006142916,0.00038644433,0.0005516383,0.00015686311,0.0004710367,0.0015650681],"category_scores_gemma":[0.0013907884,0.00025437798,0.00022404522,0.0005211947,0.00020986548,0.00044912143,0.00033106076,0.00038676994,0.0003034018],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00036253865,0.00003625006,0.99795425,0.000008119319,0.000020594476,0.00005604981,0.000032264634,0.000020860442,0.00065747043,0.0000070690094,0.00002269949,0.0008217703],"study_design_scores_gemma":[0.000017166465,0.00045683281,0.998216,0.000008454518,0.00002819224,0.00047726146,0.00014056465,0.00028875322,0.0002387845,0.000027266677,0.00009733853,0.0000033517401],"about_ca_topic_score_codex":0.0008841774,"about_ca_topic_score_gemma":0.0010045464,"teacher_disagreement_score":0.0015650681,"about_ca_system_score_codex":0.0001483928,"about_ca_system_score_gemma":0.00011528275,"threshold_uncertainty_score":0.005235672},"labels":[],"label_agreement":null},{"id":"W4401550758","doi":"10.1111/jvh.13995","title":"Mixed‐Genotype <scp>HCV</scp> Direct Acting Antiviral Outcomes: A <scp>CANUHC</scp> Analysis","year":2024,"lang":"en","type":"article","venue":"Journal of Viral Hepatitis","topic":"Hepatitis C virus research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Ottawa; University of Toronto; Dalhousie University; McMaster University; Ottawa Hospital; Vancouver Infectious Diseases Centre; Université Laval; University of Saskatchewan; William Osler Health System; University of Victoria; University of Calgary","funders":"Public Health Agency; Public Health Agency of Canada; Gilead Sciences","keywords":"Genotype; Hepatitis C virus; Medicine; Cohort; Hepatitis C; Virology; Hepacivirus; Antiviral therapy; Internal medicine; Immunology; Virus; Chronic hepatitis; Biology; Gene; Genetics","score_opus":0.03353887622847949,"score_gpt":0.33256066659367933,"score_spread":0.2990217903651998,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4401550758","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9810941,0.0008778025,0.0005615167,0.00013012439,0.000024574783,0.0002728738,0.012969246,0.000018620154,0.004051154],"genre_scores_gemma":[0.9918039,0.00013303632,0.0004168432,0.00005016103,0.000015730462,0.00012683403,0.005972709,0.000015205667,0.0014655624],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998295,0.00025580754,0.000083079605,0.00021576394,0.0006396363,0.0005106718],"domain_scores_gemma":[0.99843496,0.00023939833,0.00033852912,0.00018149489,0.00045218624,0.00035352717],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0021267626,0.00081266277,0.0008353095,0.0013210633,0.0007924025,0.0010484812,0.0009775078,0.00042699804,0.0053486186],"category_scores_gemma":[0.0026771699,0.00025339084,0.0022893928,0.001930069,0.0004418902,0.00037373308,0.00096324034,0.0006471336,0.00028071555],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0060533565,0.000089218025,0.97930896,0.00022333232,0.0040929234,0.00012471911,0.00013678591,0.00044098427,0.0007211084,0.0004313576,0.0026581127,0.0057191285],"study_design_scores_gemma":[0.0003690333,0.0006652848,0.9914778,0.00005292976,0.0021963876,0.00015071615,0.00031359683,0.0019200261,0.00025499376,0.00012098793,0.002455444,0.000022741891],"about_ca_topic_score_codex":0.58728683,"about_ca_topic_score_gemma":0.66886973,"teacher_disagreement_score":0.58728683,"about_ca_system_score_codex":0.0045093605,"about_ca_system_score_gemma":0.0077055036,"threshold_uncertainty_score":0.83028746},"labels":[],"label_agreement":null},{"id":"W4401648035","doi":"10.1111/jvh.13989","title":"Epidemiology, Treatment Patterns and Survival in Canadian Patients With Chronic Hepatitis B‐Related Hepatocellular Carcinoma","year":2024,"lang":"en","type":"article","venue":"Journal of Viral Hepatitis","topic":"Hepatitis B Virus Studies","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Saskatchewan; University of Alberta; University of Manitoba; Ottawa Hospital; McGill University Health Centre; University of Ottawa; Toronto Liver Centre; University of British Columbia; University of Calgary; Western University; University of Toronto; London Health Sciences Centre","funders":"","keywords":"Medicine; Hepatocellular carcinoma; Internal medicine; Cohort; Gastroenterology; Epidemiology; Hepatitis B; Retrospective cohort study; Chronic hepatitis; HBeAg; Cohort study; Liver cancer; Stage (stratigraphy); Hepatitis B virus; Immunology; HBsAg; Virus","score_opus":0.01849142444006027,"score_gpt":0.26855844847251253,"score_spread":0.2500670240324523,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4401648035","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98872656,0.0023110092,0.000082785475,0.0007073927,0.000018496015,0.000028300643,0.0050517074,0.000015005852,0.0030588359],"genre_scores_gemma":[0.9969919,0.000819535,0.00007429434,0.00010081592,0.000010618665,0.000009110491,0.0016866229,0.0000046570144,0.00030244963],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99929214,0.00004526545,0.000046480567,0.000109976434,0.0002646869,0.00024145613],"domain_scores_gemma":[0.99844307,0.00008310754,0.00047110397,0.000047970454,0.0005453739,0.00040938184],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00039964318,0.0002682124,0.0003407089,0.0014924364,0.0017863163,0.00086551456,0.0008128486,0.00049173005,0.0023047216],"category_scores_gemma":[0.0021575144,0.0002741492,0.00058272365,0.0040638936,0.0005418401,0.0003049582,0.00057748845,0.00058561726,0.00019025091],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007965429,0.000015356907,0.9951473,0.00002907988,0.000034907538,0.00007807491,0.00020885262,0.0001051518,0.000093241986,0.00006822686,0.00088772364,0.0032523521],"study_design_scores_gemma":[0.0000076284787,0.000023127208,0.9980552,0.000031618263,0.000020701282,0.00018233321,0.00045668916,0.00024989108,0.000021597385,0.00002646909,0.0009132097,0.000011665747],"about_ca_topic_score_codex":0.97609586,"about_ca_topic_score_gemma":0.9754336,"teacher_disagreement_score":0.023904145,"about_ca_system_score_codex":0.015026219,"about_ca_system_score_gemma":0.016034953,"threshold_uncertainty_score":0.10902333},"labels":[],"label_agreement":null},{"id":"W4403567445","doi":"10.1111/jvh.14023","title":"Community Pop‐Up Clinic: Cascade of Care and <scp>HCV</scp> Treatment of Vancouver's Inner‐City <scp>PWID</scp> Populations","year":2024,"lang":"en","type":"article","venue":"Journal of Viral Hepatitis","topic":"HIV, Drug Use, Sexual Risk","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Simon Fraser University; Vancouver Infectious Diseases Centre","funders":"","keywords":"Medicine; Inner city; Internal medicine","score_opus":0.06191032226575992,"score_gpt":0.36874125980294004,"score_spread":0.3068309375371801,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4403567445","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99847156,0.00009475107,0.00004368376,0.00012158437,0.000004795547,0.00009245188,0.00028900185,0.000003497543,0.00087868876],"genre_scores_gemma":[0.9987985,0.00013006588,0.0001914764,0.00011109465,0.000006453713,0.00005316976,0.0002508681,0.0000019920444,0.00045635892],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99871194,0.00048213187,0.000053996613,0.00014990666,0.00027084237,0.00033109126],"domain_scores_gemma":[0.9978089,0.00023494897,0.000499349,0.00007414221,0.00041910034,0.0009636927],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009201167,0.00025146044,0.00025651365,0.0005578926,0.0015029043,0.0011520683,0.00067783316,0.0003887878,0.0024702062],"category_scores_gemma":[0.0031344795,0.00027187195,0.00030928018,0.0010002552,0.0004169762,0.00038048852,0.0012850967,0.0005291114,0.00024261793],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00029160513,0.0004881457,0.98221016,0.000046222707,0.00005457008,0.0002120738,0.0010544537,0.00024648476,0.00023515434,0.0000444519,0.0006738898,0.014442841],"study_design_scores_gemma":[0.00005798587,0.00050273,0.9956321,0.000035606034,0.00003125443,0.00016646655,0.002290621,0.00059750106,0.00009297531,0.000026060245,0.0005548592,0.000011873608],"about_ca_topic_score_codex":0.62980604,"about_ca_topic_score_gemma":0.7818311,"teacher_disagreement_score":0.37019396,"about_ca_system_score_codex":0.0046573486,"about_ca_system_score_gemma":0.0049569244,"threshold_uncertainty_score":0.74474823},"labels":[],"label_agreement":null},{"id":"W4404593012","doi":"10.1111/jvh.14037","title":"Seroprevalence of Hepatitis C in Ethiopia: First National Study Based on the 2016 Ethiopian Demographic and Health Survey","year":2024,"lang":"en","type":"article","venue":"Journal of Viral Hepatitis","topic":"Hepatitis C virus research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"Mekelle University; Addis Ababa University; University of Gondar; McMaster University; Hebrew University of Jerusalem; Jimma University; University of Bristol; Government of the United Kingdom; Wellcome Trust; National Institute for Health and Care Research; National Institute for Health Research Health Protection Research Unit; University of Dundee","keywords":"Seroprevalence; Demography; Medicine; Population; Public health; Confidence interval; Geography; Environmental health; Serology; Immunology","score_opus":0.07046535734050845,"score_gpt":0.37920812111244123,"score_spread":0.30874276377193277,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404593012","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99154836,0.0017300948,0.00019506436,0.00013889796,0.000025897178,0.000078272096,0.0055810665,0.0000051570096,0.0006971085],"genre_scores_gemma":[0.99113035,0.0026686164,0.00093525444,0.00025165107,0.000027610708,0.00016599636,0.004432042,0.0000052360974,0.0003833177],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9995234,0.00012622957,0.00010099078,0.00009581898,0.000082960956,0.000070564405],"domain_scores_gemma":[0.99920493,0.00010600995,0.00023800477,0.00005173326,0.0002527625,0.00014655638],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001573414,0.00047851048,0.0005227012,0.0012393597,0.0005362332,0.00059478823,0.00035684847,0.0002911454,0.0007671176],"category_scores_gemma":[0.0014778981,0.0006099868,0.00060272537,0.0012724373,0.00021226348,0.0006388175,0.0006080032,0.0004206095,0.00024792095],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011334075,0.000076915116,0.9932545,0.00024917812,0.000109495384,0.00016439478,0.0006087615,0.000060792667,0.0002873468,0.00004327709,0.00089438213,0.0041376813],"study_design_scores_gemma":[0.00001263773,0.00010589437,0.99547285,0.00023802888,0.000103537066,0.0006454965,0.0014618023,0.0001019166,0.00014548526,0.000039052702,0.0016575104,0.000015837786],"about_ca_topic_score_codex":0.012153551,"about_ca_topic_score_gemma":0.015578117,"teacher_disagreement_score":0.012153551,"about_ca_system_score_codex":0.0008376597,"about_ca_system_score_gemma":0.0011814816,"threshold_uncertainty_score":0.02416563},"labels":[],"label_agreement":null},{"id":"W4406219554","doi":"10.1111/jvh.14058","title":"Resistance‐Associated Substitution Testing Trends and Impact on <scp>HCV</scp> Treatment Outcomes in Canada: A <scp>CanHepC</scp>‐<scp>CANUHC</scp> Analysis","year":2025,"lang":"en","type":"article","venue":"Journal of Viral Hepatitis","topic":"Hepatitis C virus research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Ottawa; McMaster University; University Health Network; Dalhousie University; William Osler Health System; University of Victoria; University of Calgary; Ottawa Hospital","funders":"AbbVie; Public Health Agency; Public Health Agency of Canada; Gilead Sciences","keywords":"Substitution (logic); Food science; Computer science; Chemistry","score_opus":0.025118117911860225,"score_gpt":0.32053392030387146,"score_spread":0.2954158023920112,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406219554","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9674231,0.0019713417,0.0002867287,0.0015427069,0.00003994328,0.00012921447,0.023177985,0.000037487218,0.0053915232],"genre_scores_gemma":[0.99076396,0.00079259695,0.00030585093,0.0004345735,0.000014274163,0.000037820228,0.0063879266,0.000027855918,0.0012351397],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99678564,0.0002414063,0.00020455362,0.0004019613,0.0011168008,0.0012496238],"domain_scores_gemma":[0.98949605,0.00053485006,0.0016798064,0.00029845355,0.0059423875,0.0020483786],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018466735,0.00051182986,0.00076559494,0.0020987901,0.0026986443,0.0020201644,0.0018467639,0.00072919746,0.0038537467],"category_scores_gemma":[0.006272544,0.0005364195,0.0016099043,0.007978324,0.0010714781,0.0006083104,0.0017029875,0.0014282267,0.00035971895],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002367909,0.00003668792,0.99078006,0.000085176296,0.0001764192,0.00006769598,0.00043214695,0.00030664622,0.00010276045,0.0002510866,0.002682059,0.004842409],"study_design_scores_gemma":[0.000025064981,0.000051556257,0.9960075,0.000081103106,0.0001432401,0.00007005121,0.0010724331,0.00076556957,0.00007148825,0.000045527795,0.001644029,0.000022446686],"about_ca_topic_score_codex":0.9973654,"about_ca_topic_score_gemma":0.9977198,"teacher_disagreement_score":0.061404966,"about_ca_system_score_codex":0.061404966,"about_ca_system_score_gemma":0.08797878,"threshold_uncertainty_score":0.4455263},"labels":[],"label_agreement":null},{"id":"W4406874429","doi":"10.1111/jvh.70004","title":"Association of <scp>MASLD</scp> Phenotypes With Liver Fibrosis in Hepatitis C: The Role of Cardiometabolic Risk Factors","year":2025,"lang":"en","type":"article","venue":"Journal of Viral Hepatitis","topic":"Liver Disease Diagnosis and Treatment","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre; Ottawa Hospital; Queen's University; University of British Columbia; McGill University","funders":"Canadian Institutes of Health Research; Fonds de Recherche du Québec - Santé; Public Health Agency; Public Health Agency of Canada","keywords":"Transient elastography; Medicine; Steatosis; Internal medicine; Fatty liver; Gastroenterology; Overweight; Fibrosis; Odds ratio; Hepatitis C; Liver disease; Confounding; Diabetes mellitus; Confidence interval; Metabolic syndrome; Liver fibrosis; Obesity; Disease; Endocrinology","score_opus":0.004297691688626713,"score_gpt":0.2200469515465357,"score_spread":0.215749259857909,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406874429","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99875295,0.00042102227,0.00019441833,0.00009300632,0.000006035808,0.000006371601,0.00021809523,0.0000046624787,0.0003033172],"genre_scores_gemma":[0.9994006,0.000064602,0.0001666504,0.000022527409,0.000017205863,0.000004787853,0.00023742767,0.0000030752358,0.00008315417],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9994758,0.00022044052,0.00005788334,0.000104746534,0.00007750146,0.00006366651],"domain_scores_gemma":[0.9978237,0.00054364355,0.0009858552,0.0001761452,0.0001416444,0.00032895643],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011082788,0.00042882055,0.00038278478,0.0005321121,0.00034362514,0.0006127067,0.0003338677,0.00059074786,0.0016680873],"category_scores_gemma":[0.0027889488,0.0001981583,0.0006462338,0.00071823545,0.00034642976,0.00037183767,0.00047094334,0.000710236,0.00016653222],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00035179188,0.000022491919,0.99814403,0.000015720198,0.00006716742,0.000056810448,0.000017498309,0.00004736932,0.00028265492,0.000022589364,0.000049867584,0.0009219633],"study_design_scores_gemma":[0.0000064643414,0.00007857019,0.99899143,0.0000060870316,0.000035263944,0.0002777605,0.0000318785,0.00042644117,0.00004516413,0.000040495295,0.000058185346,0.0000020844188],"about_ca_topic_score_codex":0.0033937823,"about_ca_topic_score_gemma":0.0035541418,"teacher_disagreement_score":0.0033937823,"about_ca_system_score_codex":0.00018796725,"about_ca_system_score_gemma":0.00026702316,"threshold_uncertainty_score":0.0067480206},"labels":[],"label_agreement":null},{"id":"W4410403438","doi":"10.1111/jvh.70031","title":"Chronic Hepatitis B Patients Referred for Liver Transplantation After Nucleos(t)ide Analog Cessation","year":2025,"lang":"en","type":"article","venue":"Journal of Viral Hepatitis","topic":"Hepatitis B Virus Studies","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto General Hospital; University of British Columbia; University Health Network","funders":"","keywords":"Medicine; Discontinuation; Internal medicine; Decompensation; Cirrhosis; Liver transplantation; Hepatocellular carcinoma; Ascites; Gastroenterology; Hepatic encephalopathy; Jaundice; Adverse effect; Hepatitis; Referral; Transplantation","score_opus":0.012204622904713502,"score_gpt":0.27926232038915083,"score_spread":0.2670576974844373,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4410403438","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99833184,0.0005168813,0.000056187604,0.00010306854,0.000015684189,0.00001851468,0.000031916083,0.0000055853934,0.00092032127],"genre_scores_gemma":[0.99928015,0.00023074856,0.000032601845,0.00019726226,0.000055738732,0.000008066091,0.00005860357,0.0000020031691,0.00013478378],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9995308,0.000105021376,0.000059025253,0.000057354107,0.00009661745,0.00015124751],"domain_scores_gemma":[0.99857855,0.00032736908,0.00057681475,0.000043150845,0.00008803964,0.00038595215],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003344287,0.00017370506,0.000474066,0.0006437672,0.0014090174,0.00069066486,0.0002179846,0.0007069032,0.0016762718],"category_scores_gemma":[0.0013663528,0.0001853572,0.00045825588,0.00071594137,0.00041473084,0.0003771497,0.00038877185,0.00072230893,0.00029338236],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012850492,0.000078075864,0.9871034,0.000016400776,0.0000132090445,0.00915254,0.00032923056,0.000020219853,0.00037118886,0.000018504048,0.00014574561,0.0026228782],"study_design_scores_gemma":[0.00003248778,0.0008900782,0.9523664,0.000053878684,0.000044702705,0.043631095,0.0015637702,0.00016218305,0.00024954908,0.000089170775,0.0009013899,0.000015288062],"about_ca_topic_score_codex":0.0023024268,"about_ca_topic_score_gemma":0.002977012,"teacher_disagreement_score":0.0023024268,"about_ca_system_score_codex":0.00038467968,"about_ca_system_score_gemma":0.00047010375,"threshold_uncertainty_score":0.0056076646},"labels":[],"label_agreement":null},{"id":"W4412522284","doi":"10.1111/jvh.70057","title":"<scp>CHIME</scp> : Sofosbuvir/Velpatasvir (S/V) for the Treatment of <scp>HCV</scp> Infection Among Vulnerable Inner‐City Residents","year":2025,"lang":"en","type":"article","venue":"Journal of Viral Hepatitis","topic":"Hepatitis C virus research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver Infectious Diseases Centre; Simon Fraser University","funders":"Gilead Sciences","keywords":"Medicine; Context (archaeology); Sofosbuvir; Internal medicine; Outreach; Hepatitis C; Pill; Clinical trial; Family medicine; Immunology; Hepatitis C virus; Ribavirin; Pharmacology","score_opus":0.02751808271297786,"score_gpt":0.33581268234618883,"score_spread":0.308294599633211,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412522284","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99891007,0.00015391772,0.00006585386,0.000031687923,0.000002468417,0.00013516333,0.00026507414,0.0000044508565,0.00043129988],"genre_scores_gemma":[0.998195,0.00021672701,0.00026845522,0.00012729515,0.00001395882,0.00015867507,0.00046408284,0.0000021734672,0.0005536245],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99984336,0.000053398704,0.0000145093145,0.000026277057,0.000027253864,0.000035133427],"domain_scores_gemma":[0.9997904,0.000028778748,0.00008024382,0.00000941698,0.000015718972,0.00007554805],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003076366,0.00016916009,0.0001947138,0.00031635576,0.00051964005,0.0002659322,0.00017106057,0.00017233954,0.0020087117],"category_scores_gemma":[0.00043366104,0.000081450795,0.00018635349,0.00027848914,0.00022662812,0.00011861536,0.00034091115,0.00015076624,0.00042862704],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0020924176,0.0008773159,0.9463048,0.00040480358,0.00006649163,0.001294059,0.0010953582,0.00009388168,0.005979375,0.00010309175,0.0019740604,0.03971425],"study_design_scores_gemma":[0.00010445286,0.0019005028,0.9920535,0.00006897871,0.000039408726,0.001671504,0.0005116078,0.00018710489,0.0008950706,0.000037213424,0.0025222911,0.000008413952],"about_ca_topic_score_codex":0.0041358415,"about_ca_topic_score_gemma":0.008296991,"teacher_disagreement_score":0.0041358415,"about_ca_system_score_codex":0.00024985516,"about_ca_system_score_gemma":0.0005316629,"threshold_uncertainty_score":0.008223534},"labels":[],"label_agreement":null},{"id":"W4413114408","doi":"10.1111/jvh.70062","title":"Treatment Discontinuation and Adherence in Patients With Chronic Hepatitis B Infection Newly Initiating Nucleos(t)ide Analogues in Japan: A Retrospective Cohort Study","year":2025,"lang":"en","type":"article","venue":"Journal of Viral Hepatitis","topic":"Hepatitis B Virus Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Impact","funders":"GlaxoSmithKline","keywords":"Discontinuation; Medicine; Internal medicine; Retrospective cohort study; Entecavir; Cohort; Chronic hepatitis; Hepatitis C; Tenofovir alafenamide; Pediatrics; Viral load; Human immunodeficiency virus (HIV); Immunology; Virus; Antiretroviral therapy","score_opus":0.009536338422640227,"score_gpt":0.27596850002608514,"score_spread":0.2664321616034449,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4413114408","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9993962,0.00019785343,0.00003905313,0.000015486661,0.0000034399727,0.0000139622825,0.00021756988,0.0000011101471,0.000115296876],"genre_scores_gemma":[0.9992379,0.0001623862,0.00006017517,0.000032526215,0.000009839247,0.000022611206,0.00040836932,0.0000016365232,0.00006451705],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99902,0.0001790926,0.00018169964,0.0002745889,0.00018104304,0.00016363303],"domain_scores_gemma":[0.9979206,0.00018551592,0.0010707465,0.00024777494,0.00025445197,0.00032091164],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001115221,0.0003555208,0.00068174105,0.0009650688,0.0008840026,0.0008530482,0.00050939724,0.0005615598,0.00060556264],"category_scores_gemma":[0.0020595335,0.00064646604,0.0010002552,0.0017765793,0.00030031215,0.00067573984,0.00063788117,0.00069675874,0.000117651995],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000052425003,0.000019959922,0.99942315,0.00000575902,0.00004388556,0.000043657183,0.000073998395,0.0000084630965,0.00003646939,0.0000028939235,0.000028585298,0.0002608037],"study_design_scores_gemma":[0.0000083563355,0.00006683433,0.999265,0.0000060651287,0.000050242932,0.00017758066,0.00018982962,0.00011600754,0.000013520019,0.000004547066,0.00009773865,0.000004350011],"about_ca_topic_score_codex":0.018659139,"about_ca_topic_score_gemma":0.017730983,"teacher_disagreement_score":0.018659139,"about_ca_system_score_codex":0.0005756678,"about_ca_system_score_gemma":0.0006169757,"threshold_uncertainty_score":0.03710109},"labels":[],"label_agreement":null},{"id":"W4413696125","doi":"10.1111/jvh.70064","title":"Global Systematic Review of the Measurement of Stigma Associated With People Living With Hepatitis B or Hepatitis C Viruses","year":2025,"lang":"en","type":"review","venue":"Journal of Viral Hepatitis","topic":"Hepatitis C virus research","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Stigma (botany); Psychosocial; Shame; Psychological intervention; Blame; PsycINFO; Social stigma; Hepatitis C; Medicine; Psychology; Clinical psychology; MEDLINE; Psychiatry; Family medicine; Social psychology; Political science; Human immunodeficiency virus (HIV)","score_opus":0.05396017689478415,"score_gpt":0.3536008672767428,"score_spread":0.2996406903819586,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4413696125","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0010670931,0.9956103,0.00028190218,0.0005861987,0.00013882841,0.0006751457,0.001132657,0.0000135651435,0.0004943043],"genre_scores_gemma":[0.011750592,0.98398054,0.0010617324,0.0007966297,0.00005837312,0.0015754995,0.0005766206,0.000010744833,0.00018929529],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9823866,0.006500433,0.0070586433,0.00097570545,0.002730719,0.00034783312],"domain_scores_gemma":[0.94343233,0.041144587,0.008542798,0.00094689487,0.005436152,0.0004971901],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.016611738,0.0016861823,0.0077240244,0.01375421,0.000961408,0.0030619213,0.002173314,0.002197736,0.0055321],"category_scores_gemma":[0.08042992,0.0012141035,0.0068672076,0.015039711,0.001515992,0.0028551505,0.002645647,0.0015649564,0.0005058221],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007945775,0.0000063406933,0.00040646977,0.9669221,0.0033475556,0.000074040945,0.00030146298,0.000052769894,0.00009423656,0.00018365655,0.0017537865,0.02677809],"study_design_scores_gemma":[0.0000776751,0.000088531786,0.0028803614,0.9546333,0.024984103,0.00023888677,0.00032329303,0.000030663563,0.00011677695,0.0002799947,0.016323308,0.000023236465],"about_ca_topic_score_codex":0.014896563,"about_ca_topic_score_gemma":0.03935376,"teacher_disagreement_score":0.016611738,"about_ca_system_score_codex":0.0055259042,"about_ca_system_score_gemma":0.02417285,"threshold_uncertainty_score":0.0878523},"labels":[],"label_agreement":null},{"id":"W4413988252","doi":"10.1111/jvh.70066","title":"Early Read‐Time Performance of the <scp>OraQuick HCV</scp> Rapid Antibody Assay for the Exclusion of <scp>HCV</scp> Viremia","year":2025,"lang":"en","type":"article","venue":"Journal of Viral Hepatitis","topic":"Hepatitis C virus research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto General Hospital; Ontario Stroke Network","funders":"National Institute of Diabetes and Digestive and Kidney Diseases","keywords":"Viremia; Medicine; Hepatitis C virus; Hepatitis C; Antibody; Confidence interval; Nat; Virology; Immunology; Whole blood; Internal medicine; Virus","score_opus":0.015128761994287516,"score_gpt":0.30971625933365265,"score_spread":0.2945874973393651,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4413988252","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99350476,0.00042973194,0.0028647566,0.00007440906,0.000032913562,0.00011905716,0.00046202473,0.00012290676,0.0023892708],"genre_scores_gemma":[0.9953892,0.00010987533,0.0030441075,0.00010726662,0.000022833197,0.00007674639,0.0003156511,0.00001671005,0.00091764535],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987293,0.0004841549,0.000108666274,0.00026230927,0.0002802009,0.00013535735],"domain_scores_gemma":[0.996894,0.001036783,0.0010763147,0.00019702896,0.0005877168,0.00020823964],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018248848,0.00059567124,0.00036343586,0.00047905106,0.00026441377,0.0005990326,0.000334533,0.00035770595,0.0017032219],"category_scores_gemma":[0.0039353007,0.0002718188,0.00037712004,0.00025241406,0.00017147211,0.0003668341,0.00030451344,0.000345484,0.00074339856],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0038720302,0.0005939075,0.928406,0.00018843594,0.0001223291,0.00019275378,0.00064179243,0.00036251504,0.021857927,0.00011463297,0.001781516,0.041866183],"study_design_scores_gemma":[0.000045634326,0.0021559491,0.9807413,0.000040502553,0.00006708272,0.0004577007,0.00015167463,0.0019226122,0.013219245,0.000049940816,0.0011220895,0.000026239872],"about_ca_topic_score_codex":0.0030097566,"about_ca_topic_score_gemma":0.005439304,"teacher_disagreement_score":0.0030097566,"about_ca_system_score_codex":0.0002740985,"about_ca_system_score_gemma":0.0003423907,"threshold_uncertainty_score":0.009651005},"labels":[],"label_agreement":null},{"id":"W4414081650","doi":"10.1111/jvh.70070","title":"Prescriber Specialty Involvement in Medicare Patients With Chronic Hepatitis B","year":2025,"lang":"en","type":"article","venue":"Journal of Viral Hepatitis","topic":"Hepatitis B Virus Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"American College of Gastroenterology","keywords":"Specialty; Medical prescription; Chronic hepatitis; Hepatitis B; Workforce; Health care; MEDLINE","score_opus":0.009498336770853247,"score_gpt":0.26167136868471214,"score_spread":0.25217303191385887,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414081650","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9947189,0.0006277182,0.00008734237,0.001176101,0.000025539304,0.000023504785,0.001101164,0.000006850767,0.0022329153],"genre_scores_gemma":[0.9973973,0.00041128098,0.00022032662,0.0008146436,0.000058817368,0.000031100903,0.0006270497,0.000004005585,0.00043544162],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984302,0.000426329,0.00020873804,0.00023202019,0.00045953647,0.0002431581],"domain_scores_gemma":[0.9920229,0.0015174488,0.0047578076,0.00018429961,0.0005068499,0.0010106913],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000950269,0.00014451098,0.00021993829,0.0011038654,0.000897377,0.0008206391,0.00037205624,0.0005539221,0.0049421084],"category_scores_gemma":[0.0094136875,0.0002422975,0.0005780248,0.0015604397,0.00019517551,0.0006841671,0.0010240737,0.0008220326,0.00037996678],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000022624987,0.000039795963,0.99622333,0.000014226761,0.000019216837,0.000066568835,0.0002577086,0.000020692316,0.00003586533,0.000032063836,0.0006066517,0.0026612824],"study_design_scores_gemma":[0.000006086958,0.000031210147,0.99740857,0.00003963377,0.000016445229,0.0003478176,0.0008185735,0.00026947036,0.000026261712,0.000038472408,0.0009932949,0.0000041324515],"about_ca_topic_score_codex":0.037115656,"about_ca_topic_score_gemma":0.05506726,"teacher_disagreement_score":0.037115656,"about_ca_system_score_codex":0.0010905878,"about_ca_system_score_gemma":0.0014777777,"threshold_uncertainty_score":0.07379925},"labels":[],"label_agreement":null},{"id":"W4414081815","doi":"10.1111/jvh.70079","title":"Clinical Impact of Continuation Versus Cessation of Antiviral Therapy in Chronic Hepatitis B: A Modelling Study With Implications for Hepatitis B Cure","year":2025,"lang":"en","type":"article","venue":"Journal of Viral Hepatitis","topic":"Hepatitis B Virus Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Infection and Immunity","funders":"National Institute of Allergy and Infectious Diseases; National Institutes of Health; Massachusetts General Hospital","keywords":"HBsAg; Hepatitis B virus; Hepatitis B; Chronic hepatitis; Antiviral treatment; Cirrhosis; Antiviral therapy; Clinical trial","score_opus":0.06054938451196684,"score_gpt":0.41222115021863814,"score_spread":0.3516717657066713,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414081815","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9933531,0.0008554402,0.0026872146,0.00062178477,0.000024050927,0.00013274529,0.00038155084,0.000024557214,0.001919595],"genre_scores_gemma":[0.99668103,0.00045661302,0.0013409306,0.000095024894,0.000017153168,0.00012153312,0.00018926471,0.0000099502395,0.0010884684],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9983919,0.0012138283,0.000043470165,0.00010199734,0.000059443195,0.00018941665],"domain_scores_gemma":[0.98078144,0.017225614,0.0009158977,0.00026387064,0.00039409107,0.00041899935],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003957939,0.0010931721,0.0014163569,0.00076405646,0.0004424837,0.0014915762,0.001339912,0.0021486518,0.0034922513],"category_scores_gemma":[0.013521535,0.0005770172,0.00325775,0.00074212695,0.0006841192,0.00081516826,0.0008104831,0.0016303929,0.00022245389],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004697866,0.0018515971,0.025702456,0.00028383045,0.0007401365,0.0003568322,0.00020153137,0.95551974,0.0009525562,0.0025397332,0.0005480495,0.006605606],"study_design_scores_gemma":[0.0008559876,0.002809147,0.00994163,0.00008173583,0.00067201175,0.00011462318,0.00022062486,0.98196447,0.0004199521,0.0023708667,0.00048182099,0.000067116816],"about_ca_topic_score_codex":0.031262852,"about_ca_topic_score_gemma":0.015262742,"teacher_disagreement_score":0.031262852,"about_ca_system_score_codex":0.002897307,"about_ca_system_score_gemma":0.0014184193,"threshold_uncertainty_score":0.062161744},"labels":[],"label_agreement":null},{"id":"W4414162671","doi":"10.1111/jvh.70080","title":"Policymaker Perspectives on the Role of Health Systems in Sustainable Hepatitis C Point‐Of‐Care Testing in Australia","year":2025,"lang":"en","type":"article","venue":"Journal of Viral Hepatitis","topic":"Hepatitis C virus research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Jewish General Hospital; McGill University Health Centre; Ottawa Hospital","funders":"Fonds de Recherche du Québec - Santé; National Health and Medical Research Council; Fonds de recherche du Québec; Department of Health, New South Wales Government; Cepheid; AbbVie; Department of Health and Aged Care, Australian Government; Medical Research Future Fund; Gilead Sciences","keywords":"Sustainability; Thematic analysis; Healthcare system; Corporate governance; Health care; Health policy; Public health; Hepatitis C virus","score_opus":0.031101508926970826,"score_gpt":0.365247347827999,"score_spread":0.33414583890102817,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414162671","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.4352516,0.0036732627,0.0032436482,0.49845827,0.0005841045,0.00018757432,0.00003439166,0.000021202137,0.058545977],"genre_scores_gemma":[0.98391354,0.0011080549,0.0007092823,0.011898157,0.00008503212,0.0000594954,0.0000074694335,0.000007411737,0.0022115314],"study_design_codex":"qualitative","study_design_gemma":"qualitative","domain_scores_codex":[0.961217,0.025905816,0.0010586877,0.0013251965,0.0026658168,0.007827451],"domain_scores_gemma":[0.9631698,0.019825116,0.003239561,0.0006026318,0.004504098,0.0086587565],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.038151465,0.00033962118,0.00050956046,0.0017184329,0.014432591,0.017001646,0.0020039473,0.007927716,0.003745675],"category_scores_gemma":[0.036218107,0.00082973036,0.0006754749,0.0014032158,0.02178447,0.010119793,0.01617935,0.009993652,0.00020665898],"study_design_candidate":"qualitative","study_design_consensus":"qualitative","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000053866675,0.00017244702,0.012927539,0.0004862698,0.000036395184,0.0025701898,0.6490608,0.001605746,0.0016901848,0.30777675,0.005621192,0.017998558],"study_design_scores_gemma":[0.000050533698,0.0003402326,0.030449416,0.0013354862,0.000050914547,0.00044296772,0.73205316,0.0039067785,0.00085915555,0.09873012,0.13163164,0.0001495821],"about_ca_topic_score_codex":0.09816948,"about_ca_topic_score_gemma":0.0706468,"teacher_disagreement_score":0.09816948,"about_ca_system_score_codex":0.034006365,"about_ca_system_score_gemma":0.055605892,"threshold_uncertainty_score":0.24673462},"labels":[],"label_agreement":null},{"id":"W4415147410","doi":"10.1111/jvh.70094","title":"Real‐World Study for Mother‐To‐Child Transmission of Hepatitis B in Guangdong Province, 2021–2023","year":2025,"lang":"en","type":"article","venue":"Journal of Viral Hepatitis","topic":"Hepatitis B Virus Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ministry of Education and Child Care","funders":"","keywords":"HBsAg; Transmission (telecommunications); Hepatitis B virus; Pregnancy; Hepatitis B; Logistic regression","score_opus":0.014590684903210945,"score_gpt":0.3174970634064063,"score_spread":0.30290637850319535,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4415147410","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9987306,0.00017607678,0.000044817374,0.000059328886,0.0000036963124,0.000012707971,0.00066811265,0.000001916002,0.00030280868],"genre_scores_gemma":[0.9989856,0.00014227451,0.00007039541,0.000027325146,0.000003582294,0.00001972384,0.00061792834,6.551256e-7,0.00013257017],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9997701,0.000052146414,0.00003367391,0.000048866827,0.00004143953,0.000053653028],"domain_scores_gemma":[0.99938786,0.00007472693,0.00029433085,0.000054925633,0.00006422119,0.0001238921],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005100697,0.00022901576,0.00014923098,0.0005195821,0.00048505364,0.00025897892,0.0001869044,0.00023418381,0.0009064871],"category_scores_gemma":[0.0008281746,0.00021799978,0.000316139,0.0009696554,0.0002409597,0.00026944524,0.0003615237,0.00031045833,0.00011400839],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000017696957,0.0000069249295,0.99907815,0.0000078565945,0.000009894097,0.00006841475,0.000089806505,0.000017824617,0.000104524785,0.000006750394,0.000069041555,0.0005230996],"study_design_scores_gemma":[0.0000017911158,0.000014496276,0.99955386,0.00000365746,0.000004318082,0.00006605235,0.00017987196,0.000051010156,0.000016771404,0.000002973301,0.00010404394,0.0000011294725],"about_ca_topic_score_codex":0.12279681,"about_ca_topic_score_gemma":0.13305351,"teacher_disagreement_score":0.12279681,"about_ca_system_score_codex":0.00093410426,"about_ca_system_score_gemma":0.0010252886,"threshold_uncertainty_score":0.24416411},"labels":[],"label_agreement":null},{"id":"W4415470278","doi":"10.1111/jvh.70098","title":"Hepatitis B Virus ( <scp>HBV</scp> ) Treatment Eligibility in the <scp>UK</scp> : Retrospective Longitudinal Cohort Data to Explore the Impact of Changes in Clinical Guidelines","year":2025,"lang":"en","type":"article","venue":"Journal of Viral Hepatitis","topic":"Hepatitis B Virus Studies","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Infection and Immunity","funders":"University College London Hospitals NHS Foundation Trust; University College London; Department of Health and Social Care; National Institute for Health and Care Research; Francis Crick Institute; Home Instead Charities","keywords":"Medical prescription; Hepatitis B virus; Population; Cohort; Retrospective cohort study; Hepatitis B; Liver disease; Viral load; Chronic hepatitis; Hepatitis C","score_opus":0.16806041236078237,"score_gpt":0.4592097661135547,"score_spread":0.2911493537527723,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4415470278","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99394715,0.000328434,0.00011843079,0.00009834048,0.000009257657,0.000037242313,0.0051160026,0.0000046713103,0.00034047326],"genre_scores_gemma":[0.9935289,0.00027315514,0.000269824,0.00014806725,0.000016562964,0.00006879263,0.005314901,0.0000042829156,0.00037561485],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99722606,0.0008326701,0.00057950313,0.000546281,0.00040672207,0.0004087569],"domain_scores_gemma":[0.9907699,0.0010113048,0.005673149,0.0009963388,0.0007872576,0.00076200115],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0021152655,0.00033423904,0.000529943,0.0011516222,0.00052579655,0.0014345783,0.00062213506,0.0006202053,0.0018926429],"category_scores_gemma":[0.0077336095,0.00066330563,0.0007637456,0.0025994948,0.00050080946,0.00075298786,0.0015786188,0.0008254286,0.0005615834],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006563295,0.000019008963,0.9984124,0.000026700287,0.00007741724,0.00005279004,0.0001737231,0.000043690252,0.00005653421,0.00002049225,0.0003971042,0.0006544632],"study_design_scores_gemma":[0.000008672911,0.00005324392,0.998899,0.00003153461,0.000029681118,0.000114301285,0.00019719773,0.00013364982,0.00003171657,0.0000097011925,0.00048678773,0.0000045223287],"about_ca_topic_score_codex":0.10670803,"about_ca_topic_score_gemma":0.13557884,"teacher_disagreement_score":0.10670803,"about_ca_system_score_codex":0.0013969749,"about_ca_system_score_gemma":0.0011994375,"threshold_uncertainty_score":0.21217382},"labels":[],"label_agreement":null},{"id":"W4416763469","doi":"10.1111/jvh.70109","title":"Pharmacist‐Led Hepatitis C Diagnosis and Rapid Management—In Community ( <scp>PHARM</scp> ‐C): Results From a Phase <scp>IV</scp> Nonblinded Randomised Controlled Trial","year":2025,"lang":"en","type":"article","venue":"Journal of Viral Hepatitis","topic":"Hepatitis C virus research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Maple Leaf Medical Clinic; Toronto Liver Centre; York University","funders":"AbbVie Canada","keywords":"Randomized controlled trial; Hepatitis C virus; Hepatitis C; Standard of care; Hepacivirus; Clinical trial; Phase (matter)","score_opus":0.039812007641403586,"score_gpt":0.36855772658802677,"score_spread":0.3287457189466232,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416763469","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9631256,0.01617876,0.0010649705,0.0021306814,0.000953818,0.009991237,0.0010304451,0.00015568038,0.0053688167],"genre_scores_gemma":[0.983235,0.005564835,0.0028926106,0.0014802088,0.0006203476,0.0043865093,0.00046534618,0.000017663211,0.0013373949],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9975799,0.0017305918,0.00018627362,0.0001911425,0.00015072589,0.00016154804],"domain_scores_gemma":[0.9966028,0.001659505,0.00064918137,0.00017045967,0.00023650727,0.00068151817],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0030782495,0.00056565943,0.0015299611,0.00030875934,0.00039056534,0.0009139534,0.0005287391,0.0018758738,0.007338931],"category_scores_gemma":[0.006771031,0.00031870976,0.0017492832,0.0003485815,0.0006264317,0.0007409842,0.00041353662,0.0018644158,0.00054109306],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.90188795,0.015031457,0.00081957196,0.0040109535,0.0022220137,0.000050650357,0.00014352844,0.0002892163,0.0013017899,0.00020266057,0.0014381357,0.072602145],"study_design_scores_gemma":[0.9494013,0.046534132,0.0022227825,0.00022455753,0.00053679576,0.000023174573,0.000033242424,0.00013643008,0.00014446228,0.00011100142,0.00062118,0.000011007486],"about_ca_topic_score_codex":0.0018795754,"about_ca_topic_score_gemma":0.00428487,"teacher_disagreement_score":0.007338931,"about_ca_system_score_codex":0.00069260213,"about_ca_system_score_gemma":0.0017571109,"threshold_uncertainty_score":0.024551213},"labels":[],"label_agreement":null},{"id":"W4416780202","doi":"10.1111/jvh.70112","title":"Time to Hepatitis C Care Engagement and Treatment Outcomes in Canadian Immigrants Have Markedly Improved Over Three Decades","year":2025,"lang":"en","type":"article","venue":"Journal of Viral Hepatitis","topic":"Hepatitis C virus research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Ottawa; Ottawa Hospital; University of Toronto","funders":"","keywords":"Immigration; Cohort; Hepatitis C; Hepatitis C virus; Specialty; Retrospective cohort study; Medical record; Cohort study","score_opus":0.016583927344971997,"score_gpt":0.3206791233556869,"score_spread":0.3040951960107149,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416780202","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99538547,0.0010810489,0.000046756548,0.0004554306,0.000016197326,0.000010870741,0.0016949385,0.000008477008,0.0013007509],"genre_scores_gemma":[0.9981096,0.00046932598,0.00006233513,0.00009667653,0.000008771747,0.0000060811362,0.0009434786,0.0000026173902,0.0003011469],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99910223,0.000057664274,0.000052224415,0.00011673792,0.0002606695,0.00041047062],"domain_scores_gemma":[0.9977939,0.00010424666,0.0007519008,0.000059782244,0.0007696772,0.0005205341],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008109199,0.00034409622,0.0003585371,0.0011410954,0.0022070622,0.0014232051,0.0008583823,0.0005485597,0.0015178893],"category_scores_gemma":[0.0034068064,0.00019344654,0.00068599364,0.003160066,0.0007367395,0.00045919232,0.0010177734,0.0006946715,0.00014773813],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007455148,0.000017278142,0.9943626,0.000018774,0.00004511963,0.00005946381,0.00052944984,0.000083542196,0.00006715795,0.000060372244,0.00046645448,0.004215243],"study_design_scores_gemma":[0.0000031944955,0.000016353033,0.998563,0.000018505161,0.000015493302,0.000042781598,0.00058013457,0.000095079566,0.000023226767,0.000009190259,0.00062554027,0.0000074717136],"about_ca_topic_score_codex":0.97808456,"about_ca_topic_score_gemma":0.9814088,"teacher_disagreement_score":0.021915436,"about_ca_system_score_codex":0.017602196,"about_ca_system_score_gemma":0.021859087,"threshold_uncertainty_score":0.1277135},"labels":[],"label_agreement":null}]}